<html lang="en" class="pb-page fonts-loaded fonts-loaded" data-request-id="4b70a61e-6af6-4af6-b466-e85ec600292c" style="--article-sticky-top: 82.00019999999999px; --scroll-padding: 163.594px auto auto;"><head data-pb-dropzone="head"><meta name="pbContext" content=";product:product:elsevier\:product\:cell;website:website:cell-site;issue:issue:pii\:S0092867421X00050;ctype:string:Journal Content;journal:journal:cell;pageGroup:string:Article View;page:string:Show Full Text;requestedJournal:journal:cell;wgroup:string:Default Website Group;subPage:string:Full Text;article:article:pii\:S0092867421015610">




<!-- if there is any customization for Responsive Project widget  -->


























    
    







    
            
        



        
                <meta name="robots" content="noarchive,nocache">
            
    






    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=1, user-scalable=1">











        <meta property="og:title" content="Magnesium sensing via LFA-1 regulates CD8+ T&nbsp;cell effector function">
    


        <meta property="og:type" content="Article">
    


        <meta property="og:url" content="https://www.cell.com/cell/abstract/S0092-8674(21)01561-0">
    



        <meta property="og:site_name" content="Cell">
    


        <meta property="og:image" content="https://www.cell.com/cms/asset/40cde963-e19f-439e-b3f0-4e8923936411/fx1.jpg">
    


        <meta property="og:description" content="The T&nbsp;cell co-stimulatory molecule LFA-1 binds extracellular magnesium ions, allowing
it to modulate murine and human CD8+ T&nbsp;cell effector function in response to magnesium
levels during normal responses and in the context of immunotherapy.">
    











        <meta name="twitter:title" content="Magnesium sensing via LFA-1 regulates CD8+ T&nbsp;cell effector function">
    




        <meta name="twitter:image" content="https://www.cell.com/cms/asset/40cde963-e19f-439e-b3f0-4e8923936411/fx1.jpg">
    


        <meta name="twitter:description" content="The T&nbsp;cell co-stimulatory molecule LFA-1 binds extracellular magnesium ions, allowing
it to modulate murine and human CD8+ T&nbsp;cell effector function in response to magnesium
levels during normal responses and in the context of immunotherapy.">
    

        <meta name="twitter:card" content="summary_large_image">
    











    
    
            
            
        <link rel="canonical" href="https://www.cell.com/cell/fulltext/S0092-8674(21)01561-0">
    


<meta name="tdm-reservation" content="1">
<meta name="tdm-policy" content="https://www.elsevier.com/tdm/tdmrep-policy.json">

<title>Magnesium sensing via LFA-1 regulates CD8+ T&nbsp;cell effector function: Cell</title><meta name="citation_journal_title" content="Cell"> <meta name="citation_journal_abbrev" content="Cell"> <meta name="citation_publisher" content="Elsevier"> <meta name="citation_title" content="Magnesium sensing via LFA-1 regulates CD8+ T&nbsp;cell effector function"> <meta name="citation_date" content="2022/02/17"> <meta name="citation_online_date" content="2022/01/19"> <meta name="citation_volume" content="185"> <meta name="citation_issue" content="4"> <meta name="citation_firstpage" content="585"> <meta name="citation_lastpage" content="602.e29"> <meta name="citation_pmid" content="35051368"> <meta name="citation_abstract_html_url" content="https://www.cell.com/action/showAbstract?pii=S0092867421015610"> <meta name="citation_fulltext_html_url" content="https://www.cell.com/action/showFullText?pii=S0092867421015610"> <meta name="citation_pdf_url" content="https://www.cell.com/action/showPdf?pii=S0092867421015610"> <meta name="citation_issn" content="0092-8674"> <meta name="citation_issn" content="1097-4172"> <meta name="citation_language" content="English"> <meta name="citation_doi" content="10.1016/j.cell.2021.12.039"> <meta name="citation_pmid" content="35051368"> <meta name="citation_author" content="Jonas Lötscher"><meta name="citation_author_institution" content="Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland"><meta name="citation_author" content="Adrià-Arnau Martí i Líndez"><meta name="citation_author_institution" content="Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland"><meta name="citation_author_institution" content="Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland"><meta name="citation_author_institution" content="Department of Medicine, CITIID, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK"><meta name="citation_author" content="Nicole Kirchhammer"><meta name="citation_author_orcid" content="0000-0001-6043-5143"><meta name="citation_author_institution" content="Department of Biomedicine, Cancer Immunology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland"><meta name="citation_author" content="Elisabetta Cribioli"><meta name="citation_author_institution" content="Ludwig Institute for Cancer Research, University of Lausanne, 1066 Epalinges, Switzerland"><meta name="citation_author_institution" content="Department of Oncology, University Hospital of Lausanne, 1011 Lausanne, Switzerland"><meta name="citation_author" content="Greta Maria Paola Giordano Attianese"><meta name="citation_author_institution" content="Ludwig Institute for Cancer Research, University of Lausanne, 1066 Epalinges, Switzerland"><meta name="citation_author_institution" content="Department of Oncology, University Hospital of Lausanne, 1011 Lausanne, Switzerland"><meta name="citation_author" content="Marcel P. Trefny"><meta name="citation_author_orcid" content="0000-0001-6755-7899"><meta name="citation_author_institution" content="Department of Biomedicine, Cancer Immunology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland"><meta name="citation_author" content="Markus Lenz"><meta name="citation_author_orcid" content="0000-0001-6832-3218"><meta name="citation_author_institution" content="University of Applied Science Northwestern Switzerland, Institute for Ecopreneurship, 4132 Muttenz, Switzerland"><meta name="citation_author" content="Sacha I. Rothschild"><meta name="citation_author_institution" content="Division of Medical Oncology and Comprehensive Cancer Center, University Hospital Basel, 4031 Basel, Switzerland"><meta name="citation_author_institution" content="Swiss Group for Clinical Cancer Research, 3008 Bern, Switzerland"><meta name="citation_author" content="Paolo Strati"><meta name="citation_author_institution" content="Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA"><meta name="citation_author" content="Marco Künzli"><meta name="citation_author_institution" content="Department of Biomedicine, Immune Cell Biology, University and University Hospital of Basel, 4031 Basel, Switzerland"><meta name="citation_author" content="Claudia Lotter"><meta name="citation_author_institution" content="Department of Pharmaceutical Sciences, Pharmaceutical Technology, University of Basel, 4056 Basel, Switzerland"><meta name="citation_author" content="Susanne H. Schenk"><meta name="citation_author_institution" content="Department of Pharmaceutical Sciences, Pharmaceutical Technology, University of Basel, 4056 Basel, Switzerland"><meta name="citation_author" content="Philippe Dehio"><meta name="citation_author_orcid" content="0000-0002-9869-2601"><meta name="citation_author_institution" content="Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland"><meta name="citation_author" content="Jordan Löliger"><meta name="citation_author_institution" content="Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland"><meta name="citation_author" content="Ludivine Litzler"><meta name="citation_author_institution" content="Department of Biomedicine, Immune Cell Biology, University and University Hospital of Basel, 4031 Basel, Switzerland"><meta name="citation_author" content="David Schreiner"><meta name="citation_author_institution" content="Department of Biomedicine, Immune Cell Biology, University and University Hospital of Basel, 4031 Basel, Switzerland"><meta name="citation_author" content="Victoria Koch"><meta name="citation_author_orcid" content="0000-0001-9641-3720"><meta name="citation_author_institution" content="Department of Biomedicine, Cancer Immunology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland"><meta name="citation_author" content="Nicolas Page"><meta name="citation_author_institution" content="Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland"><meta name="citation_author" content="Dahye Lee"><meta name="citation_author_orcid" content="0000-0002-6391-5369"><meta name="citation_author_institution" content="Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland"><meta name="citation_author" content="Jasmin Grählert"><meta name="citation_author_institution" content="Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland"><meta name="citation_author" content="Dmitry Kuzmin"><meta name="citation_author_institution" content="Hornet Therapeutics Ltd, London SW1Y 5ES, UK"><meta name="citation_author_institution" content="Department of Medical Oncology, Yale School of Medicine, New Haven, CT 06510, USA"><meta name="citation_author" content="Anne-Valérie Burgener"><meta name="citation_author_institution" content="Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland"><meta name="citation_author" content="Doron Merkler"><meta name="citation_author_institution" content="Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland"><meta name="citation_author" content="Miklos Pless"><meta name="citation_author_institution" content="Swiss Group for Clinical Cancer Research, 3008 Bern, Switzerland"><meta name="citation_author_institution" content="Department of Oncology, Cantonal Hospital Winterthur, 8400 Winterthur, Switzerland"><meta name="citation_author" content="Maria L. Balmer"><meta name="citation_author_institution" content="Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland"><meta name="citation_author_institution" content="Department for Biomedical Research (DBMR), University Clinic for Diabetes, Endocrinology, Clinical Nutrition and Metabolism, Inselspital, University of Bern, 3008 Bern, Switzerland"><meta name="citation_author_institution" content="Diabetes Center Berne (DCB), 3010 Bern, Switzerland"><meta name="citation_author" content="Walter Reith"><meta name="citation_author_institution" content="Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland"><meta name="citation_author" content="Jörg Huwyler"><meta name="citation_author_institution" content="Department of Pharmaceutical Sciences, Pharmaceutical Technology, University of Basel, 4056 Basel, Switzerland"><meta name="citation_author" content="Melita Irving"><meta name="citation_author_orcid" content="0000-0002-6849-7194"><meta name="citation_author_institution" content="Ludwig Institute for Cancer Research, University of Lausanne, 1066 Epalinges, Switzerland"><meta name="citation_author_institution" content="Department of Oncology, University Hospital of Lausanne, 1011 Lausanne, Switzerland"><meta name="citation_author" content="Carolyn G. King"><meta name="citation_author_institution" content="Department of Biomedicine, Immune Cell Biology, University and University Hospital of Basel, 4031 Basel, Switzerland"><meta name="citation_author" content="Alfred Zippelius"><meta name="citation_author_institution" content="Department of Biomedicine, Cancer Immunology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland"><meta name="citation_author_institution" content="Division of Medical Oncology and Comprehensive Cancer Center, University Hospital Basel, 4031 Basel, Switzerland"><meta name="citation_author" content="Christoph Hess"><meta name="citation_author_email" content="chess@uhbs.ch"><meta name="citation_author_institution" content="Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland"><meta name="citation_author_institution" content="Department of Medicine, CITIID, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK"><meta name="citation_keywords" content="immune control; memory CD8 T&nbsp;cells; microenvironment; magnesium; Mg2+; co-stimulation/LFA-1; integration of microenvironment and T&nbsp;cell function; tumor-specific T&nbsp;cells; CAR T&nbsp;cells; T cell engaging antibodies"><meta name="citation_reference" content="citation_title=Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (transcend NHL 001): a multicentre seamless design study; citation_author=J.S. Abramson; citation_author=M.L. Palomba; citation_author=L.I. Gordon; citation_author=M.A. Lunning; citation_author=M. Wang; citation_author=J. Arnason; citation_author=A. Mehta; citation_author=E. Purev; citation_author=D.G. Maloney; citation_author=C. Andreadis; citation_author=et al.; citation_journal_title=Lancet; citation_volume=396; citation_firstpage=839; citation_lastpage=852; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Daily magnesium intake and serum magnesium concentration among Japanese people; citation_author=Y. Akizawa; citation_author=S. Koizumi; citation_author=Y. Itokawa; citation_author=T. Ojima; citation_author=Y. Nakamura; citation_author=T. Tamura; citation_author=Y. Kusaka; citation_journal_title=J.&nbsp;Epidemiol.; citation_volume=18; citation_firstpage=151; citation_lastpage=159; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia; citation_author=L. Angenendt; citation_author=I. Hilgefort; citation_author=J.H. Mikesch; citation_author=B. Schlüter; citation_author=W.E. Berdel; citation_author=G. Lenz; citation_author=M. Stelljes; citation_author=C. Schliemann; citation_journal_title=Ann. Hematol.; citation_volume=100; citation_firstpage=1871; citation_lastpage=1878; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=The spectrum of T&nbsp;cell metabolism in health and disease; citation_author=G.R. Bantug; citation_author=L. Galluzzi; citation_author=G. Kroemer; citation_author=C. Hess; citation_journal_title=Nat. Rev. Immunol.; citation_volume=18; citation_firstpage=19; citation_lastpage=34; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Bistable regulation of integrin adhesiveness by a bipolar metal ion cluster; citation_author=J. Chen; citation_author=A. Salas; citation_author=T.A. Springer; citation_journal_title=Nat. Struct. Biol.; citation_volume=10; citation_firstpage=995; citation_lastpage=1001; citation_publication_date=2003; "><meta name="citation_reference" content="citation_title=Perspective: the case for an evidence-based reference interval for serum magnesium: the time has come; citation_author=R.B. Costello; citation_author=R.J. Elin; citation_author=A. Rosanoff; citation_author=T.C. Wallace; citation_author=F. Guerrero-Romero; citation_author=A. Hruby; citation_author=P.L. Lutsey; citation_author=F.H. Nielsen; citation_author=M. Rodriguez-Moran; citation_author=Y. Song; citation_author=L.V. Van Horn; citation_journal_title=Adv. Nutr.; citation_volume=7; citation_firstpage=977; citation_lastpage=993; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Interpreting magnesium status to enhance clinical care: Key indicators; citation_author=R.B. Costello; citation_author=F. Nielsen; citation_journal_title=Curr. Opin. Clin. Nutr. Metab. Care; citation_volume=20; citation_firstpage=504; citation_lastpage=511; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Open-label, phase 2 study of Blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma; citation_author=L. Coyle; citation_author=N.J. Morley; citation_author=A. Rambaldi; citation_author=K.D. Mason; citation_author=G. Verhoef; citation_author=C.L. Furness; citation_author=A. Zhang; citation_author=A.S. Jung; citation_author=D. Cohan; citation_author=J.L. Franklin; citation_journal_title=Leuk; citation_volume=61; citation_firstpage=2103; citation_lastpage=2112; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Interaction of leukocyte integrins with ligand is necessary but not sufficient for function; citation_author=I. Dransfield; citation_author=C. Cabañas; citation_author=J. Barrett; citation_author=N. Hogg; citation_journal_title=J.&nbsp;Cell Biol.; citation_volume=116; citation_firstpage=1527; citation_lastpage=1535; citation_publication_date=1992; "><meta name="citation_reference" content="citation_title=Divalent cation regulation of the function of the leukocyte integrin LFA-1; citation_author=I. Dransfield; citation_author=C. Cabañas; citation_author=A. Craig; citation_author=N. Hogg; citation_journal_title=J.&nbsp;Cell Biol.; citation_volume=116; citation_firstpage=219; citation_lastpage=226; citation_publication_date=1992; "><meta name="citation_reference" content="citation_title=Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes; citation_author=M.E. Dudley; citation_author=J.R. Wunderlich; citation_author=P.F. Robbins; citation_author=J.C. Yang; citation_author=P. Hwu; citation_author=D.J. Schwartzentruber; citation_author=S.L. Topalian; citation_author=R. Sherry; citation_author=N.P. Restifo; citation_author=A.M. Hubicki; citation_author=et al.; citation_journal_title=Science; citation_volume=298; citation_firstpage=850; citation_lastpage=854; citation_publication_date=2002; "><meta name="citation_reference" content="citation_title=Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T&nbsp;cells; citation_author=M. Enamorado; citation_author=S. Iborra; citation_author=E. Priego; citation_author=F.J. Cueto; citation_author=J.A. Quintana; citation_author=S. Martínez-Cano; citation_author=E. Mejías-Pérez; citation_author=M. Esteban; citation_author=I. Melero; citation_author=A. Hidalgo; citation_author=D. Sancho; citation_journal_title=Nat. Commun.; citation_volume=8; citation_firstpage=16073; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=CD11a/CD18 (LFA-1) integrin engagement enhances biosynthesis of early cytokines by activated T&nbsp;cells. Cell; citation_author=S.T. Fan; citation_author=A.A. Brian; citation_author=B.A. Lollo; citation_author=N. Mackman; citation_author=N.L. Shen; citation_author=T.S. Edgington; citation_journal_title=Immunol; citation_volume=148; citation_firstpage=48; citation_lastpage=59; citation_publication_date=1993; "><meta name="citation_reference" content="citation_title=Neutrophil recruitment limited by high-affinity bent β2 integrin binding ligand in cis; citation_author=Z. Fan; citation_author=S. McArdle; citation_author=A. Marki; citation_author=Z. Mikulski; citation_author=E. Gutierrez; citation_author=B. Engelhardt; citation_author=U. Deutsch; citation_author=M. Ginsberg; citation_author=A. Groisman; citation_author=K. Ley; citation_journal_title=Nat. Commun.; citation_volume=7; citation_firstpage=12658; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Triggered drug release from liposomes: Exploiting the outer and inner tumor environment; citation_author=M.S. Franco; citation_author=E.R. Gomes; citation_author=M.C. Roque; citation_author=M.C. Oliveira; citation_journal_title=Front. Oncol.; citation_volume=11; citation_firstpage=623760; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Blinatumomab for the treatment of adult B-cell acute lymphoblastic leukemia: toward a new era of targeted immunotherapy; citation_author=M.J. Franquiz; citation_author=N.J. Short; citation_journal_title=Biologics; citation_volume=14; citation_firstpage=23; citation_lastpage=34; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=LFA-1 in T&nbsp;cell priming, differentiation, and effector functions; citation_author=A. Gérard; citation_author=A.P. Cope; citation_author=C. Kemper; citation_author=R. Alon; citation_author=R. Köchl; citation_journal_title=Trends Immunol; citation_volume=42; citation_firstpage=706; citation_lastpage=722; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=Lymphocyte function-associated antigen-1-mediated T&nbsp;cell adhesion is impaired by low molecular weight phosphotyrosine phosphatase-dependent inhibition of FAK activity; citation_author=E. Giannoni; citation_author=P. Chiarugi; citation_author=G. Cozzi; citation_author=L. Magnelli; citation_author=M.L. Taddei; citation_author=T. Fiaschi; citation_author=F. Buricchi; citation_author=G. Raugei; citation_author=G. Ramponi; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=278; citation_firstpage=36763; citation_lastpage=36776; citation_publication_date=2003; "><meta name="citation_reference" content="citation_title=Integrins as therapeutic targets; citation_author=S.L. Goodman; citation_author=M. Picard; citation_journal_title=Trends Pharmacol. Sci.; citation_volume=33; citation_firstpage=405; citation_lastpage=412; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Memory CD8+ T&nbsp;cell responses to cancer; citation_author=J. Han; citation_author=N. Khatwani; citation_author=T.G. Searles; citation_author=M.J. Turk; citation_author=C.V. Angeles; citation_journal_title=Semin. Immunol.; citation_volume=49; citation_firstpage=101435; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Molecular insights for optimizing T&nbsp;cell receptor specificity against cancer; citation_author=M. Hebeisen; citation_author=S.G. Oberle; citation_author=D. Presotto; citation_author=D.E. Speiser; citation_author=D. Zehn; citation_author=N. Rufer; citation_journal_title=Front. Immunol.; citation_volume=4; citation_firstpage=154; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=InteractiVenn: A web-based tool for the analysis of sets through Venn diagrams; citation_author=H. Heberle; citation_author=G.V. Meirelles; citation_author=F.R. da Silva; citation_author=G.P. Telles; citation_author=R. Minghim; citation_journal_title=BMC Bioinformatics; citation_volume=16; citation_firstpage=169; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=The insider's guide to leukocyte integrin signalling and function; citation_author=N. Hogg; citation_author=I. Patzak; citation_author=F. Willenbrock; citation_journal_title=Nat. Rev. Immunol.; citation_volume=11; citation_firstpage=416; citation_lastpage=426; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Receptor mediated delivery of daunomycin using immunoliposomes: Pharmacokinetics and tissue distribution in the rat; citation_author=J. Huwyler; citation_author=J. Yang; citation_author=W.M. Pardridge; citation_journal_title=J.&nbsp;Pharmacol. Exp. Ther.; citation_volume=282; citation_firstpage=1541; citation_lastpage=1546; citation_publication_date=1997; "><meta name="citation_reference" content="citation_title=Dietary modifications for enhanced cancer therapy; citation_author=N. Kanarek; citation_author=B. Petrova; citation_author=D.M. Sabatini; citation_journal_title=Nature; citation_volume=579; citation_firstpage=507; citation_lastpage=517; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Mg2+ regulation of kinase signaling and immune function; citation_author=C. Kanellopoulou; citation_author=A.B. George; citation_author=E. Masutani; citation_author=J.L. Cannons; citation_author=J.C. Ravell; citation_author=T.N. Yamamoto; citation_author=M.G. Smelkinson; citation_author=P.D. Jiang; citation_author=M. Matsuda-Lennikov; citation_author=J. Reilley; citation_author=et al.; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=216; citation_firstpage=1828; citation_lastpage=1842; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Phase 1b/2 study of Blinatumomab in Japanese adults with relapsed/refractory acute lymphoblastic leukemia; citation_author=H. Kiyoi; citation_author=J.D. Morris; citation_author=I. Oh; citation_author=Y. Maeda; citation_author=H. Minami; citation_author=T. Miyamoto; citation_author=T. Sakura; citation_author=H. Iida; citation_author=C.A. Tuglus; citation_author=Y. Chen; citation_author=et al.; citation_journal_title=Cancer Sci; citation_volume=111; citation_firstpage=1314; citation_lastpage=1323; citation_publication_date=2020; "><meta name="citation_reference" content="citation_title=Intracellular phospho-protein staining techniques for flow cytometry: Monitoring single cell signaling events; citation_author=P.O. Krutzik; citation_author=G.P. Nolan; citation_journal_title=Cytometry A; citation_volume=55; citation_firstpage=61; citation_lastpage=70; citation_publication_date=2003; "><meta name="citation_reference" content="citation_title=Molecular regulation of the interaction between leukocyte function-associated antigen-1 and soluble ICAM-1 by divalent metal cations; citation_author=M.E. Labadia; citation_author=D.D. Jeanfavre; citation_author=G.O. Caviness; citation_author=M.M. Morelock; citation_journal_title=J.&nbsp;Immunol.; citation_volume=161; citation_firstpage=836; citation_lastpage=842; citation_publication_date=1998; "><meta name="citation_reference" content="citation_title=Cisplatin and hypomagnesemia; citation_author=H. Lajer; citation_author=G. Daugaard; citation_journal_title=Cancer Treat. Rev.; citation_volume=25; citation_firstpage=47; citation_lastpage=58; citation_publication_date=1999; "><meta name="citation_reference" content="citation_title=Dietary magnesium intake and risk of stroke: A meta-analysis of prospective studies; citation_author=S.C. Larsson; citation_author=N. Orsini; citation_author=A. Wolk; citation_journal_title=Am. J. Clin. Nutr.; citation_volume=95; citation_firstpage=362; citation_lastpage=366; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy; citation_author=C. Lee; citation_author=L. Raffaghello; citation_author=S. Brandhorst; citation_author=F.M. Safdie; citation_author=G. Bianchi; citation_author=A. Martin-Montalvo; citation_author=V. Pistoia; citation_author=M. Wei; citation_author=S. Hwang; citation_author=A. Merlino; citation_author=et al.; citation_journal_title=Sci. Transl. Med.; citation_volume=4; citation_firstpage=124ra27; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=LFA-1 regulates CD8+T cell activation via T&nbsp;cell receptor-mediated and LFA-1-mediated ERK1/2 signal pathways; citation_author=D. Li; citation_author=J.J. Molldrem; citation_author=Q. Ma; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=284; citation_firstpage=21001; citation_lastpage=21010; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Hypomagnesemia and survival in patients with ovarian cancer who received chemotherapy with carboplatin; citation_author=W. Liu; citation_author=A. Qdaisat; citation_author=P.T. Soliman; citation_author=L. Ramondetta; citation_author=G. Lopez; citation_author=S. Narayanan; citation_author=S. Zhou; citation_author=L. Cohen; citation_author=E. Bruera; citation_author=S.J. Yeung; citation_journal_title=Oncologist; citation_volume=24; citation_firstpage=e312; citation_lastpage=e317; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial; citation_author=F.L. Locke; citation_author=A. Ghobadi; citation_author=C.A. Jacobson; citation_author=D.B. Miklos; citation_author=L.J. Lekakis; citation_author=O.O. Oluwole; citation_author=Y. Lin; citation_author=I. Braunschweig; citation_author=B.T. Hill; citation_author=J.M. Timmerman; citation_author=et al.; citation_journal_title=Lancet Oncol; citation_volume=20; citation_firstpage=31; citation_lastpage=42; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Sensing between reactions - how the metabolic microenvironment shapes immunity; citation_author=J. Lötscher; citation_author=M.L. Balmer; citation_journal_title=Clin. Exp. Immunol.; citation_volume=197; citation_firstpage=161; citation_lastpage=169; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Serum magnesium levels in the United States, 1971–1974; citation_author=F.W. Lowenstein; citation_author=M.F. Stanton; citation_journal_title=J.&nbsp;Am. Coll. Nutr.; citation_volume=5; citation_firstpage=399; citation_lastpage=414; citation_publication_date=1986; "><meta name="citation_reference" content="citation_title=Measuring integrin conformational change on the cell surface with super-resolution microscopy; citation_author=T.I. Moore; citation_author=J. Aaron; citation_author=T.L. Chew; citation_author=T.A. Springer; citation_journal_title=Cell Rep; citation_volume=22; citation_firstpage=1903; citation_lastpage=1912; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Role of ADMIDAS cation-binding site in ligand recognition by integrin alpha 5 beta 1; citation_author=A.P. Mould; citation_author=S.J. Barton; citation_author=J.A. Askari; citation_author=S.E. Craig; citation_author=M.J. Humphries; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=278; citation_firstpage=51622; citation_lastpage=51629; citation_publication_date=2003; "><meta name="citation_reference" content="citation_title=Nanodrug delivery: Is the enhanced permeability and retention effect sufficient for curing cancer?; citation_author=Y. Nakamura; citation_author=A. Mochida; citation_author=P.L. Choyke; citation_author=H. Kobayashi; citation_journal_title=Bioconjug. Chem.; citation_volume=27; citation_firstpage=2225; citation_lastpage=2238; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Magnesium deficiency inhibits primary tumor growth but favors metastasis in mice; citation_author=A. Nasulewicz; citation_author=J. Wietrzyk; citation_author=F.I. Wolf; citation_author=S. Dzimira; citation_author=J. Madej; citation_author=J.A. Maier; citation_author=Y. Rayssiguier; citation_author=A. Mazur; citation_author=A. Opolski; citation_journal_title=Biochim. Biophys. Acta; citation_volume=1739; citation_firstpage=26; citation_lastpage=32; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=Axicabtagene Ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma; citation_author=S.S. Neelapu; citation_author=F.L. Locke; citation_author=N.L. Bartlett; citation_author=L.J. Lekakis; citation_author=D.B. Miklos; citation_author=C.A. Jacobson; citation_author=I. Braunschweig; citation_author=O.O. Oluwole; citation_author=T. Siddiqi; citation_author=Y. Lin; citation_author=et al.; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=377; citation_firstpage=2531; citation_lastpage=2544; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Micromolar Ca2+ concentrations are essential for Mg2+-dependent binding of collagen by the integrin alpha 2beta 1 in human platelets; citation_author=D.J. Onley; citation_author=C.G. Knight; citation_author=D.S. Tuckwell; citation_author=M.J. Barnes; citation_author=R.W. Farndale; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=275; citation_firstpage=24560; citation_lastpage=24564; citation_publication_date=2000; "><meta name="citation_reference" content="citation_title=Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management; citation_author=B. Oronsky; citation_author=S. Caroen; citation_author=A. Oronsky; citation_author=V.E. Dobalian; citation_author=N. Oronsky; citation_author=M. Lybeck; citation_author=T.R. Reid; citation_author=C.A. Carter; citation_journal_title=Cancer Chemother. Pharmacol.; citation_volume=80; citation_firstpage=895; citation_lastpage=907; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Magnesium and the risk of cardiovascular events: A meta-analysis of prospective cohort studies; citation_author=X. Qu; citation_author=F. Jin; citation_author=Y. Hao; citation_author=H. Li; citation_author=T. Tang; citation_author=H. Wang; citation_author=W. Yan; citation_author=K. Dai; citation_journal_title=PLoS One; citation_volume=8; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Plasma magnesium is inversely associated with Epstein-Barr virus load in peripheral blood and Burkitt lymphoma in Uganda; citation_author=J. Ravell; citation_author=I. Otim; citation_author=H. Nabalende; citation_author=I.D. Legason; citation_author=S.J. Reynolds; citation_author=M.D. Ogwang; citation_author=C.M. Ndugwa; citation_author=V. Marshall; citation_author=D. Whitby; citation_author=J.J. Goedert; citation_author=et al.; citation_journal_title=Cancer Epidemiol; citation_volume=52; citation_firstpage=70; citation_lastpage=74; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=SAKK 16/14: durvalumab in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small-cell lung cancer-a multicenter single-arm phase II trial; citation_author=S.I. Rothschild; citation_author=A. Zippelius; citation_author=E.I. Eboulet; citation_author=S. Savic Prince; citation_author=D. Betticher; citation_author=A. Bettini; citation_author=M. Früh; citation_author=M. Joerger; citation_author=D. Lardinois; citation_author=H. Gelpke; citation_author=et al.; citation_journal_title=J.&nbsp;Clin. Oncol.; citation_volume=39; citation_firstpage=2872; citation_lastpage=2880; citation_publication_date=2021; "><meta name="citation_reference" content="citation_title=A synaptic basis for paracrine interleukin-2 signaling during homotypic T&nbsp;cell interaction; citation_author=C.A. Sabatos; citation_author=J. Doh; citation_author=S. Chakravarti; citation_author=R.S. Friedman; citation_author=P.G. Pandurangi; citation_author=A.J. Tooley; citation_author=M.F. Krummel; citation_journal_title=Immunity; citation_volume=29; citation_firstpage=238; citation_lastpage=248; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis; citation_author=Y. Sakaguchi; citation_author=N. Fujii; citation_author=T. Shoji; citation_author=T. Hayashi; citation_author=H. Rakugi; citation_author=Y. Isaka; citation_journal_title=Kidney Int; citation_volume=85; citation_firstpage=174; citation_lastpage=181; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Rolling adhesion through an extended conformation of integrin alphaLbeta2 and relation to alpha I and beta I-like domain interaction; citation_author=A. Salas; citation_author=M. Shimaoka; citation_author=A.N. Kogan; citation_author=C. Harwood; citation_author=U.H. von Andrian; citation_author=T.A. Springer; citation_journal_title=Immunity; citation_volume=20; citation_firstpage=393; citation_lastpage=406; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=On the affinity regulation of the metal-ion-dependent adhesion sites in integrins; citation_author=E.S. San Sebastian; citation_author=J.M. Mercero; citation_author=R.H. Stote; citation_author=A. Dejaegere; citation_author=F.P. Cossío; citation_author=X. Lopez; citation_journal_title=J.&nbsp;Am. Chem. Soc.; citation_volume=128; citation_firstpage=3554; citation_lastpage=3563; citation_publication_date=2006; "><meta name="citation_reference" content="citation_title=T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regression; citation_author=S.P. Santoro; citation_author=S. Kim; citation_author=G.T. Motz; citation_author=D. Alatzoglou; citation_author=C. Li; citation_author=M. Irving; citation_author=D.J. Powell; citation_author=G. Coukos; citation_journal_title=Cancer Immunol. Res.; citation_volume=3; citation_firstpage=68; citation_lastpage=84; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Magnesium. An update on physiological, clinical and analytical aspects; citation_author=N.E. Saris; citation_author=E. Mervaala; citation_author=H. Karppanen; citation_author=J.A. Khawaja; citation_author=A. Lewenstam; citation_journal_title=Clin. Chim. Acta; citation_volume=294; citation_firstpage=1; citation_lastpage=26; citation_publication_date=2000; "><meta name="citation_reference" content="citation_title=Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src; citation_author=M.D. Schaller; citation_author=J.D. Hildebrand; citation_author=J.D. Shannon; citation_author=J.W. Fox; citation_author=R.R. Vines; citation_author=J.T. Parsons; citation_journal_title=Mol. Cell. Biol.; citation_volume=14; citation_firstpage=1680; citation_lastpage=1688; citation_publication_date=1994; "><meta name="citation_reference" content="citation_title=Evidence for a TCR affinity threshold delimiting maximal CD8 T&nbsp;cell function; citation_author=D.A. Schmid; citation_author=M.B. Irving; citation_author=V. Posevitz; citation_author=M. Hebeisen; citation_author=A. Posevitz-Fejfar; citation_author=J.C. Sarria; citation_author=R. Gomez-Eerland; citation_author=M. Thome; citation_author=T.N. Schumacher; citation_author=P. Romero; citation_author=et al.; citation_journal_title=J.&nbsp;Immunol.; citation_volume=184; citation_firstpage=4936; citation_lastpage=4946; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis; citation_author=M.B. Schulze; citation_author=M. Schulz; citation_author=C. Heidemann; citation_author=A. Schienkiewitz; citation_author=K. Hoffmann; citation_author=H. Boeing; citation_journal_title=Arch. Intern. Med.; citation_volume=167; citation_firstpage=956; citation_lastpage=965; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Regulation of integrin affinity on cell surfaces; citation_author=T. Schürpf; citation_author=T.A. Springer; citation_journal_title=EMBO J; citation_volume=30; citation_firstpage=4712; citation_lastpage=4727; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Importance of integrin LFA-1 deactivation for the generation of immune responses; citation_author=M. Semmrich; citation_author=A. Smith; citation_author=C. Feterowski; citation_author=S. Beer; citation_author=B. Engelhardt; citation_author=D.H. Busch; citation_author=B. Bartsch; citation_author=M. Laschinger; citation_author=N. Hogg; citation_author=K. Pfeffer; citation_author=B. Holzmann; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=201; citation_firstpage=1987; citation_lastpage=1998; citation_publication_date=2005; "><meta name="citation_reference" content="citation_title=Ligand- and cation-induced structural alterations of the leukocyte integrin LFA-1; citation_author=M. Sen; citation_author=A.C. Koksal; citation_author=K. Yuki; citation_author=J. Wang; citation_author=T.A. Springer; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=293; citation_firstpage=6565; citation_lastpage=6577; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Small molecule integrin antagonists that bind to the β2 subunit I-like domain and activate signals in one direction and block them in the other; citation_author=M. Shimaoka; citation_author=A. Salas; citation_author=W. Yang; citation_author=G. Weitz-Schmidt; citation_author=T.A. Springer; citation_journal_title=Immunity; citation_volume=19; citation_firstpage=391; citation_lastpage=402; citation_publication_date=2003; "><meta name="citation_reference" content="citation_title=Rapid undetectable MRD (uMRD) responses in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) treated with lisocabtagene maraleucel (liso-cel), a CD19-directed CAR T&nbsp;cell product: updated results from transcend CLL 004, a phase 1/2 study including patients with high-risk disease previously treated with ibrutinib; citation_author=T. Siddiqi; citation_author=J.D. Soumerai; citation_author=K.A. Dorritie; citation_author=D.M. Stephens; citation_author=P.A. Riedell; citation_author=J.E. Arnason; citation_author=T.J. Kipps; citation_author=H.H. Gillenwater; citation_author=L. Gong; citation_author=J.A. Dubovsky; citation_journal_title=Blood; citation_volume=134; citation_firstpage=503; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Magnesium supplementation and osteoporosis; citation_author=J.E. Sojka; citation_author=C.M. Weaver; citation_journal_title=Nutr. Rev.; citation_volume=53; citation_firstpage=71; citation_lastpage=74; citation_publication_date=1995; "><meta name="citation_reference" content="citation_title=NY-ESO-1 based immunotherapy of cancer: current perspectives; citation_author=R. Thomas; citation_author=G. Al-Khadairi; citation_author=J. Roelands; citation_author=W. Hendrickx; citation_author=S. Dermime; citation_author=D. Bedognetti; citation_author=J. Decock; citation_journal_title=Front. Immunol.; citation_volume=9; citation_firstpage=947; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Safety and activity of Blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: A multicentre, single-arm, phase 2 study; citation_author=M.S. Topp; citation_author=N. Gökbuget; citation_author=A.S. Stein; citation_author=G. Zugmaier; citation_author=S. O'Brien; citation_author=R.C. Bargou; citation_author=H. Dombret; citation_author=A.K. Fielding; citation_author=L. Heffner; citation_author=R.A. Larson; citation_author=et al.; citation_journal_title=Lancet Oncol; citation_volume=16; citation_firstpage=57; citation_lastpage=66; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Calcium signalling in T&nbsp;cells; citation_author=M. Trebak; citation_author=J.P. Kinet; citation_journal_title=Nat. Rev. Immunol.; citation_volume=19; citation_firstpage=154; citation_lastpage=169; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Distinct roles of beta1 metal ion-dependent adhesion site (MIDAS), adjacent to MIDAS (ADMIDAS), and ligand-associated metal-binding site (LIMBS) cation-binding sites in ligand recognition by integrin alpha2beta1; citation_author=D. Valdramidou; citation_author=M.J. Humphries; citation_author=A.P. Mould; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=283; citation_firstpage=32704; citation_lastpage=32714; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Label-free analysis of CD8+ T&nbsp;cell subset proteomes supports a progressive differentiation model of human-virus-specific T&nbsp;cells; citation_author=M.C. van Aalderen; citation_author=M. van den Biggelaar; citation_author=E.B.M. Remmerswaal; citation_author=F.P.J. van Alphen; citation_author=A.B. Meijer; citation_author=I.J.M. Ten Berge; citation_author=R.A.W. van Lier; citation_journal_title=Cell Rep; citation_volume=19; citation_firstpage=1068; citation_lastpage=1079; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=The connection between metal ion affinity and ligand affinity in integrin I domains; citation_author=T. Vorup-Jensen; citation_author=T.T. Waldron; citation_author=N. Astrof; citation_author=M. Shimaoka; citation_author=T.A. Springer; citation_journal_title=Biochim. Biophys. Acta; citation_volume=1774; citation_firstpage=1148; citation_lastpage=1155; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=LFA-1 affinity regulation is necessary for the activation and proliferation of naive T&nbsp;cells; citation_author=Y. Wang; citation_author=D. Li; citation_author=R. Nurieva; citation_author=J. Yang; citation_author=M. Sen; citation_author=R. Carreño; citation_author=S. Lu; citation_author=B.W. McIntyre; citation_author=J.J. Molldrem; citation_author=G.B. Legge; citation_author=Q. Ma; citation_journal_title=J.&nbsp;Biol. Chem.; citation_volume=284; citation_firstpage=12645; citation_lastpage=12653; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Association between serum magnesium and anemia: China health and nutrition survey; citation_author=Y. Zhan; citation_author=R. Chen; citation_author=W. Zheng; citation_author=C. Guo; citation_author=L. Lu; citation_author=X. Ji; citation_author=Z. Chi; citation_author=J. Yu; citation_journal_title=Biol. Trace Elem. Res.; citation_volume=159; citation_firstpage=39; citation_lastpage=45; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=The regulation of integrin function by divalent cations; citation_author=K. Zhang; citation_author=J. Chen; citation_journal_title=Cell Adh. Migr.; citation_volume=6; citation_firstpage=20; citation_lastpage=29; citation_publication_date=2012; "><meta name="citation_abstract" content="<h2>Summary</h2><p>The relevance of extracellular magnesium in cellular immunity remains largely unknown. Here, we show that the co-stimulatory cell-surface molecule LFA-1 requires magnesium to adopt its active conformation on CD8<sup>+</sup> T&nbsp;cells, thereby augmenting calcium flux, signal transduction, metabolic reprogramming, immune synapse formation, and, as a consequence, specific cytotoxicity. Accordingly, magnesium-sufficiency sensed via LFA-1 translated to the superior performance of pathogen- and tumor-specific T&nbsp;cells, enhanced effectiveness of bi-specific T&nbsp;cell engaging antibodies, and improved CAR T&nbsp;cell function. Clinically, low serum magnesium levels were associated with more rapid disease progression and shorter overall survival in CAR T&nbsp;cell and immune checkpoint antibody-treated patients. LFA-1 thus directly incorporates information on the composition of the microenvironment as a determinant of outside-in signaling activity. These findings conceptually link co-stimulation and nutrient sensing and point to the magnesium-LFA-1 axis as a therapeutically amenable biologic system.</p>"><meta charset="UTF-8"><!--

    Pagebuild admin UI
-->



<script type="text/javascript" src="https://bam.nr-data.net/1/16e2192192?a=916957862&amp;sa=1&amp;v=1177.96a4d39&amp;t=Unnamed%20Transaction&amp;rst=7933&amp;ck=1&amp;ref=https://www.cell.com/cell/fulltext/S0092-8674(21)01561-0&amp;be=3847&amp;fe=7893&amp;dc=7676&amp;af=err,xhr,stn,ins,spa&amp;perf=%7B%22timing%22:%7B%22of%22:1749592583009,%22n%22:0,%22f%22:3253,%22dn%22:3254,%22dne%22:3254,%22c%22:3254,%22s%22:3254,%22ce%22:3254,%22rq%22:3254,%22rp%22:3827,%22rpe%22:4664,%22dl%22:3833,%22di%22:4903,%22ds%22:7676,%22de%22:7687,%22dc%22:7892,%22l%22:7892,%22le%22:7925%7D,%22navigation%22:%7B%7D%7D&amp;jsonp=NREUM.setToken"></script><script src="https://js-agent.newrelic.com/nr-spa-1177.min.js"></script><script type="text/javascript">
    ;window.NREUM||(NREUM={});NREUM.init={privacy:{cookies_enabled:true}};
    window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{c.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(26),c={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(c.console=!0,o.indexOf("dev")!==-1&&(c.dev=!0),o.indexOf("nr_dev")!==-1&&(c.nrDev=!0))}catch(s){}c.nrDev&&i.on("internal-error",function(t){r(t.stack)}),c.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),c.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(c,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,c){try{l?l-=1:o(c||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,s.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:s.now();i("err",[t,n])}var i=t("handle"),a=t(27),c=t("ee"),s=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError",l=0;s.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(13),t(12),"addEventListener"in window&&t(6),s.xhrWrappable&&t(14),d=!0)}c.on("fn-start",function(t,e,n){d&&(l+=1)}),c.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),c.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),c.on("internal-error",function(t){i("ierr",[t,s.now(),!0])})},{}],3:[function(t,e,n){t("loader").features.ins=!0},{}],4:[function(t,e,n){function r(){_++,T=g.hash,this[u]=y.now()}function o(){_--,g.hash!==T&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var c="-start",s="-end",f="-body",u="fn"+c,d="fn"+s,p="cb"+c,l="cb"+s,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable){var x=t(10),b=t(11),E=t(8),R=t(6),O=t(13),N=t(7),M=t(14),P=t(9),S=t("ee"),C=S.get("tracer");t(16),y.features.spa=!0;var T,_=0;S.on(u,r),S.on(p,r),S.on(d,o),S.on(l,o),S.buffer([u,d,"xhr-done","xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+s,"clearTimeout"+c,u]),M.buffer([u,"new-xhr","send-xhr"+c]),N.buffer([m+c,m+"-done",m+f+c,m+f+s]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+c]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(M,"send-xhr"+c),a(S,"xhr-resolved"),a(S,"xhr-done"),a(N,m+c),a(N,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,!0),w[v]("load",i,!0),w[v]("popstate",function(){i(0,_>1)},!0)}},{}],5:[function(t,e,n){function r(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var o=t("ee"),i=t("handle"),a=t(13),c=t(12),s="learResourceTimings",f="addEventListener",u="resourcetimingbufferfull",d="bstResource",p="resource",l="-start",h="-end",m="fn"+l,v="fn"+h,w="bstTimer",g="pushState",y=t("loader");y.features.stn=!0,t(8),"addEventListener"in window&&t(6);var x=NREUM.o.EV;o.on(m,function(t,e){var n=t[0];n instanceof x&&(this.bstStart=y.now())}),o.on(v,function(t,e){var n=t[0];n instanceof x&&i("bst",[n,e,this.bstStart,y.now()])}),a.on(m,function(t,e,n){this.bstStart=y.now(),this.bstType=n}),a.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),this.bstType])}),c.on(m,function(){this.bstStart=y.now()}),c.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),"requestAnimationFrame"])}),o.on(g+l,function(t){this.time=y.now(),this.startPath=location.pathname+location.hash}),o.on(g+h,function(t){i("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),f in window.performance&&(window.performance["c"+s]?window.performance[f](u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["c"+s]()},!1):window.performance[f]("webkit"+u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["webkitC"+s]()},!1)),document[f]("scroll",r,{passive:!0}),document[f]("keypress",r,!1),document[f]("click",r,!1)}},{}],6:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){c.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),c=t("wrap-function")(a,!0),s=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1],r=s(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?c(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],7:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var c=r.apply(this,t);return o.emit(n+"start",[t,a],c),c.then(function(t){return o.emit(n+"end",[null,t],c),t},function(t){throw o.emit(n+"end",[t],c),t})})}var o=t("ee").get("fetch"),i=t(27),a=t(26);e.exports=o;var c=window,s="fetch-",f=s+"body-",u=["arrayBuffer","blob","json","text","formData"],d=c.Request,p=c.Response,l=c.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(c,"fetch",s),o.on(s+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(s+"done",[null,e],n)}else o.emit(s+"done",[t],n)}))},{}],8:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],9:[function(t,e,n){function r(t){function e(){s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}function n(){s.emit("jsonp-error",[],p),s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var u=c(a),d="function"==typeof u.parent[u.key];if(d){var p={};f.inPlace(u.parent,[u.key],"cb-",p),t.addEventListener("load",e,!1),t.addEventListener("error",n,!1),s.emit("new-jsonp",[t.src],p)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(u);return e?e[1]:null}function a(t,e){var n=t.match(p),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function c(t){var e=t.match(d);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var s=t("ee").get("jsonp"),f=t("wrap-function")(s);if(e.exports=s,o()){var u=/[?&](?:callback|cb)=([^&#]+)/,d=/(.*)\.([^.]+)/,p=/^(\w+)(\.|$)(.*)$/,l=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?f.inPlace(Node.prototype,l,"dom-"):(f.inPlace(HTMLElement.prototype,l,"dom-"),f.inPlace(HTMLHeadElement.prototype,l,"dom-"),f.inPlace(HTMLBodyElement.prototype,l,"dom-")),s.on("dom-start",function(t){r(t[0])})}},{}],10:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],11:[function(t,e,n){function r(t){var e=a.context(),n=c(t,"executor-",e),r=new f(n);return a.context(r).getCtx=function(){return e},a.emit("new-promise",[r,e],e),r}function o(t,e){return e}var i=t("wrap-function"),a=t("ee").get("promise"),c=i(a),s=t(26),f=NREUM.o.PR;e.exports=a,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){a.emit("propagate",[null,!o],i),o=o||!t}}var o=!1;s(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var i=e.apply(f,arguments),c=f.resolve(i);return c}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&a.emit("propagate",[t,!0],n),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),s(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),a.on("executor-start",function(t){t[0]=c(t[0],"resolve-",this),t[1]=c(t[1],"resolve-",this)}),a.on("executor-err",function(t,e,n){t[1](n)}),c.inPlace(f.prototype,["then"],"then-",o),a.on("then-start",function(t,e){this.promise=e,t[0]=c(t[0],"cb-",this),t[1]=c(t[1],"cb-",this)}),a.on("then-end",function(t,e,n){this.nextPromise=n;var r=this.promise;a.emit("propagate",[r,!0],n)}),a.on("cb-end",function(t,e,n){a.emit("propagate",[n,!0],this.nextPromise)}),a.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=a.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],12:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],13:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),c="setTimeout",s="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[c,"setImmediate"],c+d),a.inPlace(window,[s],s+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(s+u,r),i.on(c+u,o)},{}],14:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",c)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,g,"fn-",c)}function i(t){y.push(t),h&&(b?b.then(a):v?v(a):(E=-E,R.data=E))}function a(){for(var t=0;t<y.length;t++)r([],y[t]);y.length&&(y=[])}function c(t,e){return e}function s(t,e){for(var n in t)e[n]=t[n];return e}t(6);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=NREUM.o,l=p.XHR,h=p.MO,m=p.PR,v=p.SI,w="readystatechange",g=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],y=[];e.exports=u;var x=window.XMLHttpRequest=function(t){var e=new l(t);try{u.emit("new-xhr",[e],e),e.addEventListener(w,o,!1)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(s(l,x),x.prototype=l.prototype,d.inPlace(x.prototype,["open","send"],"-xhr-",c),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),h){var b=m&&m.resolve();if(!v&&!m){var E=1,R=document.createTextNode(E);new h(a).observe(R,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===w||a()})},{}],15:[function(t,e,n){function r(t){if(!c(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||s(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&s(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",c=1,s="",f="";return o+"@nr="+i+"-"+c+"-"+n+"-"+r+"-"+t+"-"+a+"-"+s+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var c={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(c.d.tk=i),btoa(JSON.stringify(c))}function c(t){return f()&&s(t)}function s(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(23),h=t(17);e.exports={generateTracePayload:r,shouldGenerateTrace:c}},{}],16:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,u.emit("xhr-done",[t],t),c("xhr",[e,n,this.startTime]))}}function o(t,e){var n=s(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=s(e),t.sameOrigin=t.parsedOrigin.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable){var c=t("handle"),s=t(17),f=t(15).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(21),m=t(20),v=t(18),w=window.XMLHttpRequest;a.features.xhr=!0,t(14),t(7),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,t.addEventListener("load",function(n){i(e,t)},!1),h&&(h>34||h<10)||window.opera||t.addEventListener("progress",function(t){e.lastSize=t.loaded},!1)}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var c=0;c<p;c++)e.addEventListener(d[c],this.listener,!1)}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("addEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof w&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url&&(n=t[0].url),n&&(this.parsedOrigin=s(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)})}},{}],17:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,c=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||c),"/"===o.pathname&&(r[t]=o),o}},{}],18:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(20);e.exports=r},{}],19:[function(t,e,n){function r(){}function o(t,e,n){return function(){return i(t,[f.now()].concat(c(arguments)),e?null:this,n),e?void 0:this}}var i=t("handle"),a=t(26),c=t(27),s=t("ee").get("tracer"),f=t("loader"),u=NREUM;"undefined"==typeof window.newrelic&&(newrelic=u);var d=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],p="api-",l=p+"ixn-";a(d,function(t,e){u[e]=o(p+e,!0,"api")}),u.addPageAction=o(p+"addPageAction",!0),u.setCurrentRouteName=o(p+"routeName",!0),e.exports=newrelic,u.interaction=function(){return(new r).get()};var h=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(l+"tracer",[f.now(),t,n],r),function(){if(s.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw s.emit("fn-err",[arguments,this,t],n),t}finally{s.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){h[e]=o(l+e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),i("err",[t,f.now(),!1,e])}},{}],20:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],21:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],22:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?d("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&d("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();n.length>0&&d("lcp",[n[n.length-1]])}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||d("cls",[t])})}function a(t){if(t instanceof h&&!v){var e=Math.round(t.timeStamp),n={type:t.type};e<=p.now()?n.fid=p.now()-e:e>p.offset&&e<=Date.now()?(e-=p.offset,n.fid=p.now()-e):e=p.now(),v=!0,d("timing",["fi",e,n])}}function c(t){d("pageHide",[p.now(),t])}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var s,f,u,d=t("handle"),p=t("loader"),l=t(25),h=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){s=new PerformanceObserver(r);try{s.observe({entryTypes:["paint"]})}catch(m){}f=new PerformanceObserver(o);try{f.observe({entryTypes:["largest-contentful-paint"]})}catch(m){}u=new PerformanceObserver(i);try{u.observe({type:"layout-shift",buffered:!0})}catch(m){}}if("addEventListener"in document){var v=!1,w=["click","keydown","mousedown","pointerdown","touchstart"];w.forEach(function(t){document.addEventListener(t,a,!1)})}l(c)}},{}],23:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",c=0;c<i.length;c++)o=i[c],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(31)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],24:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var c=navigator.userAgent,s=c.match(a);s&&c.indexOf("Chrome")===-1&&c.indexOf("Chromium")===-1&&(o="Safari",i=s[1])}e.exports={agent:o,version:i,match:r}},{}],25:[function(t,e,n){function r(t){function e(){t(a&&document[a]?document[a]:document[o]?"hidden":"visible")}"addEventListener"in document&&i&&document.addEventListener(i,e,!1)}e.exports=r;var o,i,a;"undefined"!=typeof document.hidden?(o="hidden",i="visibilitychange",a="visibilityState"):"undefined"!=typeof document.msHidden?(o="msHidden",i="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(o="webkitHidden",i="webkitvisibilitychange",a="webkitVisibilityState")},{}],26:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],27:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],28:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?s(t,c,i):i()}function n(n,r,o,i){if(!p.aborted||i){t&&t(n,r,o);for(var a=e(o),c=m(n),s=c.length,f=0;f<s;f++)c[f].apply(a,r);var d=u[y[n]];return d&&d.push([x,n,r,a]),a}}function l(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return d[t]=d[t]||o(n)}function w(t,e){f(t,function(t,n){e=e||"feature",y[n]=e,e in u||(u[e]=[])})}var g={},y={},x={on:l,addEventListener:l,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:a,aborted:!1};return x}function i(){return new r}function a(){(u.api||u.feature)&&(p.aborted=!0,u=p.backlog={})}var c="nr@context",s=t("gos"),f=t(26),u={},d={},p=e.exports=o();p.backlog=u},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!E++){var t=b.info=NREUM.info,e=l.getElementsByTagName("script")[0];if(setTimeout(u.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return u.abort();f(y,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+b.offset],null,"api"),s("timing",["load",n]);var r=l.createElement("script");r.src="https://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===l.readyState&&i()}function i(){s("mark",["domContent",a()+b.offset],null,"api")}function a(){return R.exists&&performance.now?Math.round(performance.now()):(c=Math.max((new Date).getTime(),c))-b.offset}var c=(new Date).getTime(),s=t("handle"),f=t(26),u=t("ee"),d=t(24),p=window,l=p.document,h="addEventListener",m="attachEvent",v=p.XMLHttpRequest,w=v&&v.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:v,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var g=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1177.min.js"},x=v&&w&&w[h]&&!/CriOS/.test(navigator.userAgent),b=e.exports={offset:c,now:a,origin:g,features:{},xhrWrappable:x,userAgent:d};t(19),t(22),l[h]?(l[h]("DOMContentLoaded",i,!1),p[h]("load",r,!1)):(l[m]("onreadystatechange",o),p[m]("onload",r)),s("mark",["firstbyte",c],null,"api");var E=0,R=t(28)},{}],"wrap-function":[function(t,e,n){function r(t){return!(t&&t instanceof Function&&t.apply&&!t[a])}var o=t("ee"),i=t(27),a="nr@original",c=Object.prototype.hasOwnProperty,s=!1;e.exports=function(t,e){function n(t,e,n,o){function nrWrapper(){var r,a,c,s;try{a=this,r=i(arguments),c="function"==typeof n?n(r,a):n||{}}catch(f){p([f,"",[r,a,o],c])}u(e+"start",[r,a,o],c);try{return s=t.apply(a,r)}catch(d){throw u(e+"err",[r,a,d],c),d}finally{u(e+"end",[r,a,s],c)}}return r(t)?t:(e||(e=""),nrWrapper[a]=t,d(t,nrWrapper),nrWrapper)}function f(t,e,o,i){o||(o="");var a,c,s,f="-"===o.charAt(0);for(s=0;s<e.length;s++)c=e[s],a=t[c],r(a)||(t[c]=n(a,f?c+o:o,i,c))}function u(n,r,o){if(!s||e){var i=s;s=!0;try{t.emit(n,r,o,e)}catch(a){p([a,n,r,o])}s=i}}function d(t,e){if(Object.defineProperty&&Object.keys)try{var n=Object.keys(t);return n.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(r){p([r])}for(var o in t)c.call(t,o)&&(e[o]=t[o]);return e}function p(e){try{t.emit("internal-error",e)}catch(n){}}return t||(t=o),n.inPlace=f,n.flag=a,n}},{}]},{},["loader",2,16,5,3,4]);
    ;NREUM.loader_config={accountID:"2095297",trustKey:"2038175",agentID:"916957862",licenseKey:"16e2192192",applicationID:"916957862"}
    ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"16e2192192",applicationID:"916957862",sa:1}
</script>
    <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="dada9834-04e2-4bcd-b5ba-cae44d498dfa"></script>
    <script type="text/javascript">
        function getCookie(name) {
            var value = "; " + document.cookie;
            var parts = value.split("; " + name + "=");
            if (parts.length == 2) {
                return true;
            }
        }
            function OptanonWrapper() {
                var optCookie = getCookie("OptanonAlertBoxClosed");
                var isActiveCategory = "false";
                var isFoundCookieBox = "false";
                if(isActiveCategory == 'false' && isFoundCookieBox == 'false' && optCookie) {
                    OneTrust.InsertScript('/pb-assets/adobe/prod/adobedtm-1616606406233.js', 'head', null, null, '2');
                }
            }
    </script>


<noscript>
    <style>.requiresJS {
        display: none
    }

    .dartAd {
        display: block !important
    }</style>
</noscript>
        <script type="text/javascript" src="/wro/o4ny~selected-legacy.js"></script>
        <link rel="stylesheet" type="text/css" href="/wro/o4ny~selected-legacy.css">
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans">
        <script>window.MSInputMethodContext && document.documentMode && document.write('<script src="https://cdn.jsdelivr.net/gh/nuxodin/ie11CustomProperties@4.1.0/ie11CustomProperties.min.js"><\x2fscript>');</script><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/build-b26f3342b722959c7931.css"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/print-b26f3342b722959c7931.css" media="print"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/themes/theme-cell.css">







        
        
        <script class="optanon-category-4" type="text/plain" async="" src="https://www.youtube.com/iframe_api"></script>
        
    





<!---->
<meta http-equiv="X-UA-Compatible" content="IE=edge">












<script src="https://cdn.cookielaw.org/scripttemplates/202411.2.0/otBannerSdk.js" async="" type="text/javascript"></script><style id="onetrust-style">#onetrust-banner-sdk .onetrust-vendors-list-handler{cursor:pointer;color:#1f96db;font-size:inherit;font-weight:bold;text-decoration:none;margin-left:5px}#onetrust-banner-sdk .onetrust-vendors-list-handler:hover{color:#1f96db}#onetrust-banner-sdk:focus{outline:2px solid #000;outline-offset:-2px}#onetrust-banner-sdk a:focus{outline:2px solid #000}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{outline-offset:1px}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{height:64px;width:64px}#onetrust-banner-sdk .ot-tcf2-vendor-count.ot-text-bold{font-weight:bold}#onetrust-banner-sdk .ot-close-icon,#onetrust-pc-sdk .ot-close-icon,#ot-sync-ntfy .ot-close-icon{background-size:contain;background-repeat:no-repeat;background-position:center;height:12px;width:12px}#onetrust-banner-sdk .powered-by-logo,#onetrust-banner-sdk .ot-pc-footer-logo a,#onetrust-pc-sdk .powered-by-logo,#onetrust-pc-sdk .ot-pc-footer-logo a,#ot-sync-ntfy .powered-by-logo,#ot-sync-ntfy .ot-pc-footer-logo a{background-size:contain;background-repeat:no-repeat;background-position:center;height:25px;width:152px;display:block;text-decoration:none;font-size:.75em}#onetrust-banner-sdk .powered-by-logo:hover,#onetrust-banner-sdk .ot-pc-footer-logo a:hover,#onetrust-pc-sdk .powered-by-logo:hover,#onetrust-pc-sdk .ot-pc-footer-logo a:hover,#ot-sync-ntfy .powered-by-logo:hover,#ot-sync-ntfy .ot-pc-footer-logo a:hover{color:#565656}#onetrust-banner-sdk h3 *,#onetrust-banner-sdk h4 *,#onetrust-banner-sdk h6 *,#onetrust-banner-sdk button *,#onetrust-banner-sdk a[data-parent-id] *,#onetrust-pc-sdk h3 *,#onetrust-pc-sdk h4 *,#onetrust-pc-sdk h6 *,#onetrust-pc-sdk button *,#onetrust-pc-sdk a[data-parent-id] *,#ot-sync-ntfy h3 *,#ot-sync-ntfy h4 *,#ot-sync-ntfy h6 *,#ot-sync-ntfy button *,#ot-sync-ntfy a[data-parent-id] *{font-size:inherit;font-weight:inherit;color:inherit}#onetrust-banner-sdk .ot-hide,#onetrust-pc-sdk .ot-hide,#ot-sync-ntfy .ot-hide{display:none !important}#onetrust-banner-sdk button.ot-link-btn:hover,#onetrust-pc-sdk button.ot-link-btn:hover,#ot-sync-ntfy button.ot-link-btn:hover{text-decoration:underline;opacity:1}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-column{padding:0}#onetrust-pc-sdk .ot-sdk-container{padding-right:0}#onetrust-pc-sdk .ot-sdk-row{flex-direction:initial;width:100%}#onetrust-pc-sdk [type=checkbox]:checked,#onetrust-pc-sdk [type=checkbox]:not(:checked){pointer-events:initial}#onetrust-pc-sdk [type=checkbox]:disabled+label::before,#onetrust-pc-sdk [type=checkbox]:disabled+label:after,#onetrust-pc-sdk [type=checkbox]:disabled+label{pointer-events:none;opacity:.8}#onetrust-pc-sdk #vendor-list-content{transform:translate3d(0, 0, 0)}#onetrust-pc-sdk li input[type=checkbox]{z-index:1}#onetrust-pc-sdk li .ot-checkbox label{z-index:2}#onetrust-pc-sdk li .ot-checkbox input[type=checkbox]{height:auto;width:auto}#onetrust-pc-sdk li .host-title a,#onetrust-pc-sdk li .ot-host-name a,#onetrust-pc-sdk li .accordion-text,#onetrust-pc-sdk li .ot-acc-txt{z-index:2;position:relative}#onetrust-pc-sdk input{margin:3px .1ex}#onetrust-pc-sdk .pc-logo,#onetrust-pc-sdk .ot-pc-logo{height:60px;width:180px;background-position:center;background-size:contain;background-repeat:no-repeat;display:inline-flex;justify-content:center;align-items:center}#onetrust-pc-sdk .pc-logo img,#onetrust-pc-sdk .ot-pc-logo img{max-height:100%;max-width:100%}#onetrust-pc-sdk .screen-reader-only,#onetrust-pc-sdk .ot-scrn-rdr,.ot-sdk-cookie-policy .screen-reader-only,.ot-sdk-cookie-policy .ot-scrn-rdr{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#onetrust-pc-sdk.ot-fade-in,.onetrust-pc-dark-filter.ot-fade-in,#onetrust-banner-sdk.ot-fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.ot-hide{display:none !important}.onetrust-pc-dark-filter.ot-hide{display:none !important}#ot-sdk-btn.ot-sdk-show-settings,#ot-sdk-btn.optanon-show-settings{color:#fff;background-color:#468254;height:auto;white-space:normal;word-wrap:break-word;padding:.8em 2em;font-size:.8em;line-height:1.2;cursor:pointer;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease}#ot-sdk-btn.ot-sdk-show-settings:hover,#ot-sdk-btn.optanon-show-settings:hover{color:#fff;background-color:#2c6415}#ot-sdk-btn.ot-sdk-show-settings:active,#ot-sdk-btn.optanon-show-settings:active{color:#fff;background-color:#2c6415;border:1px solid rgba(162,192,169,.5)}.onetrust-pc-dark-filter{background:rgba(0,0,0,.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}.ot-cookie-label{text-decoration:underline}@media only screen and (min-width: 426px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk p{font-size:.75em}}#onetrust-banner-sdk .banner-option-input:focus+label{outline:1px solid #000;outline-style:auto}.category-vendors-list-handler+a:focus,.category-vendors-list-handler+a:focus-visible{outline:2px solid #000}#onetrust-pc-sdk .ot-userid-title{margin-top:10px}#onetrust-pc-sdk .ot-userid-title>span,#onetrust-pc-sdk .ot-userid-timestamp>span{font-weight:700}#onetrust-pc-sdk .ot-userid-desc{font-style:italic}#onetrust-pc-sdk .ot-host-desc a{pointer-events:initial}#onetrust-pc-sdk .ot-ven-hdr>p a{position:relative;z-index:2;pointer-events:initial}#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info a{margin-right:auto}#onetrust-pc-sdk .ot-pc-footer-logo img{width:136px;height:16px}#onetrust-pc-sdk .ot-pur-vdr-count{font-weight:400;font-size:.7rem;padding-top:3px;display:block}#onetrust-banner-sdk .ot-optout-signal,#onetrust-pc-sdk .ot-optout-signal{border:1px solid #32ae88;border-radius:3px;padding:5px;margin-bottom:10px;background-color:#f9fffa;font-size:.85rem;line-height:2}#onetrust-banner-sdk .ot-optout-signal .ot-optout-icon,#onetrust-pc-sdk .ot-optout-signal .ot-optout-icon{display:inline;margin-right:5px}#onetrust-banner-sdk .ot-optout-signal svg,#onetrust-pc-sdk .ot-optout-signal svg{height:20px;width:30px;transform:scale(0.5)}#onetrust-banner-sdk .ot-optout-signal svg path,#onetrust-pc-sdk .ot-optout-signal svg path{fill:#32ae88}#onetrust-consent-sdk .ot-general-modal{overflow:hidden;position:fixed;margin:0 auto;top:50%;left:50%;width:40%;padding:1.5rem;max-width:575px;min-width:575px;z-index:2147483647;border-radius:2.5px;transform:translate(-50%, -50%)}#onetrust-consent-sdk .ot-signature-health-group{margin-top:1rem;padding-left:1.25rem;padding-right:1.25rem;margin-bottom:.625rem;width:calc(100% - 2.5rem)}#onetrust-consent-sdk .ot-signature-health-group .ot-signature-health-form{gap:.5rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:70%;gap:.35rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-input{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-consent-sdk .ot-signature-health .ot-signature-subtitle{font-size:1.125rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-group-title{font-size:1.25rem;font-weight:bold}#onetrust-consent-sdk .ot-signature-health,#onetrust-consent-sdk .ot-signature-health-group{display:flex;flex-direction:column;gap:1rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-cont{display:flex;flex-direction:column;gap:.25rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-paragraph,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-paragraph{margin:0;line-height:20px;font-size:max(14px,.875rem)}#onetrust-consent-sdk .ot-signature-health .ot-health-signature-error,#onetrust-consent-sdk .ot-signature-health-group .ot-health-signature-error{color:#4d4d4d;font-size:min(12px,.75rem)}#onetrust-consent-sdk .ot-signature-health .ot-signature-buttons-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-buttons-cont{margin-top:max(.75rem,2%);gap:1rem;display:flex;justify-content:flex-end}#onetrust-consent-sdk .ot-signature-health .ot-signature-button,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button{flex:1;height:auto;color:#fff;cursor:pointer;line-height:1.2;min-width:125px;font-weight:600;font-size:.813em;border-radius:2px;padding:12px 10px;white-space:normal;word-wrap:break-word;word-break:break-word;background-color:#68b631;border:2px solid #68b631}#onetrust-consent-sdk .ot-signature-health .ot-signature-button.reject,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button.reject{background-color:#fff}#onetrust-consent-sdk .ot-input-field-cont{display:flex;flex-direction:column;gap:.5rem}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:65%}#onetrust-consent-sdk .ot-signature-health-form{display:flex;flex-direction:column}#onetrust-consent-sdk .ot-signature-health-form .ot-signature-label{margin-bottom:0;line-height:20px;font-size:max(14px,.875rem)}@media only screen and (max-width: 600px){#onetrust-consent-sdk .ot-general-modal{min-width:100%}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:100%}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:100%}}#onetrust-banner-sdk,#onetrust-pc-sdk,#ot-sdk-cookie-policy,#ot-sync-ntfy{font-size:16px}#onetrust-banner-sdk *,#onetrust-banner-sdk ::after,#onetrust-banner-sdk ::before,#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before,#ot-sdk-cookie-policy *,#ot-sdk-cookie-policy ::after,#ot-sdk-cookie-policy ::before,#ot-sync-ntfy *,#ot-sync-ntfy ::after,#ot-sync-ntfy ::before{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}#onetrust-banner-sdk div,#onetrust-banner-sdk span,#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-banner-sdk p,#onetrust-banner-sdk img,#onetrust-banner-sdk svg,#onetrust-banner-sdk button,#onetrust-banner-sdk section,#onetrust-banner-sdk a,#onetrust-banner-sdk label,#onetrust-banner-sdk input,#onetrust-banner-sdk ul,#onetrust-banner-sdk li,#onetrust-banner-sdk nav,#onetrust-banner-sdk table,#onetrust-banner-sdk thead,#onetrust-banner-sdk tr,#onetrust-banner-sdk td,#onetrust-banner-sdk tbody,#onetrust-banner-sdk .ot-main-content,#onetrust-banner-sdk .ot-toggle,#onetrust-banner-sdk #ot-content,#onetrust-banner-sdk #ot-pc-content,#onetrust-banner-sdk .checkbox,#onetrust-pc-sdk div,#onetrust-pc-sdk span,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#onetrust-pc-sdk p,#onetrust-pc-sdk img,#onetrust-pc-sdk svg,#onetrust-pc-sdk button,#onetrust-pc-sdk section,#onetrust-pc-sdk a,#onetrust-pc-sdk label,#onetrust-pc-sdk input,#onetrust-pc-sdk ul,#onetrust-pc-sdk li,#onetrust-pc-sdk nav,#onetrust-pc-sdk table,#onetrust-pc-sdk thead,#onetrust-pc-sdk tr,#onetrust-pc-sdk td,#onetrust-pc-sdk tbody,#onetrust-pc-sdk .ot-main-content,#onetrust-pc-sdk .ot-toggle,#onetrust-pc-sdk #ot-content,#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk .checkbox,#ot-sdk-cookie-policy div,#ot-sdk-cookie-policy span,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy p,#ot-sdk-cookie-policy img,#ot-sdk-cookie-policy svg,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy section,#ot-sdk-cookie-policy a,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy input,#ot-sdk-cookie-policy ul,#ot-sdk-cookie-policy li,#ot-sdk-cookie-policy nav,#ot-sdk-cookie-policy table,#ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy tr,#ot-sdk-cookie-policy td,#ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy .ot-main-content,#ot-sdk-cookie-policy .ot-toggle,#ot-sdk-cookie-policy #ot-content,#ot-sdk-cookie-policy #ot-pc-content,#ot-sdk-cookie-policy .checkbox,#ot-sync-ntfy div,#ot-sync-ntfy span,#ot-sync-ntfy h1,#ot-sync-ntfy h2,#ot-sync-ntfy h3,#ot-sync-ntfy h4,#ot-sync-ntfy h5,#ot-sync-ntfy h6,#ot-sync-ntfy p,#ot-sync-ntfy img,#ot-sync-ntfy svg,#ot-sync-ntfy button,#ot-sync-ntfy section,#ot-sync-ntfy a,#ot-sync-ntfy label,#ot-sync-ntfy input,#ot-sync-ntfy ul,#ot-sync-ntfy li,#ot-sync-ntfy nav,#ot-sync-ntfy table,#ot-sync-ntfy thead,#ot-sync-ntfy tr,#ot-sync-ntfy td,#ot-sync-ntfy tbody,#ot-sync-ntfy .ot-main-content,#ot-sync-ntfy .ot-toggle,#ot-sync-ntfy #ot-content,#ot-sync-ntfy #ot-pc-content,#ot-sync-ntfy .checkbox{font-family:inherit;font-weight:normal;-webkit-font-smoothing:auto;letter-spacing:normal;line-height:normal;padding:0;margin:0;height:auto;min-height:0;max-height:none;width:auto;min-width:0;max-width:none;border-radius:0;border:none;clear:none;float:none;position:static;bottom:auto;left:auto;right:auto;top:auto;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;white-space:normal;background:none;overflow:visible;vertical-align:baseline;visibility:visible;z-index:auto;box-shadow:none}#onetrust-banner-sdk label:before,#onetrust-banner-sdk label:after,#onetrust-banner-sdk .checkbox:after,#onetrust-banner-sdk .checkbox:before,#onetrust-pc-sdk label:before,#onetrust-pc-sdk label:after,#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before,#ot-sdk-cookie-policy label:before,#ot-sdk-cookie-policy label:after,#ot-sdk-cookie-policy .checkbox:after,#ot-sdk-cookie-policy .checkbox:before,#ot-sync-ntfy label:before,#ot-sync-ntfy label:after,#ot-sync-ntfy .checkbox:after,#ot-sync-ntfy .checkbox:before{content:"";content:none}#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{position:relative;width:100%;max-width:100%;margin:0 auto;padding:0 20px;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{width:100%;float:left;box-sizing:border-box;padding:0;display:initial}@media(min-width: 400px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:90%;padding:0}}@media(min-width: 550px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:100%}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{margin-left:4%}#onetrust-banner-sdk .ot-sdk-column:first-child,#onetrust-banner-sdk .ot-sdk-columns:first-child,#onetrust-pc-sdk .ot-sdk-column:first-child,#onetrust-pc-sdk .ot-sdk-columns:first-child,#ot-sdk-cookie-policy .ot-sdk-column:first-child,#ot-sdk-cookie-policy .ot-sdk-columns:first-child{margin-left:0}#onetrust-banner-sdk .ot-sdk-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-two.ot-sdk-columns{width:13.3333333333%}#onetrust-banner-sdk .ot-sdk-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-three.ot-sdk-columns{width:22%}#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eight.ot-sdk-columns{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-nine.ot-sdk-columns{width:74%}#onetrust-banner-sdk .ot-sdk-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-ten.ot-sdk-columns{width:82.6666666667%}#onetrust-banner-sdk .ot-sdk-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eleven.ot-sdk-columns{width:91.3333333333%}#onetrust-banner-sdk .ot-sdk-twelve.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-twelve.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-twelve.ot-sdk-columns{width:100%;margin-left:0}}#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6{margin-top:0;font-weight:600;font-family:inherit}#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem;line-height:1.2}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem;line-height:1.25}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem;line-height:1.3}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem;line-height:1.35}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem;line-height:1.5}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem;line-height:1.6}@media(min-width: 550px){#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem}}#onetrust-banner-sdk p,#onetrust-pc-sdk p,#ot-sdk-cookie-policy p{margin:0 0 1em 0;font-family:inherit;line-height:normal}#onetrust-banner-sdk a,#onetrust-pc-sdk a,#ot-sdk-cookie-policy a{color:#565656;text-decoration:underline}#onetrust-banner-sdk a:hover,#onetrust-pc-sdk a:hover,#ot-sdk-cookie-policy a:hover{color:#565656;text-decoration:none}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{display:inline-block;height:38px;padding:0 30px;color:#555;text-align:center;font-size:.9em;font-weight:400;line-height:38px;letter-spacing:.01em;text-decoration:none;white-space:nowrap;background-color:rgba(0,0,0,0);border-radius:2px;border:1px solid #bbb;cursor:pointer;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-button:hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#onetrust-pc-sdk .ot-sdk-button:hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#ot-sdk-cookie-policy .ot-sdk-button:hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus{color:#333;border-color:#888;opacity:.9}#onetrust-banner-sdk .ot-sdk-button:focus,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:focus,#onetrust-pc-sdk .ot-sdk-button:focus,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:focus,#ot-sdk-cookie-policy .ot-sdk-button:focus,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:focus{outline:2px solid #000}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-banner-sdk button.ot-sdk-button-primary,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-pc-sdk button.ot-sdk-button-primary,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary,#ot-sdk-cookie-policy button.ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary{color:#fff;background-color:#33c3f0;border-color:#33c3f0}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-banner-sdk button.ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-banner-sdk button.ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:focus,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-pc-sdk button.ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-pc-sdk button.ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:focus{color:#fff;background-color:#1eaedb;border-color:#1eaedb}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{-webkit-appearance:none;-moz-appearance:none;appearance:none}#onetrust-banner-sdk input[type=text]:focus,#onetrust-pc-sdk input[type=text]:focus,#ot-sdk-cookie-policy input[type=text]:focus{border:1px solid #000;outline:0}#onetrust-banner-sdk label,#onetrust-pc-sdk label,#ot-sdk-cookie-policy label{display:block;margin-bottom:.5rem;font-weight:600}#onetrust-banner-sdk input[type=checkbox],#onetrust-pc-sdk input[type=checkbox],#ot-sdk-cookie-policy input[type=checkbox]{display:inline}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{list-style:circle inside}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{padding-left:0;margin-top:0}#onetrust-banner-sdk ul ul,#onetrust-pc-sdk ul ul,#ot-sdk-cookie-policy ul ul{margin:1.5rem 0 1.5rem 3rem;font-size:90%}#onetrust-banner-sdk li,#onetrust-pc-sdk li,#ot-sdk-cookie-policy li{margin-bottom:1rem}#onetrust-banner-sdk th,#onetrust-banner-sdk td,#onetrust-pc-sdk th,#onetrust-pc-sdk td,#ot-sdk-cookie-policy th,#ot-sdk-cookie-policy td{padding:12px 15px;text-align:left;border-bottom:1px solid #e1e1e1}#onetrust-banner-sdk button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-container:after,#onetrust-banner-sdk .ot-sdk-row:after,#onetrust-pc-sdk .ot-sdk-container:after,#onetrust-pc-sdk .ot-sdk-row:after,#ot-sdk-cookie-policy .ot-sdk-container:after,#ot-sdk-cookie-policy .ot-sdk-row:after{content:"";display:table;clear:both}#onetrust-banner-sdk .ot-sdk-row,#onetrust-pc-sdk .ot-sdk-row,#ot-sdk-cookie-policy .ot-sdk-row{margin:0;max-width:none;display:block}#onetrust-banner-sdk{box-shadow:0 0 18px rgba(0,0,0,.2)}#onetrust-banner-sdk.otFlat{position:fixed;z-index:2147483645;bottom:0;right:0;left:0;background-color:#fff;max-height:90%;overflow-x:hidden;overflow-y:auto}#onetrust-banner-sdk.otFlat.top{top:0px;bottom:auto}#onetrust-banner-sdk.otRelFont{font-size:1rem}#onetrust-banner-sdk>.ot-sdk-container{overflow:hidden}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-banner-sdk{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-banner-sdk #onetrust-policy{margin:1.25em 0 .625em 2em;overflow:hidden}#onetrust-banner-sdk #onetrust-policy .ot-gv-list-handler{float:left;font-size:.82em;padding:0;margin-bottom:0;border:0;line-height:normal;height:auto;width:auto}#onetrust-banner-sdk #onetrust-policy-title{font-size:1.2em;line-height:1.3;margin-bottom:10px}#onetrust-banner-sdk #onetrust-policy-text{clear:both;text-align:left;font-size:.88em;line-height:1.4}#onetrust-banner-sdk #onetrust-policy-text *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk #onetrust-policy-text a{font-weight:bold;margin-left:5px}#onetrust-banner-sdk #onetrust-policy-title,#onetrust-banner-sdk #onetrust-policy-text{color:dimgray;float:left}#onetrust-banner-sdk #onetrust-button-group-parent{min-height:1px;text-align:center}#onetrust-banner-sdk #onetrust-button-group{display:inline-block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{background-color:#68b631;color:#fff;border-color:#68b631;margin-right:1em;min-width:125px;height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:12px 10px;line-height:1.2;font-size:.813em;font-weight:600}#onetrust-banner-sdk #onetrust-pc-btn-handler.cookie-setting-link{background-color:#fff;border:none;color:#68b631;text-decoration:underline;padding-left:0;padding-right:0}#onetrust-banner-sdk .onetrust-close-btn-ui{width:44px;height:44px;background-size:12px;border:none;position:relative;margin:auto;padding:0}#onetrust-banner-sdk .banner_logo{display:none}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{position:absolute;top:50%;transform:translateY(-50%);left:0px}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-policy{margin-left:65px}#onetrust-banner-sdk .ot-b-addl-desc{clear:both;float:left;display:block}#onetrust-banner-sdk #banner-options{float:left;display:table;margin-right:0;margin-left:1em;width:calc(100% - 1em)}#onetrust-banner-sdk .banner-option-input{cursor:pointer;width:auto;height:auto;border:none;padding:0;padding-right:3px;margin:0 0 10px;font-size:.82em;line-height:1.4}#onetrust-banner-sdk .banner-option-input *{pointer-events:none;font-size:inherit;line-height:inherit}#onetrust-banner-sdk .banner-option-input[aria-expanded=true]~.banner-option-details{display:block;height:auto}#onetrust-banner-sdk .banner-option-input[aria-expanded=true] .ot-arrow-container{transform:rotate(90deg)}#onetrust-banner-sdk .banner-option{margin-bottom:12px;margin-left:0;border:none;float:left;padding:0}#onetrust-banner-sdk .banner-option:first-child{padding-left:2px}#onetrust-banner-sdk .banner-option:not(:first-child){padding:0;border:none}#onetrust-banner-sdk .banner-option-header{cursor:pointer;display:inline-block}#onetrust-banner-sdk .banner-option-header :first-child{color:dimgray;font-weight:bold;float:left}#onetrust-banner-sdk .banner-option-header .ot-arrow-container{display:inline-block;border-top:6px solid rgba(0,0,0,0);border-bottom:6px solid rgba(0,0,0,0);border-left:6px solid dimgray;margin-left:10px;vertical-align:middle}#onetrust-banner-sdk .banner-option-details{display:none;font-size:.83em;line-height:1.5;padding:10px 0px 5px 10px;margin-right:10px;height:0px}#onetrust-banner-sdk .banner-option-details *{font-size:inherit;line-height:inherit;color:dimgray}#onetrust-banner-sdk .ot-arrow-container,#onetrust-banner-sdk .banner-option-details{transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk .ot-dpd-container{float:left}#onetrust-banner-sdk .ot-dpd-title{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-title,#onetrust-banner-sdk .ot-dpd-desc{font-size:.88em;line-height:1.4;color:dimgray}#onetrust-banner-sdk .ot-dpd-title *,#onetrust-banner-sdk .ot-dpd-desc *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text *{margin-bottom:0}#onetrust-banner-sdk.ot-iab-2 .onetrust-vendors-list-handler{display:block;margin-left:0;margin-top:5px;clear:both;margin-bottom:0;padding:0;border:0;height:auto;width:auto}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk.ot-close-btn-link{padding-top:25px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container{top:15px;transform:none;right:15px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container button{padding:0;white-space:pre-wrap;border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em}#onetrust-banner-sdk #onetrust-policy-text,#onetrust-banner-sdk .ot-dpd-desc,#onetrust-banner-sdk .ot-b-addl-desc{font-size:.813em;line-height:1.5}#onetrust-banner-sdk .ot-dpd-desc{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-desc>.ot-b-addl-desc{margin-top:10px;margin-bottom:10px;font-size:1em}@media only screen and (max-width: 425px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:6px;right:2px}#onetrust-banner-sdk #onetrust-policy{margin-left:0;margin-top:3em}#onetrust-banner-sdk #onetrust-button-group{display:block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk .onetrust-close-btn-ui{top:auto;transform:none}#onetrust-banner-sdk #onetrust-policy-title{display:inline;float:none}#onetrust-banner-sdk #banner-options{margin:0;padding:0;width:100%}}@media only screen and (min-width: 426px)and (max-width: 896px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:0;right:0}#onetrust-banner-sdk #onetrust-policy{margin-left:1em;margin-right:1em}#onetrust-banner-sdk .onetrust-close-btn-ui{top:10px;right:10px}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:95%}#onetrust-banner-sdk.ot-iab-2 #onetrust-group-container{width:100%}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-button-group-parent{padding-left:50px}#onetrust-banner-sdk #onetrust-button-group-parent{width:100%;position:relative;margin-left:0}#onetrust-banner-sdk #onetrust-button-group button{display:inline-block}#onetrust-banner-sdk #onetrust-button-group{margin-right:0;text-align:center}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler{float:left}#onetrust-banner-sdk .has-reject-all-button #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-accept-btn-handler{float:right}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group{width:calc(100% - 2em);margin-right:0}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler.cookie-setting-link{padding-left:0px;text-align:left}#onetrust-banner-sdk.ot-buttons-fw .ot-sdk-three button{width:100%;text-align:center}#onetrust-banner-sdk.ot-buttons-fw #onetrust-button-group-parent button{float:none}#onetrust-banner-sdk.ot-buttons-fw #onetrust-pc-btn-handler.cookie-setting-link{text-align:center}}@media only screen and (min-width: 550px){#onetrust-banner-sdk .banner-option:not(:first-child){border-left:1px solid #d8d8d8;padding-left:25px}}@media only screen and (min-width: 425px)and (max-width: 550px){#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group,#onetrust-banner-sdk.ot-iab-2 #onetrust-policy,#onetrust-banner-sdk.ot-iab-2 .banner-option{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler{float:left}}@media only screen and (min-width: 769px){#onetrust-banner-sdk #onetrust-button-group{margin-right:30%}#onetrust-banner-sdk #banner-options{margin-left:2em;margin-right:5em;margin-bottom:1.25em;width:calc(100% - 7em)}}@media only screen and (min-width: 897px)and (max-width: 1023px){#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:75%;transform:translateY(-50%)}#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;padding:0;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{position:relative;margin:0;right:-22px;top:2px}}@media only screen and (min-width: 1024px){#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{right:-12px}#onetrust-banner-sdk #onetrust-policy{margin-left:2em}#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:60%;transform:translateY(-50%)}#onetrust-banner-sdk .ot-optout-signal{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-title{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text,#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:1em;width:50%;border-right:1px solid #d8d8d8;padding-right:1rem}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-container{width:45%;padding-left:1rem;display:inline-block;float:none}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-title{line-height:1.7}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group-parent{left:auto;right:4%;margin-left:0}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:auto;width:30%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:60%}#onetrust-banner-sdk #onetrust-button-group{margin-right:auto}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{margin-top:1em}}@media only screen and (min-width: 890px){#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group-parent{padding-left:3%;padding-right:4%;margin-left:0}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{margin-right:0;margin-top:1.25em;width:100%}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button{width:100%;margin-bottom:5px;margin-top:5px}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type{margin-bottom:20px}}@media only screen and (min-width: 1280px){#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:55%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{width:44%;padding-left:2%;padding-right:2%}#onetrust-banner-sdk:not(.ot-iab-2).vertical-align-content #onetrust-button-group-parent{position:absolute;left:55%}}
        #onetrust-consent-sdk #onetrust-banner-sdk {background-color: #FFF;}
            #onetrust-consent-sdk #onetrust-policy-title,
                    #onetrust-consent-sdk #onetrust-policy-text,
                    #onetrust-consent-sdk .ot-b-addl-desc,
                    #onetrust-consent-sdk .ot-dpd-desc,
                    #onetrust-consent-sdk .ot-dpd-title,
                    #onetrust-consent-sdk #onetrust-policy-text *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk .ot-dpd-desc *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk #onetrust-banner-sdk #banner-options *,
                    #onetrust-banner-sdk .ot-cat-header,
                    #onetrust-banner-sdk .ot-optout-signal
                    {
                        color: #2E2E2E;
                    }
            #onetrust-consent-sdk #onetrust-banner-sdk .banner-option-details {
                    background-color: #E9E9E9;}
             #onetrust-consent-sdk #onetrust-banner-sdk a[href],
                    #onetrust-consent-sdk #onetrust-banner-sdk a[href] font,
                    #onetrust-consent-sdk #onetrust-banner-sdk .ot-link-btn
                        {
                            color: #007398;
                        }#onetrust-consent-sdk #onetrust-accept-btn-handler,
                         #onetrust-banner-sdk #onetrust-reject-all-handler {
                            background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-banner-sdk *:focus,
            #onetrust-consent-sdk #onetrust-banner-sdk:focus {
               outline-color: #000000;
               outline-width: 1px;
            }
            #onetrust-consent-sdk #onetrust-pc-btn-handler,
            #onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
                color: #6CC04A; border-color: #6CC04A;
                background-color:
                #FFF;
            }/*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
#onetrust-pc-sdk.otPcCenter{overflow:hidden;position:fixed;margin:0 auto;top:5%;right:0;left:0;width:40%;max-width:575px;min-width:575px;border-radius:2.5px;z-index:2147483647;background-color:#fff;-webkit-box-shadow:0px 2px 10px -3px #999;-moz-box-shadow:0px 2px 10px -3px #999;box-shadow:0px 2px 10px -3px #999}#onetrust-pc-sdk.otPcCenter[dir=rtl]{right:0;left:0}#onetrust-pc-sdk.otRelFont{font-size:1rem}#onetrust-pc-sdk .ot-optout-signal{margin-top:.625rem}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus,#onetrust-pc-sdk .ot-hide-tgl{visibility:hidden}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr *,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus *,#onetrust-pc-sdk .ot-hide-tgl *{visibility:hidden}#onetrust-pc-sdk #ot-gn-venlst .ot-ven-item .ot-acc-hdr{min-height:40px}#onetrust-pc-sdk .ot-pc-header{height:39px;padding:10px 0 10px 30px;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk #ot-pc-title,#onetrust-pc-sdk #ot-category-title,#onetrust-pc-sdk .ot-cat-header,#onetrust-pc-sdk #ot-lst-title,#onetrust-pc-sdk .ot-ven-hdr .ot-ven-name,#onetrust-pc-sdk .ot-always-active{font-weight:bold;color:dimgray}#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:55%;font-weight:700}#onetrust-pc-sdk .ot-cat-item p{clear:both;float:left;margin-top:10px;margin-bottom:5px;line-height:1.5;font-size:.812em;color:dimgray}#onetrust-pc-sdk .ot-close-icon{height:44px;width:44px;background-size:10px}#onetrust-pc-sdk #ot-pc-title{float:left;font-size:1em;line-height:1.5;margin-bottom:10px;margin-top:10px;width:100%}#onetrust-pc-sdk #accept-recommended-btn-handler{margin-right:10px;margin-bottom:25px;outline-offset:-1px}#onetrust-pc-sdk #ot-pc-desc{clear:both;width:100%;font-size:.812em;line-height:1.5;margin-bottom:25px}#onetrust-pc-sdk #ot-pc-desc *{font-size:inherit;line-height:inherit}#onetrust-pc-sdk #ot-pc-desc ul li{padding:10px 0px}#onetrust-pc-sdk a{color:#656565;cursor:pointer}#onetrust-pc-sdk a:hover{color:#3860be}#onetrust-pc-sdk label{margin-bottom:0}#onetrust-pc-sdk #vdr-lst-dsc{font-size:.812em;line-height:1.5;padding:10px 15px 5px 15px}#onetrust-pc-sdk button{max-width:394px;padding:12px 30px;line-height:1;word-break:break-word;word-wrap:break-word;white-space:normal;font-weight:bold;height:auto}#onetrust-pc-sdk .ot-link-btn{padding:0;margin-bottom:0;border:0;font-weight:normal;line-height:normal;width:auto;height:auto}#onetrust-pc-sdk #ot-pc-content{position:absolute;overflow-y:scroll;padding-left:2px;padding-right:30px;top:60px;bottom:110px;margin:1px 3px 0 30px;width:calc(100% - 63px)}#onetrust-pc-sdk .ot-vs-list .ot-always-active,#onetrust-pc-sdk .ot-cat-grp .ot-always-active{float:right;clear:none;color:#3860be;margin:0;font-size:.813em;line-height:1.3}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-track{margin-right:20px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar{width:11px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-thumb{border-radius:10px;background:#d8d8d8}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-pc-scrollbar{scrollbar-arrow-color:#d8d8d8;scrollbar-darkshadow-color:#d8d8d8;scrollbar-face-color:#d8d8d8;scrollbar-shadow-color:#d8d8d8}#onetrust-pc-sdk .save-preference-btn-handler{margin-right:20px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-right:10px}#onetrust-pc-sdk #ot-pc-desc .privacy-notice-link{margin-left:0;margin-right:8px}#onetrust-pc-sdk #ot-pc-desc .ot-imprint-handler{margin-left:0;margin-right:8px}#onetrust-pc-sdk .ot-subgrp-cntr{display:inline-block;clear:both;width:100%;padding-top:15px}#onetrust-pc-sdk .ot-switch+.ot-subgrp-cntr{padding-top:10px}#onetrust-pc-sdk ul.ot-subgrps{margin:0;font-size:initial}#onetrust-pc-sdk ul.ot-subgrps li p,#onetrust-pc-sdk ul.ot-subgrps li h5{font-size:.813em;line-height:1.4;color:dimgray}#onetrust-pc-sdk ul.ot-subgrps .ot-switch{min-height:auto}#onetrust-pc-sdk ul.ot-subgrps .ot-switch-nob{top:0}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr{display:inline-block;width:100%}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-txt{margin:0}#onetrust-pc-sdk ul.ot-subgrps li{padding:0;border:none}#onetrust-pc-sdk ul.ot-subgrps li h5{position:relative;top:5px;font-weight:bold;margin-bottom:0;float:left}#onetrust-pc-sdk li.ot-subgrp{margin-left:20px;overflow:auto}#onetrust-pc-sdk li.ot-subgrp>h5{width:calc(100% - 100px)}#onetrust-pc-sdk .ot-cat-item p>ul,#onetrust-pc-sdk li.ot-subgrp p>ul{margin:0px;list-style:disc;margin-left:15px;font-size:inherit}#onetrust-pc-sdk .ot-cat-item p>ul li,#onetrust-pc-sdk li.ot-subgrp p>ul li{font-size:inherit;padding-top:10px;padding-left:0px;padding-right:0px;border:none}#onetrust-pc-sdk .ot-cat-item p>ul li:last-child,#onetrust-pc-sdk li.ot-subgrp p>ul li:last-child{padding-bottom:10px}#onetrust-pc-sdk .ot-pc-logo{height:40px;width:120px}#onetrust-pc-sdk .ot-pc-footer{position:absolute;bottom:0px;width:100%;max-height:160px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-refuse-all-handler{margin-bottom:0px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:160px}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-footer button{width:100%;max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:0 30px;width:calc(100% - 60px);padding-right:0}#onetrust-pc-sdk .ot-pc-footer-logo{height:30px;width:100%;text-align:right;background:#f4f4f4}#onetrust-pc-sdk .ot-pc-footer-logo a{display:inline-block;margin-top:5px;margin-right:10px}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo{direction:rtl}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo a{margin-right:25px}#onetrust-pc-sdk .ot-tgl{float:right;position:relative;z-index:1}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background-color:#468254;border:1px solid #fff}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{-webkit-transform:translateX(20px);-ms-transform:translateX(20px);transform:translateX(20px);background-color:#fff;border-color:#fff}#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch{outline:#000 solid 1px}#onetrust-pc-sdk .ot-switch{position:relative;display:inline-block;width:45px;height:25px}#onetrust-pc-sdk .ot-switch-nob{position:absolute;cursor:pointer;top:0;left:0;right:0;bottom:0;background-color:#767676;border:1px solid #ddd;transition:all .2s ease-in 0s;-moz-transition:all .2s ease-in 0s;-o-transition:all .2s ease-in 0s;-webkit-transition:all .2s ease-in 0s;border-radius:20px}#onetrust-pc-sdk .ot-switch-nob:before{position:absolute;content:"";height:18px;width:18px;bottom:3px;left:3px;background-color:#fff;-webkit-transition:.4s;transition:.4s;border-radius:20px}#onetrust-pc-sdk .ot-chkbox input:checked~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox label{position:relative;display:inline-block;padding-left:30px;cursor:pointer;font-weight:500}#onetrust-pc-sdk .ot-chkbox label::before,#onetrust-pc-sdk .ot-chkbox label::after{position:absolute;content:"";display:inline-block;border-radius:3px}#onetrust-pc-sdk .ot-chkbox label::before{height:18px;width:18px;border:1px solid #3860be;left:0px;top:auto}#onetrust-pc-sdk .ot-chkbox label::after{height:5px;width:9px;border-left:3px solid;border-bottom:3px solid;transform:rotate(-45deg);-o-transform:rotate(-45deg);-ms-transform:rotate(-45deg);-webkit-transform:rotate(-45deg);left:4px;top:5px}#onetrust-pc-sdk .ot-label-txt{display:none}#onetrust-pc-sdk .ot-chkbox input,#onetrust-pc-sdk .ot-tgl input{position:absolute;opacity:0;width:0;height:0}#onetrust-pc-sdk .ot-arw-cntr{float:right;position:relative;pointer-events:none}#onetrust-pc-sdk .ot-arw-cntr .ot-arw{width:16px;height:16px;margin-left:5px;color:dimgray;display:inline-block;vertical-align:middle;-webkit-transition:all 150ms ease-in 0s;-moz-transition:all 150ms ease-in 0s;-o-transition:all 150ms ease-in 0s;transition:all 150ms ease-in 0s}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw-cntr svg{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-tgl-cntr,#onetrust-pc-sdk .ot-arw-cntr{display:inline-block}#onetrust-pc-sdk .ot-tgl-cntr{width:45px;float:right;margin-top:2px}#onetrust-pc-sdk #ot-lst-cnt .ot-tgl-cntr{margin-top:10px}#onetrust-pc-sdk .ot-always-active-subgroup{width:auto;padding-left:0px !important;top:3px;position:relative}#onetrust-pc-sdk .ot-label-status{font-size:.75em;display:none;font-size:.75em;position:relative;top:2px;padding-right:5px;float:left}#onetrust-pc-sdk .ot-arw-cntr{margin-top:-1px}#onetrust-pc-sdk .ot-arw-cntr svg{-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s;transition:all 300ms ease-in 0s;height:10px;width:10px}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk .ot-arw{width:10px;margin-left:15px;transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0}#onetrust-pc-sdk .ot-hlst-cntr{margin-top:5px;display:inline-block;width:100%}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{clear:both;color:#3860be;margin-left:0;font-size:.813em;text-decoration:none;float:left;overflow:hidden}#onetrust-pc-sdk .category-vendors-list-handler:hover,#onetrust-pc-sdk .category-vendors-list-handler+a:hover,#onetrust-pc-sdk .category-host-list-handler:hover{text-decoration-line:underline}#onetrust-pc-sdk .category-vendors-list-handler+a{clear:none}#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{display:inline-block;height:13px;width:13px;background-repeat:no-repeat;margin-left:1px;margin-top:6px;cursor:pointer}#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{margin-bottom:-1px}#onetrust-pc-sdk .back-btn-handler{font-size:1em;text-decoration:none}#onetrust-pc-sdk .back-btn-handler:hover{opacity:.6}#onetrust-pc-sdk #ot-lst-title h3{display:inline-block;word-break:break-word;word-wrap:break-word;margin-bottom:0;color:#656565;font-size:1em;font-weight:bold;margin-left:15px}#onetrust-pc-sdk #ot-lst-title{margin:10px 0 10px 0px;font-size:1em;text-align:left}#onetrust-pc-sdk #ot-pc-hdr{margin:0 0 0 30px;height:auto;width:auto}#onetrust-pc-sdk #ot-pc-hdr input::placeholder{color:#707070;font-style:italic}#onetrust-pc-sdk #vendor-search-handler{height:31px;width:100%;border-radius:50px;font-size:.8em;padding-right:35px;padding-left:15px;float:left;margin-left:15px}#onetrust-pc-sdk .ot-ven-name{display:block;width:auto;padding-right:5px}#onetrust-pc-sdk #ot-lst-cnt{overflow-y:auto;margin-left:20px;margin-right:7px;width:calc(100% - 27px);max-height:calc(100% - 80px);height:100%;transform:translate3d(0, 0, 0)}#onetrust-pc-sdk #ot-pc-lst{width:100%;bottom:100px;position:absolute;top:60px}#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr *{visibility:hidden}#onetrust-pc-sdk #ot-pc-lst .ot-tgl-cntr{right:12px;position:absolute}#onetrust-pc-sdk #ot-pc-lst .ot-arw-cntr{float:right;position:relative}#onetrust-pc-sdk #ot-pc-lst .ot-arw{margin-left:10px}#onetrust-pc-sdk #ot-pc-lst .ot-acc-hdr{overflow:hidden;cursor:pointer}#onetrust-pc-sdk .ot-vlst-cntr{overflow:hidden}#onetrust-pc-sdk #ot-sel-blk{overflow:hidden;width:100%;position:sticky;position:-webkit-sticky;top:0;z-index:3}#onetrust-pc-sdk #ot-back-arw{height:12px;width:12px}#onetrust-pc-sdk .ot-lst-subhdr{width:100%;display:inline-block}#onetrust-pc-sdk .ot-search-cntr{float:left;width:78%;position:relative}#onetrust-pc-sdk .ot-search-cntr>svg{width:30px;height:30px;position:absolute;float:left;right:-15px}#onetrust-pc-sdk .ot-fltr-cntr{float:right;right:50px;position:relative}#onetrust-pc-sdk #filter-btn-handler{background-color:#3860be;border-radius:17px;display:inline-block;position:relative;width:32px;height:32px;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease;padding:0;margin:0}#onetrust-pc-sdk #filter-btn-handler:hover{background-color:#3860be}#onetrust-pc-sdk #filter-btn-handler svg{width:12px;height:12px;margin:3px 10px 0 10px;display:block;position:static;right:auto;top:auto}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{color:#3860be;text-decoration:none;font-weight:100;display:inline-block;padding-top:10px;transform:translate(0, 1%);-o-transform:translate(0, 1%);-ms-transform:translate(0, 1%);-webkit-transform:translate(0, 1%);position:relative;z-index:2}#onetrust-pc-sdk .ot-ven-link *,#onetrust-pc-sdk .ot-ven-legclaim-link *{font-size:inherit}#onetrust-pc-sdk .ot-ven-link:hover,#onetrust-pc-sdk .ot-ven-legclaim-link:hover{text-decoration:underline}#onetrust-pc-sdk .ot-ven-hdr{width:calc(100% - 160px);height:auto;float:left;word-break:break-word;word-wrap:break-word;vertical-align:middle;padding-bottom:3px}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{letter-spacing:.03em;font-size:.75em;font-weight:400}#onetrust-pc-sdk .ot-ven-dets{border-radius:2px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-ven-dets li:first-child p:first-child{border-top:none}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:not(:first-child){border-top:1px solid #ddd !important}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(odd){width:30%}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(even){width:50%;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p,#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{padding-top:5px;padding-bottom:5px;display:block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-last-child(-n+1){padding-bottom:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-child(-n+2):not(.disc-pur){padding-top:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur-cont{display:inline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur{position:relative;width:50% !important;word-break:break-word;word-wrap:break-word;left:calc(30% + 17px)}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur:nth-child(-n+1){position:static}#onetrust-pc-sdk .ot-ven-dets p,#onetrust-pc-sdk .ot-ven-dets h5,#onetrust-pc-sdk .ot-ven-dets span{font-size:.69em;text-align:left;vertical-align:middle;word-break:break-word;word-wrap:break-word;margin:0;padding-bottom:10px;padding-left:15px;color:#2e3644}#onetrust-pc-sdk .ot-ven-dets h5{padding-top:5px}#onetrust-pc-sdk .ot-ven-dets span{color:dimgray;padding:0;vertical-align:baseline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-pur h5{border-top:1px solid #e9e9e9;border-bottom:1px solid #e9e9e9;padding-bottom:5px;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk #ot-host-lst .ot-sel-all{float:right;position:relative;margin-right:42px;top:10px}#onetrust-pc-sdk #ot-host-lst .ot-sel-all input[type=checkbox]{width:auto;height:auto}#onetrust-pc-sdk #ot-host-lst .ot-sel-all label{height:20px;width:20px;padding-left:0px}#onetrust-pc-sdk #ot-host-lst .ot-acc-txt{overflow:hidden;width:95%}#onetrust-pc-sdk .ot-host-hdr{position:relative;z-index:1;pointer-events:none;width:calc(100% - 125px);float:left}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-desc{display:inline-block;width:90%}#onetrust-pc-sdk .ot-host-name{pointer-events:none}#onetrust-pc-sdk .ot-host-hdr>a{text-decoration:underline;font-size:.82em;position:relative;z-index:2;float:left;margin-bottom:5px;pointer-events:initial}#onetrust-pc-sdk .ot-host-name+a{margin-top:5px}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a,#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{color:dimgray;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a{font-weight:bold;font-size:.82em;line-height:1.3}#onetrust-pc-sdk .ot-host-name a{font-size:1em}#onetrust-pc-sdk .ot-host-expand{margin-top:3px;margin-bottom:3px;clear:both;display:block;color:#3860be;font-size:.72em;font-weight:normal}#onetrust-pc-sdk .ot-host-expand *{font-size:inherit}#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{font-size:.688em;line-height:1.4;font-weight:normal}#onetrust-pc-sdk .ot-host-desc{margin-top:10px}#onetrust-pc-sdk .ot-host-opt{margin:0;font-size:inherit;display:inline-block;width:100%}#onetrust-pc-sdk .ot-host-opt li>div div{font-size:.8em;padding:5px 0}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(1){width:30%;float:left}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(2){width:70%;float:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-info{border:none;display:inline-block;width:calc(100% - 10px);padding:10px;margin-bottom:10px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-host-info>div{overflow:auto}#onetrust-pc-sdk #no-results{text-align:center;margin-top:30px}#onetrust-pc-sdk #no-results p{font-size:1em;color:#2e3644;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #no-results p span{font-weight:bold}#onetrust-pc-sdk #ot-fltr-modal{width:100%;height:auto;display:none;-moz-transition:.2s ease;-o-transition:.2s ease;-webkit-transition:2s ease;transition:.2s ease;overflow:hidden;opacity:1;right:0}#onetrust-pc-sdk #ot-fltr-modal .ot-label-txt{display:inline-block;font-size:.85em;color:dimgray}#onetrust-pc-sdk #ot-fltr-cnt{z-index:2147483646;background-color:#fff;position:absolute;height:90%;max-height:300px;width:325px;left:210px;margin-top:10px;margin-bottom:20px;padding-right:10px;border-radius:3px;-webkit-box-shadow:0px 0px 12px 2px #c7c5c7;-moz-box-shadow:0px 0px 12px 2px #c7c5c7;box-shadow:0px 0px 12px 2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-scrlcnt{overflow-y:auto;overflow-x:hidden;clear:both;max-height:calc(100% - 60px)}#onetrust-pc-sdk #ot-anchor{border:12px solid rgba(0,0,0,0);display:none;position:absolute;z-index:2147483647;right:55px;top:75px;transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);-webkit-transform:rotate(45deg);background-color:#fff;-webkit-box-shadow:-3px -3px 5px -2px #c7c5c7;-moz-box-shadow:-3px -3px 5px -2px #c7c5c7;box-shadow:-3px -3px 5px -2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-btns{margin-left:15px}#onetrust-pc-sdk #filter-apply-handler{margin-right:15px}#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:5px;margin-left:15px;min-height:20px;width:75%;position:relative}#onetrust-pc-sdk .ot-fltr-opt p{display:inline-block;margin:0;font-size:.9em;color:#2e3644}#onetrust-pc-sdk .ot-chkbox label span{font-size:.85em;color:dimgray}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox][aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr,#onetrust-pc-sdk #ot-selall-hostcntr,#onetrust-pc-sdk #ot-selall-licntr,#onetrust-pc-sdk #ot-selall-gnvencntr{right:15px;position:relative;width:20px;height:20px;float:right}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label,#onetrust-pc-sdk #ot-selall-gnvencntr label{float:left;padding-left:0}#onetrust-pc-sdk #ot-ven-lst:first-child{border-top:1px solid #e2e2e2}#onetrust-pc-sdk ul{list-style:none;padding:0}#onetrust-pc-sdk ul li{position:relative;margin:0;padding:15px 15px 15px 10px;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk ul li h3,#onetrust-pc-sdk ul li h4{font-size:.75em;color:#656565;margin:0;display:inline-block;width:70%;height:auto;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk ul li p{margin:0;font-size:.7em}#onetrust-pc-sdk ul li input[type=checkbox]{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0}#onetrust-pc-sdk .ot-cat-item>button:focus,#onetrust-pc-sdk .ot-acc-cntr>button:focus,#onetrust-pc-sdk li>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-cat-item>button,#onetrust-pc-sdk .ot-acc-cntr>button,#onetrust-pc-sdk li>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-host-item>button:focus,#onetrust-pc-sdk .ot-ven-item>button:focus{outline:0;border:2px solid #000}#onetrust-pc-sdk .ot-hide-acc>button{pointer-events:none}#onetrust-pc-sdk .ot-hide-acc .ot-plus-minus>*,#onetrust-pc-sdk .ot-hide-acc .ot-arw-cntr>*{visibility:hidden}#onetrust-pc-sdk .ot-hide-acc .ot-acc-hdr{min-height:30px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt){padding-right:10px;width:calc(100% - 37px);margin-top:10px;max-height:calc(100% - 90px)}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk{background-color:#f9f9fc;border:1px solid #e2e2e2;width:calc(100% - 2px);padding-bottom:5px;padding-top:5px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt{border:unset;background-color:unset}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all-hdr{display:none}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all{padding-right:.5rem}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all .ot-chkbox{right:0}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all{padding-right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-chkbox{width:auto}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) ul li{border:1px solid #e2e2e2;margin-bottom:10px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-acc-cntr>.ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk.ot-addtl-vendors .ot-sel-all-chkbox{float:right}#onetrust-pc-sdk.ot-addtl-vendors .ot-plus-minus~.ot-sel-all-chkbox{right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-ven-lst:first-child{border-top:none}#onetrust-pc-sdk .ot-acc-cntr{position:relative;border-left:1px solid #e2e2e2;border-right:1px solid #e2e2e2;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr input{z-index:1}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr{background-color:#f9f9fc;padding:5px 0 5px 15px;width:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-plus-minus{vertical-align:middle;top:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-arw-cntr{right:10px}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr input{z-index:2}#onetrust-pc-sdk .ot-acc-cntr.ot-add-tech .ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk .ot-acc-cntr>input[type=checkbox]:checked~.ot-acc-hdr{border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-txt{padding-left:10px;padding-right:10px}#onetrust-pc-sdk .ot-acc-cntr button[aria-expanded=true]~.ot-acc-txt{width:auto}#onetrust-pc-sdk .ot-acc-cntr .ot-addtl-venbox{display:none}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0;width:100%}#onetrust-pc-sdk .ot-vensec-title{font-size:.813em;vertical-align:middle;display:inline-block}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a{margin-left:0;margin-top:10px}#onetrust-pc-sdk #ot-selall-vencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-adtlvencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-licntr.line-through label::after,#onetrust-pc-sdk #ot-selall-hostcntr.line-through label::after,#onetrust-pc-sdk #ot-selall-gnvencntr.line-through label::after{height:auto;border-left:0;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none;left:5px;top:9px}#onetrust-pc-sdk #ot-category-title{float:left;padding-bottom:10px;font-size:1em;width:100%}#onetrust-pc-sdk .ot-cat-grp{margin-top:10px}#onetrust-pc-sdk .ot-cat-item{line-height:1.1;margin-top:10px;display:inline-block;width:100%}#onetrust-pc-sdk .ot-btn-container{text-align:right}#onetrust-pc-sdk .ot-btn-container button{display:inline-block;font-size:.75em;letter-spacing:.08em;margin-top:19px}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon{position:absolute;top:10px;right:0;z-index:1;padding:0;background-color:rgba(0,0,0,0);border:none}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon svg{display:block;height:10px;width:10px}#onetrust-pc-sdk #clear-filters-handler{margin-top:20px;margin-bottom:10px;float:right;max-width:200px;text-decoration:none;color:#3860be;font-size:.9em;font-weight:bold;background-color:rgba(0,0,0,0);border-color:rgba(0,0,0,0);padding:1px}#onetrust-pc-sdk #clear-filters-handler:hover{color:#2285f7}#onetrust-pc-sdk #clear-filters-handler:focus{outline:#000 solid 1px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl,#onetrust-pc-sdk .ot-enbl-chr h4~.ot-always-active{right:45px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl+.ot-tgl{right:120px}#onetrust-pc-sdk .ot-enbl-chr .ot-pli-hdr.ot-leg-border-color span:first-child{width:90px}#onetrust-pc-sdk .ot-enbl-chr li.ot-subgrp>h5+.ot-tgl-cntr{padding-right:25px}#onetrust-pc-sdk .ot-plus-minus{width:20px;height:20px;font-size:1.5em;position:relative;display:inline-block;margin-right:5px;top:3px}#onetrust-pc-sdk .ot-plus-minus span{position:absolute;background:#27455c;border-radius:1px}#onetrust-pc-sdk .ot-plus-minus span:first-of-type{top:25%;bottom:25%;width:10%;left:45%}#onetrust-pc-sdk .ot-plus-minus span:last-of-type{left:25%;right:25%;height:10%;top:45%}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:first-of-type,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{transform:rotate(90deg)}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{left:50%;right:50%}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk .ot-host-item .ot-plus-minus,#onetrust-pc-sdk .ot-ven-item .ot-plus-minus{float:left;margin-right:8px;top:10px}#onetrust-pc-sdk .ot-ven-item ul{list-style:none inside;font-size:100%;margin:0}#onetrust-pc-sdk .ot-ven-item ul li{margin:0 !important;padding:0;border:none !important}#onetrust-pc-sdk .ot-pli-hdr{color:#77808e;overflow:hidden;padding-top:7.5px;padding-bottom:7.5px;width:calc(100% - 2px);border-top-left-radius:3px;border-top-right-radius:3px}#onetrust-pc-sdk .ot-pli-hdr span:first-child{top:50%;transform:translateY(50%);max-width:90px}#onetrust-pc-sdk .ot-pli-hdr span:last-child{padding-right:10px;max-width:95px;text-align:center}#onetrust-pc-sdk .ot-li-title{float:right;font-size:.813em}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color{background-color:#f4f4f4;border:1px solid #d8d8d8}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color span:first-child{text-align:left;width:70px}#onetrust-pc-sdk li.ot-subgrp>h5,#onetrust-pc-sdk .ot-cat-header{width:calc(100% - 130px)}#onetrust-pc-sdk li.ot-subgrp>h5+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-acc-grpdesc{margin-bottom:5px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-acc-grpcntr .ot-vlst-cntr+.ot-subgrp-cntr{border-top:none}#onetrust-pc-sdk .ot-acc-hdr .ot-arw-cntr+.ot-tgl-cntr,#onetrust-pc-sdk .ot-acc-txt h4+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-subgrp>h5,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header{width:calc(100% - 145px)}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item h5+.ot-tgl-cntr,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header+.ot-tgl{padding-left:28px}#onetrust-pc-sdk .ot-sel-all-hdr,#onetrust-pc-sdk .ot-sel-all-chkbox{display:inline-block;width:100%;position:relative}#onetrust-pc-sdk .ot-sel-all-chkbox{z-index:1}#onetrust-pc-sdk .ot-sel-all{margin:0;position:relative;padding-right:23px;float:right}#onetrust-pc-sdk .ot-consent-hdr,#onetrust-pc-sdk .ot-li-hdr{float:right;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-li-hdr{max-width:100px;padding-right:10px}#onetrust-pc-sdk .ot-consent-hdr{max-width:55px}#onetrust-pc-sdk #ot-selall-licntr{display:block;width:21px;height:auto;float:right;position:relative;right:80px}#onetrust-pc-sdk #ot-selall-licntr label{position:absolute}#onetrust-pc-sdk .ot-ven-ctgl{margin-left:66px}#onetrust-pc-sdk .ot-ven-litgl+.ot-arw-cntr{margin-left:81px}#onetrust-pc-sdk .ot-enbl-chr .ot-host-cnt .ot-tgl-cntr{width:auto}#onetrust-pc-sdk #ot-lst-cnt:not(.ot-host-cnt) .ot-tgl-cntr{width:auto;top:auto;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox label{position:absolute;padding:0;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-acc-grpdesc+.ot-leg-btn-container{padding-left:20px;padding-right:20px;width:calc(100% - 40px);margin-bottom:5px}#onetrust-pc-sdk .ot-subgrp .ot-leg-btn-container{margin-bottom:5px}#onetrust-pc-sdk #ot-ven-lst .ot-leg-btn-container{margin-top:10px}#onetrust-pc-sdk .ot-leg-btn-container{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .ot-leg-btn-container button{height:auto;padding:6.5px 8px;margin-bottom:0;letter-spacing:0;font-size:.75em;line-height:normal}#onetrust-pc-sdk .ot-leg-btn-container svg{display:none;height:14px;width:14px;padding-right:5px;vertical-align:sub}#onetrust-pc-sdk .ot-active-leg-btn{cursor:default;pointer-events:none}#onetrust-pc-sdk .ot-active-leg-btn svg{display:inline-block}#onetrust-pc-sdk .ot-remove-objection-handler{text-decoration:underline;padding:0;font-size:.75em;font-weight:600;line-height:1;padding-left:10px}#onetrust-pc-sdk .ot-obj-leg-btn-handler span{font-weight:bold;text-align:center;font-size:inherit;line-height:1.5}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em;background:none;right:15px;top:15px;width:auto;font-weight:normal}#onetrust-pc-sdk .ot-pgph-link{font-size:.813em !important;margin-top:5px;position:relative}#onetrust-pc-sdk .ot-pgph-link.ot-pgph-link-subgroup{margin-bottom:1rem}#onetrust-pc-sdk .ot-pgph-contr{margin:0 2.5rem}#onetrust-pc-sdk .ot-pgph-title{font-size:1.18rem;margin-bottom:2rem}#onetrust-pc-sdk .ot-pgph-desc{font-size:1rem;font-weight:400;margin-bottom:2rem;line-height:1.5rem}#onetrust-pc-sdk .ot-pgph-desc:not(:last-child):after{content:"";width:96%;display:block;margin:0 auto;padding-bottom:2rem;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk .ot-cat-header{float:left;font-weight:600;font-size:.875em;line-height:1.5;max-width:90%;vertical-align:middle}#onetrust-pc-sdk .ot-vnd-item>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-vnd-item>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{position:relative;border-radius:2px;margin:0;padding:0;border:1px solid #d8d8d8;border-top:none;width:calc(100% - 2px);float:left}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{margin-top:10px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc{padding-left:20px;padding-right:20px;width:calc(100% - 40px);font-size:.812em;margin-bottom:10px;margin-top:15px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul{padding-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul li{padding-top:0;line-height:1.5;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout div+.ot-acc-grpdesc{margin-top:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:first-child{margin-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:last-child,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr:last-child{margin-bottom:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding-top:11.5px;padding-bottom:11.5px;padding-left:20px;padding-right:20px;width:calc(100% - 40px);display:inline-block}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-txt{width:100%;padding:0}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp-cntr{padding-left:20px;padding-right:15px;padding-bottom:0;width:calc(100% - 35px)}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp{padding-right:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpcntr{z-index:1;position:relative}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr{position:absolute;top:50%;transform:translateY(-50%);right:20px;margin-top:-2px}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr .ot-arw{width:15px;height:20px;margin-left:5px;color:dimgray}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{float:none;color:#2e3644;margin:0;display:inline-block;height:auto;word-wrap:break-word;min-height:inherit}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding-left:20px;width:calc(100% - 20px);display:inline-block;margin-top:0;padding-bottom:2px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{position:relative;min-height:25px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl,#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{position:absolute;top:50%;transform:translateY(-50%);right:20px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl+.ot-tgl{right:95px}#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler,#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler+a{margin-top:5px}#onetrust-pc-sdk #ot-lst-cnt{margin-top:1rem;max-height:calc(100% - 96px)}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list,#onetrust-pc-sdk .ot-vnd-serv{width:auto;padding:1rem 1.25rem;padding-bottom:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:600;font-size:.95em;line-height:2;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item{border:none;margin:0;padding:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button{outline:none;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button[aria-expanded=true],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button[aria-expanded=true]{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:first-child{margin-top:.25rem;border-top:unset}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child{margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child button{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 1.75rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-lbl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-cnt,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt{padding-left:40px}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-size:.8em}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-cat-header{font-size:.8em}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv{margin-bottom:1rem;padding:1rem .95rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:700;font-size:.8em;line-height:20px;margin-left:.82rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-cat-header{font-weight:700;font-size:.8em;line-height:20px}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-vnd-serv .ot-vnd-lst-cont .ot-accordion-layout .ot-acc-hdr div.ot-chkbox{margin-left:.82rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr{padding:.7rem 0;margin:0;display:flex;width:100%;align-items:center;justify-content:space-between}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:first-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:first-child{margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:last-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:last-child{margin-right:.5rem;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-always-active{position:relative;right:unset;top:unset;transform:unset}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-plus-minus{top:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-arw-cntr{float:none;top:unset;right:unset;transform:unset;margin-top:-2px;position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-cat-header{flex:1;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-tgl{position:relative;transform:none;right:0;top:0;float:none}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox{position:relative;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label{padding:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label::before{position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox input{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0;z-index:1}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h5.ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h4.ot-cat-header{margin:0}#onetrust-pc-sdk .ot-vs-config .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp h5{top:0;line-height:20px}#onetrust-pc-sdk .ot-vs-list{display:flex;flex-direction:column;padding:0;margin:.5rem 4px}#onetrust-pc-sdk .ot-vs-selc-all{display:flex;padding:0;float:unset;align-items:center;justify-content:flex-start}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf{justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf.ot-caret-conf .ot-sel-all-chkbox{margin-right:48px}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf .ot-sel-all-chkbox{margin:0;padding:0;margin-right:14px;justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-chkbox,#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-tgl{display:inline-block;right:unset;width:auto;height:auto;float:none}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr label{width:45px;height:25px}#onetrust-pc-sdk .ot-vs-selc-all .ot-sel-all-chkbox{margin-right:11px;margin-left:.75rem;display:flex;align-items:center}#onetrust-pc-sdk .ot-vs-selc-all .sel-all-hdr{margin:0 1.25rem;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-vnd-list-cnt #ot-selall-vencntr.ot-chkbox{float:unset;right:0}#onetrust-pc-sdk[dir=rtl] #ot-back-arw,#onetrust-pc-sdk[dir=rtl] input~.ot-acc-hdr .ot-arw{transform:rotate(180deg);-o-transform:rotate(180deg);-ms-transform:rotate(180deg);-webkit-transform:rotate(180deg)}#onetrust-pc-sdk[dir=rtl] input:checked~.ot-acc-hdr .ot-arw{transform:rotate(270deg);-o-transform:rotate(270deg);-ms-transform:rotate(270deg);-webkit-transform:rotate(270deg)}#onetrust-pc-sdk[dir=rtl] .ot-chkbox label::after{transform:rotate(45deg);-webkit-transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);border-left:0;border-right:3px solid}#onetrust-pc-sdk[dir=rtl] .ot-search-cntr>svg{right:0}@media only screen and (max-width: 600px){#onetrust-pc-sdk.otPcCenter{left:0;min-width:100%;height:100%;top:0;border-radius:0}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:1px 3px 0 10px;padding-right:10px;width:calc(100% - 23px)}#onetrust-pc-sdk .ot-btn-container button{max-width:none;letter-spacing:.01em}#onetrust-pc-sdk #close-pc-btn-handler{top:10px;right:17px}#onetrust-pc-sdk p{font-size:.7em}#onetrust-pc-sdk #ot-pc-hdr{margin:10px 10px 0 5px;width:calc(100% - 15px)}#onetrust-pc-sdk .vendor-search-handler{font-size:1em}#onetrust-pc-sdk #ot-back-arw{margin-left:12px}#onetrust-pc-sdk #ot-lst-cnt{margin:0;padding:0 5px 0 10px;min-width:95%}#onetrust-pc-sdk .switch+p{max-width:80%}#onetrust-pc-sdk .ot-ftr-stacked button{width:100%}#onetrust-pc-sdk #ot-fltr-cnt{max-width:320px;width:90%;border-top-right-radius:0;border-bottom-right-radius:0;margin:0;margin-left:15px;left:auto;right:40px;top:85px}#onetrust-pc-sdk .ot-fltr-opt{margin-left:25px;margin-bottom:10px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-bottom:0}#onetrust-pc-sdk #ot-fltr-cnt{right:40px}}@media only screen and (max-width: 476px){#onetrust-pc-sdk .ot-fltr-cntr,#onetrust-pc-sdk #ot-fltr-cnt{right:10px}#onetrust-pc-sdk #ot-anchor{right:25px}#onetrust-pc-sdk button{width:100%}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-sel-all{padding-right:9px}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr{right:0}}@media(min-width: 768px){#onetrust-pc-sdk.ot-tgl-with-label .ot-label-status{display:inline}#onetrust-pc-sdk.ot-tgl-with-label #ot-pc-lst .ot-label-status{display:none}}@media only screen and (max-width: 896px)and (max-height: 425px)and (orientation: landscape){#onetrust-pc-sdk.otPcCenter{left:0;top:0;min-width:100%;height:100%;border-radius:0}#onetrust-pc-sdk .ot-pc-header{height:auto;min-height:20px}#onetrust-pc-sdk .ot-pc-header .ot-pc-logo{max-height:30px}#onetrust-pc-sdk .ot-pc-footer{max-height:60px;overflow-y:auto}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{bottom:70px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:70px}#onetrust-pc-sdk #ot-anchor{left:initial;right:50px}#onetrust-pc-sdk #ot-lst-title{margin-top:12px}#onetrust-pc-sdk #ot-lst-title *{font-size:inherit}#onetrust-pc-sdk #ot-pc-hdr input{margin-right:0;padding-right:45px}#onetrust-pc-sdk .switch+p{max-width:85%}#onetrust-pc-sdk #ot-sel-blk{position:static}#onetrust-pc-sdk #ot-pc-lst{overflow:auto}#onetrust-pc-sdk #ot-lst-cnt{max-height:none;overflow:initial}#onetrust-pc-sdk #ot-lst-cnt.no-results{height:auto}#onetrust-pc-sdk input{font-size:1em !important}#onetrust-pc-sdk p{font-size:.6em}#onetrust-pc-sdk #ot-fltr-modal{width:100%;top:0}#onetrust-pc-sdk ul li p,#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{font-size:.6em}#onetrust-pc-sdk.ot-shw-fltr #ot-anchor{display:none !important}#onetrust-pc-sdk.ot-shw-fltr #ot-pc-lst{height:100% !important;overflow:hidden;top:0px}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-cnt{margin:0;height:100%;max-height:none;padding:10px;top:0;width:calc(100% - 20px);position:absolute;right:0;left:0;max-width:none}#onetrust-pc-sdk.ot-shw-fltr .ot-fltr-scrlcnt{max-height:calc(100% - 65px)}}
            #onetrust-consent-sdk #onetrust-pc-sdk,
                #onetrust-consent-sdk #ot-search-cntr,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-switch.ot-toggle,
                #onetrust-consent-sdk #onetrust-pc-sdk ot-grp-hdr1 .checkbox,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title:after
                ,#onetrust-consent-sdk #onetrust-pc-sdk #ot-sel-blk,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-cnt,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-anchor {
                    background-color: #FFF;
                }
               
            #onetrust-consent-sdk #onetrust-pc-sdk h3,
                #onetrust-consent-sdk #onetrust-pc-sdk h4,
                #onetrust-consent-sdk #onetrust-pc-sdk h5,
                #onetrust-consent-sdk #onetrust-pc-sdk h6,
                #onetrust-consent-sdk #onetrust-pc-sdk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-ven-lst .ot-ven-opts p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-desc,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-li-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-sel-all-hdr span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-modal #modal-header,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-checkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-sel-blk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-lst-title h3,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .back-btn-handler p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .ot-ven-name,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-ven-lst .consent-category,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-label-status,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-chkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-optout-signal
                {
                    color: #2E2E2E;
                }
             #onetrust-consent-sdk #onetrust-pc-sdk .privacy-notice-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-pgph-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler + a,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-host-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-legclaim-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-name a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-acc-hdr .ot-host-expand,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-content #ot-pc-desc .ot-link-btn,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info a
                    {
                        color: #007398;
                    }
            #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler:hover { text-decoration: underline;}
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-subgrp-tgl .ot-switch.ot-toggle
             {
                background-color: #F8F8F8;
            }
             #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-ven-dets
                            {
                                background-color: #F8F8F8;
                            }
        #onetrust-consent-sdk #onetrust-pc-sdk
            button:not(#clear-filters-handler):not(.ot-close-icon):not(#filter-btn-handler):not(.ot-remove-objection-handler):not(.ot-obj-leg-btn-handler):not([aria-expanded]):not(.ot-link-btn),
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-active-leg-btn {
                background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {
                border-color: #007398;
            }
            
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-remove-objection-handler{
                background-color: transparent;
                border: 1px solid transparent;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn {
                background-color: #FFFFFF;
                color: #4D4D4D; border-color: #4D4D4D;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-tgl input:focus + .ot-switch, .ot-switch .ot-switch-nob, .ot-switch .ot-switch-nob:before,
            #onetrust-pc-sdk .ot-checkbox input[type="checkbox"]:focus + label::before,
            #onetrust-pc-sdk .ot-chkbox input[type="checkbox"]:focus + label::before {
                outline-color: #000000;
                outline-width: 1px;
                outline-offset: 1px;
            }
            #onetrust-pc-sdk .ot-host-item > button:focus, #onetrust-pc-sdk .ot-ven-item > button:focus {
                border: 1px solid #000000;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk *:focus,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-vlst-cntr > a:focus {
               outline: 1px solid #000000;
               outline-offset: 1px;
            }#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,  #onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{
                    background-image: url('https://cdn.cookielaw.org/logos/static/ot_external_link.svg');
                }
            /*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
.ot-sdk-cookie-policy{font-family:inherit;font-size:16px}.ot-sdk-cookie-policy.otRelFont{font-size:1rem}.ot-sdk-cookie-policy h3,.ot-sdk-cookie-policy h4,.ot-sdk-cookie-policy h6,.ot-sdk-cookie-policy p,.ot-sdk-cookie-policy li,.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy #cookie-policy-description,.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}.ot-sdk-cookie-policy h4{font-size:1.2em}.ot-sdk-cookie-policy h6{font-size:1em;margin-top:2em}.ot-sdk-cookie-policy th{min-width:75px}.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy a:hover{background:#fff}.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}.ot-sdk-cookie-policy .ot-mobile-border{display:none}.ot-sdk-cookie-policy section{margin-bottom:2em}.ot-sdk-cookie-policy table{border-collapse:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy{font-family:inherit;font-size:1rem}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup{margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group-desc,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-table-header,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td{font-size:.9em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td a{font-size:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group{font-size:1em;margin-bottom:.6em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-title{margin-bottom:1.2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy>section{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th{min-width:75px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a:hover{background:#fff}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-mobile-border{display:none}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy section{margin-bottom:2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li{list-style:disc;margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li h4{display:inline-block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{border-collapse:inherit;margin:auto;border:1px solid #d7d7d7;border-radius:5px;border-spacing:initial;width:100%;overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border-bottom:1px solid #d7d7d7;border-right:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr th:last-child,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr td:last-child{border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:25%}.ot-sdk-cookie-policy[dir=rtl]{text-align:left}#ot-sdk-cookie-policy h3{font-size:1.5em}@media only screen and (max-width: 530px){.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) table,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tbody,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) th,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{display:block}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead tr{position:absolute;top:-9999px;left:-9999px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{margin:0 0 1em 0}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd),.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd) a{background:#f6f6f4}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td{border:none;border-bottom:1px solid #eee;position:relative;padding-left:50%}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{position:absolute;height:100%;left:6px;width:40%;padding-right:10px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) .ot-mobile-border{display:inline-block;background-color:#e4e4e4;position:absolute;height:100%;top:0;left:45%;width:2px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{content:attr(data-label);font-weight:bold}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border:none;border-bottom:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{display:block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:auto}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{margin:0 0 1em 0}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{height:100%;width:40%;padding-right:10px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{content:attr(data-label);font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead tr{position:absolute;top:-9999px;left:-9999px;z-index:-9999}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:1px solid #d7d7d7;border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td:last-child{border-bottom:0px}}
                
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h5,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group {
                        color: #696969;
                    }
                    
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title {
                            color: #696969;
                        }
                    
            
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th {
                            background-color: #F8F8F8;
                        }
                    
            .ot-floating-button__front{background-image:url('https://cdn.cookielaw.org/logos/static/ot_persistent_cookie_icon.png')}</style><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><style></style><link href="https://crossmark-cdn.crossref.org/widget/v2.0/style.css" type="text/css" rel="stylesheet"></head>
<body class="pb-ui">
    <div class="skip">
        <a href="#page-body-id" id="skipNavigationLink" title="Skip to Main Content" tabindex="0" class="skipToContent">Skip to Main Content</a>
        <a href="#mega-menu-nav" id="skipToMainMenu" title="Skip to Main Menu" tabindex="0" class="skipToContent">Skip to Main Menu</a>
    </div>



    <div id="pb-page-content" data-ng-non-bindable="">
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="ux3-layout-widget" data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" class="ux3">
        
    

        


    

            

            
                <div class="cell fonts-loaded">
            

            <div data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" data-widget-name="ux3-layout-widget"><div>
    

        


    

            

            

            <div id="a1f1ba25-79af-4194-aaa9-66206104a800" class="widget loginPopup none widget-none widget-compact-all"><div class="wrapped"><div class="widget-body body body-none body-compact-all"><div role="dialog" aria-modal="true" aria-label="Login" class="popup login-popup hidden"><div class="content"><a href="#" aria-label="Close login popup" title="Close login popup" role="button" class="close"><i class="icon-close_thin"></i></a><h2 class="login-title">Login to your account</h2><div class="login-form"><p tabindex="-1" class="message error"></p><form action="/action/doLogin?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901561-0" method="post"><input type="hidden" name="redirectUri" value="https://www.cell.com/cell/fulltext/S0092-8674(21)01561-0"><input type="hidden" name="referer" value="/cell/fulltext/S0092-8674(21)01561-0"><input type="hidden" name="ecommRedirect"><input type="hidden" name="code" value="cell-site"><input type="hidden" name="UX3LoginWidget" value="true"><input type="hidden" name="isPopup" value="true"><div class="input-group login-input--wrapper"><div class="label"><label for="login">Email/Username</label></div><input id="login" type="text" name="login" value="" size="15" class="login"><div role="alert" class="error-hint js--hidden"><div class="error-hint__text"><div class="error-text">Your email address is a required field.</div><div class="email-example">E.g., j.smith@mail.com</div></div></div></div><div class="input-group login-input--wrapper"><div class="label"><label for="password">Password</label></div><input id="password" type="password" name="password" value="" autocomplete="off" class="password"><a href="#" class="login__field__action js-show-password">Show</a><div role="alert" class="error-hint js--hidden"><span class="error-hint__text">Your password is a required field.</span></div><div class="actions"><a href="https://www.cell.com/action/requestResetPassword" class="link show-request-reset-password">Forgot password?</a></div></div><div class="remember"><input type="checkbox" name="savePassword" id="a1f1ba25-79af-4194-aaa9-66206104a800-remember" value="1" checked="checked"><label for="a1f1ba25-79af-4194-aaa9-66206104a800-remember">Remember me</label></div><div class="submit"><input type="submit" name="submit" value="Log in" class="button submit primary"></div></form></div><div class="create-account"><div>Don’t have an account?</div><a href="/action/registration?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901561-0" class="show-registration">Create a Free Account</a></div></div></div></div></div></div>

            

        

    

        


    

            

            

            <div role="dialog" aria-modal="true" aria-label="Reset password" class="popup top-drawer request-reset-password-drawer hidden"><div class="content"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" role="button" class="close"><i class="icon-close_thin"></i></a><div class="request-reset"><div class="form"><p class="sub">If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password</p><div tabindex="-1" class="message error"></div><form action="/action/requestResetPassword" method="post" class="request-reset-password-form"><input type="hidden" name="platform"><input type="hidden" name="requestResetPassword" value="true"><input type="hidden" name="codeSite" value="cell-site"><div class="input-group"><div class="label"><label for="reset-password-email">Email*</label></div><input id="reset-password-email" type="text" name="email" value="" size="15" class="email"></div><div class="submit" disabled="disabled"><input type="submit" name="submit" value="Submit" disabled="disabled" class="button primary submit"></div></form></div><div class="success-template hidden"><p>If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password</p></div></div><div class="request-reset-cancel"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" class="cancel">Cancel</a></div></div></div>

            

        

    

        


    

            

            
                <div class="ux3-ads">
            

            <div class="pb-ad">
            <!-- Do Not Modify without contacting ELS-HSOnlineCampaign@elsevier.com -->
<!-- To be kept in sync with Global Commercial Publishing Operations-->
<!-- Start: GPT Async -->
<div id="gpt-Variables" data-adfile="CELLJOURNAL">
	<input type="hidden" id="gptSite" value="cell">
	<input type="hidden" id="gptLoggedIn" value="no">
	<input type="hidden" id="gptAccessType" value="ae:ANON_GUEST|ae:ANON_GUEST">
	<input type="hidden" id="gptDefaultSite" value="cell">
</div>
<div id="gpt-Interscroller" class="gpt-InScrollBox" style="display:none;">
	<div class="gpt-InScrollLabel">ADVERTISEMENT</div>
	<div class="gpt-InScrollContainer">
		<div class="gpt-InScrollWrapper">
			<div class="gpt-InScrollInner">
				<div class="gpt-adinterscroller" data-adsize="interscroller"></div>
			</div>
		</div>
	</div>
	<div class="gpt-InScrollLabel">SCROLL TO CONTINUE WITH CONTENT</div>
</div>
<div id="gpt-DebugDiv" class="gpt-DebugDiv" style="display:none;">
	<div style="width: 100%; display: table;">
		<div style="display: table-row">
			<div style="width: 200px; display: table-cell;">
				<button class="gpt-DebugBtn" onclick="gpt_ShowConsole()">Open GPT Console</button><br>
				<button id="gpt_GrapeShotDebugBtn" class="gpt-DebugBtn" onclick="gpt_GrapeShotDebug();">Open Oracle Keywords</button><br>
				<br>
				<button class="gpt-DebugBtn" onclick="gpt_LoadDebugValues()">Refresh Values</button>
			</div>
			<div style="display: table-cell;">
				<table class="gpt-DebugTable">
					<thead>
						<tr>
							<th>Property</th>
							<th>Value</th>
						</tr>
					</thead>
					<tbody>
						<tr><td class="gpt-DebugTitle">Status</td><td><div class="gptStatus_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Version</td><td><div class="gptVersion_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad File</td><td><div class="gptAdFile_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Disable Ads Flag</td><td><div class="gptDisableAds_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Environment</td><td><div class="gptTestENV_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Init</td><td><div class="gptMoatInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Ready</td><td><div class="gptMoatReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Ready</td><td><div class="gptContextualReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual URL</td><td><div class="gptContextualURL_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Initial Segments</td><td><div class="gptContextualInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Used Segments</td><td><div class="gptContextualResult_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">AdUnit</td><td><div class="gptSite_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">SubAdUnit</td><td><div class="gptPage_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Custom Targeting</td><td><div class="gptCustomTargeting_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad Events</td><td><div class="gptEvent_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Invalid Ad Sizes</td><td><div class="gptInvalidAdSize_Debug"></div></td></tr>
					</tbody>
				</table>
			</div>
		</div>
	</div>
</div>
<style type="text/css">
	.gpt-DebugBtn {
		display: inline-block;
		text-align: center;
		text-decoration: none;
		margin: 2px 0;
		border: solid 1px #122b40;
		border-radius: 0.4em;
		padding: 0.5em 1em;
		color: #ffffff;
		background-color: #204d74;
		font-weight: normal;
		font-size: 12px;
	}

	.gpt-DebugDiv {
		margin: 5px;
	}

	.gpt-DebugTitle {
		font-weight: bold;
	}

	.gpt-DebugTable {
		border: 1px solid #dddddd;
		border-collapse: collapse;
		margin: 5px;
		font-size: 0.9em;
		font-family: sans-serif;
		min-width: 400px;
		margin-bottom: 25px;
	}

		.gpt-DebugTable td:first-child {
			padding: 5px;
		}

		.gpt-DebugTable thead tr th {
			background-color: #d9edf7;
			color: #ffffff;
			text-align: left;
			padding: 5px;
			border-bottom: 2px solid #204d74;
		}

		.gpt-DebugTable th,
		.gpt-DebugTable td {
			padding: 5px;
		}

		.gpt-DebugTable tbody tr {
			border-bottom: 1px solid #dddddd;
		}

			.gpt-DebugTable tbody tr:nth-of-type(even) {
				background-color: #f3f3f3;
			}

			.gpt-DebugTable tbody tr:last-of-type {
				border-bottom: 2px solid #204d74;
			}

	.gpt-InScrollLabel {
		background-color: rgb(0, 0, 0);
		color: rgb(255, 255, 255);
		position: relative;
		max-width: 100vw;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		padding: 0;
		text-align: center;
		width: 100vw !important;
		font-size: 10px;
	}

	.gpt-InScrollBox {
		height: 100vh !important;
		width: 100vw;
		cursor: pointer;
		max-width: 100vw;
		position: relative;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		margin-bottom: 50px;
		padding-top: 5px;
		padding-bottom: 5px;
		z-index: 10001;
		background-color: white;
	}

		.gpt-InScrollBox .gpt-InScrollContainer {
			height: 95vh !important;
			position: relative;
		}

		.gpt-InScrollBox .gpt-InScrollWrapper {
			position: absolute !important;
			top: 0 !important;
			left: 0;
			width: 100%;
			height: 95vh !important;
			border: 0 !important;
			margin: 0 !important;
			padding: 0 !important;
			clip: rect(0, auto, auto, 0) !important;
			-webkit-clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
			clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
		}

		.gpt-InScrollBox .gpt-InScrollInner {
			position: fixed !important;
			top: 0 !important;
			left: 0 !important;
			bottom: 0;
			margin: auto;
			width: 100vw;
			height: 95vh;
			-webkit-transform: translateZ(0) !important;
			display: -webkit-box;
			display: -ms-flexbox;
			display: flex;
			-webkit-box-orient: vertical;
			-webkit-box-direction: normal;
			-ms-flex-direction: column;
			flex-direction: column;
			-webkit-box-align: center;
			-ms-flex-align: center;
			align-items: center;
			-webkit-box-pack: center;
			-ms-flex-pack: center;
			justify-content: center;
			text-align: center;
		}
</style>
<script class="optanon-category-4" type="text/plain">
	//--------------------------------------------------------------------------
	var gpt_Version = '04072023';
	var gpt_AdFile = $('#gpt-Variables').data('adfile');
	var gpt_MaxMOATInitAttempts = 11;
	var gpt_MaxMOATReadyAttempts = 11;
	var gpt_MaxContextualReadyAttempts = 21;
	var gpt_MOATInitAttempts = 0;
	var gpt_MOATReadyAttempts = 0;
	var gpt_ContextualReadyAttempts = 0;
	var gpt_IsProd = true;
	var gpt_StartTime;
	var gs_channels = 'DEFAULT';
	var gpt_ContextualReady = false;
	var gpt_ContextualURL = 'Not enabled outside of Production';
	var gpt_DisableAdsFlagFound = false;

	var gptEvent_Debug = '';
	var gptCustomTargeting_Debug = '';
	var gptSite_Debug = "";
	var gptPage_Debug = "";
	var gptContextualEnabled = false;
	var gptContextualResult_Debug = '';
	var gptContextualInit_Debug = '';
	var gptContextualURL_Debug = '';
	var gptContextualReady_Debug = '';
	var gptMoatReady_Debug = '';
	var gptMoatInit_Debug = '';
	var gptTestENV_Debug = '';
	var gptDisableAds_Debug = '';
	var gptStatus_Debug = 'GPT Still Loading - Refresh Values';
	var gptInvalidAdSize_Debug = '';
	//--------------------------------------------------------------------------
	$(document).ready(function () {
		//Check to see if we are on a development env
		gpt_CheckEnvironment();

		if (!gpt_DisableAdsFlagFound) {
			gpt_StartTime = new Date();
			if (gpt_AdFile !== "PU") {
				//Once the dom has loaded, begin the process to init the ads.
				gpt_InitScripts();
				gpt_CheckForMOATInit();
			}
		}
	});
</script>
<script type="text/javascript">
	function gpt_CheckEnvironment() {
		if ($('#gptDisableAds').length > 0) {
			gptDisableAds_Debug = 'Flag Detected - Ads Disabled';
			gpt_DisableAdsFlagFound = true;
		}
		else {
			gptDisableAds_Debug = 'Ads Enabled';
			gpt_DisableAdsFlagFound = false;
		}
		switch (gpt_AdFile) {
			case 'PU':
				gptContextualEnabled = true;
				if ($("#Environment").val() !== "Prod") {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			case 'JBS':
			case 'LANCET':
				gptContextualEnabled = true;
				if ($(".gpt-ad").length > 0) {
					//Other ads exist, allow the Prestitial
					$(document.body).append("<div class='gpt-ad' data-adsize='prestitial'></div>");
				}
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			default:
				//Cell
				gptContextualEnabled = false;
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
    function gpt_GetNonCMEArticle() {
        var url;
        $('.articleCitation').each(function (i, obj) {
            if ($(obj).find('.toc__item__detials').length > 0) {
                var itemDetails = $(obj).first().find('.toc__item__detials');
                var cmeFound = 0;
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='CME']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='(CME)']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='Education']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='education']").length; }
                if (cmeFound == 0) {
                    var itemLink = $(itemDetails).first().find('.toc__item__title');
                    var linkCount = $(itemLink).first().find("a:contains('CME')").length;
                    if (linkCount == 0) {
                        url = $(itemLink).first().find('a').attr('href');
                        return false;   //Found a URL, break the loop
                    }
                }
            }
        });
        return url;
    }
	//--------------------------------------------------------------------------
	function gpt_GetElapsedTime() {
		var endTime = new Date();
		var timeDiff = endTime - gpt_StartTime; //in ms
		// strip the ms
		timeDiff /= 1000;

		// get seconds
		return seconds = Math.round(timeDiff) + " seconds";
	}
	//--------------------------------------------------------------------------
	function gpt_CheckSSC() {
		//Check for ScreenShot Client
		var gpt_SSC = gpt_GetQuerystring('gpt_ssc', '');
		if (gpt_SSC == '1') {
			//it's the ScreenShotClient, disable MOAT IVT Detection
			$('#gpt-Variables').append('<input type="hidden" id="gptm_data">');
			$('#gptm_data').val(0);
			gpt_Target("m_data");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_LocalSS(adTypeId) {
		window.scrollTo(0, 0);
		gpt_Sleep(1000);
		gpt_ScrollToAd(adTypeId);
		gpt_PreTearsheet(adTypeId);
	}
	//--------------------------------------------------------------------------
	function gpt_InitScripts() {
		if (gpt_AdFile == "PU") {
			if (gpt_IsProd) {
				gpt_ContextualURL = gpt_CheckForNULL($('#canonicalurl').val());
				if (gpt_ContextualURL === null) {
					gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				}
				else {
					gpt_ContextualURL = window.location.origin + gpt_ContextualURL;
				}
				var useSSL = 'https:' == document.location.protocol;
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}
		}
		else {
			//JBS-Cell-Lancet
			var useSSL = 'https:' == document.location.protocol;

			var gads = document.createElement('script');
			gads.async = true;
			gads.type = 'text/javascript';
			gads.src = (useSSL ? 'https:' : 'http:') + '//securepubads.g.doubleclick.net/tag/js/gpt.js';
			document.head.appendChild(gads);

			if (gpt_IsProd && gptContextualEnabled) {
				gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}

			var elsevierMoatHeader = document.createElement('link');
			elsevierMoatHeader.rel = 'preload';
			elsevierMoatHeader.as = 'script';
			elsevierMoatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(elsevierMoatHeader);

			var elsevierMoatAds = document.createElement('link');
			elsevierMoatAds.rel = 'preconnect';
			elsevierMoatAds.src = (useSSL ? 'https:' : 'http:') + '//mb.moatads.com';
			document.head.appendChild(elsevierMoatAds);

			var moatHeader = document.createElement('script');
			moatHeader.async = true; gads.type = 'text/javascript';
			moatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(moatHeader);
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForMOATInit() {
		//Check every 1/10 of a second until MOAT is Loaded or 1 second timeout
		if (gpt_MOATInitAttempts < gpt_MaxMOATInitAttempts) {
			gpt_MOATInitAttempts += 1;
			if (typeof window.moatPrebidApi === "object") {
				//MOAT LOADED
				gptMoatInit_Debug = '0.0' + gpt_MOATInitAttempts + ' seconds';
				gpt_CheckForMOATReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATInit(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not LOADED
			gptMoatInit_Debug = 'Timeout Expired';
			var googletag = googletag || {};
			googletag.cmd = googletag.cmd || [];
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForMOATReady() {
		//Check every 1/10 of a second until MOAT is Ready or 1 second timeout
		if (gpt_MOATReadyAttempts < gpt_MaxMOATReadyAttempts) {
			gpt_MOATReadyAttempts += 1;
			if (window.moatPrebidApi.safetyDataAvailable()) {
				//MOAT Ready
				gptMoatReady_Debug = '0.0' + gpt_MOATReadyAttempts + " seconds";
				gpt_CheckForContextualReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATReady(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not Ready
			gptMoatReady_Debug = 'Timeout Expired';
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForContextualReady() {
		//Check every 1/10 of a second until Contextual is Ready or 2 second timeout
		if (gpt_IsProd && gptContextualEnabled) {
			//Enabled
			if (gpt_ContextualReadyAttempts < gpt_MaxContextualReadyAttempts) {
				gpt_ContextualReadyAttempts += 1;
				if (gpt_ContextualReady) {
					//Contextual Ready
					gptContextualURL_Debug = gpt_ContextualURL;
					gptContextualReady_Debug = '0.0' + gpt_ContextualReadyAttempts + " seconds";
					gptContextualInit_Debug = gs_channels;
					gpt_InitAds();
				}
				else {
					setTimeout(() => { gpt_CheckForContextualReady(); }, 100);
				}
			}
			else {
				//LOG TIMEOUT error
				//REMOVE FOR NOW (SHOULD LOG TO A DIFF LOCATION)
				//TIMEOUT: Contextual Not Ready
				$('#gpt_GrapeShotDebugBtn').remove();
				gptContextualURL_Debug = gpt_ContextualURL;
				gptContextualReady_Debug = 'Timeout Expired';
				gptContextualInit_Debug = "";
				gpt_InitAds();
			}
		}
		else {
			//Not Enabled
			$('#gpt_GrapeShotDebugBtn').remove();
			switch (gpt_AdFile) {
				case 'PU':
				case 'LANCET':
				case 'JBS':
					gptContextualURL_Debug = 'Not enabled outside of Production';
					gptContextualReady_Debug = 'Not enabled outside of Production';
					gptContextualInit_Debug = 'Not enabled outside of Production';
					break;
				case "CELLJOURNAL":
				case "CELLBUCKET":
					gptContextualReady_Debug = 'Not enabled on Cell';
					gptContextualInit_Debug = 'Not enabled on Cell';
					gptContextualURL_Debug = 'Not enabled on Cell';
					break;
			}
			gpt_InitAds();
		}
	}
	//--------------------------------------------------------------------------
	function GPT_GetPageByURL() {
		var host = window.location.host.toLocaleLowerCase()
		var localpath = window.location.pathname.toLocaleLowerCase();

		///Check for Cell.com
		if (host.indexOf('cell.com') >= 0) {
			return null;
		}

		///Check for Cell.com (marlin-stag)
		if (host.indexOf('www-cell-com') >= 0) {
			return null;
		}

		///Check for Lancet
		if (host.indexOf('thelancet') >= 0) {
			return null;
		}

		if (localpath.indexOf('/article/') >= 0) {
			return 'article.fulltext';
		}

		if (localpath.indexOf('/action/dosearch') >= 0) {
			return 'search.searchResults';
		}

		if (localpath.indexOf('/content/') >= 0) {
			return 'periodical.editorial';
		}

		return 'periodical.home';
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForNULL(x, valueifnull) {
		if (typeof valueifnull == "undefined") {
			valueifnull = null;
		}

		if (typeof x == 'undefined') {
			return valueifnull;
		}
		if (x == null) {
			return valueifnull;
		}
		if (x == "null") {
			return valueifnull;
		}
		if ($.trim(x) == '') {
			return valueifnull;
		}

		return x;
	}
	//--------------------------------------------------------------------------
	function gpt_GetAdditionalTargeting() {
		//adds page level targeting of custom variables
		//the id (minus gpt) and the value will be used as a key-value pair
		//eg: <input type="hidden" id="gptissuepii" value="x" class="gpt-Target">
		//eg: target issuepii=x
		$(".gpt-Target").each(function (index) {
			var gptTargetId = $(this).attr('id');
			gptTargetId = gptTargetId.replace('gpt', '').toLowerCase();
			if (gptTargetId !== '') {
				gpt_Target(gptTargetId);
			}
		})
	}
	//--------------------------------------------------------------------------
	function gpt_GetQuerystring(key, default_) {
		//function to read querystring variables
		if (default_ === null) default_ = '';
		key = key.replace(/[\[]/, "\\\[").replace(/[\]]/, "\\\]");
		var regex = new RegExp("[\\?&]" + key + "=([^&#]*)");
		var qs = regex.exec(window.location.href);
		if (qs === null)
			return default_;
		else
			return qs[1];
	}
	//--------------------------------------------------------------------------
	function gpt_GetDFPTestId() {
		//Get any request for a test id from querystring and set custom targeting parameter
		var gptDFPTestId = gpt_GetQuerystring('dfptestid', '');
		if (gptDFPTestId !== '') {
			$('#gpt-Variables').append('<input type="hidden" id="gptDFPTestId">');
			$('#gptDFPTestId').val(gptDFPTestId);
			gpt_Target("DFPTestId");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Target(targetName) {
		//Set page level target if value is found
		if ($('#gpt' + targetName).length > 0) {
			var targetValue = $('#gpt' + targetName).val();

			if (targetValue !== '') {
				targetValue = targetValue.replace(/[^-a-z0-9]/ig, '');	//Only Allow a-z, 0-9
				googletag.pubads().setTargeting(targetName.toLowerCase(), targetValue.toLowerCase());
				gptCustomTargeting_Debug = gptCustomTargeting_Debug + targetName.toLowerCase() + ' = ' + targetValue.toLowerCase() + '<br>';
			}
		}
	}
	//--------------------------------------------------------------------------
	function gpt_TargetAccessType() {
		var currentAccessType = $('#gptAccessType').val();
		if (typeof currentAccessType == "undefined") {
			currentAccessType = "";
		}
		if (currentAccessType.indexOf('ANON_IP') >= 0) {
			googletag.pubads().setTargeting("loggedin", "yes");
		}
		else {
			gpt_Target("LoggedIn");
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_PreTearsheet(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		//Remove Elsevier Cookie Policy Notice
		if ($("#onetrust-consent-sdk").length > 0) {
			$("#onetrust-consent-sdk").remove();
		}

        //Mobile Nav
        $('#skip').remove();
        $('skipNavigationLink').remove();

		//JBS Modals
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.usabilla__overlay').length > 0) {
			$('.usabilla__overlay').remove();
		}

		//Pendo
		if ($('._pendo-step-container').length > 0) {
			$('._pendo-step-container').remove();
		}
		if ($('._pendo-guide-tt_').length > 0) {
			$('._pendo-guide-tt_').remove();
		}
		if ($('._pendo-image').length > 0) {
			$('._pendo-image').remove();
		}
		if ($('._pendo-badge-image').length > 0) {
			$('._pendo-badge-image').remove();
		}

		switch (gpt_AdFile) {
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Mobile Bug Fix on Cell
				if (parseInt(adTypeId) == 5) {
					$('.widget-horizontalAd').css('position', 'static');
					$('.body-horizontalAd').css('display', 'block');
				}
				break;
			case "JBS":
			case "LANCET":
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 3: //MPU
					case 4: //SkyScraper
						//BUGFIX: Show Sidebar ad for JBS
						//skyscraper & mpu
						if ($('.widget-verticalAd').length > 0) {
							$('.widget-verticalAd').css('display', 'block');
						}
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
					case 6:     //Prestitial
						$('#backgroundLayer').css('display', 'block');
						break;
					default:
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Sleep(ms) {
		return new Promise(resolve => setTimeout(resolve, ms));
	}
	//--------------------------------------------------------------------------
	async function gpt_ScrollToAd(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		var adId = "";
		var offset = 0;
		var objLeaderboard = "";
		var gpt_ScrollToAd = true;

		switch (gpt_AdFile) {
			case "PU": //PracticeUpdate
				var hideOtherAds = true;
				$('#modalPrestitial').modal('hide');
				$('.jumbotron-welcome').hide();
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 2:
						//LeaderBoard, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 3:
						//MPU
						adId = "adSlot2";
						break;
					case 4:
						//SkyScraper
						adId = "adSlot3";
						$('.most-read').hide();
						break;
					case 5:
						//Mobile, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 6:
						//Interstitial
						gpt_ScrollToAd = false;
						adId = "adSlot15";
						await gpt_Sleep(1000);
						$(objLeaderboard).hide();
						$('#modalPrestitial').unbind();
						$('#modalPrestitial').modal();
						break;
					case 7:
						//Native Ad
						break;
					case 10:
						//Master Companion
						hideOtherAds = false;
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
				}
				if (hideOtherAds) {
					//Hide all other ads
					$('.ad-container').each(function (i, obj) {
						if (this.id !== adId) {
							var tempParent = this.id;
							tempParent = tempParent.replace("adSlot", "adParent");
							$("#" + tempParent).addClass('hide');
						}
					});
				}
				break;
			case "JBS":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$(".widget-verticalAd").hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="sidebar"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					case 13:	    //Phone - Portrait
					case 14:        //Phone - Landscape
						$(objLeaderboard).hide();
						offset = 60;
						adId = 'gpt-Interscroller';
						gpt_ScrollToAd = true;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
			case "CELLJOURNAL":
			case "CELLBUCKET":
				objLeaderboard = ".js__adToHide";
				offset = 260;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="boombox"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				//Hide the second ad if found
				var tCount = 0;
				$(".widget.literatumAd.none.GPT-ad-placeholder.widget-horizontalAd.widget-compact-all").each(function (index) {
					tCount += 1;
					if (tCount !== 1) {
						$(this).hide();
					}
				});
				break;
			case "LANCET":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="skyscraper"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
		}

		//Scroll to Top
		var gpt_container = $("html,body");
		gpt_container.animate({ scrollTop: 0, scrollLeft: 0 });

		if (gpt_ScrollToAd) {
			//If Adexists, scroll to it
			var gpt_scrollTo = $('#' + adId);
			if (gpt_scrollTo.length > 0) {
				//Scroll to the Ad
				var gpt_topPosition = gpt_scrollTo.offset().top - gpt_container.offset().top + gpt_container.scrollTop();
				if (gpt_topPosition > 0) {
					gpt_container.animate({ scrollTop: gpt_topPosition, scrollLeft: 0 });
					if (gpt_topPosition - offset > 0 && offset > 0) {
						gpt_container.animate({ scrollTop: gpt_topPosition - offset, scrollLeft: 0 });
					}
				}
			}
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForCookiePolicy() {
		var returnVal = false;
		if ($('#onetrust-accept-btn-handler').length > 0) {
			$('#onetrust-accept-btn-handler').click();
			returnVal = true;
		}
		return returnVal;
	}
	//--------------------------------------------------------------------------
	function gpt_InitAds() {
		var gpt_ResponsiveHomepage = false;

		switch (gpt_AdFile) {
			case "JBS":
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Responsive Check
				if ($('#hdrHomeBrand').length > 0) {
					gpt_ResponsiveHomepage = true;
				}
				break;
		}

		//InterScroller Check
		if (gpt_AdFile === "JBS") {
			var gpt_InterScrollerEnabled = false;
			var gpt_InterScrollerInsertObj;

			if ($("#articleHeader").length > 0) {
				//It's an article Page
				if ($('.article__sections > section').length > 0) {
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".article__sections > section");
				}
			}
			else {
				if ($('.toc__section').length > 0) {
					//It's a TOC Page
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".toc__section").first();
				}
			}

			//Add the Interscroller
			if (gpt_InterScrollerEnabled) {
				gpt_InterScrollerInsertObj.first().append($("#gpt-Interscroller").clone());
				$("#gpt-Interscroller").remove();
				$(".gpt-adinterscroller").addClass("gpt-ad");
			}
		}

		googletag.cmd.push(function () {
			var gptBoomBoxSizeMapping;
			var gptFluidMapping;
			var gptHomePageSidebarMapping;
			var gptCellHomePageSidebarMapping;
			var gptInterscrollerMapping;
			var gptLeaderboardSizeMapping;
			var gptMobileSizeMapping;
			var gptPrestitialMapping;
			var gptRectangleShortSizeMapping;
			var gptRectangleSizeMapping;
			var gptSideBarSizeMapping;
			var gptTallSizeMapping;
			var gptWideSizeMapping;
			var gptWideRectangleSizeMapping;

			//***********************************************
			//Start Define Size mapping based on client Viewport
			//***********************************************
			if (gpt_AdFile === 'PU') {
				gptTallSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 600], [160, 600], [120, 600]]).
					addSize([0, 0], []).
					build();

				gptRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250]]).
					addSize([0, 0], []).
					build();

				gptRectangleShortSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250], [320, 50], [300, 50]]).
					addSize([0, 0], [[300, 250], [320, 50], [300, 50]]).
					build();

				gptWideSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([760, 0], [[728, 90], [320, 50], [300, 50]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptWideRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], []).
					addSize([760, 0], [[320, 50], [300, 50], [300, 250]]).
					addSize([0, 0], [[320, 50], [300, 50], [300, 250]]).
					build();

				gptMobileSizeMapping = googletag.sizeMapping().
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([760, 0], [[1, 1]]).
					build();
			}
			else {
				//JBS-CELL-LANCET
				gptLeaderboardSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([768, 0], [[728, 90]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptHomePageSidebarMapping = googletag.sizeMapping().
					addSize([2090, 795], [[300, 600], [300, 250], [160, 600], [120, 600]]).
					addSize([1910, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptCellHomePageSidebarMapping = googletag.sizeMapping().
                    addSize([2180, 795], [[300, 600], [160, 600], [120, 600], [300, 250], [336, 280]]).
					addSize([2180, 445], [[336, 280]]).
                    addSize([2090, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
                    addSize([2090, 445], [[300, 250]]).
					addSize([1830, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptSideBarSizeMapping = googletag.sizeMapping().
					addSize([1140, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
					addSize([1140, 445], [[300, 250]]).
					addSize([0, 0], []). 				
					build();

				gptBoomBoxSizeMapping = googletag.sizeMapping().
					addSize([768, 0], [[300, 250], [336, 280]]).
					addSize([0, 0], []). 						
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([600, 700], [[1, 1]]).
					addSize([0, 0], []).
					build();

				gptInterscrollerMapping = googletag.sizeMapping().
					addSize([1140, 445], []).
					addSize([1024, 768], [[1024, 768]]).
					addSize([768, 1024], [[768, 1024]]).
					addSize([480, 320], [[480, 320]]).
					addSize([320, 480], [[320, 480]]).
					build();
			}
			//***********************************************
			//End Define Size mapping based on client Viewport
			//***********************************************

			//***********************************************
			//Start detection for ad slots on page
			//***********************************************
			var gptMasterPage = gpt_CheckForNULL($('#gptPage').val());
			var gptMasterSite;

			if (gpt_AdFile === 'PU') {
				gptMasterSite = $('#gptSite').val();
			}
			else {
				//JBS-CELL-LANCET
				gptMasterSite = "dev";

				if (gpt_IsProd) {
					gptMasterSite = gpt_CheckForNULL($('#gptSite').val());

					//If there is no master site, check for a defaultsite
					if (gptMasterSite == null) {
						gptMasterSite = gpt_CheckForNULL($('#gptDefaultSite').val());
					}
				}
				else {
					//Dev ENV
					//If the page has no gptSite Value, assume no value which will disable ads
					if (gpt_CheckForNULL($('#gptSite').val()) === null) {
						gptMasterSite = null;
					}
				}

				//If there is no master Page, check for a Page using the URL
				if (gptMasterPage === null) {
					gptMasterPage = GPT_GetPageByURL();
				}
			}

			$(".gpt-ad").each(function (index) {
				var gptPage = '';
				var adSizeMapping = '';
				var gptPOS;
				var gptTC;
				var gptNative;
				var adId;
				var gptSite;
				var tempSlot = null;


                if (gpt_IsProd) {
					if (gpt_AdFile !== "CELLJOURNAL") {
						//Check if the ad slot has it's own site defined
						if (typeof $(this).data('site') === 'undefined') {
							gptSite = gptMasterSite;
						}
						else {
							gptSite = gpt_CheckForNULL($(this).data('site'));
						}
					}
					else {
						gptSite = gptMasterSite;
					}
                }
                else {
					gptSite = gptMasterSite;
                }



				if (gpt_AdFile === 'PU') {
					adId = $(this).attr('id');
				}
				else {
					//JBS-CELL-LANCET
					adId = 'gpt-ad-' + index + 1;
				}

				if (gpt_CheckForNULL(gptSite) !== null) {
					gptSite_Debug = gptSite;

					gptPOS = parseInt($(this).data('pos')) || -1;
					if (gptPOS === -1) {
						gptPOS = index + 1;
					}

					//Check if the ad slot has it's own page defined
					gptPage = $(this).data('page');
					if (gpt_CheckForNULL(gptPage) == null) {
						//Use the Master Page
						gptPage = gptMasterPage;
					}

					//If the page is not null, preceed it with a slash
					if (gptPage !== null) {
						gptPage = '/' + gptPage;
					}
					else {
						gptPage = '';
					}
					gptPage_Debug = gptPage;


					gptTC = $(this).data('tc');
					if (typeof gptTC === "undefined") {
						gptTC = '';
					}

					gptNative = $(this).data('native');
					if (typeof gptNative === "undefined") {
						gptNative = '';
					}

					//Determine sizemapping based on data-adsize
					if (gpt_AdFile === 'PU') {
						switch ($(this).data('adsize')) {
							case 'tall':
								adSizeMapping = gptTallSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600]], adId);
								break;
							case 'rectangle':
								adSizeMapping = gptRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								break;
							case 'rectangleshort':
								adSizeMapping = gptRectangleShortSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [320, 50], [300, 50]], adId);
								break;
							case 'wide':
								adSizeMapping = gptWideSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'widerectangle':
								adSizeMapping = gptWideRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50], [300, 250]], adId);
								break;
							case 'mobile':
								adSizeMapping = gptMobileSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50]], adId);
								break;
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[1, 1]], adId);
								break;
						}
					}
					else {
						//JBS-CELL-LANCET
						switch ($(this).data('adsize')) {
							case 'cell-leaderboard':
							case 'leaderboard':
								adSizeMapping = gptLeaderboardSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'bottom':
								if (gpt_ResponsiveHomepage) {
									adSizeMapping = gptHomePageSidebarMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'boombox':
								if (gpt_AdFile === "CELLJOURNAL" || gpt_AdFile == "CELLBUCKET") {
									if (gpt_ResponsiveHomepage) {
										adSizeMapping = gptCellHomePageSidebarMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250], [336, 280]], adId);
									}
									else {
										adSizeMapping = gptBoomBoxSizeMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [336, 280]], adId);
									}
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'interscroller':
								adSizeMapping = gptInterscrollerMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 480], [480, 320], [768, 1024], [1024, 768]], adId);
								break;
							case 'sidebar':
							case 'skyscraper':
								adSizeMapping = gptSideBarSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								break;
							case 'native':
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
						}
					}
				}

				//Ignore any invalid adsizes that could be on the page
				if (adSizeMapping !== '') {
					$(this).addClass('gpt-ad-defined');
					if (gpt_AdFile !== 'PU') {
						$(this).attr('id', adId);
					}
					tempSlot.defineSizeMapping(adSizeMapping).addService(googletag.pubads()).setTargeting("pos", gptPOS);

					if (gptTC !== '') {
						tempSlot.setTargeting("tc", gptTC);
					}
					if (gptNative !== '') {
						tempSlot.setTargeting("native", gptNative);
					}
					gptEvent_Debug = gptEvent_Debug + $(this).data('adsize') + ' Requested<br>';
				}
				else {
					gptInvalidAdSize_Debug = gptInvalidAdSize_Debug + "Invalid Size Found, Id: " + $(this).prop('id') + ', adSize: ' + $(this).data('adsize') + '<br>';
					$(this).remove();
				}
			});
			if (gpt_CheckForNULL(gptInvalidAdSize_Debug) === null) {
				gptInvalidAdSize_Debug = "None Detected";
			}
			//***********************************************
			//End detection for ad slots on page
			//***********************************************

			//***********************************************
			//Start page level targeting
			//***********************************************
			if (gpt_AdFile !== 'PU') {
				//Logged in or IP Access
				gpt_TargetAccessType();

				//Check for Screenshot Client
				gpt_CheckSSC();
			}

			//Check for DFP Test
			gpt_GetDFPTestId();

			//Check for Additional Targeting
			gpt_GetAdditionalTargeting();

			if (gpt_IsProd && gptContextualEnabled) {
				var gpt_ContextualRetry = false;
				//Check for Contextual Targeting
				if (gs_channels !== "DEFAULT") {
					var gpt_ContextualCategories = Array.from(gs_channels);
					for (var i = 0; i < gpt_ContextualCategories.length; i++) {
						if (gpt_ContextualCategories[i] == 'gx_retry') {
							gpt_ContextualRetry = true;
						}
						if (!gpt_ContextualCategories[i].startsWith("custom_")) {
							//Remove any tag that is not custom
							gpt_ContextualCategories.splice(i, 1);
							i--;
						}
						else {
							//Strip the 'custom_' from the tag
							gpt_ContextualCategories[i] = gpt_ContextualCategories[i].replace("custom_", "")
						}
					}
					if (gpt_ContextualCategories.length > 0) {
						googletag.pubads().setTargeting("gs_cat", gpt_ContextualCategories);
					}
					else {
						gpt_ContextualCategories = 'none';
					}
					if (gpt_ContextualRetry) {
						gpt_ContextualCategories = "*Indexing*";
					}
					gptContextualResult_Debug = gpt_ContextualCategories;
				}
				else {
					gptContextualResult_Debug = 'No segments found';
				}
			}
			else {
				//Not Prod || Contextual not enabled
				gptContextualResult_Debug = 'Not enabled';
				
				if (!gpt_IsProd) {
                    var gpt_DevSite = gpt_CheckForNULL($('#gptSite').val(), "dev");
                    $('#gpt-Variables').append('<input type="hidden" id="gptEnvironment" value="' + gpt_DevSite + '">');
                    gpt_Target("Environment");
                }

			}
			//***********************************************
			//End page level targeting
			//***********************************************

			//Enable google dfp services
			if (parseInt($('#gptLazyLoading').val()) === 1) {
				googletag.pubads().enableLazyLoad({
					fetchMarginPercent: 200,
					renderMarginPercent: 0,
					mobileScaling: 2.0
				});
			}
			else {
				googletag.pubads().enableSingleRequest();
			}

			//Add Listener for RenderEnded
			googletag.pubads().addEventListener('slotRenderEnded', function (event) {
				if (!event.isEmpty) {
					if (typeof LocalAdLoaded === "function") {
						LocalAdLoaded(event);
					}
					if (gpt_ResponsiveHomepage) {
						if (typeof positionAd === "function") {
							positionAd();
						}
					}
					if (event.size[0] == "480" || event.size[1] == "480") {
						$('.gpt-InScrollBox').css('display', 'block');
						gptEvent_Debug = gptEvent_Debug + 'Interscroller ' + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}
					else {
						gptEvent_Debug = gptEvent_Debug + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}

				}
			});

			if (gpt_AdFile !== 'PU') {
				googletag.pubads().collapseEmptyDivs();
			}
			googletag.enableServices();

			//Populate Defined Ad Slots
			$(".gpt-ad-defined").each(function (index) {
				var adId = $(this).attr('id');
				googletag.cmd.push(function () { googletag.display(adId); });
			});

			gptStatus_Debug = 'GPT Complete';
		});
	}
	//--------------------------------------------------------------------------
	function gpt_DisplayDebug() {
		//Clone the template and append to Body
		$(document.body).append($('#gpt-DebugDiv').clone());
		$('#gpt-DebugDiv').remove();

		//Populate the Values
		gpt_LoadDebugValues();

		//Display and scroll to debug section
		$('.gpt-DebugDiv').css('display', 'block');
		window.scrollTo(0, document.body.scrollHeight);
	}
	//--------------------------------------------------------------------------
	function gpt_LoadDebugValues() {
		$('.gpt-DebugBtn').blur();
		$('.gptVersion_Debug').text(gpt_Version);
		$('.gptAdFile_Debug').html(gpt_AdFile);
		$('.gptEvent_Debug').html(gptEvent_Debug);
		$('.gptCustomTargeting_Debug').html(gptCustomTargeting_Debug);
		$('.gptSite_Debug').text(gptSite_Debug);
		$('.gptContextualResult_Debug').text(gptContextualResult_Debug);
		$('.gptContextualInit_Debug').text(gptContextualInit_Debug);
		$('.gptContextualURL_Debug').text(gptContextualURL_Debug);
		$('.gptContextualReady_Debug').text(gptContextualReady_Debug);
		$('.gptMoatReady_Debug').text(gptMoatReady_Debug);
		$('.gptMoatInit_Debug').text(gptMoatInit_Debug);
		$('.gptTestENV_Debug').text(gptTestENV_Debug);
		$('.gptDisableAds_Debug').text(gptDisableAds_Debug);
		$('.gptStatus_Debug').text(gptStatus_Debug);
		$('.gptPage_Debug').text(gptPage_Debug);
		$('.gptInvalidAdSize_Debug').html(gptInvalidAdSize_Debug);
	}
	//--------------------------------------------------------------------------
	function gpt_GrapeShotDebug() {
		$('.gpt-DebugBtn').blur();
		window.open("http://admin-elsevier.grapeshot.co.uk/custom/bookmarklet.cgi?blocking=1&vn=2&url=" + encodeURIComponent(document.location), "GRAPESHOT_POPUP", "width=650,height=600,scrollbars=yes,screenX=40,screenY=50,menubar=no,toolbar=no,resizable=yes", "Custom").focus();
	}
	//--------------------------------------------------------------------------
	function gpt_ShowConsole() {
		$('.gpt-DebugBtn').blur();
		googletag.openConsole();
	}
	//--------------------------------------------------------------------------
</script>
        </div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="912135d6-7135-4d45-b457-b503cacc3c8b" data-widget-name="ux3-layout-widget"><header class="header base fixed">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header js__adToHide widget-horizontalAd" id="9d6062d7-fad6-4e64-81cc-7dd25d99b23d">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 1 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="1"></div>
<!-- End AdSlot 1 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" class="header__wrapper clearfix" data-db-parent-of="quickSearch"><div id="brandingRow"><a href="/" data-aa-name="science that inspires" data-aa-region="cp global header" title="Visit Cell.com">Science that inspires</a><p id="brandingRowRight"><a href="/" data-aa-name="cell press endorsement" data-aa-region="cp global header" title="Visit Cell.com">A Cell Press journal</a></p></div>
        
    

        


    

            

            

            <div data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" data-widget-name="ux3-layout-widget"><div class="col-xs-6 header__left-side">
    

        


    

            

            
                <a href="/home" id="cpIconLnk" data-aa-name="cell press logo" data-aa-region="cp global header" title="Cell Press" target="_blank"><svg id="cp_logo" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 100 98.1" style="enable-background:new 0 0 100 98.1;" xml:space="preserve" height="100" width="98.1"><path style="fill:#FFFFFF;" d="M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z"></path></svg></a><div class="journal-logos">
            

            <span data-widget-id="35d8d734-3aa0-4ec8-9e2d-14babe803594" data-widget-name="ux3-general-image"><a href="/cell/home" title="Cell"><img alt="Cell" src="/pb-assets/ux3/logos/cell/Cell_white-1532516611593.svg"></a></span>

            
                </div>
            

        

    

        


    

            

            
                <div class="journal-logos">
            

            <span data-widget-id="3ffcbf1f-79fd-4ba3-85b5-bef10a63475f" data-widget-name="ux3-general-image"><a href="https://www.cell.com/open-access?utm_source=oa-label&amp;__hstc=109691226.e4e812b53ff324eccbdbdb2e4fb9a6ab.1644503737405.1644524234622.1644587109507.4&amp;__hssc=109691226.7.1644587109507&amp;__hsfp=3253153019" title="This journal offers authors two options (open access or subscription) to publish research"><img alt="This journal offers authors two options (open access or subscription) to publish research" src="/pb-assets/ux3/logos/cell/Supports_open_access_border-1645554937897.svg"></a></span>

            
                </div>
            

        
</div><div class="col-xs-6">
    

        


    

            

            

            <div data-widget-id="2555f6db-b333-4edb-8b15-ef9213f1f0a5" data-widget-name="ux3-layout-widget"><div class="header__nav row">
    

        


    

            

            

            <ul data-widget-id="52432d24-0331-4c9d-85f3-2033edc7208b" data-widget-name="UX3ProfileLinksWidget" class="rlist rlist--inline profile-links"><li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login-dropdown"><div class="profile-links__user-list__wrapper"><button data-db-target-for="loginmenu-403554" aria-expanded="false" aria-controls="login-links-403554" title="Log in links dropdown" class="profile-links__username"><span>Log in</span></button><div data-db-target-of="loginmenu-403554" id="login-links--403554" class="profile-links__user-list__holder dropBlock__holder"><ul class="rlist profile-links__list"><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901561-0" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901561-0" target="_self" data-profile-link="true">Get Institutional Access</a></li></ul></div></div></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901561-0" target="_self" data-profile-link="true">Register</a></li><li class="hidden-lg"> <div class="profile-links__controls"> <button aria-expanded="false" aria-controls="links-dialog-403554" data-opens="#links-dialog-403554" class="profile-links__btn--open"><span class="sr-only">open links dialog</span><i aria-hidden="true" class="icon-gizmo-person"></i></button></div><dialog id="links-dialog-403554" aria-modal="true"><button data-closes="#links-dialog-403554" class="profile-links__btn--close"><span class="sr-only">close links dialog</span><i aria-hidden="true" class="icon-close-solid"></i></button><ul>   <li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901561-0" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901561-0" target="_self" data-profile-link="true">Get Institutional Access</a></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2821%2901561-0" target="_self" data-profile-link="true">Register</a></li></ul></dialog></li></ul>

            

        
</div></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasInstitutionBanner none  widget-none" id="51b7fa33-2137-4f58-9e98-9746c4400513" style="display: none;">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><div class="ui-state-highlight ui-corner-all csas-institution-banner hidden" data-doi="10.1016/j.cell.2021.12.039">
    <span class="ui-icon ui-icon-close banner-close"></span>
    <p>
        Access provided by <span class="accountName"></span>
    </p>
</div>

<style>
    .csas-institution-banner {
        padding: 10px 0 0 10px;
        margin: 5px;
    }

    .csas-institution-banner.ui-state-highlight .ui-icon {
        background-image: url("/templates/jsp/css/jquery-ui-1.10.2/base/images/ui-icons_454545_256x240.png");
        margin-right: 5px;
        margin-top: -4px;
    }

    .csas-institution-banner .banner-close {
        float: right;
    }
</style>

<script>

    function resetBanner(doi) {
        $.get('/action/getAccount?doi=' + doi, function(data) {
            if (data) {
                $(".csas-institution-banner p .accountName").html(data);
                $(".csasInstitutionBanner").fadeIn();
                $(".csas-institution-banner").fadeIn();
            }
        });
    }

    var flag = 0;
    $(document).ready(function() {
        if(!$(".csas-institution-banner").is(":visible")){
            $(".csasInstitutionBanner").hide();
        }

        $(".banner-close").click(function() {
            $.get("/action/dismissBanner", function(data) {
                $(".csasInstitutionBanner").fadeOut(function () {
                    if(typeof UX !== 'undefined') {
                        UX.pageBody.init();
                    }
                });
            });
        });

        $(".articleContent .tabs li[role='tab'].showFullText").click(function() {
           flag = 1;
        });

        $(document).on("reloadTabsContent", function() {
            var isSelected = $(".articleContent .tabs li[role='tab'].showFullText").hasClass("active");
            if (isSelected) {
                var isHidden =  $(".csas-institution-banner").is(".hidden");
                if (!isHidden) {
                    resetBanner($(".csas-institution-banner").data("doi"));
                    console.log("fadeIn");
                }
            } else {
                $(".csas-institution-banner").fadeOut();
                console.log("fadeOut");
            }
            flag = 0;
        });

        $(document).on("click", ".articleContent .tabs li[role='tab']", function() {

        });
    });
</script></div>
                </div>
                </div>

        
</header></div>

            

        










        <div data-widget-def="graphQueryWidget" data-widget-id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" class="ux3">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget graphQueryWidget none top-padding-handler noMargin axel-mega-menu widget-none widget-compact-all fonts-loaded" id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" style="padding-top: 115.594px;">
                
                
                    
                

                <div class="wrapped " id="CP TOP LEVEL NAV MENU">
                    
                    <div class="widget-body body body-none  body-compact-all"><nav id="mega-menu-nav" role="navigation" class="mega-menu-nav">
  <!--.skip//a(href='#searchText' aria-label='Skip menu') Skip menu
  -->
  <div class="mega-menu-nav__wrapper">
    <button class="mega-menu__toggle"><span class="sr-only">Main menu</span><i aria-hidden="true" class="icon-gizmo-hamburger"></i></button>
    <ul role="menubar" class="mega-menu rlist">
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-1" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-1" data-item-link="main-menu-link-1" data-index="0" class="mega-menu__item-link menu-link"><span>This journal</span></a>
        <div id="main-menu-panel-1" aria-labelledby="main-menu-link-1" data-item-wrapper="main-menu-link-1" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <div aria-label="Menu dropzone section" tabindex="-1" class="listDropZone">
    

        


    

            

            

            <div class="cover-image"><div class="cover-image__thumb"><a href="/issue/S0092-8674(24)X0012-4" class="menu-link"><img src="/cms/asset/atypon:cms:attachment:img:d5e6:rev:1748270185670-389:pii:S0092867424X00124/cover.tif.jpg" alt="Cover Image - Cell, Volume 188, Issue 11"></a></div><div class="cover-image__meta"></div></div>

            

        
</div>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-2" class="sub-menu__heading">Read
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/newarticles" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Online now</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/current" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Current issue</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/archive" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Archive</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/action/showPreferences?menuTab=Alerts" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Publication alerts</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sneakpeek" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Sneak Peek - preprints</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-3" class="sub-menu__heading">About
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-2">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/advisory-board" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Advisory board</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/aims" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Aims and scope</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/contact" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/editors-and-staff" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Editors and staff</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/editorial-ethics" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Ethics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/permissions" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Permissions</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Reviewer instructions</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-2" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-2" data-item-link="main-menu-link-2" data-index="1" class="mega-menu__item-link menu-link"><span>Journals</span></a>
        <div id="main-menu-panel-2" aria-labelledby="main-menu-link-2" data-item-wrapper="main-menu-link-2" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-1" class="sub-menu__heading">Life &amp; medical sciences
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-4">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cancer-cell/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cancer Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-chemical-biology" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Chemical Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-genomics/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Genomics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-host-microbe/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Host &amp; Microbe</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-metabolism/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-medicine/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-stem-cell/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Stem Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-systems/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Systems</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/current-biology/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Current Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/developmental-cell/home" data-index="11" role="menuitem" class="sub-menu__item-link menu-link"><span>Developmental Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/immunity/home" data-index="12" role="menuitem" class="sub-menu__item-link menu-link"><span>Immunity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/med/home" data-index="13" role="menuitem" class="sub-menu__item-link menu-link"><span>Med</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-cell/home" data-index="14" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/neuron/home" data-index="15" role="menuitem" class="sub-menu__item-link menu-link"><span>Neuron</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/structure/home" data-index="16" role="menuitem" class="sub-menu__item-link menu-link"><span>Structure</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/ajhg/home" data-index="17" role="menuitem" class="sub-menu__item-link menu-link"><span>American Journal of Human Genetics (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysj/home" data-index="18" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Journal (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysreports/home" data-index="19" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/hgg-advances/home" data-index="20" role="menuitem" class="sub-menu__item-link menu-link"><span>Human Genetics and Genomics Advances (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-plant/home" data-index="21" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Plant (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/molecular-therapy/home" data-index="22" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/methods/home" data-index="23" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Methods &amp; Clinical Development (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/nucleic-acids/home" data-index="24" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Nucleic Acids (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/oncology/home" data-index="25" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Oncology (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/plant-communications/home" data-index="26" role="menuitem" class="sub-menu__item-link menu-link"><span>Plant Communications (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/stem-cell-reports/home" data-index="27" role="menuitem" class="sub-menu__item-link menu-link"><span>Stem Cell Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biochemical-sciences/home" data-index="28" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biochemical Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cancer/home" data-index="29" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cancer</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cell-biology/home" data-index="30" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cell Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/ecology-evolution/home" data-index="31" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Ecology &amp; Evolution</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/endocrinology-metabolism/home" data-index="32" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Endocrinology &amp; Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/genetics/home" data-index="33" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Genetics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/immunology/home" data-index="34" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Immunology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/microbiology/home" data-index="35" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Microbiology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/molecular-medicine/home" data-index="36" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Molecular Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/neurosciences/home" data-index="37" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Neurosciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/parasitology/home" data-index="38" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Parasitology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/pharmacological-sciences/home" data-index="39" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Pharmacological Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/plant-science/home" data-index="40" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Plant Science</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 5/6" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-2" class="sub-menu__heading">Physical sciences &amp; engineering
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-biomaterials/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Biomaterials</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-physical-science/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Physical Science</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem-catalysis/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem Catalysis</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/device/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Device</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/joule/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Joule</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/matter/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Matter</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/newton/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Newton</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/chemistry/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Chemistry</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 6/7" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-3" class="sub-menu__heading">Multidisciplinary
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-methods/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Methods</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-sustainability/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Sustainability</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/heliyon/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Heliyon</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/iscience/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>iScience</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/one-earth/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>One Earth</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/patterns/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Patterns</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/star-protocols/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Protocols</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/nexus/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Nexus (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/the-innovation/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>The Innovation (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biotechnology/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biotechnology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cognitive-sciences/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cognitive Sciences</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-3" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-3" data-item-link="main-menu-link-3" data-index="2" class="mega-menu__item-link menu-link"><span>Publish</span></a>
        <div id="main-menu-panel-3" aria-labelledby="main-menu-link-3" data-item-wrapper="main-menu-link-3" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-1" class="sub-menu__heading">Authors
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://www.editorialmanager.com/cell?__hstc=25856994.7201670a4397fa03148684920d4a8d38.1672762013831.1694716659709.1694718909620.146&amp;__hssc=25856994.15.1694718909620&amp;__hsfp=1366844671" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Submit article
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/information-for-authors" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for authors</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/multi-journal-submission" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Multi-Journal Submission</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/star-authors-guide" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Methods</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-2" class="sub-menu__heading">Reviewers
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for reviewers</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-4" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-4" data-item-link="main-menu-link-4" data-index="3" class="mega-menu__item-link menu-link"><span>News &amp; events</span></a>
        <div id="main-menu-panel-4" aria-labelledby="main-menu-link-4" data-item-wrapper="main-menu-link-4" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/newsroom" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Newsroom</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/events" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Events</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/symposia" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Symposia</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/webinars" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Webinars</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/consortia" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Consortia Hub</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-5" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-5" data-item-link="main-menu-link-5" data-index="4" class="mega-menu__item-link menu-link"><span>About Cell Press</span></a>
        <div id="main-menu-panel-5" aria-labelledby="main-menu-link-5" data-item-wrapper="main-menu-link-5" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-1" class="sub-menu__heading">Cell Press
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/about" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>About Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/contact" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact us</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="https://service.elsevier.com/app/overview/cell-press/" data-index="2" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Help &amp; support
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access at Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/diversity" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Inclusion and diversity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-50" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>50th anniversary</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-2" class="sub-menu__heading">Hubs
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/biotechnology-bioengineering" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Biotechnology and bioengineering</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-chemistry" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Chemistry</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/clinical-translational" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Clinical and translational</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/covid-19" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>COVID-19</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/fundamental-biology" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Fundamental biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sustainability" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Sustainability</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/4" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-3" class="sub-menu__heading">Careers
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Press careers
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
    </ul>
    <div class="mega-menu-nav__quick-search">
    

        


    

            

            

            <div data-widget-id="a1f05748-166f-41e0-b01a-ca8ac1cc95d4" data-widget-name="UX3QuickSearchWidget" class="quick-search"><div class="dropBlock"><form action="https://www.cell.com/action/doSearch?journalCode=cell" name="quickSearchBar" method="get" title="Quick Search"><input id="type" type="hidden" value="quicksearch" name="type"><div class="quick-search__toggle autoCompleteWrapper"><input id="searchText" type="text" name="text1" placeholder="Search for..." enterkeyhint="search" autocomplete="off" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" data-group-titles-conf="3" data-publication-items-conf="3" aria-label="Enter a search term" class="searchText searchText-autocomplete ui-autocomplete-input"><button type="submit" title="Search" aria-label="Submit the search form" class="btn quick-search__button icon-search"><span>Go search</span></button><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" unselectable="on" style="display: none;"></ul></div><div class="quick-search__box"><div class="quick-search__box-inner"><div class="quick-search__box-wrapper"><select name="field1" aria-label="Select a search area"><option value="AllField">All content</option><option value="Title">Article title</option><option value="Contrib">Authors</option><option value="Keyword">Keywords</option><option value="Abstract">Abstract</option><option value="AbstractTitleKeywordFilterField">Article title, abstract, keywords</option></select><input type="hidden" name="journalCode" value="cell"><div class="quick-search__scope-options"><span>Search within:</span><label title="This journal" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeSeries-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" title="This journal" value="cell" checked="checked" aria-label="Search within current journal"><span>This journal</span></label><label title="Full site" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeFullSite-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" value="" title="Full site" aria-label="Search within full site"><span>Full site</span></label></div><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a></div><a href="javascript:void(0)" aria-label="Close search options" title="Close search options" class="quick-search__box-close"><i aria-hidden="true" class="icon-tools_close"></i></a></div></div><div class="quick-search__alert hidden"><p>Please enter a term before submitting your search.</p><a href="#" class="quick-search__alert--close"> Ok</a></div></form></div></div>

            

        
</div>
  </div>
</nav>
<div id="page-body-id" class="page-body-flag"></div></div>
                </div>
                </div>

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="f8c6daf9-9df1-4fd9-ba3a-7f5d7b3d4466" data-widget-name="UX3HTMLWidget"><style>
.journal-logos:nth-of-type(2) img {
max-height: 30px !important;
}
.journal-logos:nth-of-type(3) img {
max-height: 30px !important;
}
.ux3 .journal-logos + .journal-logos {
margin-left: 30px;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 55%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 45%;
}
@media screen and (max-width: 1000px) {
.ux3 .journal-logos + .journal-logos {
display: none;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 50%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 50%;
}
}

.ux3 .journal-logos:first-of-type {
   max-width: 500px;
}

.profile-links {
   white-space: nowrap;
}

@media only screen and (min-width: 740px) and (max-width: 1600px) {
   .journal-logos:nth-of-type(2) img {
      max-width: 250px !important;
   }
}

@media only screen and (min-width: 1024px) and (max-width: 1600px) {
   .header__wrapper.clearfix .col-xs-6:first-of-type {
      width: 60% !important;
   }
   .header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
      width: 40% !important;
   }
}

@media only screen and (max-width: 1240px) {
   .ux3 .journal-logos + .journal-logos {
      display: none !important;
   }
}

</style></div>

            

        
</div></div>

            
                </div>
            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget axelPublicationContent none  widget-none" id="cadc9b41-a542-448a-9de4-8d0803320174">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/marlin/cell/releasedAssets/css/build-article-b26f3342b722959c7931.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" vocab="http://schema.org/" typeof="ScholarlyArticle" data-pii="S0092-8674(21)01561-0" lang="en" dir="ltr"><div data-core-wrapper="header"><header data-extent="frontmatter"><div class="core-container"><div data-article-access="free" data-article-access-type="open" class="meta-panel"><span class="meta-panel__left-content"><span class="meta-panel__type"><span>Article</span></span></span><span class="meta-panel__middle-content"><span class="meta-panel__volumeIssue"><a href="/cell/issue?pii=S0092-8674(21)X0005-0"><span>Volume 185</span>, <span>Issue 4</span></a></span><span class="meta-panel__pages"><span>p585-602.e29</span></span><span class="meta-panel__onlineDate">February 17, 2022</span></span><span class="meta-panel__right-content"><span class="meta-panel__access meta-panel__access--archive"><span>Open Archive</span></span></span><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=185&amp;issue=4&amp;pii=S0092-8674%2821%29X0005-0" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div><h1 property="name">Magnesium sensing via LFA-1 regulates CD8<sup>+</sup> T&nbsp;cell effector function</h1><div class="contributors"><span class="authors"><span role="list"><span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au1" aria-controls="axel_author_au1"><span property="givenName">Jonas</span> <span property="familyName">Lötscher</span></a><div id="au1" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jonas</span> <span property="familyName">Lötscher</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/L%C3%B6tscher/Jonas" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au2" aria-controls="axel_author_au2"><span property="givenName">Adrià-Arnau</span> <span property="familyName">Martí i Líndez</span></a><div id="au2" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Adrià-Arnau</span> <span property="familyName">Martí i Líndez</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">19</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, CITIID, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Mart%C3%AD+i+L%C3%ADndez/Adri%C3%A0-Arnau" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a role="doc-noteref">19</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au3" aria-controls="axel_author_au3"><span property="givenName">Nicole</span> <span property="familyName">Kirchhammer</span></a><div id="au3" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Nicole</span> <span property="familyName">Kirchhammer</span> <a class="orcid-id" href="https://orcid.org/0000-0001-6043-5143" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-6043-5143</a></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">19</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biomedicine, Cancer Immunology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Kirchhammer/Nicole" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a role="doc-noteref">19</a></sup></span><span data-displayed-on="all"> ∙ … </span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au4" aria-controls="axel_author_au4"><span property="givenName">Elisabetta</span> <span property="familyName">Cribioli</span></a><div id="au4" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Elisabetta</span> <span property="familyName">Cribioli</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">20</div><div id="fn2"><div id="ntpara0115" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Ludwig Institute for Cancer Research, University of Lausanne, 1066 Epalinges, Switzerland</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Oncology, University Hospital of Lausanne, 1011 Lausanne, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Cribioli/Elisabetta" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">6</a>,<a role="doc-noteref">20</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au5" aria-controls="axel_author_au5"><span property="givenName">Greta Maria Paola</span> <span property="familyName">Giordano Attianese</span></a><div id="au5" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Greta Maria Paola</span> <span property="familyName">Giordano Attianese</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">20</div><div id="fn2"><div id="ntpara0115" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Ludwig Institute for Cancer Research, University of Lausanne, 1066 Epalinges, Switzerland</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Oncology, University Hospital of Lausanne, 1011 Lausanne, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Giordano+Attianese/Greta+Maria+Paola" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">6</a>,<a role="doc-noteref">20</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au6" aria-controls="axel_author_au6"><span property="givenName">Marcel P.</span> <span property="familyName">Trefny</span></a><div id="au6" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Marcel P.</span> <span property="familyName">Trefny</span> <a class="orcid-id" href="https://orcid.org/0000-0001-6755-7899" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-6755-7899</a></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">20</div><div id="fn2"><div id="ntpara0115" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biomedicine, Cancer Immunology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Trefny/Marcel+P" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a role="doc-noteref">20</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au7" aria-controls="axel_author_au7"><span property="givenName">Markus</span> <span property="familyName">Lenz</span></a><div id="au7" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Markus</span> <span property="familyName">Lenz</span> <a class="orcid-id" href="https://orcid.org/0000-0001-6832-3218" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-6832-3218</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">University of Applied Science Northwestern Switzerland, Institute for Ecopreneurship, 4132 Muttenz, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Lenz/Markus" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">7</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au8" aria-controls="axel_author_au8"><span property="givenName">Sacha I.</span> <span property="familyName">Rothschild</span></a><div id="au8" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Sacha I.</span> <span property="familyName">Rothschild</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Division of Medical Oncology and Comprehensive Cancer Center, University Hospital Basel, 4031 Basel, Switzerland</span></div><div property="affiliation" typeof="Organization"><span property="name">Swiss Group for Clinical Cancer Research, 3008 Bern, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Rothschild/Sacha+I" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">8</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">9</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au9" aria-controls="axel_author_au9"><span property="givenName">Paolo</span> <span property="familyName">Strati</span></a><div id="au9" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Paolo</span> <span property="familyName">Strati</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Strati/Paolo" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">10</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au10" aria-controls="axel_author_au10"><span property="givenName">Marco</span> <span property="familyName">Künzli</span></a><div id="au10" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Marco</span> <span property="familyName">Künzli</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biomedicine, Immune Cell Biology, University and University Hospital of Basel, 4031 Basel, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/K%C3%BCnzli/Marco" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">11</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au11" aria-controls="axel_author_au11"><span property="givenName">Claudia</span> <span property="familyName">Lotter</span></a><div id="au11" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Claudia</span> <span property="familyName">Lotter</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Pharmaceutical Sciences, Pharmaceutical Technology, University of Basel, 4056 Basel, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Lotter/Claudia" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">12</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au12" aria-controls="axel_author_au12"><span property="givenName">Susanne H.</span> <span property="familyName">Schenk</span></a><div id="au12" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Susanne H.</span> <span property="familyName">Schenk</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Pharmaceutical Sciences, Pharmaceutical Technology, University of Basel, 4056 Basel, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Schenk/Susanne+H" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">12</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au13" aria-controls="axel_author_au13"><span property="givenName">Philippe</span> <span property="familyName">Dehio</span></a><div id="au13" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Philippe</span> <span property="familyName">Dehio</span> <a class="orcid-id" href="https://orcid.org/0000-0002-9869-2601" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-9869-2601</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Dehio/Philippe" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au14" aria-controls="axel_author_au14"><span property="givenName">Jordan</span> <span property="familyName">Löliger</span></a><div id="au14" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jordan</span> <span property="familyName">Löliger</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/L%C3%B6liger/Jordan" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au15" aria-controls="axel_author_au15"><span property="givenName">Ludivine</span> <span property="familyName">Litzler</span></a><div id="au15" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Ludivine</span> <span property="familyName">Litzler</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biomedicine, Immune Cell Biology, University and University Hospital of Basel, 4031 Basel, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Litzler/Ludivine" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">11</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au16" aria-controls="axel_author_au16"><span property="givenName">David</span> <span property="familyName">Schreiner</span></a><div id="au16" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">David</span> <span property="familyName">Schreiner</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biomedicine, Immune Cell Biology, University and University Hospital of Basel, 4031 Basel, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Schreiner/David" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">11</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au17" aria-controls="axel_author_au17"><span property="givenName">Victoria</span> <span property="familyName">Koch</span></a><div id="au17" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au17"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Victoria</span> <span property="familyName">Koch</span> <a class="orcid-id" href="https://orcid.org/0000-0001-9641-3720" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0001-9641-3720</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biomedicine, Cancer Immunology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Koch/Victoria" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au18" aria-controls="axel_author_au18"><span property="givenName">Nicolas</span> <span property="familyName">Page</span></a><div id="au18" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au18"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Nicolas</span> <span property="familyName">Page</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Page/Nicolas" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">13</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au19" aria-controls="axel_author_au19"><span property="givenName">Dahye</span> <span property="familyName">Lee</span></a><div id="au19" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au19"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Dahye</span> <span property="familyName">Lee</span> <a class="orcid-id" href="https://orcid.org/0000-0002-6391-5369" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-6391-5369</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Lee/Dahye" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au20" aria-controls="axel_author_au20"><span property="givenName">Jasmin</span> <span property="familyName">Grählert</span></a><div id="au20" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au20"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jasmin</span> <span property="familyName">Grählert</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Gr%C3%A4hlert/Jasmin" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au21" aria-controls="axel_author_au21"><span property="givenName">Dmitry</span> <span property="familyName">Kuzmin</span></a><div id="au21" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au21"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Dmitry</span> <span property="familyName">Kuzmin</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Hornet Therapeutics Ltd, London SW1Y 5ES, UK</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Medical Oncology, Yale School of Medicine, New Haven, CT 06510, USA</span></div></div><div class="core-author-link"><a href="/authored-by/Kuzmin/Dmitry" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">14</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">15</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au22" aria-controls="axel_author_au22"><span property="givenName">Anne-Valérie</span> <span property="familyName">Burgener</span></a><div id="au22" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au22"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Anne-Valérie</span> <span property="familyName">Burgener</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Burgener/Anne-Val%C3%A9rie" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au23" aria-controls="axel_author_au23"><span property="givenName">Doron</span> <span property="familyName">Merkler</span></a><div id="au23" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au23"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Doron</span> <span property="familyName">Merkler</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Merkler/Doron" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">13</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au24" aria-controls="axel_author_au24"><span property="givenName">Miklos</span> <span property="familyName">Pless</span></a><div id="au24" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au24"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Miklos</span> <span property="familyName">Pless</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Swiss Group for Clinical Cancer Research, 3008 Bern, Switzerland</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Oncology, Cantonal Hospital Winterthur, 8400 Winterthur, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Pless/Miklos" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">9</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">16</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au25" aria-controls="axel_author_au25"><span property="givenName">Maria L.</span> <span property="familyName">Balmer</span></a><div id="au25" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au25"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Maria L.</span> <span property="familyName">Balmer</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland</span></div><div property="affiliation" typeof="Organization"><span property="name">Department for Biomedical Research (DBMR), University Clinic for Diabetes, Endocrinology, Clinical Nutrition and Metabolism, Inselspital, University of Bern, 3008 Bern, Switzerland</span></div><div property="affiliation" typeof="Organization"><span property="name">Diabetes Center Berne (DCB), 3010 Bern, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Balmer/Maria+L" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">17</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">18</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au26" aria-controls="axel_author_au26"><span property="givenName">Walter</span> <span property="familyName">Reith</span></a><div id="au26" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au26"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Walter</span> <span property="familyName">Reith</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Reith/Walter" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au27" aria-controls="axel_author_au27"><span property="givenName">Jörg</span> <span property="familyName">Huwyler</span></a><div id="au27" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au27"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jörg</span> <span property="familyName">Huwyler</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Pharmaceutical Sciences, Pharmaceutical Technology, University of Basel, 4056 Basel, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Huwyler/J%C3%B6rg" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">12</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au28" aria-controls="axel_author_au28"><span property="givenName">Melita</span> <span property="familyName">Irving</span></a><div id="au28" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au28"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Melita</span> <span property="familyName">Irving</span> <a class="orcid-id" href="https://orcid.org/0000-0002-6849-7194" property="identifier" aria-label="ORCID identifier" target="_blank">0000-0002-6849-7194</a></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Ludwig Institute for Cancer Research, University of Lausanne, 1066 Epalinges, Switzerland</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Oncology, University Hospital of Lausanne, 1011 Lausanne, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Irving/Melita" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">6</a></sup></span></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au29" aria-controls="axel_author_au29"><span property="givenName">Carolyn G.</span> <span property="familyName">King</span></a><div id="au29" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au29"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Carolyn G.</span> <span property="familyName">King</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biomedicine, Immune Cell Biology, University and University Hospital of Basel, 4031 Basel, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/King/Carolyn+G" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">11</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au30" aria-controls="axel_author_au30"><span property="givenName">Alfred</span> <span property="familyName">Zippelius</span></a><div id="au30" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au30"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Alfred</span> <span property="familyName">Zippelius</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biomedicine, Cancer Immunology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland</span></div><div property="affiliation" typeof="Organization"><span property="name">Division of Medical Oncology and Comprehensive Cancer Center, University Hospital Basel, 4031 Basel, Switzerland</span></div></div><div class="core-author-link"><a href="/authored-by/Zippelius/Alfred" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">8</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au31" aria-controls="axel_author_au31"><span property="givenName">Christoph</span> <span property="familyName">Hess</span></a><div id="au31" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au31"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Christoph</span> <span property="familyName">Hess</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0015" href="mailto:chess@uhbs.ch" property="email" title="Send email to Christoph Hess">chess@uhbs.ch</a></div></div><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">21</div><div id="fn3"><div id="ntpara0015" role="paragraph">Lead contact</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Medicine, CITIID, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK</span></div></div><div class="core-author-link"><a href="/authored-by/Hess/Christoph" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a role="doc-noteref">21</a></sup> <a id="eadd0015" href="mailto:chess@uhbs.ch" property="email" title="Send email to Christoph Hess">chess@uhbs.ch</a></span><span data-displayed-on="all"> … <span><span data-action="reveal" tabindex="0" role="listitem">Show more</span></span> </span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">Show less</span></span></span></span></div><div class="core-self-citation"><div class="expandable-triggers"><button aria-controls="core-affiliations-notes" aria-expanded="false" tabindex="0" role="button"><span>Affiliations &amp; Notes</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button><button aria-controls="core-content-info" aria-expanded="false" tabindex="0" role="button"><span>Article Info</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button></div><div id="core-linked-content">
    

        

</div><div class="expandable-content"><div id="core-affiliations-notes" role="region" data-expandable="item" style="display: none;"><div class="affiliations"><div property="affiliation" typeof="Organization"><span class="label">1</span><span id="aff1" property="name">Department of Biomedicine, Immunobiology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland</span></div><div property="affiliation" typeof="Organization"><span class="label">2</span><span id="aff2" property="name">Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland</span></div><div property="affiliation" typeof="Organization"><span class="label">3</span><span id="aff3" property="name">Department of Medicine, CITIID, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge CB2 0AW, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">4</span><span id="aff4" property="name">Department of Biomedicine, Cancer Immunology, University of Basel and University Hospital of Basel, 4031 Basel, Switzerland</span></div><div property="affiliation" typeof="Organization"><span class="label">5</span><span id="aff5" property="name">Ludwig Institute for Cancer Research, University of Lausanne, 1066 Epalinges, Switzerland</span></div><div property="affiliation" typeof="Organization"><span class="label">6</span><span id="aff6" property="name">Department of Oncology, University Hospital of Lausanne, 1011 Lausanne, Switzerland</span></div><div property="affiliation" typeof="Organization"><span class="label">7</span><span id="aff7" property="name">University of Applied Science Northwestern Switzerland, Institute for Ecopreneurship, 4132 Muttenz, Switzerland</span></div><div property="affiliation" typeof="Organization"><span class="label">8</span><span id="aff8" property="name">Division of Medical Oncology and Comprehensive Cancer Center, University Hospital Basel, 4031 Basel, Switzerland</span></div><div property="affiliation" typeof="Organization"><span class="label">9</span><span id="aff9" property="name">Swiss Group for Clinical Cancer Research, 3008 Bern, Switzerland</span></div><div property="affiliation" typeof="Organization"><span class="label">10</span><span id="aff10" property="name">Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">11</span><span id="aff11" property="name">Department of Biomedicine, Immune Cell Biology, University and University Hospital of Basel, 4031 Basel, Switzerland</span></div><div property="affiliation" typeof="Organization"><span class="label">12</span><span id="aff12" property="name">Department of Pharmaceutical Sciences, Pharmaceutical Technology, University of Basel, 4056 Basel, Switzerland</span></div><div property="affiliation" typeof="Organization"><span class="label">13</span><span id="aff13" property="name">Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland</span></div><div property="affiliation" typeof="Organization"><span class="label">14</span><span id="aff14" property="name">Hornet Therapeutics Ltd, London SW1Y 5ES, UK</span></div><div property="affiliation" typeof="Organization"><span class="label">15</span><span id="aff15" property="name">Department of Medical Oncology, Yale School of Medicine, New Haven, CT 06510, USA</span></div><div property="affiliation" typeof="Organization"><span class="label">16</span><span id="aff16" property="name">Department of Oncology, Cantonal Hospital Winterthur, 8400 Winterthur, Switzerland</span></div><div property="affiliation" typeof="Organization"><span class="label">17</span><span id="aff17" property="name">Department for Biomedical Research (DBMR), University Clinic for Diabetes, Endocrinology, Clinical Nutrition and Metabolism, Inselspital, University of Bern, 3008 Bern, Switzerland</span></div><div property="affiliation" typeof="Organization"><span class="label">18</span><span id="aff18" property="name">Diabetes Center Berne (DCB), 3010 Bern, Switzerland</span></div></div><div class="core-authors-notes"><div role="doc-footnote" data-has="label"><div class="label">19</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div><div role="doc-footnote" data-has="label"><div class="label">20</div><div id="fn2"><div id="ntpara0115" role="paragraph">These authors contributed equally</div></div></div><div role="doc-footnote" data-has="label"><div class="label">21</div><div id="fn3"><div id="ntpara0015" role="paragraph">Lead contact</div></div></div></div></div><div id="core-content-info" role="region" data-expandable="item" style="display: none;"><div class="history"><div>Publication History:</div><div><span>Received March 22, 2021</span>; <span>Revised November 15, 2021</span>; <span>Accepted December 22, 2021</span>; <span>Published online January 19, 2022</span></div></div><div class="core-links"><span class="doi">DOI: <a href="https://doi.org/10.1016/j.cell.2021.12.039" property="sameAs" target="_blank">10.1016/j.cell.2021.12.039 <span class="sr-only">External Link</span></a></span><span class="science-direct">Also available on <a href="https://www.sciencedirect.com/science/article/pii/S0092867421015610" target="_blank">ScienceDirect <span class="sr-only">External Link</span></a></span></div><div role="paragraph">Copyright: © 2021 Elsevier Inc.</div><div class="core-links"><span>User License: <a href="http://www.elsevier.com/open-access/userlicense/1.0/" target="_blank">Elsevier user license</a> | <a href="https://www.elsevier.com/open-access" target="_blank">Elsevier's open access license policy</a></span></div><div class="core-crossmark-badge"><a data-target="crossmark" href="#" title="Check for updates on crossmark" data-doi="10.1016/j.cell.2021.12.039" data-id="article-info-crossmark" class="crossmark__link" style="cursor: pointer;"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 290 58" height="22px" role="presentation"><path fill="url(#horizontal_crossmark)" stroke="#948F8F" stroke-miterlimit="10" stroke-width=".75" d="M287 1H3a2 2 0 0 0-2 2v52a2 2 0 0 0 2 2h284a2 2 0 0 0 2-2V3a2 2 0 0 0-2-2Z"></path><path fill="#535353" d="M80.3 23.58a6.395 6.395 0 0 0-.55-1.43 3.92 3.92 0 0 0-2.19-1.86 5.099 5.099 0 0 0-1.71-.29 5 5 0 0 0-2.46.58 4.831 4.831 0 0 0-1.69 1.54 6.921 6.921 0 0 0-1 2.19 10.16 10.16 0 0 0 0 5 6.921 6.921 0 0 0 1 2.19 4.83 4.83 0 0 0 1.69 1.5 5 5 0 0 0 2.46.58 4.44 4.44 0 0 0 1.85-.36 4.12 4.12 0 0 0 1.38-1c.39-.436.695-.942.9-1.49A7.094 7.094 0 0 0 80.4 29h3a8.46 8.46 0 0 1-.69 2.92 7.179 7.179 0 0 1-1.59 2.29 7 7 0 0 1-2.35 1.49 8.14 8.14 0 0 1-3 .52 8.43 8.43 0 0 1-3.59-.74 7.88 7.88 0 0 1-2.69-2 9.001 9.001 0 0 1-1.69-3 11.41 11.41 0 0 1 0-7.23 9.001 9.001 0 0 1 1.69-3 8.001 8.001 0 0 1 2.69-2 8.3 8.3 0 0 1 3.59-.75 9.44 9.44 0 0 1 2.83.41c.866.242 1.68.642 2.4 1.18A6.229 6.229 0 0 1 82.65 21a6.66 6.66 0 0 1 .78 2.58H80.3ZM85.9 17.9h2.85v6.63h.05a4.15 4.15 0 0 1 1.56-1.46 4.61 4.61 0 0 1 2.31-.59 4.83 4.83 0 0 1 3.33 1.1 4.21 4.21 0 0 1 1.22 3.3v8.88H94.4v-8.13a3.51 3.51 0 0 0-.65-2.21 2.36 2.36 0 0 0-1.87-.69 3.1 3.1 0 0 0-1.3.26 2.821 2.821 0 0 0-1 .73A3.41 3.41 0 0 0 89 26.8a3.88 3.88 0 0 0-.23 1.33v7.63H85.9V17.9ZM102.47 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7A5.349 5.349 0 0 1 109.7 35a5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4A5.953 5.953 0 0 1 100 32a8.748 8.748 0 0 1-.41-2.75 7.768 7.768 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.264.905.352 1.852.26 2.79h-9.53Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.594 3.594 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM122.88 27.15a2.666 2.666 0 0 0-1-1.81 3.14 3.14 0 0 0-2-.61c-.4.005-.798.07-1.18.19-.435.136-.83.376-1.15.7a3.92 3.92 0 0 0-.87 1.43 6.783 6.783 0 0 0-.35 2.39c.002.539.065 1.076.19 1.6.113.509.316.993.6 1.43.273.41.635.752 1.06 1a3 3 0 0 0 1.58.39 2.872 2.872 0 0 0 2.06-.77 3.596 3.596 0 0 0 1-2.18h2.85a6.26 6.26 0 0 1-1.91 3.86 5.83 5.83 0 0 1-4 1.34 6.61 6.61 0 0 1-2.69-.51 5.695 5.695 0 0 1-2-1.4 6.001 6.001 0 0 1-1.21-2.11 8.279 8.279 0 0 1-.41-2.65 8.987 8.987 0 0 1 .4-2.72 6.237 6.237 0 0 1 1.2-2.21 5.614 5.614 0 0 1 2-1.47 6.7 6.7 0 0 1 2.79-.54 7.801 7.801 0 0 1 2.14.29 5.634 5.634 0 0 1 1.8.86c.529.386.969.88 1.29 1.45a5 5 0 0 1 .6 2.07h-2.85l.06-.02ZM128.13 17.9H131V28l5.15-5.22h3.5l-5 4.75 5.42 8.17h-3.47l-4-6.27-1.6 1.7v4.63h-2.85V17.9h-.02ZM147.15 22.83h2.13v-1.08a5.505 5.505 0 0 1 .3-2c.161-.456.436-.862.8-1.18.33-.273.721-.462 1.14-.55.44-.094.89-.141 1.34-.14a8.158 8.158 0 0 1 2 .18v2.24a4.113 4.113 0 0 0-.59-.11 6.343 6.343 0 0 0-.74 0 1.74 1.74 0 0 0-1 .27 1.204 1.204 0 0 0-.41 1.08v1.33h2.42V25h-2.42v10.8h-2.85V25h-2.12v-2.17ZM162.23 36.1a6.999 6.999 0 0 1-2.76-.51 5.877 5.877 0 0 1-2-1.41 5.998 5.998 0 0 1-1.33-2.18 8.775 8.775 0 0 1 0-5.48 6.008 6.008 0 0 1 1.27-2.15 5.894 5.894 0 0 1 2-1.41A7.71 7.71 0 0 1 165 23a5.894 5.894 0 0 1 2 1.41 6.003 6.003 0 0 1 1.28 2.15c.585 1.78.585 3.7 0 5.48a5.99 5.99 0 0 1-3.28 3.54 7.002 7.002 0 0 1-2.77.52Zm0-2.25a3.268 3.268 0 0 0 1.65-.4c.447-.262.83-.621 1.12-1.05.304-.444.528-.938.66-1.46a6.581 6.581 0 0 0 0-3.31 4.416 4.416 0 0 0-.66-1.46 3.526 3.526 0 0 0-1.15-1 3.6 3.6 0 0 0-3.3 0 3.526 3.526 0 0 0-1.15 1 4.414 4.414 0 0 0-.66 1.46 6.558 6.558 0 0 0 0 3.31c.132.522.356 1.016.66 1.46a3.47 3.47 0 0 0 1.15 1.05 3.26 3.26 0 0 0 1.68.4ZM171.13 22.83h2.67v2.5c.097-.362.264-.701.49-1 .251-.341.547-.647.88-.91a4.404 4.404 0 0 1 1.14-.66 3.41 3.41 0 0 1 1.28-.25c.23-.013.46-.013.69 0h.39v2.79l-.61-.09a5.173 5.173 0 0 0-.61 0 3.278 3.278 0 0 0-1.36.29 3.131 3.131 0 0 0-1.11.85 4.171 4.171 0 0 0-.75 1.39 6 6 0 0 0-.28 1.9v6.15h-2.85V22.83h.03ZM198.22 35.75h-2.8V34a3.907 3.907 0 0 1-1.56 1.56 4.25 4.25 0 0 1-2.11.59 4.742 4.742 0 0 1-3.75-1.31 5.537 5.537 0 0 1-1.12-3.84v-8.2h2.85v7.92a3.503 3.503 0 0 0 .65 2.4 2.38 2.38 0 0 0 1.83.7 3.599 3.599 0 0 0 1.5-.27 2.66 2.66 0 0 0 1-.74c.259-.326.444-.705.54-1.11a5.79 5.79 0 0 0 .16-1.4v-7.5h2.85v12.95h-.04ZM201.3 22.83h2.7v1.75a3.523 3.523 0 0 1 1.72-1.58 5.568 5.568 0 0 1 2.33-.49 6.17 6.17 0 0 1 2.66.54 5.246 5.246 0 0 1 1.89 1.47c.515.65.899 1.394 1.13 2.19.257.87.385 1.773.38 2.68.001.851-.114 1.7-.34 2.52a6.568 6.568 0 0 1-1 2.16 5.002 5.002 0 0 1-4.21 2.06c-.419 0-.837-.036-1.25-.11a5.39 5.39 0 0 1-1.2-.36A4.737 4.737 0 0 1 205 35a3.567 3.567 0 0 1-.81-.91v6.45h-2.89V22.83Zm10 6.47c0-.574-.078-1.146-.23-1.7a4.606 4.606 0 0 0-.67-1.46 3.475 3.475 0 0 0-1.12-1 3.06 3.06 0 0 0-1.55-.39A3.141 3.141 0 0 0 205 26a5.518 5.518 0 0 0-1 3.3c-.004.611.077 1.22.24 1.81.138.523.38 1.012.71 1.44a3.55 3.55 0 0 0 1.14 1 3.242 3.242 0 0 0 1.54.35 3.18 3.18 0 0 0 1.65-.4c.438-.25.817-.59 1.11-1 .299-.44.513-.931.63-1.45a7.38 7.38 0 0 0 .23-1.75h.05ZM228.67 35.75H226V34a3.38 3.38 0 0 1-1.67 1.61 5.668 5.668 0 0 1-2.33.49 6.17 6.17 0 0 1-2.66-.54 5.307 5.307 0 0 1-1.89-1.46 6.254 6.254 0 0 1-1.12-2.19 9.48 9.48 0 0 1-.37-2.71 8.67 8.67 0 0 1 .47-3 6.058 6.058 0 0 1 1.26-2.1 4.89 4.89 0 0 1 1.8-1.21 5.738 5.738 0 0 1 2.06-.39c.412 0 .824.037 1.23.11.413.073.815.194 1.2.36.38.166.736.381 1.06.64.32.255.594.562.81.91V17.9h2.85v17.85h-.03Zm-10-6.33c-.001.55.069 1.098.21 1.63.13.511.35.996.65 1.43.288.414.668.757 1.11 1a3.241 3.241 0 0 0 1.6.38 3.199 3.199 0 0 0 1.64-.4 3.398 3.398 0 0 0 1.13-1.05c.297-.447.517-.94.65-1.46.14-.542.211-1.1.21-1.66a5.227 5.227 0 0 0-1-3.35 3.175 3.175 0 0 0-2.61-1.2 3.23 3.23 0 0 0-1.69.41 3.478 3.478 0 0 0-1.12 1.07 4.494 4.494 0 0 0-.62 1.5 7.871 7.871 0 0 0-.11 1.7h-.05ZM242.6 32.88c-.018.258.03.516.14.75a.577.577 0 0 0 .54.23h.3c.135-.002.269-.019.4-.05v2l-.39.11-.49.08-.5.08h-.42a2.75 2.75 0 0 1-1.45-.35 1.731 1.731 0 0 1-.75-1.23 4.998 4.998 0 0 1-2.09 1.2 8.224 8.224 0 0 1-2.39.38 5.861 5.861 0 0 1-1.67-.24 4.394 4.394 0 0 1-1.41-.7 3.35 3.35 0 0 1-1-1.18 3.624 3.624 0 0 1-.36-1.66 3.84 3.84 0 0 1 .44-2 3.246 3.246 0 0 1 1.15-1.17 5.195 5.195 0 0 1 1.6-.61c.593-.127 1.19-.223 1.79-.29a14.77 14.77 0 0 1 1.47-.21 6.896 6.896 0 0 0 1.24-.21c.318-.077.611-.236.85-.46a1.286 1.286 0 0 0 .31-.94 1.458 1.458 0 0 0-.26-.9A1.759 1.759 0 0 0 239 25a2.807 2.807 0 0 0-.86-.25 6.941 6.941 0 0 0-.9-.06 3.58 3.58 0 0 0-2 .5 2 2 0 0 0-.87 1.55h-2.85c.021-.73.227-1.442.6-2.07.338-.54.797-.996 1.34-1.33a5.475 5.475 0 0 1 1.84-.7c.692-.134 1.395-.2 2.1-.2.632 0 1.262.067 1.88.2a5.337 5.337 0 0 1 1.66.65 3.6 3.6 0 0 1 1.19 1.16c.314.525.47 1.129.45 1.74v6.65l.02.04Zm-2.85-3.6a3.45 3.45 0 0 1-1.6.51c-.667.06-1.3.147-1.9.26a6.137 6.137 0 0 0-.87.21 2.64 2.64 0 0 0-.75.38c-.22.164-.395.38-.51.63a2.129 2.129 0 0 0-.19.94c-.011.29.085.575.27.8.182.215.407.388.66.51.269.128.555.216.85.26.277.05.558.076.84.08a4.63 4.63 0 0 0 1-.12 3.418 3.418 0 0 0 1-.43 2.73 2.73 0 0 0 .81-.76 1.93 1.93 0 0 0 .32-1.14v-2.14l.07.01ZM244.37 22.83h2.15V19h2.85v3.88h2.58V25h-2.58v6.9a7.064 7.064 0 0 0 0 .77c.016.194.074.381.17.55a.84.84 0 0 0 .41.34 2 2 0 0 0 .75.11h.6c.203-.01.404-.04.6-.09v2.2l-.93.1a8.403 8.403 0 0 1-.92 0 6.33 6.33 0 0 1-1.81-.21 2.421 2.421 0 0 1-1.08-.62 2.15 2.15 0 0 1-.52-1 7.791 7.791 0 0 1-.16-1.42V25h-2.15v-2.17h.04ZM256.22 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7a5.352 5.352 0 0 1-2.1 3.26 5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4 5.947 5.947 0 0 1-1.21-2.18 8.754 8.754 0 0 1-.41-2.75 7.758 7.758 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.243.916.308 1.87.19 2.81h-9.5V30Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.575 3.575 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM270 31.6a2.154 2.154 0 0 0 .95 1.75c.607.35 1.3.524 2 .5.304-.002.608-.022.91-.06a3.943 3.943 0 0 0 1-.24c.286-.105.54-.28.74-.51a1.23 1.23 0 0 0 .26-.89 1.261 1.261 0 0 0-.4-.9 2.779 2.779 0 0 0-1-.56 9.315 9.315 0 0 0-1.34-.36l-1.5-.33a14.219 14.219 0 0 1-1.54-.42 4.937 4.937 0 0 1-1.33-.68 3.12 3.12 0 0 1-.94-1.09 3.472 3.472 0 0 1-.35-1.64 2.94 2.94 0 0 1 .51-1.76 3.913 3.913 0 0 1 1.3-1.15 5.66 5.66 0 0 1 1.75-.61 10.316 10.316 0 0 1 1.84-.17 8.418 8.418 0 0 1 1.91.21 5.19 5.19 0 0 1 1.65.69c.496.318.916.741 1.23 1.24.341.559.55 1.188.61 1.84h-3a1.783 1.783 0 0 0-.94-1.37 3.892 3.892 0 0 0-1.69-.35 6.093 6.093 0 0 0-.71 0 3.327 3.327 0 0 0-.78.19 1.642 1.642 0 0 0-.61.4 1 1 0 0 0-.25.69 1.093 1.093 0 0 0 .36.85c.294.245.634.428 1 .54.437.153.885.274 1.34.36l1.55.33a20.9 20.9 0 0 1 1.53.42c.479.157.931.386 1.34.68.41.277.751.643 1 1.07.255.494.379 1.045.36 1.6a3.48 3.48 0 0 1-.52 2 4.15 4.15 0 0 1-1.36 1.3 6.19 6.19 0 0 1-1.86.73 9.435 9.435 0 0 1-2 .23 8.823 8.823 0 0 1-2.26-.27 5.265 5.265 0 0 1-1.8-.84 4 4 0 0 1-1.2-1.4 4.445 4.445 0 0 1-.46-2h2.7v-.02Z"></path><path fill="#C72914" d="m21.94 38.74 18.12-12.08v-14.5H21.94v26.58Z"></path><path fill="#EF3340" d="M40.06 38.74 21.94 26.66v-14.5h18.12v26.58Z"></path><path fill="#3EB1C8" d="M31 9a20 20 0 1 0 0 40 20 20 0 0 0 0-40Zm0 35.1a15.1 15.1 0 1 1 0-30.2 15.1 15.1 0 0 1 0 30.2Z"></path><path fill="#FFC72C" d="M42.09 39.23A15.09 15.09 0 0 1 17 23.38l-4.2-2.64a20 20 0 0 0 33.49 21.14l-4.2-2.65Z"></path><defs><linearGradient id="horizontal_crossmark" x1="145" x2="145" y1="7.33" y2="56.82" gradientUnits="userSpaceOnUse"><stop stop-color="#fff"></stop><stop offset="1" stop-color="#c4c4c4"></stop></linearGradient></defs></svg></a></div><div class="core-content-info"></div></div></div></div></div></header><div class="core-header-aside">
    

        


    

            

            

            <div class="cover-image cover-image--axel"><div class="cover-image__thumb"><a href="https://www.cell.com/cell/issue?pii=S0092-8674(21)X0005-0"><img src="/cms/asset/d2f73de4-38aa-4e45-9a79-56db1db17e18/cov200h.gif" alt="Cover Image - Cell, Volume 185, Issue 4"></a></div></div>

            

        
</div></div><div data-core-wrapper="content"><div id="dummy-sticky-observer"></div><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="navigation-menu-pdf">
    

        


    

            

            

            <div data-widget-id="ecff07e8-0bc4-4533-b1f1-49365e2ead20" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><a href="/action/showPdf?pii=S0092-8674%2821%2901561-0" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" role="menuitem" class="article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></div>

            

        
</div><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Outline</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><div class="heading">Outline<button aria-haspopup="true" aria-controls="article_sections_menu" title="Close outline menu"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★Methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental Information (1)</a></li><li><a href="#data-availability">Data and code availability</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div><div class="navigation-menu-share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="5f978446-c80a-450c-a185-94d633df2db2" data-widget-name="UX3share" aria-hidden="false" role="group" class="article-tools__dropblock article-tools__share"><button aria-label="Toggle share menu" aria-expanded="false" aria-haspopup="true" role="menuitem" aria-controls="navigation_menu_share_block" aria-labelledby="share-label" class="article-tools__item__share"><i aria-hidden="true" class="icon-article-share"></i><span id="share-label">Share</span></button><div id="navigation_menu_share_block" role="menu" class="share__block axel-share article-tools__dropblock__holder"><h4 class="axel-share__title heading">Share<button title="Close share menu" aria-expanded="false" aria-haspopup="true" aria-controls="navigation_menu_share_block"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2821%2901561-0" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="f1a208d3-ac5e-4db2-9c3a-40ef97ddfa10" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2021.12.039">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</div><div><button data-id="article-nav-menubar-more" aria-controls="article_more_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle more menu"><i aria-hidden="true" class="icon-more-mobile"></i><span>More</span></button><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__article_tools info-panel__item"><div id="article_more_menu" aria-label="More menu" data-core-nav="more"><div class="heading">More<button title="Close more menu" aria-controls="article_more_menu" aria-haspopup="true"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div>
    

        


    

            

            

            <ul data-widget-id="183a17a2-87b5-4e6f-bb85-6b5cda068c89" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><li class="article-tools__item article-tools__pdf"><a href="/action/showPdf?pii=S0092-8674%2821%2901561-0" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" class="article-tools__ctrl article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></li><li><a href="https://www.cell.com/action/showCitFormats?doi=10.1016%2Fj.cell.2021.12.039&amp;pii=S0092-8674%2821%2901561-0" title="Cite" target="_blank" aria-label="Open Cite in new tab" class="article-tools__item__displayExportCitation"><i aria-hidden="true" class="icon-export-Citation"></i><span>Cite</span></a></li><li id="article_tools_share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" data-widget-name="UX3share" class="dropBlock article-tools__dropblock article-tools__share"><button data-db-target-for="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" aria-expanded="false" title="open Share menu" class="article-tools__ctrl share__ctrl"><i aria-hidden="true" class="icon-article-share"></i><span>Share</span></button><div data-db-target-of="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da_Pop" class="share__block axel-share dropBlock__holder article-tools__dropblock__holder"><h4 class="axel-share__title">Share</h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2821%2901561-0" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>Bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="ae9bf5c5-a2ee-4f5c-8e41-9b21638b1a9f" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2021.12.039">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</li><li><a href="https://www.cell.com/action/addCitationAlert?doi=10.1016%2Fj.cell.2021.12.039" title="Set Alert" target="_blank" aria-label="Open Set Alert in new tab" class="article-tools__item__displayCreateCitationAlert"><i aria-hidden="true" class="icon-set-alert"></i><span>Set Alert</span></a></li><li><a href="https://s100.copyright.com/AppDispatchServlet?publisherName=ELS&amp;contentID=S0092867421015610&amp;orderBeanReset=true&amp;orderSource=Phoenix" title="Get Rights" target="_blank" aria-label="Open Get Rights in new tab" class="article-tools__item__request"><i aria-hidden="true" class="icon-get-rights"></i><span>Get Rights</span></a></li><li><a href="https://www.contentednet.com/salesforce-form/?pii=S0092867421015610&amp;issn=00928674&amp;source=jbs" title="Reprints" target="_blank" aria-label="Open Reprints in new tab" class="article-tools__item__reprints"><i aria-hidden="true" class="icon-article-reprints"></i><span>Reprints</span></a></li></ul>

            

        
</div></div><div class="info-panel__download-issue info-panel__item"><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=185&amp;issue=4&amp;pii=S0092-8674%2821%29X0005-0" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div></div><div class="info-panel__right-content"><div class="info-panel__navigation info-panel__item"><div class="content-navigation"><a href="/cell/fulltext/S0092-8674(22)00005-8" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><i aria-hidden="true" class="icon-arrow_l"></i><span>Previous article</span></a><a href="/cell/fulltext/S0092-8674(21)01489-6" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><span>Next article</span><i aria-hidden="true" class="icon-arrow_r"></i></a></div></div></div></div></div></div></div><div class="core-sections-menu-outer"><div class="core-sections-menu"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-show-outline" aria-hidden="true"></i><span>Show Outline</span></button><nav id="article_sections_menu-desktop" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-hide-outline" aria-hidden="true"></i><span>Hide Outline</span></button><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★Methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental Information (1)</a></li><li><a href="#data-availability">Data and code availability</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div></div><div><div class="core-content-inner"><div class="core-linked-content"></div><div id="abstracts" data-extent="frontmatter"><div class="core-container"><section id="author-highlights-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Highlights</h2><div id="abspara0020" role="paragraph"><div id="ulist0010" role="list"><div id="u0010" role="listitem"><div class="label">•</div><div class="content"><div id="p0010" role="paragraph">LFA-1 mediated co-stimulation of CD8<sup>+</sup> T&nbsp;cells depends on extracellular magnesium</div></div></div><div id="u0015" role="listitem"><div class="label">•</div><div class="content"><div id="p0015" role="paragraph">Magnesium is sensed via LFA-1 and regulates the effector function of CD8<sup>+</sup> T&nbsp;cells</div></div></div><div id="u0020" role="listitem"><div class="label">•</div><div class="content"><div id="p0020" role="paragraph">Low serum magnesium levels are associated with worse outcomes in cancer immunotherapy</div></div></div><div id="u0025" role="listitem"><div class="label">•</div><div class="content"><div id="p0025" role="paragraph">The magnesium-LFA-1 axis has translational potential</div></div></div></div></div></section><section id="author-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Summary</h2><div id="abspara0010" role="paragraph">The relevance of extracellular magnesium in cellular immunity remains largely unknown. Here, we show that the co-stimulatory cell-surface molecule LFA-1 requires magnesium to adopt its active conformation on CD8<sup>+</sup> T&nbsp;cells, thereby augmenting calcium flux, signal transduction, metabolic reprogramming, immune synapse formation, and, as a consequence, specific cytotoxicity. Accordingly, magnesium-sufficiency sensed via LFA-1 translated to the superior performance of pathogen- and tumor-specific T&nbsp;cells, enhanced effectiveness of bi-specific T&nbsp;cell engaging antibodies, and improved CAR T&nbsp;cell function. Clinically, low serum magnesium levels were associated with more rapid disease progression and shorter overall survival in CAR T&nbsp;cell and immune checkpoint antibody-treated patients. LFA-1 thus directly incorporates information on the composition of the microenvironment as a determinant of outside-in signaling activity. These findings conceptually link co-stimulation and nutrient sensing and point to the magnesium-LFA-1 axis as a therapeutically amenable biologic system.</div></section><section id="graphical-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Graphical abstract</h2><div id="abspara0015" role="paragraph"><div class="figure-wrap"><figure id="undfig1" class="graphic" data-figureviewer-ignore="true"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.12.039/asset/2b0613ca-61fe-4dcb-8e5b-4f7fb201cbbb/main.assets/fx1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx1" alt="Graphical abstract undfig1" src="/cms/10.1016/j.cell.2021.12.039/asset/40cde963-e19f-439e-b3f0-4e8923936411/main.assets/fx1.jpg" height="375" width="375" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/2b0613ca-61fe-4dcb-8e5b-4f7fb201cbbb/main.assets/fx1_lrg.jpg" loading="lazy"></a></figure></div></div></section></div></div><div class="core-linked-content"></div><section id="keywords" property="keywords"><h2>Keywords</h2><ol><li><a href="/action/doSearch?AllField=&quot;immune+control&quot;" alt="Search on this keyword" rel="nofollow">immune control</a></li><li><a href="/action/doSearch?AllField=&quot;memory+CD8+T%C2%A0cells&quot;" alt="Search on this keyword" rel="nofollow">memory CD8 T&nbsp;cells</a></li><li><a href="/action/doSearch?AllField=&quot;microenvironment&quot;" alt="Search on this keyword" rel="nofollow">microenvironment</a></li><li><a href="/action/doSearch?AllField=&quot;magnesium&quot;" alt="Search on this keyword" rel="nofollow">magnesium</a></li><li><a href="/action/doSearch?AllField=&quot;Mg2%2B&quot;" alt="Search on this keyword" rel="nofollow">Mg2+</a></li><li><a href="/action/doSearch?AllField=&quot;co-stimulation%2FLFA-1&quot;" alt="Search on this keyword" rel="nofollow">co-stimulation/LFA-1</a></li><li><a href="/action/doSearch?AllField=&quot;integration+of+microenvironment+and+T%C2%A0cell+function&quot;" alt="Search on this keyword" rel="nofollow">integration of microenvironment and T&nbsp;cell function</a></li><li><a href="/action/doSearch?AllField=&quot;tumor-specific+T%C2%A0cells&quot;" alt="Search on this keyword" rel="nofollow">tumor-specific T&nbsp;cells</a></li><li><a href="/action/doSearch?AllField=&quot;CAR+T%C2%A0cells&quot;" alt="Search on this keyword" rel="nofollow">CAR T&nbsp;cells</a></li><li><a href="/action/doSearch?AllField=&quot;T+cell+engaging+antibodies&quot;" alt="Search on this keyword" rel="nofollow">T cell engaging antibodies</a></li></ol></section><div class="core-linked-content"></div><div class="core-linked-content"></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text"><div class="core-container"><section id="sec-1"><h2>Introduction</h2><div id="p0035" role="paragraph">Low dietary Mg<sup>2+</sup> intake and hypomagnesemia have been implicated in the pathophysiology of various diseases, including infection and cancer (<span class="dropBlock reference-citations"><a id="body-ref-sref7" href="#" role="doc-biblioref" data-xml-rid="bib7" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref7" aria-controls="sref7">Costello and Nielsen, 2017</a><div class="dropBlock__holder" data-db-target-of="sref7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Costello, R.B. ∙ Nielsen, F.</div><div><strong>Interpreting magnesium status to enhance clinical care: Key indicators</strong></div><div><em>Curr. Opin. Clin. Nutr. Metab. Care.</em> 2017; <strong>20</strong>:504-511</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1097/MCO.0000000000000410" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85030773304" target="_blank" aria-label="Open Scopus in new tab">Scopus (38)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28806179/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1097%2FMCO.0000000000000410&amp;pmid=28806179" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref31" href="#" role="doc-biblioref" data-xml-rid="bib31" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref31" aria-controls="sref31">Larsson et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref31"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Larsson, S.C. ∙ Orsini, N. ∙ Wolk, A.</div><div><strong>Dietary magnesium intake and risk of stroke: A meta-analysis of prospective studies</strong></div><div><em>Am. J. Clin. Nutr.</em> 2012; <strong>95</strong>:362-366</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3945/ajcn.111.022376" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84856380753" target="_blank" aria-label="Open Scopus in new tab">Scopus (143)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22205313/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3945%2Fajcn.111.022376&amp;pmid=22205313" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref45" href="#" role="doc-biblioref" data-xml-rid="bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref45" aria-controls="sref45">Qu et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref45"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Qu, X. ∙ Jin, F. ∙ Hao, Y. ...</div><div><strong>Magnesium and the risk of cardiovascular events: A meta-analysis of prospective cohort studies</strong></div><div><em>PLoS One.</em> 2013; <strong>8</strong>, e57720</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pone.0057720" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84874780456" target="_blank" aria-label="Open Scopus in new tab">Scopus (155)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23520480/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pone.0057720&amp;pmid=23520480" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref46" href="#" role="doc-biblioref" data-xml-rid="bib46" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref46" aria-controls="sref46">Ravell et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref46"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>Ravell, J. ∙ Otim, I. ∙ Nabalende, H. ...</div><div><strong>Plasma magnesium is inversely associated with Epstein-Barr virus load in peripheral blood and Burkitt lymphoma in Uganda</strong></div><div><em>Cancer Epidemiol.</em> 2018; <strong>52</strong>:70-74</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canep.2017.12.004" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85038022583" target="_blank" aria-label="Open Scopus in new tab">Scopus (17)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29248801/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canep.2017.12.004&amp;pmid=29248801" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref49" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49" aria-controls="sref49">Sakaguchi et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref49"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Sakaguchi, Y. ∙ Fujii, N. ∙ Shoji, T. ...</div><div><strong>Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis</strong></div><div><em>Kidney Int.</em> 2014; <strong>85</strong>:174-181</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1038%2Fki.2013.327&amp;cf=fulltext&amp;site=kint-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1038%2Fki.2013.327&amp;cf=pdf&amp;site=kint-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84891560448" target="_blank" aria-label="Open Scopus in new tab">Scopus (246)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23986148/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fki.2013.327&amp;pmid=23986148" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref53" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53" aria-controls="sref53">Saris et&nbsp;al., 2000</a><div class="dropBlock__holder" data-db-target-of="sref53"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Saris, N.E. ∙ Mervaala, E. ∙ Karppanen, H. ...</div><div><strong>Magnesium. An update on physiological, clinical and analytical aspects</strong></div><div><em>Clin. Chim. Acta.</em> 2000; <strong>294</strong>:1-26</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0009-8981(99)00258-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0034015289" target="_blank" aria-label="Open Scopus in new tab">Scopus (1245)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10727669/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0009-8981%2899%2900258-2&amp;pmid=10727669" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref56" href="#" role="doc-biblioref" data-xml-rid="bib56" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref56" aria-controls="sref56">Schulze et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref56"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Schulze, M.B. ∙ Schulz, M. ∙ Heidemann, C. ...</div><div><strong>Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis</strong></div><div><em>Arch. Intern. Med.</em> 2007; <strong>167</strong>:956-965</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/archinte.167.9.956" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-34248554410" target="_blank" aria-label="Open Scopus in new tab">Scopus (477)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17502538/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1001%2Farchinte.167.9.956&amp;pmid=17502538" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref62" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62" aria-controls="sref62">Sojka and Weaver, 1995</a><div class="dropBlock__holder" data-db-target-of="sref62"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Sojka, J.E. ∙ Weaver, C.M.</div><div><strong>Magnesium supplementation and osteoporosis</strong></div><div><em>Nutr. Rev.</em> 1995; <strong>53</strong>:71-74</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/j.1753-4887.1995.tb01505.x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0029014977" target="_blank" aria-label="Open Scopus in new tab">Scopus (146)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7770187/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fj.1753-4887.1995.tb01505.x&amp;pmid=7770187" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Only limited experimental data are available exploring how organismal Mg<sup>2+</sup> abundance may affect the immune system. It has been reported, however, that in mice fed a Mg<sup>2+</sup>-deficient diet, (1) metastatic spread of carcinoma cells was accelerated (<span class="dropBlock reference-citations"><a id="body-ref-sref41" href="#" role="doc-biblioref" data-xml-rid="bib41" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref41" aria-controls="sref41">Nasulewicz et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref41"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Nasulewicz, A. ∙ Wietrzyk, J. ∙ Wolf, F.I. ...</div><div><strong>Magnesium deficiency inhibits primary tumor growth but favors metastasis in mice</strong></div><div><em>Biochim. Biophys. Acta.</em> 2004; <strong>1739</strong>:26-32</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.bbadis.2004.08.003" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-10644240115" target="_blank" aria-label="Open Scopus in new tab">Scopus (78)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15607114/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.bbadis.2004.08.003&amp;pmid=15607114" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and (2) immune responses against influenza were impaired due to insufficient inducible T&nbsp;cell kinase (ITK) activity (<span class="dropBlock reference-citations"><a id="body-ref-sref26" href="#" role="doc-biblioref" data-xml-rid="bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26" aria-controls="sref26">Kanellopoulou et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref26"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">26.</div><div>Kanellopoulou, C. ∙ George, A.B. ∙ Masutani, E. ...</div><div><strong>Mg2+ regulation of kinase signaling and immune function</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2019; <strong>216</strong>:1828-1842</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20181970" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85070636174" target="_blank" aria-label="Open Scopus in new tab">Scopus (44)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31196981/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20181970&amp;pmid=31196981" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Whether in these models an effect of extracellular Mg<sup>2+</sup> was contributing to shaping adaptive immune responses has not been assessed.</div><div id="p0040" role="paragraph">CD8<sup>+</sup> T&nbsp;cells are a key component of the adaptive immune system, playing a critical role in recognizing and eliminating infected or malignantly transformed cells. Immune surveillance of peripheral tissues by effector-memory (EM) CD8<sup>+</sup> T&nbsp;cells is a challenging task, requiring adaptation to constantly changing microenvironments with highly variable nutrient and oxygen content (<span class="dropBlock reference-citations"><a id="body-ref-sref4" href="#" role="doc-biblioref" data-xml-rid="bib4" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref4" aria-controls="sref4">Bantug et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Bantug, G.R. ∙ Galluzzi, L. ∙ Kroemer, G. ...</div><div><strong>The spectrum of T&nbsp;cell metabolism in health and disease</strong></div><div><em>Nat. Rev. Immunol.</em> 2018; <strong>18</strong>:19-34</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri.2017.99" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85039067207" target="_blank" aria-label="Open Scopus in new tab">Scopus (302)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28944771/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri.2017.99&amp;pmid=28944771" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref36" href="#" role="doc-biblioref" data-xml-rid="bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36" aria-controls="sref36">Lötscher and Balmer, 2019</a><div class="dropBlock__holder" data-db-target-of="sref36"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">36.</div><div>Lötscher, J. ∙ Balmer, M.L.</div><div><strong>Sensing between reactions - how the metabolic microenvironment shapes immunity</strong></div><div><em>Clin. Exp. Immunol.</em> 2019; <strong>197</strong>:161-169</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/cei.13291" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85063410302" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30868561/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fcei.13291&amp;pmid=30868561" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Whether and, if so, how Mg<sup>2+</sup> availability in tissues is sensed and integrated functionally by CD8<sup>+</sup> T&nbsp;cells has not been investigated.</div></section><section id="sec-2"><h2>Results</h2><div id="p0045" role="paragraph">First, we explored how Mg<sup>2+</sup> affected memory CD8<sup>+</sup> T&nbsp;cell function <i>in&nbsp;vitro</i>, using complete media containing 1.2&nbsp;mM Mg<sup>2+</sup> versus no Mg<sup>2+</sup> as the only difference. Analysis of metabolic flux profiles revealed that rapid induction of glycolysis of human EM CD8<sup>+</sup> T&nbsp;cells (defined as CD45RA<sup>−</sup> and CD62L<sup>−</sup>) activated by injection of soluble anti-CD3 and anti-28 monoclonal antibodies (mAb) was blunted in the absence of Mg<sup>2+</sup>. This deficit was reverted when adding back Mg<sup>2+</sup> just prior to activation (<a id="crosref0320" href="#figs1">Figure&nbsp;S1</a>A). By contrast, Mg<sup>2+</sup> did not affect activation-induced upregulation of glycolysis in naive CD8<sup>+</sup> T&nbsp;cells (defined as CD45RA<sup>+</sup> and CD62L<sup>+</sup>; <a id="crosref0325" href="#figs1">Figure&nbsp;S1</a>B). Next, we assessed the dose effect of Mg<sup>2+</sup> in EM CD8<sup>+</sup> T&nbsp;cells upon stimulation with anti-CD3 and CD28 mAb, staining for markers of early and late activation (CD69 and CD25, respectively), metabolic adaptation (CD71, CD98), and degranulation (CD107a). These experiments demonstrated a strict Mg<sup>2+</sup> dose response, plateauing at 0.6–1.2&nbsp;mM, that is, in the physiologic range of plasma concentrations reported for Mg<sup>2+</sup> (<a id="crosref0330" href="#figs1">Figure&nbsp;S1</a>C) (<span class="dropBlock reference-citations"><a id="body-ref-sref2" href="#" role="doc-biblioref" data-xml-rid="bib2" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref2" aria-controls="sref2">Akizawa et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Akizawa, Y. ∙ Koizumi, S. ∙ Itokawa, Y. ...</div><div><strong>Daily magnesium intake and serum magnesium concentration among Japanese people</strong></div><div><em>J.&nbsp;Epidemiol.</em> 2008; <strong>18</strong>:151-159</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.2188/jea.JE2007381" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-54449099515" target="_blank" aria-label="Open Scopus in new tab">Scopus (24)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18635902/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.2188%2Fjea.JE2007381&amp;pmid=18635902" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref6" href="#" role="doc-biblioref" data-xml-rid="bib6" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref6" aria-controls="sref6">Costello et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">6.</div><div>Costello, R.B. ∙ Elin, R.J. ∙ Rosanoff, A. ...</div><div><strong>Perspective: the case for an evidence-based reference interval for serum magnesium: the time has come</strong></div><div><em>Adv. Nutr.</em> 2016; <strong>7</strong>:977-993</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3945/an.116.012765" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84997207644" target="_blank" aria-label="Open Scopus in new tab">Scopus (144)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28140318/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3945%2Fan.116.012765&amp;pmid=28140318" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref37" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37" aria-controls="sref37">Lowenstein and Stanton, 1986</a><div class="dropBlock__holder" data-db-target-of="sref37"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Lowenstein, F.W. ∙ Stanton, M.F.</div><div><strong>Serum magnesium levels in the United States, 1971–1974</strong></div><div><em>J.&nbsp;Am. Coll. Nutr.</em> 1986; <strong>5</strong>:399-414</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/07315724.1986.10720143" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0022510113" target="_blank" aria-label="Open Scopus in new tab">Scopus (129)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/3771947/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F07315724.1986.10720143&amp;pmid=3771947" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref70" href="#" role="doc-biblioref" data-xml-rid="bib70" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref70" aria-controls="sref70">Zhan et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref70"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">70.</div><div>Zhan, Y. ∙ Chen, R. ∙ Zheng, W. ...</div><div><strong>Association between serum magnesium and anemia: China health and nutrition survey</strong></div><div><em>Biol. Trace Elem. Res.</em> 2014; <strong>159</strong>:39-45</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s12011-014-9967-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84902537269" target="_blank" aria-label="Open Scopus in new tab">Scopus (38)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24789475/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs12011-014-9967-x&amp;pmid=24789475" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The difference in the capacity of memory CD8<sup>+</sup> T&nbsp;cells to upregulate these phenotypic markers in the presence versus absence of Mg<sup>2+</sup> is summarized in <a id="crosref0355" href="#figs1">Figure&nbsp;S1</a>D, <i>left panel</i>. Cytokine release followed the same pattern, with decreased production under Mg<sup>2+</sup>-depleted conditions in EM cells (<a id="crosref0360" href="#figs1">Figure&nbsp;S1</a>D, <i>middle panel</i>). EM CD8<sup>+</sup> T&nbsp;cell viability was not affected by the lack of Mg<sup>2+</sup> in the culture media (<a id="crosref0365" href="#figs1">Figure&nbsp;S1</a>D, <i>right panel</i>). Analogous to induction of glycolysis, no Mg<sup>2+</sup>-related effect was observed for naive CD8<sup>+</sup> T&nbsp;cells for each of these measures (<a id="crosref0370" href="#figs1">Figure&nbsp;S1</a>E, <i>left and middle panels</i>), and also, in naive cells, viability was not affected by the lack of Mg<sup>2+</sup> in culture media (<a id="crosref0375" href="#figs1">Figure&nbsp;S1</a>E, <i>right panel</i>). The immediacy with which Mg<sup>2+</sup> affected reactivity of EM CD8<sup>+</sup> T&nbsp;cells (<a id="crosref0380" href="#figs1">Figure&nbsp;S1</a>A) suggested the possibility that a Mg<sup>2+</sup>-sensitive target (or targets) expressed on the cell surface could (co-)affect T&nbsp;cell function. Clustering of activated T&nbsp;cell blasts was also reduced in the absence of Mg<sup>2+</sup>, lending further support to the idea that Mg<sup>2+</sup> was impacting a target (or targets) on the cell surface (<a id="crosref0385" href="#figs1">Figure&nbsp;S1</a>F). This notion was also supported by the lack of evidence for rapid Mg<sup>2+</sup> flux into Mg<sup>2+</sup>-deprived CD8<sup>+</sup> T&nbsp;cells, which was in contrast to Ca<sup>2+</sup> flux tested in the same setting (<a id="crosref0390" href="#figs1">Figure&nbsp;S1</a>G). Guided by these phenotypic and functional data, we overlaid genes from gene ontology (GO) lists in a Venn diagram, inputting the following terms: <i>metal ion binding</i> (parent term of <i>Mg</i><sup><i>2+</i></sup> <i>binding</i>), <i>immune synapse</i> (CD3/28 activation), and <i>leukocyte adhesion</i> (clustering experiments), together with a published list of proteins preferentially expressed by EM over naive CD8<sup>+</sup> T&nbsp;cells (differential impact of Mg<sup>2+</sup>) (<span class="dropBlock reference-citations"><a id="body-ref-sref67-1" href="#" role="doc-biblioref" data-xml-rid="bib67" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref67-1" aria-controls="sref67-1">van Aalderen et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref67-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>van Aalderen, M.C. ∙ van den Biggelaar, M. ∙ Remmerswaal, E.B.M. ...</div><div><strong>Label-free analysis of CD8+ T&nbsp;cell subset proteomes supports a progressive differentiation model of human-virus-specific T&nbsp;cells</strong></div><div><em>Cell Rep.</em> 2017; <strong>19</strong>:1068-1079</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.celrep.2017.04.014&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.celrep.2017.04.014&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85018956495" target="_blank" aria-label="Open Scopus in new tab">Scopus (22)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28467900/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2017.04.014&amp;pmid=28467900" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This approach identified <i>ITGAL</i> (the gene encoding the integrin subunit alpha L chain, CD11a) as a candidate gene plausibly linked to the input criteria (<a id="crosref0400" href="#fig1">Figure&nbsp;1</a>A). CD11a combines with CD18 to form the leukocyte function-associated antigen 1 (LFA-1). LFA-1 is an integrin that is involved in T&nbsp;cell activation via immune synapse formation as well as in leukocyte trafficking and extravasation (<span class="dropBlock reference-citations"><a id="body-ref-sref23" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23" aria-controls="sref23">Hogg et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref23"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>Hogg, N. ∙ Patzak, I. ∙ Willenbrock, F.</div><div><strong>The insider's guide to leukocyte integrin signalling and function</strong></div><div><em>Nat. Rev. Immunol.</em> 2011; <strong>11</strong>:416-426</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri2986" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-79957621253" target="_blank" aria-label="Open Scopus in new tab">Scopus (322)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21597477/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri2986&amp;pmid=21597477" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Upon TCR stimulation, inside-out signaling mediates LFA-1 conformational changes, which regulate LFA-1 ligand-binding affinity and the molecule's capacity for outside-in signaling. Binding of Mg<sup>2+</sup> to metal-ion-dependent adhesion sites (MIDAS), one each on CD18 and CD11a, impacts these conformational changes. Specifically, MIDAS binding of Mg<sup>2+</sup> modulates the interchain allosteric relay (stalk extension) and external ligand affinity (headpiece conformation) (<span class="dropBlock reference-citations"><a id="body-ref-sref57-1" href="#" role="doc-biblioref" data-xml-rid="bib57" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref57-1" aria-controls="sref57-1">Schürpf and Springer, 2011</a><div class="dropBlock__holder" data-db-target-of="sref57-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Schürpf, T. ∙ Springer, T.A.</div><div><strong>Regulation of integrin affinity on cell surfaces</strong></div><div><em>EMBO J.</em> 2011; <strong>30</strong>:4712-4727</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/emboj.2011.333" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-82455189778" target="_blank" aria-label="Open Scopus in new tab">Scopus (144)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21946563/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Femboj.2011.333&amp;pmid=21946563" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref71" href="#" role="doc-biblioref" data-xml-rid="bib71" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref71" aria-controls="sref71">Zhang and Chen, 2012</a><div class="dropBlock__holder" data-db-target-of="sref71"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">71.</div><div>Zhang, K. ∙ Chen, J.</div><div><strong>The regulation of integrin function by divalent cations</strong></div><div><em>Cell Adh. Migr.</em> 2012; <strong>6</strong>:20-29</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4161/cam.18702" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84860360231" target="_blank" aria-label="Open Scopus in new tab">Scopus (166)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22647937/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4161%2Fcam.18702&amp;pmid=22647937" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The overall expression of LFA-1, which can be assessed using mAb TS2/4, was lowest on naive CD8<sup>+</sup> T&nbsp;cells, higher on EM CD8<sup>+</sup> T&nbsp;cells, and highest on T&nbsp;cell blasts (<a id="crosref0420" href="#fig1">Figure&nbsp;1</a>B). Memory cell-selective Mg<sup>2+</sup> dependency of metabolic reprogramming and activation and Mg<sup>2+</sup> dependency of clustering of T&nbsp;cell blasts thus aligned with the selection of <i>ITGAL</i> in our GO-term integration approach. The molecular conformation of LFA-1 can be probed by staining conformational epitopes. Specifically, KIM127 recognizes extended LFA-1, whereas m24 binds LFA1 when the headpiece is in its open position (<a id="crosref0425" href="#fig1">Figure&nbsp;1</a>C). These probing antibodies were used to assess how LFA-1 extension and headpiece opening related to activation (i.e., inside-out signaling) across a range of Mg<sup>2+</sup> concentrations in T&nbsp;cell blasts. Cell-surface expression of LFA-1, irrespective of conformation (i.e., mAb TS2/4 staining), was similar in nonactivated and activated cells and independent of Mg<sup>2+</sup> availability (<a id="crosref0430" href="#fig1">Figure&nbsp;1</a>D, <i>first panel, upper row</i>). LFA-1 extension (KIM127 binding) was detected on activated cells only and regulated by Mg<sup>2+</sup> (<a id="crosref0435" href="#fig1">Figure&nbsp;1</a>D, <i>second panel, upper row</i>). LFA-1 headpiece opening (m24 binding) was likewise detected on activated cells only and also modulated by Mg<sup>2+</sup> (<a id="crosref0440" href="#fig1">Figure&nbsp;1</a>D, <i>third pane, upper row</i>). The effect of Mg<sup>2+</sup> on LFA-1 headpiece opening was also observed in primary human CD8<sup>+</sup> T&nbsp;cells (<a id="crosref0445" href="#figs1">Figure&nbsp;S1</a>H). In a Mg<sup>2+</sup>-modulated manner, T&nbsp;cell activation further induced proximal and distal signaling activity (focal adhesion kinase (FAK) and extracellular signal-regulated protein kinase 1/2 (ERK1/2) phosphorylation, respectively) (<span class="dropBlock reference-citations"><a id="body-ref-sref18" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18" aria-controls="sref18">Giannoni et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref18"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>Giannoni, E. ∙ Chiarugi, P. ∙ Cozzi, G. ...</div><div><strong>Lymphocyte function-associated antigen-1-mediated T&nbsp;cell adhesion is impaired by low molecular weight phosphotyrosine phosphatase-dependent inhibition of FAK activity</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2003; <strong>278</strong>:36763-36776</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M302686200&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M302686200&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0141703588" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12815062/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M302686200&amp;pmid=12815062" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref54" href="#" role="doc-biblioref" data-xml-rid="bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54" aria-controls="sref54">Schaller et&nbsp;al., 1994</a><div class="dropBlock__holder" data-db-target-of="sref54"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Schaller, M.D. ∙ Hildebrand, J.D. ∙ Shannon, J.D. ...</div><div><strong>Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src</strong></div><div><em>Mol. Cell. Biol.</em> 1994; <strong>14</strong>:1680-1688</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/MCB.14.3.1680" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0028350859" target="_blank" aria-label="Open Scopus in new tab">Scopus (1133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7509446/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FMCB.14.3.1680&amp;pmid=7509446" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), nutrient (2-NBDG) uptake, TNF production, and expression of CD107a and CD69 (<a id="crosref0460" href="#fig1">Figure&nbsp;1</a>D, <i>fourth and fifth panels, upper row and lower row</i>). We then aimed to differentiate whether extension or headpiece opening was the critical event enabling LFA-1 outside-in signaling. To that end, effects of LFA-1 inhibitors (XVA143, BIRT377, and TS1/18) and LFA-1 activators (CBR LFA-1/2 and Mn<sup>2+</sup>) were tested regarding proximal LFA-1 outside-in signaling (FAK phosphorylation) in activated T&nbsp;cell blasts, both in the presence and absence of Mg<sup>2+</sup>. In the presence of Mg<sup>2+</sup>, XVA143 (allosteric antagonist inhibiting the ligand-binding I domain while stabilizing extended conformation), BIRT377 (allosteric inhibitor stabilizing bent conformation), and the mAb TS1/18 (allosteric inhibitor stabilizing the closed headpiece) all suppressed activation-induced FAK phosphorylation to levels that were observed when Mg<sup>2+</sup> was lacking (<a id="crosref0465" href="#fig1">Figure&nbsp;1</a>E). Extending LFA-1 with the activating mAb CBR LFA-1/2 in the presence of Mg<sup>2+</sup> increased FAK phosphorylation above the level observed in the presence of Mg<sup>2+</sup> alone, and yet, extension in the absence of Mg<sup>2+</sup> did not increase LFA-1 outside-in signaling (<a id="crosref0470" href="#fig1">Figure&nbsp;1</a>E). Mn<sup>2+</sup>, which binds both MIDAS, functions as a universal activator of integrins (<span class="dropBlock reference-citations"><a id="body-ref-sref10-1" href="#" role="doc-biblioref" data-xml-rid="bib10" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref10-1" aria-controls="sref10-1">Dransfield et&nbsp;al., 1992b</a><div class="dropBlock__holder" data-db-target-of="sref10-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">10.</div><div>Dransfield, I. ∙ Cabañas, C. ∙ Craig, A. ...</div><div><strong>Divalent cation regulation of the function of the leukocyte integrin LFA-1</strong></div><div><em>J.&nbsp;Cell Biol.</em> 1992; <strong>116</strong>:219-226</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.116.1.219" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0026601096" target="_blank" aria-label="Open Scopus in new tab">Scopus (431)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/1346139/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.116.1.219&amp;pmid=1346139" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref51" href="#" role="doc-biblioref" data-xml-rid="bib51" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref51" aria-controls="sref51">San Sebastian et&nbsp;al., 2006</a><div class="dropBlock__holder" data-db-target-of="sref51"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">51.</div><div>San Sebastian, E.S. ∙ Mercero, J.M. ∙ Stote, R.H. ...</div><div><strong>On the affinity regulation of the metal-ion-dependent adhesion sites in integrins</strong></div><div><em>J.&nbsp;Am. Chem. Soc.</em> 2006; <strong>128</strong>:3554-3563</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/ja054142a" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-33645408058" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16536528/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fja054142a&amp;pmid=16536528" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref68" href="#" role="doc-biblioref" data-xml-rid="bib68" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref68" aria-controls="sref68">Vorup-Jensen et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref68"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">68.</div><div>Vorup-Jensen, T. ∙ Waldron, T.T. ∙ Astrof, N. ...</div><div><strong>The connection between metal ion affinity and ligand affinity in integrin I domains</strong></div><div><em>Biochim. Biophys. Acta.</em> 2007; <strong>1774</strong>:1148-1155</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.bbapap.2007.06.014" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-34548288408" target="_blank" aria-label="Open Scopus in new tab">Scopus (34)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17702677/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.bbapap.2007.06.014&amp;pmid=17702677" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), was largely compensating for the absence of Mg<sup>2+</sup> in terms of FAK phosphorylation (<a id="crosref0490" href="#fig1">Figure&nbsp;1</a>E). Of note, Mn<sup>2+</sup> did not affect the cell-intrinsic glycolytic or mitochondrial functional capacity of T&nbsp;cell blasts—core metabolic activities that were also similar in presence versus absence of Mg<sup>2+</sup> in the culture media (<a id="crosref0495" href="#figs1">Figures S1</a>I and S1J). From these experiments, we concluded that extension was required but not sufficient to trigger FAK phosphorylation, and that headpiece opening—which was fully dependent on Mg<sup>2+</sup> (<a id="crosref0500" href="#fig1">Figure&nbsp;1</a>D)—was necessary for FAK phosphorylation to occur. Birt377 stabilizes LFA-1 in its bent state by eliminating the basal interaction between CD11a and CD18 (<span class="dropBlock reference-citations"><a id="body-ref-sref38" href="#" role="doc-biblioref" data-xml-rid="bib38" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref38" aria-controls="sref38">Moore et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref38"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">38.</div><div>Moore, T.I. ∙ Aaron, J. ∙ Chew, T.L. ...</div><div><strong>Measuring integrin conformational change on the cell surface with super-resolution microscopy</strong></div><div><em>Cell Rep.</em> 2018; <strong>22</strong>:1903-1912</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.celrep.2018.01.062&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.celrep.2018.01.062&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85042002828" target="_blank" aria-label="Open Scopus in new tab">Scopus (44)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29444440/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2018.01.062&amp;pmid=29444440" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref50" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50" aria-controls="sref50">Salas et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref50"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Salas, A. ∙ Shimaoka, M. ∙ Kogan, A.N. ...</div><div><strong>Rolling adhesion through an extended conformation of integrin alphaLbeta2 and relation to alpha I and beta I-like domain interaction</strong></div><div><em>Immunity.</em> 2004; <strong>20</strong>:393-406</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS1074-7613%2804%2900082-2&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS1074-7613%2804%2900082-2&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-1842684991" target="_blank" aria-label="Open Scopus in new tab">Scopus (172)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15084269/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1074-7613%2804%2900082-2&amp;pmid=15084269" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Therefore, adding Mn<sup>2+</sup>, which binds to the beta I-MIDAS with high affinity, is expected to extend LFA-1 even in the presence of Birt377 while keeping the headpiece closed—which is indeed what we observed (<a id="crosref0515" href="#fig1">Figures 1</a>F and 1G). In this scenario, the extension of LFA-1 did not drive FAK phosphorylation, corroborating the notion that headpiece opening was a requirement for FAK phosphorylation to be initiated, while extension alone was not sufficient (<a id="crosref0520" href="#fig1">Figure&nbsp;1</a>H). The same applied to downstream events regulated by LFA-1, namely activation-induced glycolysis and degranulation (<a id="crosref0525" href="#fig1">Figures 1</a>I and 1J). Intercellular adhesion molecules (ICAMs) are the ligands of LFA-1, and high-affinity LFA-1-ICAM interactions promote immune synapse formation. LFA-1 can also interact with ICAMs in <i>cis</i> (<span class="dropBlock reference-citations"><a id="body-ref-sref14" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14" aria-controls="sref14">Fan et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Fan, Z. ∙ McArdle, S. ∙ Marki, A. ...</div><div><strong>Neutrophil recruitment limited by high-affinity bent β2 integrin binding ligand in cis</strong></div><div><em>Nat. Commun.</em> 2016; <strong>7</strong>:12658</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms12658" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84985018876" target="_blank" aria-label="Open Scopus in new tab">Scopus (86)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27578049/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms12658&amp;pmid=27578049" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), as well in homotypic cell-cell interactions (<span class="dropBlock reference-citations"><a id="body-ref-sref13" href="#" role="doc-biblioref" data-xml-rid="bib13" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref13" aria-controls="sref13">Fan et&nbsp;al., 1993</a><div class="dropBlock__holder" data-db-target-of="sref13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Fan, S.T. ∙ Brian, A.A. ∙ Lollo, B.A. ...</div><div><strong>CD11a/CD18 (LFA-1) integrin engagement enhances biosynthesis of early cytokines by activated T&nbsp;cells. Cell</strong></div><div><em>Immunol.</em> 1993; <strong>148</strong>:48-59</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.T.FanA.A.BrianB.A.LolloN.MackmanN.L.ShenT.S.EdgingtonCD11a%2FCD18+%28LFA-1%29+integrin+engagement+enhances+biosynthesis+of+early+cytokines+by+activated+T%C2%A0cells.+CellImmunol14819934859" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref48" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48" aria-controls="sref48">Sabatos et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref48"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">48.</div><div>Sabatos, C.A. ∙ Doh, J. ∙ Chakravarti, S. ...</div><div><strong>A synaptic basis for paracrine interleukin-2 signaling during homotypic T&nbsp;cell interaction</strong></div><div><em>Immunity.</em> 2008; <strong>29</strong>:238-248</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.immuni.2008.05.017&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.immuni.2008.05.017&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-48749084864" target="_blank" aria-label="Open Scopus in new tab">Scopus (119)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18674934/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2008.05.017&amp;pmid=18674934" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). To define how ICAM binding contributed to LFA-1 outside-in signaling in the presence or absence of Mg<sup>2+</sup> in our <i>in&nbsp;vitro</i> system, we assessed the surface expression of ICAMs on T&nbsp;cells. On T&nbsp;cell blasts, expression of ICAM-3 was highest, followed by that of ICAM-1 and ICAM-2 (<a id="crosref0545" href="#figs1">Figure&nbsp;S1</a>K). Primary human naive CD8<sup>+</sup> T&nbsp;cells expressed less ICAM-3 than EM CD8<sup>+</sup> T&nbsp;cells; expression of ICAM-3 on EM CD8<sup>+</sup> T&nbsp;cells and T&nbsp;cell blasts was similar (<a id="crosref0550" href="#figs1">Figure&nbsp;S1</a>L). We then used blocking antibodies to prevent ICAMs from interacting with LFA-1, both in the presence and absence of Mg<sup>2+</sup>. Blocking of ICAM-3 moderately reduced LFA-1 headpiece opening upon activation of T&nbsp;cell blasts (<a id="crosref0555" href="#figs1">Figure&nbsp;S1</a>M) and decreased the interlinked upregulation of CD69 (<a id="crosref0560" href="#figs1">Figure&nbsp;S1</a>N).</div><div class="figure-wrap"><figure id="fig1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.12.039/asset/5fea6f02-b490-4125-9828-8a2030db1879/main.assets/gr1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr1" src="/cms/10.1016/j.cell.2021.12.039/asset/2749bce4-823c-42cd-a4c4-33083ae04a91/main.assets/gr1.jpg" height="919" width="659" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/5fea6f02-b490-4125-9828-8a2030db1879/main.assets/gr1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;1</span> <span class="figure__title__text">Sensing of extracellular magnesium through LFA-1 shapes T&nbsp;cell activation</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0015" role="paragraph">(A) Venn diagram of GO-term lists and differentially expressed proteins between CD8<sup>+</sup> T&nbsp;cell subsets (memory &gt; naive).</div><div id="fspara0020" role="paragraph">(B) Representative CD11a expression profile on human naive and EM CD8<sup>+</sup> T&nbsp;cells as well as human PHA blasts as determined by flow cytometry (<i>left panel</i>) and a summary bar graph (<i>right panel</i>).</div><div id="fspara0025" role="paragraph">(C) Schematic of LFA-1 conformational states and antibodies used to probe them.</div><div id="fspara0030" role="paragraph">(D) Flow cytometric analysis of human PHA blasts ± TCR stimulation at indicated Mg<sup>2+</sup> concentrations, detecting LFA-1 expression independent of conformational state (TS2/4 binding: <i>first panel, upper row</i>); extended LFA-1 (KIM127 binding: <i>second panel, upper row</i>); LFA-1 open headpiece conformation (m24 binding: <i>third panel, upper row</i>); phosphorylation of FAK (<i>fourth panel, upper row</i>); phosphorylation of ERK1/2 (<i>fifth panel, upper row</i>); uptake of 2-NBDG, indicating glucose/nutrient uptake (<i>first panel, lower row</i>); TNF production (<i>second panel, lower row</i>); degranulation as indicated by upregulation of CD107a (<i>third panel, lower row</i>); and expression of the activation marker CD69 (<i>forth panel, lower row</i>). PHA blasts established from n&nbsp;= 5–7 healthy donors were used.</div><div id="fspara0035" role="paragraph">(E) FAK phosphorylation in PHA blasts after activation in medium ± Mg<sup>2+</sup> using BIRT377 (α I allosteric antagonist), XVA143 (α/β I-like allosteric antagonist), TS1/18 (blocking antibody-binding β<sub>2</sub> chain), CBR-LFA1/2 (activating antibody-binding β<sub>2</sub> chain), or Mn<sup>2+</sup>. The mean signal of each condition was compared with the mean control signal of 1.2 or 0&nbsp;mM Mg<sup>2+</sup>, respectively.</div><div id="fspara0040" role="paragraph">(F–J) Assessment of human PHA blasts in medium ± Mg<sup>2+</sup>; ± Mn<sup>2+</sup>; ± BIRT377, as indicated, with regard to activation-induced LFA-1 extension (KIM127 binding) (F); headpiece opening (m24 binding) (G); FAK phosphorylation (H); glycolytic activity—metabolic flux traces from a representative experiment (<i>left panel</i>), summary (<i>right panel</i>) (I), and degranulation (J). Each symbol represents an individual healthy donor. Data are presented as mean ± SD, except <i>left panel</i> of (I), where symbols indicate mean ± SEM. Statistical significance was assessed by one-way ANOVA with Sidak’s multiple comparison test (B and E–J). <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.12.039/asset/08789da6-9833-4035-b3c9-5efe4e8d5ed3/main.assets/figs1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs1" src="/cms/10.1016/j.cell.2021.12.039/asset/b4a993ed-77f1-4537-ba1f-25748f12e244/main.assets/figs1.jpg" height="907" width="657" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/08789da6-9833-4035-b3c9-5efe4e8d5ed3/main.assets/figs1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S1</span> <span class="figure__title__text">Extracellular Mg<sup>2+</sup> promotes activation of memory T&nbsp;cells, related to <a id="crosref1265" href="#fig1">Figure&nbsp;1</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0310" role="paragraph">(A and B) Glycolytic activity of human CD8<sup>+</sup> T&nbsp;cell subsets upon injection of anti-CD3 and anti-CD28 antibody in medium containing 1.2&nbsp;mM Mg<sup>2+</sup>, 0&nbsp;mM Mg<sup>2+</sup>, or medium which was reconstituted from 0&nbsp;mM to 1.2&nbsp;mM Mg<sup>2+</sup> just prior to activation (0 → 1.2&nbsp;mM Mg<sup>2+</sup>). (A) Results for human effector memory (EM), and (B) for human naive CD8<sup>+</sup> T&nbsp;cells. Traces of a representative metabolic flux experiment (<i>left panels</i>), and pooled data of n&nbsp;= 5 independent experiments (<i>right panels</i>).</div><div id="fspara0315" role="paragraph">(C) Flow cytometric analysis of the indicated surface activation markers on human EM CD8<sup>+</sup> T&nbsp;cells activated at indicated Mg<sup>2+</sup> concentrations for 24 h. Representative flow histogram of CD69 expression (<i>left panel</i>), and pooled data from two healthy donors (<i>right panel</i>).</div><div id="fspara0320" role="paragraph">(D) Surface activation markers on EM CD8+ T&nbsp;cells after activation for 24 h. Pooled data from n&nbsp;= 5 independent experiments (<i>left panel</i>). Abundance of inflammatory cytokines in corresponding cell culture supernatants. The dashed line indicates detection limit (<i>middle panel</i>). Viability of EM CD8<sup>+</sup> T&nbsp;cells (<i>right panel</i>).</div><div id="fspara0325" role="paragraph">(E) Surface marker expression on activated naive CD8<sup>+</sup> T&nbsp;cells after 24 h. Pooled data from n&nbsp;= 4 independent experiments (<i>left panel</i>). Abundance of inflammatory cytokines in corresponding cell culture supernatants. The dashed line indicates detection limit (<i>middle panel</i>). Viability of naive CD8<sup>+</sup> T&nbsp;cells (<i>right panel</i>).</div><div id="fspara0330" role="paragraph">(F) Representative brightfield images of activation-induced clustering of PHA blasts after 6 h. Scale bars indicate 50&nbsp;μm.</div><div id="fspara0335" role="paragraph">(G) Flow cytometric analysis of Mg<sup>2+</sup> influx (<i>left panel</i>) and Ca<sup>2+</sup> influx (<i>right panel</i>) into naive and EM CD8<sup>+</sup> T&nbsp;cells, using fluorescent probes.</div><div id="fspara0340" role="paragraph">(H) Flow cytometry-based assessment of TCR activation-induced LFA-1 headpiece opening (as detected by mAb m24 binding) on human EM and naive CD8<sup>+</sup> T&nbsp;cells. Pooled data of n&nbsp;= 4 independent experiments using cells from 1 to 2 individual healthy donors</div><div id="fspara0345" role="paragraph">(I) Assessment of glycolysis and glycolytic reserve of human PHA blasts. One representative experiment (<i>left panel</i>) and pooled data from two independent experiments (<i>right panel</i>) are shown. (J) Mitochondrial perturbation assay of human PHA blasts. <i>Left panel</i> depicting a representative experiment, summary bar graph in the <i>right panel</i>, representing calculated basal respiration, ATP-coupled respiration, leak respiration, maximal respiration, and spare respiratory capacity (SRC), as well nonmitochondrial respiration (pooled from two independent experiments).</div><div id="fspara0350" role="paragraph">(K) Representative ICAM1-3 expression profile on PHA blasts as determined by flow cytometry (<i>left panel</i>) and summary bar graph (<i>right panel</i>).</div><div id="fspara0355" role="paragraph">(L) Representative ICAM-3 expression profile on human naive and EM CD8<sup>+</sup> T&nbsp;cells as well human PHA blasts, as determined by flow cytometry (<i>left panel</i>) and summary bar graph (<i>right panel</i>).</div><div id="fspara0360" role="paragraph">(M and N) Flow cytometric assessment of LFA-1 headpiece opening (M), and expression of CD69 (N) on PHA blasts activated in presence of ICAM blocking mAb, as indicated (not normalized for ICAM expression). Each symbol represents an individual healthy donor. Data are presented as mean ± SD in (H, M, and N), in the <i>right panel</i> of (A–C and I–L) and the <i>left</i> as well as <i>right panels</i> of (D and E) or median ± IQR <i>middle panel</i> of (D and E). In representative metabolic flux analyses symbols indicate mean ± SEM in the <i>left panel</i> of (A, B, I, and J). Traces of Mg<sup>2+</sup> or Ca<sup>2+</sup> flux experiments indicate mean of respective fluorescent intensity (G). Statistical significance was assessed by repeated-measures one-way ANOVA with Sidak’s multiple comparison test <i>right panel</i> of (A, B, and I–L) as well as (M and N), unpaired two-tailed Student’s t test with Holm-Sidak corrected multiple comparison test <i>left panel</i> and <i>right panel</i> of (D and E) and (H), and Mann-Whitney test <i>middle panel</i> of (D and E). <sup>∗</sup> p&nbsp;&lt; 0.05, <sup>∗∗</sup> p &lt;0.01,<sup>∗∗∗</sup>p &lt; 0.001, <sup>∗∗∗∗</sup> p&nbsp;&lt; 0.0001, n.s.&nbsp;= nonsignificant.</div></div></div></div></figcaption></figure></div><div id="p0050" role="paragraph">These experiments established Mg<sup>2+</sup> as an important regulator of EM CD8<sup>+</sup> T&nbsp;cell function. Mg<sup>2+</sup> was further identified to impact both extension and headpiece opening of LFA-1 on activated T&nbsp;cells, with headpiece opening being critical to outside-in signaling and downstream T&nbsp;cell activation.</div><section id="sec-2-1"><h3>Immune synapse formation of expanded tumor-specific T&nbsp;cells is regulated via the Mg<sup>2+</sup>-LFA-1 axis</h3><div id="p0055" role="paragraph">Next, we generated NY-ESO-1-specific T&nbsp;cells using a rapid expansion protocol (REP T&nbsp;cells) (<span class="dropBlock reference-citations"><a id="body-ref-sref11" href="#" role="doc-biblioref" data-xml-rid="bib11" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref11" aria-controls="sref11">Dudley et&nbsp;al., 2002</a><div class="dropBlock__holder" data-db-target-of="sref11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">11.</div><div>Dudley, M.E. ∙ Wunderlich, J.R. ∙ Robbins, P.F. ...</div><div><strong>Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes</strong></div><div><em>Science.</em> 2002; <strong>298</strong>:850-854</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1076514" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0037174674" target="_blank" aria-label="Open Scopus in new tab">Scopus (2492)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12242449/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1076514&amp;pmid=12242449" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref63" href="#" role="doc-biblioref" data-xml-rid="bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref63" aria-controls="sref63">Thomas et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref63"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Thomas, R. ∙ Al-Khadairi, G. ∙ Roelands, J. ...</div><div><strong>NY-ESO-1 based immunotherapy of cancer: current perspectives</strong></div><div><em>Front. Immunol.</em> 2018; <strong>9</strong>:947</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3389/fimmu.2018.00947" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85046286771" target="_blank" aria-label="Open Scopus in new tab">Scopus (269)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29770138/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3389%2Ffimmu.2018.00947&amp;pmid=29770138" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). LFA-1 surface expression on human NY-ESO-1-specific REP T&nbsp;cells was as high as on T&nbsp;cell blasts (PHA blasts) (<a id="crosref0575" href="#fig2">Figure&nbsp;2</a>A). REP T&nbsp;cell killing activity was augmented by Mg<sup>2+</sup> across a spectrum of target peptide (9c) concentrations used for pulsing tumor target cells—most efficiently so at low 9c concentrations (<a id="crosref0580" href="#figs2">Figure&nbsp;S2</a>A). Also in this antigen-specific setting, Mg<sup>2+</sup> was required for LFA-1 headpiece opening, and extension of LFA-1 in the absence of headpiece opening was insufficient to initiate FAK phosphorylation, degranulation, and target cell killing (<a id="crosref0585" href="#fig2">Figure&nbsp;2</a>B), as well as ERK1/2 as well as c-Jun activity (<a id="crosref0590" href="#figs2">Figures S2</a>B and S2C). Engagement of ERK1/2 and c-Jun through the LFA-1-Mg<sup>2+</sup> regulatory axis was confirmed by immunoblot analyses in both human T&nbsp;cell blasts (<a id="crosref0595" href="#figs2">Figures S2</a>D and S2E), as well as primary human EM CD8<sup>+</sup> T&nbsp;cells (<a id="crosref0600" href="#figs2">Figure&nbsp;S2</a>F). We then visually explored immune synapse formation between NY-ESO-1-specific T&nbsp;cells and tumor cells. These experiments identified early antigen-specific LFA-1 headpiece opening at&nbsp;sites of close physical interaction between REP T&nbsp;cells and tumor targets, which was Mg<sup>2+</sup> dependent, Mn<sup>2+</sup> rescuable, and Birt377 sensitive (<a id="crosref0605" href="#fig2">Figure&nbsp;2</a>C). Phospho-tyrosine signal intensity at REP T&nbsp;cell-target cell interaction sites also mirrored LFA-1 headpiece opening across all conditions (<a id="crosref0610" href="#fig2">Figure&nbsp;2</a>C). Maturation of the immune synapse is characterized by centrosome polarization and focused delivery of cytolytic granules, two events that the Mg<sup>2+</sup>-LFA-1 axis also contributed to (<a id="crosref0615" href="#fig2">Figure&nbsp;2</a>D, imaging performed after 35–45&nbsp;min of REP T&nbsp;cells target cell co-incubation).</div><div class="figure-wrap"><figure id="fig2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.12.039/asset/47ff5cb7-1e9a-4207-954a-6d2d5392e36d/main.assets/gr2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr2" src="/cms/10.1016/j.cell.2021.12.039/asset/cbbf1e30-8eef-4902-a166-358cd5fd68d8/main.assets/gr2.jpg" height="939" width="711" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/47ff5cb7-1e9a-4207-954a-6d2d5392e36d/main.assets/gr2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;2</span> <span class="figure__title__text">The magnesium-LFA-1 axis regulates immune synapse formation of tumor-specific human T&nbsp;cells</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0050" role="paragraph">(A) Representative histogram of CD11a expression on human naive and EM CD8<sup>+</sup> T&nbsp;cells, PHA blasts and NY-ESO-1-specific REP T&nbsp;cells.</div><div id="fspara0055" role="paragraph">(B) Flow cytometric assessment of REP T&nbsp;cells after incubation with T2 target cells that were pulsed with cognate peptide. REP T&nbsp;cells were analyzed with regard to LFA-1 extension (<i>first panel</i>), LFA-1 headpiece opening (<i>second panel</i>), FAK phosphorylation (<i>third panel</i>), and degranulation (<i>fourth panel</i>). In the <i>fifth panel</i>, co-culture-induced caspase-3 activity in T2 target cells (i.e., apoptosis) is shown. Representative of n&nbsp;= 2 independent experiments with n&nbsp;= 5–7 healthy donors; <i>fourth panel</i> n&nbsp;= 1 healthy donor and 4 technical replicates.</div><div id="fspara0060" role="paragraph">(C) <i>Upper panel</i>, representative confocal projections of REP T&nbsp;cells co-cultured with T2 target cells, labeled for headpiece-open LFA-1, and pan-tyrosine phosphorylation. Scale bars indicate 10&nbsp;μm. <i>Lower left panel</i>, quantitation of headpiece-open LFA-1 within confocal 3D stacks (symbol represents an individual field of view). <i>Lower right panel</i>, quantitation of median fluorescence intensity of tyrosine phosphorylation in REP T&nbsp;cells (n&nbsp;= 203–344 cells per condition, pooled from n&nbsp;= 1–2 field of views).</div><div id="fspara0065" role="paragraph">(D) <i>Upper panel</i>, representative confocal projections of REP T&nbsp;cells co-cultured with T2 target cells. Cells were labeled for γ-tubulin (centrosome) and perforin. <i>Lower left panel</i>, quantitation of perforin, <i>lower right panel</i>, quantitation of centrosome polarization (symbol represents an individual field of view). Data are presented as mean ± SD, except for the <i>lower right panel</i> of (C), where data are presented as median ± IQR. Statistical significance was assessed by repeated-measures one-way ANOVA with Sidak’s multiple comparison test (B), one-way ANOVA with Sidak’s multiple comparison test for the <i>lower left panel</i> of (C and D), and <i>lower right panel</i> of (D). Kruskal-Wallis test with Dunn’s multiple comparison test was used for the <i>lower right panel</i> of (C). ∗p&nbsp;&lt; 0.05, ∗∗p&nbsp;&lt; 0.01, ∗∗∗p&nbsp;&lt; 0.001, ∗∗∗∗p&nbsp;&lt; 0.0001, n.s., nonsignificant.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.12.039/asset/782e85c5-f588-4ef2-94e7-4ea75010210a/main.assets/figs2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs2" src="/cms/10.1016/j.cell.2021.12.039/asset/b9c8af47-b43c-464a-a4d8-c5c28d7c57f3/main.assets/figs2.jpg" height="870" width="753" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/782e85c5-f588-4ef2-94e7-4ea75010210a/main.assets/figs2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S2</span> <span class="figure__title__text">The Mg<sup>2+</sup>-LFA-1 axis regulates cytotoxicity and phosphorylation of ERK1/2 and c-Jun, related to <a id="crosref1270" href="#fig2">Figure&nbsp;2</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0370" role="paragraph">(A) Caspase-3 activity in T2 target cells after co-incubation with NY-ESO-1-specific REP T&nbsp;cells. <i>Left panel</i> depicts fold increase of caspase-3 positive T2 cells in 1.2&nbsp;mM Mg<sup>2+</sup>, the <i>right panel</i> illustrates the corresponding percentage of caspase-3 positive T2 cells.</div><div id="fspara0375" role="paragraph">(B and C) Representative histograms (<i>left panels</i>), quantified results of n&nbsp;= 1 healthy donor with 4 technical replicates (<i>right panels</i>). Phosphorylation of ERK1/2 (B), and c-Jun (C) in human REP T&nbsp;cells after incubating with cognate-peptide pulsed T2 target cells</div><div id="fspara0380" role="paragraph">(D and E) Immunoblot analyses of ERK1/2 phosphorylation (D) and c-Jun phosphorylation (E) in activated human PHA blasts. <i>Left panel</i> depicting immunoblots that were probed for the indicated phosphorylated and total proteins, as well as actin. <i>Right panel</i> depicting summarized quantitation with 3–5 healthy donors.</div><div id="fspara0385" role="paragraph">(F) Representative immunoblots of primary human EM CD8<sup>+</sup> T&nbsp;cells. Immunoblots were probed for phosphorylated ERK1/2 and c-Jun, as well actin.</div><div id="fspara0390" role="paragraph">Each symbol represents an individual healthy donor. Bars indicate mean ± SD (A–E), and statistical significance was assessed with unpaired two-tailed Student’s t test with Holm-Sidak corrected multiple comparison test <i>right panel</i> of (A), one-way ANOVA with Sidak’s multiple comparison test <i>right panel</i> of (B–E). <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p &lt; 0.001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-2"><h3>LFA-1 is essential for Mg<sup>2+</sup> to shape cytotoxic T&nbsp;cell activity and immune synapse formation, <i>in&nbsp;vitro</i></h3><div id="p0060" role="paragraph">To genetically probe the suggested Mg<sup>2+</sup>-LFA-1 regulatory axis, experiments using LFA-1 deficient (LFA-1<sup>−/−</sup>) cytotoxic T&nbsp;cells (CTLs) and LFA-1<sup>−/−</sup> Jurkat T&nbsp;cells were performed (validation of k.o.; <a id="crosref0620" href="#figs3">Figure&nbsp;S3</a>A). First, we repeated metabolic flux analyses using LFA-1<sup>−/−</sup> CTLs. These experiments confirmed LFA-1 as the mediator through which Mg<sup>2+</sup> exerted its effect on glycolysis (<a id="crosref0625" href="#fig3">Figure&nbsp;3</a>A). 2-NBDG (glucose/nutrient) uptake assays—which were complemented with Mn<sup>2+</sup> and BIRT377—also aligned with the metabolic flux studies (<a id="crosref0630" href="#figs3">Figure&nbsp;S3</a>B). TCR stimulation mediates influx of Ca<sup>2+</sup> into the cytosol, where it functions as a second messenger (<span class="dropBlock reference-citations"><a id="body-ref-sref65" href="#" role="doc-biblioref" data-xml-rid="bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65" aria-controls="sref65">Trebak and Kinet, 2019</a><div class="dropBlock__holder" data-db-target-of="sref65"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Trebak, M. ∙ Kinet, J.P.</div><div><strong>Calcium signalling in T&nbsp;cells</strong></div><div><em>Nat. Rev. Immunol.</em> 2019; <strong>19</strong>:154-169</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41577-018-0110-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85059679768" target="_blank" aria-label="Open Scopus in new tab">Scopus (290)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30622345/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41577-018-0110-7&amp;pmid=30622345" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Depletion of extracellular Mg<sup>2+</sup> blunted early (white bar) as well as sustained (black bar) influx of Ca<sup>2+</sup> in wild-type (WT) OT-I CTLs, a finding phenocopied independently of extracellular Mg<sup>2+</sup> in LFA-1<sup>−/−</sup> OT-I CTLs (<a id="crosref0640" href="#fig3">Figure&nbsp;3</a>B). The same requirement for LFA-1 for both early and late Ca<sup>2+</sup> flux was also observed in WT versus LFA-1<sup>−/−</sup> Jurkat cells (<a id="crosref0645" href="#figs3">Figure&nbsp;S3</a>C). As a proxy for early immune synapse-initiated signaling, we further analyzed TCR ligation-induced tyrosine phosphorylation, 2&nbsp;min postactivation using confocal microscopy. In LFA-1<sup>−/−</sup> Jurkat T&nbsp;cells, TCR-induced tyrosine phosphorylation was markedly reduced, independently of extracellular Mg<sup>2+</sup> (<a id="crosref0650" href="#figs3">Figure&nbsp;S3</a>D). In WT Jurkat T&nbsp;cells, Mg<sup>2+</sup> restriction had the same effect (<a id="crosref0655" href="#figs3">Figure&nbsp;S3</a>D). Aligning with these genetic data, in anti-CD3 mAb activated T&nbsp;cell blasts, phospho-tyrosine signaling was augmented by Mg<sup>2+</sup> in a BIRT377-sensitive manner, and the absence of Mg<sup>2+</sup> was partially rescued by Mn<sup>2+</sup> (<a id="crosref0660" href="#figs3">Figure&nbsp;S3</a>E). LFA-1 further recruits and amplifies TCR-mediated ERK1/2 signaling at the immune synapse (<span class="dropBlock reference-citations"><a id="body-ref-sref33" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33" aria-controls="sref33">Li et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref33"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Li, D. ∙ Molldrem, J.J. ∙ Ma, Q.</div><div><strong>LFA-1 regulates CD8+T cell activation via T&nbsp;cell receptor-mediated and LFA-1-mediated ERK1/2 signal pathways</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2009; <strong>284</strong>:21001-21010</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M109.002865&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M109.002865&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-68949085309" target="_blank" aria-label="Open Scopus in new tab">Scopus (56)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19483086/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M109.002865&amp;pmid=19483086" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and Mg<sup>2+</sup> and partially Mn<sup>2+</sup> increased also ERK1/2 activity in CTLs in an LFA-1-dependent manner (<a id="crosref0670" href="#fig3">Figure&nbsp;3</a>C). Of note, Mg<sup>2+</sup> and Mn<sup>2+</sup> <i>per se</i> did not induce p-ERK1/2 in unstimulated T&nbsp;cells, nor did genetic deletion or LFA-1 negatively affect p-ERK1/2 signaling upon supra-physiologic activation with PMA and ionomycin (<a id="crosref0675" href="#figs3">Figure&nbsp;S3</a>F). We then investigated the impact that the Mg<sup>2+</sup>-LFA-1 system had on more downstream events in activated CTLs. CD69 and degranulation were similarly induced in activated LFA-1 competent and LFA-1<sup>−/−</sup> CTL cells; yet, as expected, only in LFA-1 competent cells they were modulated by Mg<sup>2+</sup>, and partially also by Mn<sup>2+</sup> (<a id="crosref0680" href="#fig3">Figures 3</a>D and 3E). Specific cytotoxic activity in contrast—which is a highly coordinated process requiring timed and polarized release of cytotoxic granules—was severely blunted in LFA-1<sup>−/−</sup> CTLs, while regulated via LFA-1 in a Mg<sup>2+</sup> dependent, partially Mn<sup>2+</sup> rescuable, and Birt377-sensitive manner in LFA-1 competent counterparts (<a id="crosref0685" href="#fig3">Figure&nbsp;3</a>F). This suggested that both high-affinity binding of Mn<sup>2+</sup> to the LFA-1 MIDAS and lack of LFA-1 were associated with dysregulated immune cell function, plausibly due to uncoordinated immune synapse formation in both scenarios. Using OVA variant peptides (affinity for OT-I: G4&nbsp;&lt; H7&nbsp;&lt; R7), the importance of the Mg<sup>2+</sup>-LFA-1 system in regulating proximal LFA-1-driven signaling (FAK activity), distal LFA-1-impacted signaling (ERK1/2 activity), degranulation, and specific target cell lysis was confirmed across a spectrum of TCR affinities (<a id="crosref0690" href="#fig3">Figures 3</a>G–3J). Notably, only OVA, with its very high affinity for OT-I, triggered limited lysis independently of Mg<sup>2+</sup> and LFA-1 (<a id="crosref0695" href="#fig3">Figure&nbsp;3</a>J).</div><div class="figure-wrap"><figure id="fig3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.12.039/asset/9c3faf58-3315-4d37-9917-8438e911f509/main.assets/gr3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr3" src="/cms/10.1016/j.cell.2021.12.039/asset/32dba184-c9ff-4069-9f3e-4a769e72e5e5/main.assets/gr3.jpg" height="934" width="659" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/9c3faf58-3315-4d37-9917-8438e911f509/main.assets/gr3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;3</span> <span class="figure__title__text">LFA-1 is required to regulate T&nbsp;cell activation and cytotoxicity, <i>in&nbsp;vitro</i></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0075" role="paragraph">(A) Glycolytic activity upon activation of murine WT and LFA-1<sup>−/−</sup> CTLs. Representative experiment (<i>left panel</i>), summary of ΔECAR (basal versus max.) (<i>right panel</i>) from n&nbsp;= 4 mice.</div><div id="fspara0080" role="paragraph">(B) TCR stimulation induced calcium flux in WT and LFA-1<sup>−</sup><sup>/</sup><sup>−</sup> OT-I CTLs. Representative trace (<i>left panel</i>), and quantification of area under the curve (AUC) of individual wells (<i>right panel</i>). Representative of n&nbsp;= 3 independent experiments.</div><div id="fspara0085" role="paragraph">(C–E) Representative histograms (<i>left panels</i>) and quantified results from n&nbsp;= 3 mice with three technical replicates each (<i>right panels</i>): (C) Phosphorylation of ERK1/2; (D) surface expression of CD69, and (E) surface expression of CD107a on murine WT and LFA-1<sup>−/−</sup> CTLs.</div><div id="fspara0090" role="paragraph">(F) Caspase-3 activity in EL4 target cells after co-culture with murine WT and LFA-1<sup>−/−</sup> CTLs. The representative histogram shows caspase-3 activity in EL4 cells assessed by flow cytometry (<i>left panel</i>), results are quantified from n&nbsp;= 3 mice, with two to three technical replicates each (<i>right panel</i>).</div><div id="fspara0095" role="paragraph">(G–J) Representative histograms (<i>left panels</i>) and quantified results with n&nbsp;= 4 (technical replicates) (<i>right panels</i>). (G) Phosphorylation of FAK; (H) phosphorylation of ERK1/2; (I) surface expression of CD107a, on murine WT and LFA-1<sup>−</sup><sup>/</sup><sup>−</sup> OT-I CTLs. (J) Cytotoxicity assay using WT and LFA-1<sup>−/−</sup> OT-I CTLs, co-cultured with cognate antigen-pulsed EL4 target cells. Representative histogram shows caspase-3 activity in EL4 cells assessed by flow cytometry (<i>left panel</i>), the <i>right panel</i> depicts quantified results from n&nbsp;= 4 technical replicates. Results are representative of n&nbsp;= 2 independent experiments. Data are presented as mean ± SD <i>right panel</i> of (A–J). In the representative metabolic flux traces, <i>left panel</i> of (A), symbols indicate mean ± SEM. Statistical significance was assessed by one-way ANOVA with Sidak’s multiple comparison test (A–F), and ordinary two-way ANOVA with main effects only and Tukey’s multiple comparison test (G–J). <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗∗</sup> p&nbsp;&lt; 0.0001, n.s., nonsignificant</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.12.039/asset/71dc8aaa-7aef-4879-9a99-c3fa2f42a8cd/main.assets/figs3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs3" src="/cms/10.1016/j.cell.2021.12.039/asset/c867bde5-f8d7-41dd-8566-be48dfb1a77d/main.assets/figs3.jpg" height="931" width="684" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/71dc8aaa-7aef-4879-9a99-c3fa2f42a8cd/main.assets/figs3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S3</span> <span class="figure__title__text">Extracellular Mg<sup>2+</sup> regulates Ca<sup>2+</sup> flux and immune synapse formation through LFA-1, related to <a id="crosref1275" href="#fig3">Figure&nbsp;3</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0400" role="paragraph">(A) Representative histogram comparing CD11a surface expression on CTLs derived from murine WT and LFA-1<sup>−/−</sup> CTLs (<i>left panel</i>), WT (treated with negative control guide RNA) and LFA-1<sup>−/−</sup> Jurkat T&nbsp;cells (<i>middle panel</i>), as well naive OT-I cells and CRISPR-Cas9-edited OT-I CTLs before and after purification by cell sorting (<i>right panel</i>).</div><div id="fspara0405" role="paragraph">(B) Glucose uptake by activated murine WT and LFA-1<sup>−/−</sup> CTLs. Representative flow histogram profile (<i>left panel</i>) and summary graph from n&nbsp;= 3 mice with three technical replicates each (<i>right panel</i>).</div><div id="fspara0410" role="paragraph">(C) TCR stimulation induced calcium flux in WT and LFA-1<sup>−/−</sup> Jurkat T&nbsp;cells. Representative trace (<i>left panel</i>), and quantification of area under the curve (AUC) of three independent experiments in duplicates (<i>right panel</i>).</div><div id="fspara0415" role="paragraph">(D) <i>Left panel</i>, representative immunofluorescence images of WT and LFA-1<sup>−/−</sup> Jurkat T&nbsp;cells stimulated on anti-CD3 Ab-coated coverslip. Images are displayed as confocal projections of 3D stacks. Scale bars indicate 10&nbsp;μm. <i>Right panel</i>, quantitative analysis of fluorescent signal intensity (n&nbsp;= 62–71 cells/condition, pooled from two different fields of view).</div><div id="fspara0420" role="paragraph">(E) <i>Left panel</i>, representative immunofluorescent images of PHA blasts stimulated on ±anti-CD3-coated coverslip. Cells were stained for pan-tyrosine phosphorylation, actin, and nuclei. Images are displayed as confocal projections of 3D stacks. Scale bars indicate 10&nbsp;μm. Right panel, quantitative analysis of fluorescent signal intensity (n&nbsp;= 91–146 cells/condition, pooled from 2 to 4 different field of views).</div><div id="fspara0425" role="paragraph">(F) Flow cytometric analysis of ERK1/2 phosphorylation in murine WT and LFA-1<sup>−/−</sup> CTLs. Left panel shows unstimulated baseline ERK1/2 phosphorylation, and <i>right panel</i> depicts phosphorylation status upon PMA and ionomycin treatment. Quantified results of n&nbsp;= 3 mice in duplicates each. Data are presented as mean ± SD right panel of (B and C) and <i>both panels</i> (F), median ± IQR <i>right panel</i> of (D and E). Traces of representative calcium flux, left panel of (C), indicate mean of duplicate wells. Statistical significance was assessed by one-way ANOVA with Sidak’s multiple comparison test <i>right panel</i> of (B and C) and <i>both panels</i> (F), Kruskal-Wallis test with Dunn’s multiple comparisons test was applied for (D and E). <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p &lt;0.01, <sup>∗∗∗</sup>p &lt;0.001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001, n.s., nonsignificant.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-3"><h3>LFA-1 is essential for Mg<sup>2+</sup> to shape T&nbsp;cell activation and effector function, <i>in&nbsp;vivo</i></h3><div id="p0065" role="paragraph">Our goal was then to test how genetic deletion of LFA-1 affected T&nbsp;cell function in relation to Mg<sup>2+</sup> abundance <i>in&nbsp;vivo</i>. First, we established a dietary Mg<sup>2+</sup> depletion model. Organismal extracellular magnesium abundance was mapped both during steady state and after 2&nbsp;weeks of dietary magnesium restriction (<a id="crosref0700" href="#figs4">Figure&nbsp;S4</a>A). Intriguingly, in mice fed a normal diet, extracellular magnesium distribution was heterogeneous between anatomic sites—with serum, lymph nodes, and muscle being magnesium rich, while, relatively speaking, spleen, liver, and, even more pronounced so, subcutaneous fatty tissues were naturally magnesium low (<a id="crosref0705" href="#fig4">Figure&nbsp;4</a>A). Mg<sup>2+</sup> depletion was readily induced through dietary restriction (<a id="crosref0710" href="#fig4">Figure&nbsp;4</a>A), and short-term Mg<sup>2</sup><sup>+</sup> low diet did not affect the general health status of mice (data not shown), and the body weight was comparable between cohorts (<a id="crosref0715" href="#figs4">Figure&nbsp;S4</a>B). Complete blood counts revealed only small changes in platelet and erythrocyte numbers (<a id="crosref0720" href="#figs4">Figure&nbsp;S4</a>C, <i>left panel</i>), as well as in hemoglobin levels and erythrocyte volumes (<a id="crosref0725" href="#figs4">Figure&nbsp;S4</a>C, <i>middle panel</i>). Differential white blood cell counts showed no alterations in Mg<sup>2+</sup> depleted animals (<a id="crosref0730" href="#figs4">Figure&nbsp;S4</a>C, <i>right panel</i>). Further flow cytometric analyses indicated that Mg<sup>2+</sup> depletion also had no relevant impact on CD8<sup>+</sup> T&nbsp;cell frequency, distribution of phenotypic subpopulations, and steady-state expression of the activation marker CD69 (<a id="crosref0735" href="#figs4">Figures S4</a>D–S4F). The percentage distribution of other lymphocyte subpopulations was likewise unaffected (<a id="crosref0740" href="#figs4">Figure&nbsp;S4</a>G). Using this model, LFA-1 WT and LFA-1<sup>−/−</sup> mice were then placed on normal diet versus magnesium low diet for 2&nbsp;weeks and injected with anti-CD3ε F(ab′)2 fragments to polyclonally activate CD8<sup>+</sup> T&nbsp;cells (<a id="crosref0745" href="#fig4">Figure&nbsp;4</a>B). In a strictly LFA-1-dependent manner, mice with normal organismal Mg<sup>2+</sup> abundance increased expression of the activation marker CD69 on CD8<sup>+</sup> T&nbsp;cells. By contrast, only modest upregulation of CD69 was detected on CD8<sup>+</sup> T&nbsp;cells from LFA-1<sup>−/−</sup> mice, irrespective of diet (<a id="crosref0750" href="#fig4">Figure&nbsp;4</a>C). Next, the impact of Mg<sup>2+</sup> on WT and LFA-1<sup>−/−</sup> OT-I T&nbsp;cells was tested in an MC38-OVA (murine colon cancer cell line) model (<a id="crosref0755" href="#fig4">Figure&nbsp;4</a>D). On day 9 after tumor implantation, that is, when tumors became palpable, WT or LFA-1<sup>−/−</sup> OT-I CTLs were adoptively transferred, and tumors were injected every second or third day with either 3&nbsp;mM MgCl<sub>2</sub> or 3&nbsp;mM NaCl (<a id="crosref0760" href="#fig4">Figure&nbsp;4</a>D). Intratumoral (i.t.) Mg<sup>2+</sup> application efficiently increased local Mg<sup>2+</sup> abundance (<a id="crosref0765" href="#figs4">Figure&nbsp;S4</a>H, <i>left panel</i>). By contrast, Mg<sup>2+</sup> concentrations in draining lymph nodes were variably affected and serum Mg<sup>2+</sup> concentration remained unchanged (<a id="crosref0770" href="#figs4">Figure&nbsp;S4</a>H, <i>middle and right panels</i>). In this setting, the most efficient control of cancer growth was observed in mice transferred with WT OT-I T&nbsp;cells and supplemented with Mg<sup>2+</sup> i.t. Tumor growth in mice transferred with LFA-1<sup>−/−</sup> OT-I T&nbsp;cells was insensitive to i.t. Mg<sup>2+</sup> application and largely identical to the growth seen in mice transferred WT OT-I T&nbsp;cells but injected with NaCl i.t. (<a id="crosref0775" href="#fig4">Figure&nbsp;4</a>E).</div><div class="figure-wrap"><figure id="fig4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.12.039/asset/8a16e910-128f-4f80-b587-754d38e0cfb0/main.assets/gr4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr4" src="/cms/10.1016/j.cell.2021.12.039/asset/7cdd0378-7bac-4c79-80f6-319d6d15c1d6/main.assets/gr4.jpg" height="632" width="656" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/8a16e910-128f-4f80-b587-754d38e0cfb0/main.assets/gr4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;4</span> <span class="figure__title__text">LFA-1 is required to regulate CD8<sup>+</sup> T&nbsp;cell activation and cytotoxicity <i>in&nbsp;vivo</i></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0105" role="paragraph">(A) Magnesium levels in serum (<i>left panel</i>), peritoneal lavage (<i>middle panel</i>), and interstitial fluids (<i>right panel</i>) from mice placed on Mg<sup>2+</sup> reduced or matching control diet for 2&nbsp;weeks. Results were pooled from two to three independent experiments, with n&nbsp;= 4–7 mice each. ppb, parts per billion.</div><div id="fspara0110" role="paragraph">(B) Schematic of experimental design.</div><div id="fspara0115" role="paragraph">(C) CD69 expression on CD8<sup>+</sup> T&nbsp;cells from the spleen of LFA-1<sup>−/−</sup> or WT mice. Representative flow histogram (<i>left panel</i>) and pooled data (<i>right panel</i>). Representative results from n&nbsp;= 2 independent experiments.</div><div id="fspara0120" role="paragraph">(D) Schematic of experimental design.</div><div id="fspara0125" role="paragraph">(E) Tumor growth curves with n&nbsp;= 6–7 mice per group. Each symbol represents an individual mouse (A and C), and data are presented as mean ± SD (A,C), and mean ± SEM (E). Statistical significance was assessed by unpaired two-tailed Student’s t test in the <i>left</i> and <i>middle panel</i> of (A), unpaired two-tailed Student’s t test with Holm-Sidak corrected multiple comparison test (A, <i>right panel</i>), one-way ANOVA with Sidak’s corrected multiple comparison test (C), and two-way ANOVA with Bonferroni correction for multiple analysis (E). <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.12.039/asset/1cb79309-b5ed-4140-a268-9a079d3602cf/main.assets/figs4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs4" src="/cms/10.1016/j.cell.2021.12.039/asset/ef2a5e2d-f1ab-436e-8d56-f7c3a588c804/main.assets/figs4.jpg" height="942" width="734" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/1cb79309-b5ed-4140-a268-9a079d3602cf/main.assets/figs4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S4</span> <span class="figure__title__text">Immune phenotype of short-term organismal Mg2+ depletion in uninfected mice, related to <a id="crosref1280" href="#fig4">Figure&nbsp;4</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0435" role="paragraph">(A) Schematic of experimental design.</div><div id="fspara0440" role="paragraph">(B–G) Heathy Bl/6 mice were placed on Mg<sup>2+</sup> low and matching control diet for 2&nbsp;weeks without further intervention.</div><div id="fspara0445" role="paragraph">(B) Percentage weight change compared with individual baseline value after 7 and 14&nbsp;days. Pooled data from n&nbsp;= 5 independent experiments.</div><div id="fspara0450" role="paragraph">(C) <i>Left panel</i>, complete blood count representing absolute numbers of white blood cells (WBC), platelets (PLT), and red blood cells (RBCs). <i>Middle panel</i>, quantitation of red blood cell parameters: Hemoglobin (HGB), hematocrit (HCT), mean cell volume (MCV), mean cell hemoglobin (MCH), mean cell hemoglobin concentration (MCHC). <i>Right panel</i>, white blood cell subsets in peripheral blood are shown as percentage distribution. Pooled data from n&nbsp;= 2 independent experiments.</div><div id="fspara0455" role="paragraph">(D) Abundance of CD8<sup>+</sup> T&nbsp;cells in spleen and peritoneal cavity.</div><div id="fspara0460" role="paragraph">(E and F) Flow cytometric characterization of CD8<sup>+</sup> T&nbsp;cell subsets: naive, effector memory (EM) and central-memory (CM). Composition of CD8<sup>+</sup> T&nbsp;cell subsets in spleen (E, <i>left panel</i>) and peritoneal cavity (F, <i>left panel</i>). Quantification of CD69 expression on CD8<sup>+</sup> T&nbsp;cell subsets in spleen (E, <i>right panel</i>) and peritoneal cavity (F, <i>right panel</i>).</div><div id="fspara0465" role="paragraph">(G) Analysis of relative abundance of immune cell subpopulations in spleen (<i>left panel</i>) and peritoneal cavity (<i>right panel</i>).</div><div id="fspara0470" role="paragraph">(H) Magnesium levels in interstitial fluid of tumor (<i>left panel</i>), draining lymph node (<i>middle panel</i>) and serum (<i>right panel</i>) after intratumoral application of NaCl or MgCl<sub>2</sub>. Each symbol represents an individual mouse. Data is presented as mean ± SD (B–G) and median ± 95% Cl (H). Statistical significance was assessed with unpaired two-tailed Student’s t test (H). <sup>∗∗</sup> p&nbsp;&lt; 0.01.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-4"><h3><i>In&nbsp;vivo</i> magnesium availability impacts infection control</h3><div id="p0070" role="paragraph">In order to directly monitor the effect of organismal magnesium abundance on the antigen-specific development of cytotoxic activity of memory CD8<sup>+</sup> T&nbsp;cells, <i>in&nbsp;vivo</i> killing assays were performed (<a id="crosref0780" href="#fig5">Figure&nbsp;5</a>A). Antigen-specific clearance of target cells was lower in Mg<sup>2+</sup>-depleted hosts, with cytotoxicity partially rescued by co-injecting magnesium together with target cells (<a id="crosref0785" href="#fig5">Figure&nbsp;5</a>B). To explore the effect of magnesium on memory CD8<sup>+</sup> T&nbsp;cells fighting intracellular infection, a <i>Listeria monocytogenes</i>-OVA (LmOVA) intraperitoneal (i.p.) infection model was used (<a id="crosref0790" href="#fig5">Figure&nbsp;5</a>C). Dietary depletion of Mg<sup>2+</sup> reduced the efficiency of memory CD8<sup>+</sup> T&nbsp;cell effector function also in this system, with spiking the i.p. bacterial inoculum with Mg<sup>2+</sup> immediately improving bacterial clearance (<a id="crosref0795" href="#fig5">Figure&nbsp;5</a>D). Of note, no impact of Mg<sup>2+</sup> per se on bacterial viability or growth was observed (<a id="crosref0800" href="#figs5">Figure&nbsp;S5</a>A). In line with these immune control data, the peritoneal abundance of Granzyme B was lower in Mg<sup>2+</sup>-depleted hosts and significantly rescued in mice receiving a Mg<sup>2+</sup>-spiked bacterial inoculum (<a id="crosref0805" href="#fig5">Figure&nbsp;5</a>E). Notably, the innate cytokine IL-6 followed an inverse pattern, with markedly increased peritoneal and serum concentrations in mice less able to control infection (<a id="crosref0810" href="#fig5">Figures 5</a>F and <a id="crosref0815" href="#mmc1">S5</a>B)—plausibly reflecting increased innate inflammation due to a higher bacterial burden. Aligning with better immune control, expression of CD107a and CD69 was higher on OVA-specific CD8<sup>+</sup> T&nbsp;cells from Mg<sup>2+</sup> competent than from Mg<sup>2+</sup>-depleted mice (<a id="crosref0820" href="#fig5">Figures 5</a>G and 5H). Spiking the bacterial inoculum with Mg<sup>2+</sup> rescued CD8<sup>+</sup> T&nbsp;cell reactivity also in this readout by trend (<a id="crosref0825" href="#fig5">Figures 5</a>G and 5H). The proportion of antigen-specific memory CD8<sup>+</sup> T&nbsp;cells in the peritoneal cavity was comparable between cohorts, indicating that recruitment of antigen-specific cells to the site of infection was intact in mice fed a Mg<sup>2+</sup>-depleted diet (<a id="crosref0830" href="#figs5">Figures S5</a>C and S5D).</div><div class="figure-wrap"><figure id="fig5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.12.039/asset/aae324c8-9a4d-46dc-b7c6-6f9a5d309b91/main.assets/gr5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr5" src="/cms/10.1016/j.cell.2021.12.039/asset/8414b066-4d8e-45c7-931d-72575e9c6896/main.assets/gr5.jpg" height="629" width="753" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/aae324c8-9a4d-46dc-b7c6-6f9a5d309b91/main.assets/gr5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;5</span> <span class="figure__title__text">Organismal magnesium depletion via dietary restriction impairs memory CD8<sup>+</sup> T&nbsp;cell-mediated cytotoxicity</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0135" role="paragraph">(A) Schematic of experimental design.</div><div id="fspara0140" role="paragraph">(B) Target cell clearance was evaluated in the spleen. Representative flow histogram (<i>left panel</i>), and summarized data from n&nbsp;= 2 independent experiments, with n&nbsp;= 4–9 mice each (<i>right</i>).</div><div id="fspara0145" role="paragraph">(C) Schematic of experimental design.</div><div id="fspara0150" role="paragraph">(D) Graph depicts bacterial burden in peritoneal lavage, data summarized from n&nbsp;= 3 independent experiments with n&nbsp;= 2–6 mice each. Abundance of Granzyme B (E) and IL-6 (F) in corresponding peritoneal fluids.</div><div id="fspara0155" role="paragraph">(G and H) Expression of the degranulation marker CD107a (G), and the activation marker CD69 (H) on tetramer-positive memory CD8+ T&nbsp;cells retrieved from the peritoneal cavity. Representative flow histogram (<i>left panels</i>), and summary data (<i>right panels</i>), from n&nbsp;= 5 mice each. Representative of n&nbsp;= 2 independent experiments. Each symbol represents an individual mouse, data are represented as median ± IQR (B and D–H) dashed line in (D) indicates detection limit. Statistical significance was assessed by unpaired two-tailed Student’s t test (B), and one-way ANOVA with Sidak’s corrected multiple comparison test (D–H). <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.12.039/asset/e97a97f8-161a-4c72-84dc-1799858582e2/main.assets/figs5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs5" src="/cms/10.1016/j.cell.2021.12.039/asset/d4ceacaa-186e-4ca9-9206-5a844057fe29/main.assets/figs5.jpg" height="187" width="753" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/e97a97f8-161a-4c72-84dc-1799858582e2/main.assets/figs5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S5</span> <span class="figure__title__text">Dietary restriction of Mg<sup>2+</sup> impairs memory CD8<sup>+</sup> T&nbsp;cell-mediated control of bacterial infection, related to <a id="crosref1285" href="#fig5">Figure&nbsp;5</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0480" role="paragraph">(A) Viability of LmOVA in 3&nbsp;mM NaCl or 3&nbsp;mM MgCl<sub>2</sub> inoculum solution used for <i>in&nbsp;vivo</i> infection studies (<i>left panel</i>), and number of colony forming units (CFUs) after plating the respective bacterial solution on BHI plates (<i>right panel</i>). (B–D) LmOVA infection experiments. Each symbol represents an individual mouse. (B) Bar graph representing serum IL-6 concentrations. Relative abundance (C) and absolute cell numbers (D) of OVA-tetramer specific memory CD8+ T&nbsp;cells retrieved from the peritoneal cavity. Data are presented as mean ± SD left panel of (A). Median ± IQR is shown in right panel of (A) and (B–D). Statistical significance was assessed with unpaired two-tailed Student’s t test <i>left panel</i> of (A), Mann-Whitney test <i>right panel</i> of (A) and one-way ANOVA with Sidak corrected multiple comparison test (B–D). <sup>∗∗∗∗</sup> p&nbsp;&lt; 0.0001.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-5"><h3>Intratumoral magnesium delivery improves memory CD8<sup>+</sup> T&nbsp;cell-mediated anti-tumor immunity</h3><div id="p0075" role="paragraph">Adoptive transfer experiments in NSG mice demonstrated that Mg<sup>2+</sup> improved cancer-directed effector activity of CTLs in an LFA-1-dependent manner (<a id="crosref0835" href="#fig4">Figure&nbsp;4</a>E). In immunocompetent mice harboring OVA-specific memory CD8<sup>+</sup> T&nbsp;cells (i.e., immunized with OVA), injection of Mg<sup>2+</sup> i.t. likewise improved local control of MC38 tumor growth. Injection of Mg<sup>2+</sup> i.t. in OVA-naive mice did not affect tumor growth, and neither did contralateral i.t. injection of NaCl (<a id="crosref0840" href="#fig6">Figures 6</a>A and 6B). Of note, no clinical signs or symptoms of autoimmunity were observed in Mg<sup>2+</sup> treated mice (data not shown), and anti-nuclear antibodies (ANAs) screening assays returned negative results across cohorts (<a id="crosref0845" href="#figs6">Figure&nbsp;S6</a>A). OVA immunization induces OVA-specific memory T&nbsp;cells, including memory CD8<sup>+</sup> T&nbsp;cells that play a key role in tumor rejection (<span class="dropBlock reference-citations"><a id="body-ref-sref12" href="#" role="doc-biblioref" data-xml-rid="bib12" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref12" aria-controls="sref12">Enamorado et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Enamorado, M. ∙ Iborra, S. ∙ Priego, E. ...</div><div><strong>Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T&nbsp;cells</strong></div><div><em>Nat. Commun.</em> 2017; <strong>8</strong>:16073</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms16073" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85024480656" target="_blank" aria-label="Open Scopus in new tab">Scopus (209)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28714465/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms16073&amp;pmid=28714465" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref20" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20" aria-controls="sref20">Han et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref20"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>Han, J. ∙ Khatwani, N. ∙ Searles, T.G. ...</div><div><strong>Memory CD8+ T&nbsp;cell responses to cancer</strong></div><div><em>Semin. Immunol.</em> 2020; <strong>49</strong>:101435</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.smim.2020.101435" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85096951476" target="_blank" aria-label="Open Scopus in new tab">Scopus (92)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33272898/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.smim.2020.101435&amp;pmid=33272898" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and depletion experiments established that Mg<sup>2+</sup> exerts its effect via CD8<sup>+</sup> T&nbsp;cells (<a id="crosref0860" href="#fig6">Figure&nbsp;6</a>C). Using flow cytometry, we then enumerated and phenotyped tumor-infiltrating immune cells. Notably, the number of tumor-infiltrating CD8<sup>+</sup> T&nbsp;cells was increased in the Mg<sup>2+</sup>-treated group (<a id="crosref0865" href="#fig6">Figure&nbsp;6</a>D), whereas the abundance of other immune cell subsets was not affected significantly (<a id="crosref0870" href="#figs6">Figures&nbsp;S6</a>B<b>–</b>S6I). Aligning with their increased number, more Mg<sup>2+</sup>-treated CD8<sup>+</sup> T&nbsp;cells expressed Ki67 (<a id="crosref0875" href="#fig6">Figure&nbsp;6</a>E, <i>left panel</i>). In addition, more Mg<sup>2+</sup> exposed CD8<sup>+</sup> T&nbsp;cells contained Granzyme B and expressed the activation marker CD25 (<a id="crosref0880" href="#fig6">Figure&nbsp;6</a>E, <i>middle</i> and <i>right panels</i>). Further reflecting increased activation, PD-1 and TIM-3 were also significantly more often (co-)expressed on Mg<sup>2+</sup>-treated CD8<sup>+</sup> T&nbsp;cells (<a id="crosref0885" href="#fig6">Figure&nbsp;6</a>F). Of note, <i>in&nbsp;vitro</i> re-stimulation experiments at day 3 and day 6 post-initiation of i.t. Mg<sup>2+</sup> injections did not find evidence of dysfunction (exhaustion) of CD8<sup>+</sup> T&nbsp;cells (data not shown). Since expression of PD-1 was higher on CD8<sup>+</sup> T&nbsp;cells isolated from MgCl<sub>2</sub>-treated as compared with NaCl-treated tumors, we next assessed how combining MgCl<sub>2</sub> injection with PD-1 blockade was impacting tumor-directed memory CD8<sup>+</sup> T&nbsp;cell function (<a id="crosref0890" href="#fig6">Figure&nbsp;6</a>G). Tumor control in mice receiving both intratumoral MgCl<sub>2</sub> as well as PD-1 blockade was superior compared with all other treatment regimens, with MgCl<sub>2</sub> alone again improving immune control significantly (<a id="crosref0895" href="#fig6">Figure&nbsp;6</a>H). Aligning with these tumor growth data, survival of animals injected with MgCl<sub>2</sub> up to day 26 was significantly improved compared with the NaCl-injected control group, both as a sole intervention and when combined with PD-1 blockade (<a id="crosref0900" href="#fig6">Figure&nbsp;6</a>I). Liposomal packaging might be a translational strategy to deliver Mg<sup>2+</sup> into tumors since liposomes accumulate at sites with leaky vasculature beds (<span class="dropBlock reference-citations"><a id="body-ref-sref15" href="#" role="doc-biblioref" data-xml-rid="bib15" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref15" aria-controls="sref15">Franco et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref15"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">15.</div><div>Franco, M.S. ∙ Gomes, E.R. ∙ Roque, M.C. ...</div><div><strong>Triggered drug release from liposomes: Exploiting the outer and inner tumor environment</strong></div><div><em>Front. Oncol.</em> 2021; <strong>11</strong>:623760</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3389/fonc.2021.623760" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85103384300" target="_blank" aria-label="Open Scopus in new tab">Scopus (44)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33796461/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3389%2Ffonc.2021.623760&amp;pmid=33796461" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref40" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40" aria-controls="sref40">Nakamura et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref40"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Nakamura, Y. ∙ Mochida, A. ∙ Choyke, P.L. ...</div><div><strong>Nanodrug delivery: Is the enhanced permeability and retention effect sufficient for curing cancer?</strong></div><div><em>Bioconjug. Chem.</em> 2016; <strong>27</strong>:2225-2238</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.bioconjchem.6b00437" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84992363294" target="_blank" aria-label="Open Scopus in new tab">Scopus (757)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27547843/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.bioconjchem.6b00437&amp;pmid=27547843" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and i.t. application of MgCl<sub>2</sub>-packed liposomes did replicate the effects induced by solute injections (<a id="crosref0915" href="#fig6">Figures 6</a>J–6L). Encouraged by these data, we tested the effect of i.p. applied liposomes on tumor growth. Specifically, we compared NaCl-loaded versus MgCl<sub>2</sub>-loaded liposomes coupled to PD1 mAb. The concentration of Mg<sup>2+</sup> applied i.p. with liposomal Mg<sup>2+</sup> packaging was controlled for and confirmed to be in a physiologic range (<a id="crosref0920" href="#figs6">Figure&nbsp;S6</a>J). I.p. administration of Mg<sup>2+</sup>-loaded liposomes enhanced tumor control in a manner additive to PD-1 blockade alone (<a id="crosref1300" href="#fig6">Figures 6</a>M–6O).</div><div class="figure-wrap"><figure id="fig6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.12.039/asset/b7de6730-9962-4eb0-a854-0a28ed1b7132/main.assets/gr6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr6" src="/cms/10.1016/j.cell.2021.12.039/asset/1fb99c06-0951-4bd4-9075-16972e4c9fd2/main.assets/gr6.jpg" height="915" width="659" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/b7de6730-9962-4eb0-a854-0a28ed1b7132/main.assets/gr6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;6</span> <span class="figure__title__text">Intratumoral magnesium administration improves memory CD8<sup>+</sup> T&nbsp;cell-mediated anti-tumor immunity</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0165" role="paragraph">(A) Schematic of experimental design.</div><div id="fspara0170" role="paragraph">(B) Tumor growth curves in non-immunized mice (n&nbsp;= 20) (<i>left panel</i>), and immunized mice (n&nbsp;= 19) (<i>right panel</i>). Results were pooled from two independent experiments, with n&nbsp;= 9–10 mice each.</div><div id="fspara0175" role="paragraph">(C) Tumor growth curves in ± CD8-depleted mice (n&nbsp;= 9–11). Results were pooled from two independent experiments, with n&nbsp;= 4–6 mice each.</div><div id="fspara0180" role="paragraph">(D) Absolute numbers of tumor-infiltrating CD8<sup>+</sup> T&nbsp;cells.</div><div id="fspara0185" role="paragraph">(E) Number of tumor-infiltrating CD8<sup>+</sup> T&nbsp;cells positive for Ki67 (<i>left panel</i>), Granzyme B (<i>middle panel</i>), and CD25 (<i>right panel</i>).</div><div id="fspara0190" role="paragraph">(F) Cell number of tumor-infiltrating CD8<sup>+</sup> T&nbsp;cells expressing PD-1 and TIM-3.</div><div id="fspara0195" role="paragraph">(G) Schematic of experimental design.</div><div id="fspara0200" role="paragraph">(H and I) (H) Tumor growth curves (n&nbsp;= 13-14 mice), and (I) survival (n&nbsp;= 13–14 mice). Results were pooled from two independent experiments, with n&nbsp;= 6-7 mice each (H and I).</div><div id="fspara0205" role="paragraph">(J) Schematic of experimental design.</div><div id="fspara0210" role="paragraph">(K and L) (K) Tumor growth curves (n&nbsp;= 5–6 mice), and (L) survival (n&nbsp;= 5–6 mice).</div><div id="fspara0215" role="paragraph">(M) Schematic of experimental design.</div><div id="fspara0220" role="paragraph">(N) Tumor growth curves (n&nbsp;= 11–13). Results were pooled from two independent experiments.</div><div id="fspara0225" role="paragraph">(O) Survival. Representative of n&nbsp;= 2 independent experiments with n&nbsp;= 5–7 mice per group.</div><div id="fspara0230" role="paragraph">Of note, experiments (B, H, and I) and (C–F and K–O) were conducted at different animal facilities to probe for robustness. Data are presented as mean ± SEM (B, C, and H), median ± IQR with each symbol representing one mouse (D, E, and F). Statistical significance was assessed by two-way ANOVA with Bonferroni correction (B, C, H, K, and N), unpaired two-tailed Student’s t test (D and E), two-way ANOVA with Sidak corrected multiple comparison test (F), and log-rank Mantel-Cox test (I, L, and O). <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗∗</sup>p&nbsp;&lt; 0.0001, n.s., nonsignificant.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.12.039/asset/3b4503a6-5f3e-4844-a67d-51b267e491f3/main.assets/figs6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs6" src="/cms/10.1016/j.cell.2021.12.039/asset/a91c3b6d-82c1-458e-911b-4d99f5e73367/main.assets/figs6.jpg" height="932" width="696" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/3b4503a6-5f3e-4844-a67d-51b267e491f3/main.assets/figs6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S6</span> <span class="figure__title__text">Effect of Mg<sup>2+</sup> on ANA production and intratumoral immune phenotype, related to <a id="crosref1290" href="#fig6">Figure&nbsp;6</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0490" role="paragraph">(A) Concentration of anti-nuclear antibodies (ANAs). Each symbol represents an individual mouse, n&nbsp;= 5–10 per group.</div><div id="fspara0495" role="paragraph">(B–I) Cell number of tumor-infiltrating CD4<sup>+</sup> T&nbsp;cells (B), B cells (C), granulocytes (D), macrophages (E), conventional dendritic cells (F), conventional CD4<sup>+</sup> T&nbsp;cells (G), Ki67<sup>+</sup> conventional CD4<sup>+</sup> T&nbsp;cells (H), as well the CD8:T<sub>Reg</sub> ratio (I). Each symbol represents an individual mouse, n&nbsp;= 5 per group (B–I).</div><div id="fspara0500" role="paragraph">(J) Magnesium concentration per injection of respective treatment modality. Data are presented as median ± IQR (A–I) and mean ± SD (J); dashed line in (A) indicates detection limit. Statistical significance was assessed by unpaired two-tailed Student’s t test (B–I) and one-way ANOVA with Sidak corrected multiple comparison test (J). <sup>∗∗∗∗</sup> p&nbsp;&lt; 0.0001.</div></div></div></div></figcaption></figure></div></section><section id="sec-2-6"><h3>Mg<sup>2+</sup> has translational potential across a spectrum of emerging treatment modalities in oncology</h3><div id="p0080" role="paragraph">Blinatumomab has improved the clinical outcome of select B cell malignancies (<span class="dropBlock reference-citations"><a id="body-ref-sref16" href="#" role="doc-biblioref" data-xml-rid="bib16" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref16" aria-controls="sref16">Franquiz and Short, 2020</a><div class="dropBlock__holder" data-db-target-of="sref16"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Franquiz, M.J. ∙ Short, N.J.</div><div><strong>Blinatumomab for the treatment of adult B-cell acute lymphoblastic leukemia: toward a new era of targeted immunotherapy</strong></div><div><em>Biologics.</em> 2020; <strong>14</strong>:23-34</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32103893/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=32103893" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Notably, hypomagnesemia occurs in 12%–22% of patients treated with Blinatumomab (<span class="dropBlock reference-citations"><a id="body-ref-sref8" href="#" role="doc-biblioref" data-xml-rid="bib8" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref8" aria-controls="sref8">Coyle et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Coyle, L. ∙ Morley, N.J. ∙ Rambaldi, A. ...</div><div><strong>Open-label, phase 2 study of Blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma</strong></div><div><em>Leuk.</em> 2020; <strong>61</strong>:2103-2112</div><div>Lymphoma</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.CoyleN.J.MorleyA.RambaldiK.D.MasonG.VerhoefC.L.FurnessA.ZhangA.S.JungD.CohanJ.L.FranklinOpen-label%2C+phase+2+study+of+Blinatumomab+as+second+salvage+therapy+in+adults+with+relapsed%2Frefractory+aggressive+B-cell+non-Hodgkin+lymphomaLeuk61202021032112Lymphoma" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref27-1" href="#" role="doc-biblioref" data-xml-rid="bib27" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref27-1" aria-controls="sref27-1">Kiyoi et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref27-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>Kiyoi, H. ∙ Morris, J.D. ∙ Oh, I. ...</div><div><strong>Phase 1b/2 study of Blinatumomab in Japanese adults with relapsed/refractory acute lymphoblastic leukemia</strong></div><div><em>Cancer Sci.</em> 2020; <strong>111</strong>:1314-1323</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/cas.14322" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85079468567" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31971321/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fcas.14322&amp;pmid=31971321" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref64-1" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-1" aria-controls="sref64-1">Topp et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref64-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Topp, M.S. ∙ Gökbuget, N. ∙ Stein, A.S. ...</div><div><strong>Safety and activity of Blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: A multicentre, single-arm, phase 2 study</strong></div><div><em>Lancet Oncol.</em> 2015; <strong>16</strong>:57-66</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS1470-2045%2814%2971170-2&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS1470-2045%2814%2971170-2&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84926099033" target="_blank" aria-label="Open Scopus in new tab">Scopus (1013)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25524800/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1470-2045%2814%2971170-2&amp;pmid=25524800" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Blinatumomab-mediated cytotoxicity, when used in its reported therapeutic range (230–620 pg mL<sup>−1</sup>) (<span class="dropBlock reference-citations"><a id="body-ref-sref64-2" href="#" role="doc-biblioref" data-xml-rid="bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64-2" aria-controls="sref64-2">Topp et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref64-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Topp, M.S. ∙ Gökbuget, N. ∙ Stein, A.S. ...</div><div><strong>Safety and activity of Blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: A multicentre, single-arm, phase 2 study</strong></div><div><em>Lancet Oncol.</em> 2015; <strong>16</strong>:57-66</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS1470-2045%2814%2971170-2&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS1470-2045%2814%2971170-2&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84926099033" target="_blank" aria-label="Open Scopus in new tab">Scopus (1013)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25524800/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1470-2045%2814%2971170-2&amp;pmid=25524800" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), was strongly, and in a dose-dependent manner, dependent on the availability of Mg<sup>2+</sup> (<a id="crosref0950" href="#fig7">Figure&nbsp;7</a>A). Aligning with the cytotoxicity data, the effect of Blinatumomab on cell clustering (<a id="crosref0955" href="#fig7">Figure&nbsp;7</a>B), activation-induced LFA-1 headpiece opening (<a id="crosref0960" href="#figs7">Figure&nbsp;S7</a>A), as well as FAK phosphorylation (<a id="crosref0965" href="#figs7">Figure&nbsp;S7</a>B) was likewise Mg<sup>2+</sup> sensitive. Stabilizing the headpiece of LFA-1 in its closed position, using the mAb TS1/18, almost completely abrogated Blinatumomab-mediated cytotoxicity, irrespective of Mg<sup>2+</sup> availability (<a id="crosref0970" href="#fig7">Figure&nbsp;7</a>C). Inversely, combining Blinatumomab with the LFA-1 extending mAb CBR LFA-1/2 increased target cell killing both in the presence and absence of Mg<sup>2+</sup> (<a id="crosref0975" href="#fig7">Figure&nbsp;7</a>C).</div><div class="figure-wrap"><figure id="fig7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.12.039/asset/c776df61-a6ce-4a8e-aabb-38106f419e76/main.assets/gr7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr7" src="/cms/10.1016/j.cell.2021.12.039/asset/1a385ec4-a122-480d-a345-856a3bcdd6d2/main.assets/gr7.jpg" height="941" width="687" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/c776df61-a6ce-4a8e-aabb-38106f419e76/main.assets/gr7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;7</span> <span class="figure__title__text">Extracellular magnesium impacts functionality of immunotherapeutic modalities <i>in&nbsp;vitro</i> and <i>in&nbsp;vivo</i></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0240" role="paragraph">(A) Box plots representing flow cytometric assessment of caspase-3 activity in Ramos target cells after co-culture with PHA blasts, n&nbsp;= 5 healthy donors at Mg<sup>2+</sup> and Blinatumomab concentrations as indicated.</div><div id="fspara0245" role="paragraph">(B) Representative brightfield images of Blinatumomab-induced cell aggregation between PHA blasts and Ramos target cells in dependence of Mg<sup>2+</sup>. Scale bars indicate 250&nbsp;μm.</div><div id="fspara0250" role="paragraph">(C) Caspase-3 activity in LCL target cells after co-culture with PHA blasts ± Blinatumomab (300 pg mL<sup>−1</sup>), in dependence of Mg<sup>2+</sup> plus CBR LFA-1/2, TS1/18, or isotype control mAb, as indicated (n&nbsp;= 4 healthy donors).</div><div id="fspara0255" role="paragraph">(D) Representative histograms of CD11a expression on PHA blasts, untransduced T&nbsp;cells, and anti-CD19 CAR T&nbsp;cells.</div><div id="fspara0260" role="paragraph">(E) Representative histograms (<i>left panel</i>), and results quantified from n&nbsp;= 2 healthy donor with three technical replicates (<i>right panel</i>) of caspase-3 activity in Ramos target cells, after co-culturing with anti-CD19 CAR T&nbsp;cells, ± Mg<sup>2+</sup>, ± Mn<sup>2+</sup>, and ± BIRT377, as indicated.</div><div id="fspara0265" role="paragraph">(F) Cytotoxicity assay with anti-PSMA CAR T&nbsp;cells and UTD T&nbsp;cells co-cultured with PSMA<sup>+</sup> PC3-PIP cell line. Pooled results using cells generated from n&nbsp;= 6 healthy donors and from n&nbsp;= 2 independent experiments are shown.</div><div id="fspara0270" role="paragraph">(G) Abundance of IFNγ in cell culture supernatants corresponding to conditions depicted in (F) (n&nbsp;= 8, 3 independent experiments).</div><div id="fspara0275" role="paragraph">(H) Schematic of experimental design.</div><div id="fspara0280" role="paragraph">(I) Tumor growth curves (<i>left panel</i>) and survival (<i>right panel</i>) from n&nbsp;= 6–7 mice per group.</div><div id="fspara0285" role="paragraph">(J) Schematic of experimental design.</div><div id="fspara0290" role="paragraph">(K) Tumor growth curves. Representative of n&nbsp;= 2 independent experiments with n&nbsp;= 6 mice per group.</div><div id="fspara0295" role="paragraph">(L) Stratification of patients according to mean serum magnesium levels &gt; 1.7&nbsp;mg dl<sup>−1</sup> versus &lt;1.7&nbsp;mg dl<sup>−1</sup> between day −5 and day&nbsp;+3 of adoptive cell therapy, n&nbsp;= 5 measurements per patient (<i>left panel</i>). Each symbol represents one individual. Overall survival of patients stratified according to normal and low Mg<sup>2+</sup> levels (<i>right panel</i>).</div><div id="fspara0300" role="paragraph">(M) Comparison of mean serum magnesium levels after stratification according to occurrence of ≥1 hypomagnesemia-measurement during the trial (n&nbsp;= 2–23 measurements per patient) (<i>left panel</i>). Complete pathological response (<i>middle panel</i>), and overall survival (<i>right panel</i>) according to this stratification. NSCLC, non-small cell lung cancer. Data are presented as median ± IQR (A and C), mean ± SD <i>right panel</i> of (E), (G), mean ± SEM (F and K) and <i>left panel</i> of (I), or median ± 95% CI <i>left panel</i> of (L and M). Statistical significance was assessed by two-way ANOVA with Dunnett corrected multiple comparison test (A), two-way ANOVA with Tukey’s multiple comparison test (C), one-way ANOVA with Sidak’s multiple comparison test <i>right panel</i> (E), repeated-measures two-way ANOVA with Tukey’s multiple comparison test (F), unpaired Student’s t test (G) and <i>left panel</i> of (L and M), two-way analysis of variance (ANOVA) with Bonferroni correction <i>left panel</i> of (I) as well (K), and log-rank Mantel-Cox test in <i>right panels</i> of (I, L, and M). <sup>∗</sup>p&nbsp;&lt; 0.05, <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001, <sup>∗∗∗∗</sup> p&nbsp;&lt; 0.0001, n.s., nonsignificant.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2021.12.039/asset/ce6da560-3a5d-48d3-bcd6-7259147632fe/main.assets/figs7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs7" src="/cms/10.1016/j.cell.2021.12.039/asset/d52e3150-9a37-4963-8b49-3c437b7e7e54/main.assets/figs7.jpg" height="941" width="677" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/ce6da560-3a5d-48d3-bcd6-7259147632fe/main.assets/figs7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S7</span> <span class="figure__title__text">Association of Mg<sup>2+</sup> abundance and efficacy of immune therapeutic modalities <i>in&nbsp;vitro</i> and <i>in&nbsp;vivo</i>, related to <a id="crosref1295" href="#fig7">Figure&nbsp;7</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0510" role="paragraph">(A and B) Flow cytometry-based assessment of activation-induced LFA-1 headpiece opening on PHA blasts (A), as well FAK phosphorylation in PHA blasts (B), after co-culture with Ramos cells at a Blinatumomab concentration of 300 pg mL<sup>−1</sup> (n&nbsp;= 5 healthy donors)</div><div id="fspara0515" role="paragraph">(C) Activation-induced glycolytic activity of human CAR T&nbsp;cells. Representative experiment (<i>left panel</i>), quantification of summarized data (<i>right panel</i>) from n&nbsp;= 3 healthy donors</div><div id="fspara0520" role="paragraph">(D) <i>Left panel</i>, representative histograms of surface activation markers on CAR T&nbsp;cells. <i>Right panel</i> shows quantitation of respective staining from n&nbsp;= 3 healthy donors</div><div id="fspara0525" role="paragraph">(E and F) Magnesium abundance determined by ICP-MS in serum from mice in CAR T&nbsp;cell tumor-rejection experiment after 14&nbsp;days on respective diet (E). Magnesium abundance in interstitial fluid of tumors from UTD and saline control mice reaching ethically acceptable end point (F)</div><div id="fspara0530" role="paragraph">(G) Diet consumption of mice in CAR T&nbsp;cell tumor-rejection experiment</div><div id="fspara0535" role="paragraph">(H) Body weight after 24&nbsp;days of respective diet relative to individual starting value</div><div id="fspara0540" role="paragraph">(E–H) Each symbol represents one mouse</div><div id="fspara0545" role="paragraph">(I) Study diagram and patient exclusion criteria</div><div id="fspara0550" role="paragraph">(J) Table summarizing baseline characteristics. DLBCL, diffuse large B cell lymphoma; PMCL, primary mediastinal large B cell lymphoma; TFL, transformed follicular lymphoma.</div><div id="fspara0555" role="paragraph">(K) Comparison of patients stratified according to mean serum magnesium levels between day −5 and day&nbsp;+3 of treatment in normal Mg<sup>2+</sup> group (&gt;1.7&nbsp;mg dl<sup>−1</sup>) and low Mg<sup>2+</sup> group (&lt;1.7&nbsp;mg dl<sup>−1</sup>), n&nbsp;= 5 measurements per patient. Each symbol represents individual patient</div><div id="fspara0560" role="paragraph">(L) Progression-free survival</div><div id="fspara0565" role="paragraph">(M) Study diagram and patient exclusion criteria</div><div id="fspara0570" role="paragraph">(N) Table summarizing baseline characteristics</div><div id="fspara0575" role="paragraph">(O and P) Comparison of radiographic response (O), and event-free survival (P) in normo- versus hypomagnesemic patients with NSCLC. Data are presented as mean ± SD in (A, B, E, G, H, and K) as well <i>right panels</i> of (C and D), median ± IQR (F) and in representative metabolic flux analyses symbols indicate mean ± SEM in the <i>left panel</i> of (C). Statistical significance was determined with unpaired Student’s t test (A, B, E–G, and K), one-way ANOVA with Sidak’s multiple comparison test (C), unpaired two-tailed Student’s t test with Holm-Sidak corrected multiple comparison test (D and H) and log-rank Mantel-Cox test (L and P). <sup>∗</sup> p&nbsp;&lt; 0.05, <sup>∗∗</sup>&nbsp;p&nbsp;&lt; 0.01,<sup>∗∗∗</sup>p &lt; 0.001, <sup>∗∗∗∗</sup> p&nbsp;&lt; 0.0001.</div></div></div></div></figcaption></figure></div><div id="p0085" role="paragraph">To explore the relevance of Mg<sup>2+</sup> in the context of CAR T&nbsp;cell therapy, human CD19 or prostate-specific membrane antigen (PSMA) targeting CAR T&nbsp;cells were used (<span class="dropBlock reference-citations"><a id="body-ref-sref42" href="#" role="doc-biblioref" data-xml-rid="bib42" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref42" aria-controls="sref42">Neelapu et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref42"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>Neelapu, S.S. ∙ Locke, F.L. ∙ Bartlett, N.L. ...</div><div><strong>Axicabtagene Ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2017; <strong>377</strong>:2531-2544</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1707447" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85040170618" target="_blank" aria-label="Open Scopus in new tab">Scopus (3898)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29226797/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1707447&amp;pmid=29226797" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref52" href="#" role="doc-biblioref" data-xml-rid="bib52" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref52" aria-controls="sref52">Santoro et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref52"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Santoro, S.P. ∙ Kim, S. ∙ Motz, G.T. ...</div><div><strong>T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regression</strong></div><div><em>Cancer Immunol. Res.</em> 2015; <strong>3</strong>:68-84</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2326-6066.CIR-14-0192" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84962247223" target="_blank" aria-label="Open Scopus in new tab">Scopus (85)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25358763/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2326-6066.CIR-14-0192&amp;pmid=25358763" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Introducing a CAR did not alter LFA-1 expression (<a id="crosref0990" href="#fig7">Figure&nbsp;7</a>D) or dependency of these cells on Mg<sup>2+</sup> both with respect to glycolytic reprogramming and phenotypic changes upon conventional activation via ligation of CD3 and CD28 (<a id="crosref0995" href="#figs7">Figures S7</a>C and S7D). We then went on to assess the Mg<sup>2+</sup> dependency of CAR-driven cytotoxicity. In line with our previous findings with REP T&nbsp;cells, the Mg<sup>2+</sup>-LFA-1 regulatory system reproduced in CD19 CAR T&nbsp;cells (<a id="crosref1000" href="#fig7">Figure&nbsp;7</a>E), and time-lapse killing assays demonstrated that Mg<sup>2+</sup> restriction severely blunted PSMA CAR-specific killing of target cells (<a id="crosref1005" href="#fig7">Figure&nbsp;7</a>F). Concomitantly, the release of IFN-γ by anti-PSMA CAR T&nbsp;cells was reduced in Mg<sup>2+</sup>-deplete conditions (<a id="crosref1010" href="#fig7">Figure&nbsp;7</a>G). Tumor rejection and survival were also improved in a model where CAR T&nbsp;cells were adoptively transferred into mice harboring established tumors that were then Mg<sup>2+</sup> enriched by i.t. injections (<a id="crosref1015" href="#fig7">Figures 7</a>H and 7I). We then wanted to test whether dietary Mg<sup>2+</sup> restriction, thus reducing systemic and intratumoral Mg<sup>2+</sup> abundance (<a id="crosref1020" href="#figs7">Figures S7</a>E and S7F), affects CAR T&nbsp;cell-mediated cytotoxicity (<a id="crosref1025" href="#fig7">Figure&nbsp;7</a>J). Indeed, dietary Mg<sup>2+</sup> restriction was sufficient to negatively impact CAR T&nbsp;cell-mediated tumor rejection (<a id="crosref1030" href="#fig7">Figure&nbsp;7</a>K). Food intake was comparable between the cohorts, and yet, tumor-bearing mice fed a Mg<sup>2+</sup>-depleted diet had a lower body weight by day 25 of the experiment (<a id="crosref1035" href="#figs7">Figures S7</a>G and S7H), suggestive of a more catabolic state. While the impact of (mild) intratumoral Mg<sup>2+</sup> depletion through dietary restriction was less pronounced than in the opposite experiment where Mg<sup>2+</sup> was injected into the tumors (<a id="crosref1040" href="#fig4">Figures 4</a>E, <a id="crosref1045" href="#fig6">6</a>B, 6C, 6H, 6K, and <a id="crosref1055" href="#fig7">7</a>I), the effect was still clear. This prompted us to retrospectively assess the relationship between serum Mg<sup>2+</sup> levels and clinical outcomes in a CAR T&nbsp;cell trial and in an immune checkpoint inhibitor study. The CAR trial included a cohort of 100 patients with refractory B cell lymphoma treated with CD19-directed CAR T&nbsp;cells (Axicabtagene Ciloleucel), of which four had to be excluded from the retrospective analysis due to incomplete Mg<sup>2+</sup>-serum testing (<a id="crosref1060" href="#figs7">Figure&nbsp;S7</a>I, <i>Study Diagram</i>). Patients were classified into two strata according to the mean Mg<sup>2+</sup> level between days −5 and&nbsp;+3 of treatment (n&nbsp;= 5 measurements available for each patient). An arbitrary cut-off was set at 1.7&nbsp;mg dl<sup>−1</sup> for assigning patients into normo- versus hypomagnesemia groups (Figure&nbsp;7L<b>,</b> <i>left panel</i>, and <a id="crosref1065" href="#figs7">Figure&nbsp;S7</a>K). Baseline characteristics of these retrospectively assigned study populations were similar, including age, ECOG performance status, and disease stage (<a id="crosref1070" href="#figs7">Figure&nbsp;S7</a>J). Although the number of patients with a mean Mg<sup>2+</sup> level of &lt;1.7&nbsp;mg dl<sup>−1</sup> was low, overall survival and median progression-free survival for these patients were reduced as compared with patients with normal serum Mg<sup>2+</sup> levels (Figure&nbsp;7L, <i>right panel</i>, and <a id="crosref1075" href="#figs7">Figure&nbsp;S7</a>L). We next explored how organismal Mg<sup>2+</sup> abundance was associated with outcome in a cohort of non-small cell lung cancer (NSCLC) patients enrolled in an immune checkpoint inhibitor trial (SAKK16/14) (<span class="dropBlock reference-citations"><a id="body-ref-sref47" href="#" role="doc-biblioref" data-xml-rid="bib47" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref47" aria-controls="sref47">Rothschild et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref47"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Rothschild, S.I. ∙ Zippelius, A. ∙ Eboulet, E.I. ...</div><div><strong>SAKK 16/14: durvalumab in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small-cell lung cancer-a multicenter single-arm phase II trial</strong></div><div><em>J.&nbsp;Clin. Oncol.</em> 2021; <strong>39</strong>:2872-2880</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1200/JCO.21.00276" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85116171412" target="_blank" aria-label="Open Scopus in new tab">Scopus (178)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34251873/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1200%2FJCO.21.00276&amp;pmid=34251873" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). From a total of 67 initially enrolled patients, two had to be excluded, leaving 65 that were treated with an anti-PD-L1 mAb (Durvalumab) in addition to neoadjuvant chemotherapy (<a id="crosref1085" href="#figs7">Figure&nbsp;S7</a>M, <i>study diagram</i>). Any detection of hypomagnesemia during the course of the trial (n&nbsp;= 2–23 measurements/study participant) assigned an individual to the hypomagnesemia group. This stratification strategy well discriminated the mean Mg<sup>2+</sup> levels across all available measurements (<a id="crosref1305" href="#fig7">Figure&nbsp;7</a>M, <i>left</i> panel). Also in this clinical trial, baseline characteristics were similar between the two retrospectively assigned groups (<a id="crosref1090" href="#figs7">Figure&nbsp;S7</a>N). Pathological complete response and overall survival (<a id="crosref1310" href="#fig7">Figure&nbsp;7</a>M, <i>middle and right panels</i>), as well as radiographic response and event-free survival (<a id="crosref1095" href="#figs7">Figures S7</a>O and S7P), were all reduced in patients with hypomagnesemia. While these retrospective analyses have many limitations, in the context of our experimental data, the findings aligned with the concept that Mg<sup>2+</sup>, by increasing LFA-1 outside-in signaling activity, may contribute to the clinical efficacy of CAR T&nbsp;cells and endogenous cancer-directed T&nbsp;cells in human patients.</div></section></section><section id="sec-3"><h2>Discussion</h2><div id="p0090" role="paragraph">LFA-1 inside-out signaling, or activation, has previously been shown to modulate T&nbsp;cell function by modifying the molecule co-stimulation activity (i.e., outside-in signaling) (<span class="dropBlock reference-citations"><a id="body-ref-sref17" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17" aria-controls="sref17">Gérard et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref17"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Gérard, A. ∙ Cope, A.P. ∙ Kemper, C. ...</div><div><strong>LFA-1 in T&nbsp;cell priming, differentiation, and effector functions</strong></div><div><em>Trends Immunol.</em> 2021; <strong>42</strong>:706-722</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.it.2021.06.004&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.it.2021.06.004&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85111020033" target="_blank" aria-label="Open Scopus in new tab">Scopus (43)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34266767/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.it.2021.06.004&amp;pmid=34266767" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref69" href="#" role="doc-biblioref" data-xml-rid="bib69" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref69" aria-controls="sref69">Wang et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref69"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">69.</div><div>Wang, Y. ∙ Li, D. ∙ Nurieva, R. ...</div><div><strong>LFA-1 affinity regulation is necessary for the activation and proliferation of naive T&nbsp;cells</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2009; <strong>284</strong>:12645-12653</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M807207200&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M807207200&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-67649814709" target="_blank" aria-label="Open Scopus in new tab">Scopus (45)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19297325/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M807207200&amp;pmid=19297325" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Our experiments now demonstrate that, upon activation of LFA-1, extracellular Mg<sup>2+</sup> increases LFA-1 outside-in signaling in a dose-dependent manner by contributing to extension and headpiece opening. Mg<sup>2+</sup> exerts its effects on the conformation of LFA-1 both by binding to the beta I- and the alpha I-MIDAS, with the precise contribution of the respective interactions yet to be resolved (<span class="dropBlock reference-citations"><a id="body-ref-sref57-2" href="#" role="doc-biblioref" data-xml-rid="bib57" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref57-2" aria-controls="sref57-2">Schürpf and Springer, 2011</a><div class="dropBlock__holder" data-db-target-of="sref57-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Schürpf, T. ∙ Springer, T.A.</div><div><strong>Regulation of integrin affinity on cell surfaces</strong></div><div><em>EMBO J.</em> 2011; <strong>30</strong>:4712-4727</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/emboj.2011.333" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-82455189778" target="_blank" aria-label="Open Scopus in new tab">Scopus (144)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21946563/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Femboj.2011.333&amp;pmid=21946563" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref59" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59" aria-controls="sref59">Sen et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref59"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Sen, M. ∙ Koksal, A.C. ∙ Yuki, K. ...</div><div><strong>Ligand- and cation-induced structural alterations of the leukocyte integrin LFA-1</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2018; <strong>293</strong>:6565-6577</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.RA117.000710&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.RA117.000710&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85046032698" target="_blank" aria-label="Open Scopus in new tab">Scopus (19)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29507098/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.RA117.000710&amp;pmid=29507098" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref60" href="#" role="doc-biblioref" data-xml-rid="bib60" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref60" aria-controls="sref60">Shimaoka et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref60"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">60.</div><div>Shimaoka, M. ∙ Salas, A. ∙ Yang, W. ...</div><div><strong>Small molecule integrin antagonists that bind to the β2 subunit I-like domain and activate signals in one direction and block them in the other</strong></div><div><em>Immunity.</em> 2003; <strong>19</strong>:391-402</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS1074-7613%2803%2900238-3&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS1074-7613%2803%2900238-3&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0141746138" target="_blank" aria-label="Open Scopus in new tab">Scopus (128)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/14499114/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1074-7613%2803%2900238-3&amp;pmid=14499114" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Through this activity, extracellular Mg<sup>2+</sup> defines the outcome of memory CD8<sup>+</sup> T&nbsp;cell-dependent immunity. Unsurprisingly, also in light of our data, complete pharmacological inhibition of LFA-1 causes severe immunosuppression (<span class="dropBlock reference-citations"><a id="body-ref-sref19" href="#" role="doc-biblioref" data-xml-rid="bib19" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref19" aria-controls="sref19">Goodman and Picard, 2012</a><div class="dropBlock__holder" data-db-target-of="sref19"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Goodman, S.L. ∙ Picard, M.</div><div><strong>Integrins as therapeutic targets</strong></div><div><em>Trends Pharmacol. Sci.</em> 2012; <strong>33</strong>:405-412</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.tips.2012.04.002&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.tips.2012.04.002&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84862686491" target="_blank" aria-label="Open Scopus in new tab">Scopus (317)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22633092/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.tips.2012.04.002&amp;pmid=22633092" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, it is interesting to note that, when using a mAb that stabilizes extended LFA-1 or when transferring T&nbsp;cells expressing constitutively extended LFA-1, T&nbsp;cell responses are severely impaired both <i>in&nbsp;vitro</i> and <i>in&nbsp;vivo</i> (<span class="dropBlock reference-citations"><a id="body-ref-sref9" href="#" role="doc-biblioref" data-xml-rid="bib9" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref9" aria-controls="sref9">Dransfield et&nbsp;al., 1992a</a><div class="dropBlock__holder" data-db-target-of="sref9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Dransfield, I. ∙ Cabañas, C. ∙ Barrett, J. ...</div><div><strong>Interaction of leukocyte integrins with ligand is necessary but not sufficient for function</strong></div><div><em>J.&nbsp;Cell Biol.</em> 1992; <strong>116</strong>:1527-1535</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.116.6.1527" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0026581198" target="_blank" aria-label="Open Scopus in new tab">Scopus (129)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/1541641/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.116.6.1527&amp;pmid=1541641" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref58" href="#" role="doc-biblioref" data-xml-rid="bib58" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref58" aria-controls="sref58">Semmrich et&nbsp;al., 2005</a><div class="dropBlock__holder" data-db-target-of="sref58"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Semmrich, M. ∙ Smith, A. ∙ Feterowski, C. ...</div><div><strong>Importance of integrin LFA-1 deactivation for the generation of immune responses</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2005; <strong>201</strong>:1987-1998</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20041850" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-22344438374" target="_blank" aria-label="Open Scopus in new tab">Scopus (103)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15955836/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20041850&amp;pmid=15955836" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This underscores the complex interconnection between LFA-1’s structural conformation, its outside-in signaling activity, and the function of T&nbsp;cells—a system tuned, as we show here, by Mg<sup>2+</sup> in the extracellular space. In an intricate manner, extracellular Ca<sup>2+</sup> and Mn<sup>2+</sup> coordinate with Mg<sup>2+</sup> in stabilizing beta integrin heterodimer complexes as well as in regulating conformational changes. Specifically, Ca<sup>2+</sup> at physiologic concentrations has an inhibitory effect on integrin-ligand binding, while low Ca<sup>2+</sup> abundance functions synergistically with Mg<sup>2+</sup> in mediating cell adhesion (<span class="dropBlock reference-citations"><a id="body-ref-sref10-2" href="#" role="doc-biblioref" data-xml-rid="bib10" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref10-2" aria-controls="sref10-2">Dransfield et&nbsp;al., 1992b</a><div class="dropBlock__holder" data-db-target-of="sref10-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">10.</div><div>Dransfield, I. ∙ Cabañas, C. ∙ Craig, A. ...</div><div><strong>Divalent cation regulation of the function of the leukocyte integrin LFA-1</strong></div><div><em>J.&nbsp;Cell Biol.</em> 1992; <strong>116</strong>:219-226</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.116.1.219" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0026601096" target="_blank" aria-label="Open Scopus in new tab">Scopus (431)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/1346139/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.116.1.219&amp;pmid=1346139" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref29" href="#" role="doc-biblioref" data-xml-rid="bib29" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref29" aria-controls="sref29">Labadia et&nbsp;al., 1998</a><div class="dropBlock__holder" data-db-target-of="sref29"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Labadia, M.E. ∙ Jeanfavre, D.D. ∙ Caviness, G.O. ...</div><div><strong>Molecular regulation of the interaction between leukocyte function-associated antigen-1 and soluble ICAM-1 by divalent metal cations</strong></div><div><em>J.&nbsp;Immunol.</em> 1998; <strong>161</strong>:836-842</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.161.2.836" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9670961/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.161.2.836&amp;pmid=9670961" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref43" href="#" role="doc-biblioref" data-xml-rid="bib43" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref43" aria-controls="sref43">Onley et&nbsp;al., 2000</a><div class="dropBlock__holder" data-db-target-of="sref43"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">43.</div><div>Onley, D.J. ∙ Knight, C.G. ∙ Tuckwell, D.S. ...</div><div><strong>Micromolar Ca2+ concentrations are essential for Mg2+-dependent binding of collagen by the integrin alpha 2beta 1 in human platelets</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2000; <strong>275</strong>:24560-24564</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M004111200&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M004111200&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0034636864" target="_blank" aria-label="Open Scopus in new tab">Scopus (70)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10827198/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M004111200&amp;pmid=10827198" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Ca<sup>2+</sup> exerts these modulatory effects by binding to two adjacent metal coordination sites flanking the beta I MIDAS, termed Ligand-induced metal-binding site (LIMBS) and adjacent to MIDAS (ADMIDAS) (<span class="dropBlock reference-citations"><a id="body-ref-sref5-1" href="#" role="doc-biblioref" data-xml-rid="bib5" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref5-1" aria-controls="sref5-1">Chen et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref5-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Chen, J. ∙ Salas, A. ∙ Springer, T.A.</div><div><strong>Bistable regulation of integrin adhesiveness by a bipolar metal ion cluster</strong></div><div><em>Nat. Struct. Biol.</em> 2003; <strong>10</strong>:995-1001</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nsb1011" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0344628802" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/14608374/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnsb1011&amp;pmid=14608374" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref39" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39" aria-controls="sref39">Mould et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref39"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Mould, A.P. ∙ Barton, S.J. ∙ Askari, J.A. ...</div><div><strong>Role of ADMIDAS cation-binding site in ligand recognition by integrin alpha 5 beta 1</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2003; <strong>278</strong>:51622-51629</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M306655200&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M306655200&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0347695986" target="_blank" aria-label="Open Scopus in new tab">Scopus (80)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/14532288/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M306655200&amp;pmid=14532288" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The potent integrin activator Mn<sup>2+</sup>, in contrast, operates by binding MIDAS motifs and by competing with Ca<sup>2+</sup> for LIMBS and ADMIDAS binding (<span class="dropBlock reference-citations"><a id="body-ref-sref5-2" href="#" role="doc-biblioref" data-xml-rid="bib5" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref5-2" aria-controls="sref5-2">Chen et&nbsp;al., 2003</a><div class="dropBlock__holder" data-db-target-of="sref5-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Chen, J. ∙ Salas, A. ∙ Springer, T.A.</div><div><strong>Bistable regulation of integrin adhesiveness by a bipolar metal ion cluster</strong></div><div><em>Nat. Struct. Biol.</em> 2003; <strong>10</strong>:995-1001</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nsb1011" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0344628802" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/14608374/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnsb1011&amp;pmid=14608374" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref66" href="#" role="doc-biblioref" data-xml-rid="bib66" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref66" aria-controls="sref66">Valdramidou et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref66"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Valdramidou, D. ∙ Humphries, M.J. ∙ Mould, A.P.</div><div><strong>Distinct roles of beta1 metal ion-dependent adhesion site (MIDAS), adjacent to MIDAS (ADMIDAS), and ligand-associated metal-binding site (LIMBS) cation-binding sites in ligand recognition by integrin alpha2beta1</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2008; <strong>283</strong>:32704-32714</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M802066200&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M802066200&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-57749106677" target="_blank" aria-label="Open Scopus in new tab">Scopus (47)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18820259/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M802066200&amp;pmid=18820259" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). While our data demonstrate that modifying Mg<sup>2+</sup> in the extracellular space is sufficient to impact T&nbsp;cell effector maturation <i>in&nbsp;vivo</i>, it will be interesting to study how Mg<sup>2+</sup> integrates its function with other divalent cations across physiologic and pathologic concentrations.</div><div id="p0095" role="paragraph">The compartmentalized distribution of Mg<sup>2+</sup> in healthy mice&nbsp;plausibly creates tissue-specific differences in the TCR signal strength required to activate memory CD8<sup>+</sup> T&nbsp;cells that are engaged in immune surveillance of Mg<sup>2+</sup> high versus Mg<sup>2+</sup>&nbsp;low&nbsp;tissues. It will be of value to explore whether compartment-specific effects on the CD8<sup>+</sup> T&nbsp;cell activation threshold not only affect infection control and cancer immune control but also affect the occurrence of autoimmunity.</div><div id="p0100" role="paragraph">Improving conventional cancer therapy by manipulating nutrient availability through dietary intervention is a field of growing interest (<span class="dropBlock reference-citations"><a id="body-ref-sref25" href="#" role="doc-biblioref" data-xml-rid="bib25" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref25" aria-controls="sref25">Kanarek et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref25"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Kanarek, N. ∙ Petrova, B. ∙ Sabatini, D.M.</div><div><strong>Dietary modifications for enhanced cancer therapy</strong></div><div><em>Nature.</em> 2020; <strong>579</strong>:507-517</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-020-2124-0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85082404548" target="_blank" aria-label="Open Scopus in new tab">Scopus (229)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32214253/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-020-2124-0&amp;pmid=32214253" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). For example, experimental data suggest beneficial effects of repetitive fasting cycles in mice, the rationale being to target the high metabolic requirements of cancer cells (<span class="dropBlock reference-citations"><a id="body-ref-sref32" href="#" role="doc-biblioref" data-xml-rid="bib32" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref32" aria-controls="sref32">Lee et&nbsp;al., 2012</a><div class="dropBlock__holder" data-db-target-of="sref32"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">32.</div><div>Lee, C. ∙ Raffaghello, L. ∙ Brandhorst, S. ...</div><div><strong>Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy</strong></div><div><em>Sci. Transl. Med.</em> 2012; <strong>4</strong>:124ra27</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.3003293" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84863229916" target="_blank" aria-label="Open Scopus in new tab">Scopus (509)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22323820/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.3003293&amp;pmid=22323820" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). When aiming to translate such deprivation strategies to clinical medicine, they need, however, to be carefully balanced against the danger of imposing nutrient deficiencies that may negatively impact on host immunity. Indeed, only 2&nbsp;weeks of dietary depletion of Mg<sup>2+</sup> was sufficient to affect both tumor and infection immune control in mice, and low serum Mg<sup>2+</sup> levels were associated with an unfavorable outcome both in CAR T&nbsp;cell and anti-PDL1 mAb-treated human cancer patients. Of note, hypomagnesemia is present in up to a fifth of Blinatumomab-treated individuals (<span class="dropBlock reference-citations"><a id="body-ref-sref27-2" href="#" role="doc-biblioref" data-xml-rid="bib27" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref27-2" aria-controls="sref27-2">Kiyoi et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref27-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>Kiyoi, H. ∙ Morris, J.D. ∙ Oh, I. ...</div><div><strong>Phase 1b/2 study of Blinatumomab in Japanese adults with relapsed/refractory acute lymphoblastic leukemia</strong></div><div><em>Cancer Sci.</em> 2020; <strong>111</strong>:1314-1323</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/cas.14322" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85079468567" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31971321/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fcas.14322&amp;pmid=31971321" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), a quarter of CAR T&nbsp;cell recipients (<span class="dropBlock reference-citations"><a id="body-ref-sref1" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1" aria-controls="sref1">Abramson et&nbsp;al., 2020</a><div class="dropBlock__holder" data-db-target-of="sref1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Abramson, J.S. ∙ Palomba, M.L. ∙ Gordon, L.I. ...</div><div><strong>Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (transcend NHL 001): a multicentre seamless design study</strong></div><div><em>Lancet.</em> 2020; <strong>396</strong>:839-852</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS0140-6736%2820%2931366-0&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS0140-6736%2820%2931366-0&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85090978508" target="_blank" aria-label="Open Scopus in new tab">Scopus (1357)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32888407/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0140-6736%2820%2931366-0&amp;pmid=32888407" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref35" href="#" role="doc-biblioref" data-xml-rid="bib35" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref35" aria-controls="sref35">Locke et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref35"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Locke, F.L. ∙ Ghobadi, A. ∙ Jacobson, C.A. ...</div><div><strong>Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial</strong></div><div><em>Lancet Oncol.</em> 2019; <strong>20</strong>:31-42</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS1470-2045%2818%2930864-7&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS1470-2045%2818%2930864-7&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85059501669" target="_blank" aria-label="Open Scopus in new tab">Scopus (1541)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30518502/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1470-2045%2818%2930864-7&amp;pmid=30518502" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref61" href="#" role="doc-biblioref" data-xml-rid="bib61" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref61" aria-controls="sref61">Siddiqi et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref61"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Siddiqi, T. ∙ Soumerai, J.D. ∙ Dorritie, K.A. ...</div><div><strong>Rapid undetectable MRD (uMRD) responses in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) treated with lisocabtagene maraleucel (liso-cel), a CD19-directed CAR T&nbsp;cell product: updated results from transcend CLL 004, a phase 1/2 study including patients with high-risk disease previously treated with ibrutinib</strong></div><div><em>Blood.</em> 2019; <strong>134</strong>:503</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31186276/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=31186276" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and in up to 90% of patients receiving platin-based chemotherapy (<span class="dropBlock reference-citations"><a id="body-ref-sref30" href="#" role="doc-biblioref" data-xml-rid="bib30" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref30" aria-controls="sref30">Lajer and Daugaard, 1999</a><div class="dropBlock__holder" data-db-target-of="sref30"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div><div>Lajer, H. ∙ Daugaard, G.</div><div><strong>Cisplatin and hypomagnesemia</strong></div><div><em>Cancer Treat. Rev.</em> 1999; <strong>25</strong>:47-58</div></div><div class="external-links"><div class="core-xlink-abstract"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1053%2Fctrv.1999.0097&amp;cf=abstract&amp;site=yctrv-site" target="_blank" aria-label="Open Abstract in new tab">Abstract</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1053%2Fctrv.1999.0097&amp;cf=pdf&amp;site=yctrv-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0033081313" target="_blank" aria-label="Open Scopus in new tab">Scopus (204)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10212589/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fctrv.1999.0097&amp;pmid=10212589" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref34" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34" aria-controls="sref34">Liu et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref34"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Liu, W. ∙ Qdaisat, A. ∙ Soliman, P.T. ...</div><div><strong>Hypomagnesemia and survival in patients with ovarian cancer who received chemotherapy with carboplatin</strong></div><div><em>Oncologist.</em> 2019; <strong>24</strong>:e312-e317</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1634/theoncologist.2018-0465" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85063948902" target="_blank" aria-label="Open Scopus in new tab">Scopus (13)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30940743/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1634%2Ftheoncologist.2018-0465&amp;pmid=30940743" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref44" href="#" role="doc-biblioref" data-xml-rid="bib44" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref44" aria-controls="sref44">Oronsky et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref44"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Oronsky, B. ∙ Caroen, S. ∙ Oronsky, A. ...</div><div><strong>Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management</strong></div><div><em>Cancer Chemother. Pharmacol.</em> 2017; <strong>80</strong>:895-907</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s00280-017-3392-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85025127650" target="_blank" aria-label="Open Scopus in new tab">Scopus (70)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28730291/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs00280-017-3392-8&amp;pmid=28730291" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Inversely, a recent study in patients with acute myeloid leukemia showed that higher serum magnesium levels after allogeneic stem cell transplantation were associated with a decreased incidence of relapse but with a higher risk of acute graft-versus-host disease (<span class="dropBlock reference-citations"><a id="body-ref-sref3" href="#" role="doc-biblioref" data-xml-rid="bib3" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref3" aria-controls="sref3">Angenendt et&nbsp;al., 2021</a><div class="dropBlock__holder" data-db-target-of="sref3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">3.</div><div>Angenendt, L. ∙ Hilgefort, I. ∙ Mikesch, J.H. ...</div><div><strong>Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia</strong></div><div><em>Ann. Hematol.</em> 2021; <strong>100</strong>:1871-1878</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s00277-020-04382-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85097748603" target="_blank" aria-label="Open Scopus in new tab">Scopus (4)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33341918/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs00277-020-04382-y&amp;pmid=33341918" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0105" role="paragraph">In conclusion, our data identify extracellular Mg<sup>2+</sup> as an immune modulator, regulating T&nbsp;cell activation via LFA-1 MIDAS binding. LFA-1 thus senses Mg<sup>2+</sup> and integrates its abundance in its co-stimulatory function. Through this axis, Mg<sup>2+</sup> defines the threshold of T&nbsp;cell activation in a subset selective manner.</div><section id="sec-3-1"><h3>Limitations of the study</h3><div id="p0110" role="paragraph">Autochthonous tumors are more heterogeneous in architecture, immune cell landscape, perfusion, etc., than the cancer models used in this study, and our findings, therefore, cannot be generalized. We also have not analyzed the long-term consequences of enhancing LFA-1 outside-in signaling, which will require slow growth, i.e., more chronic cancer models. Furthermore, how organismal depletion of Mg<sup>2+</sup> affects the efficiency of CAR T&nbsp;cells to attack established solid tumors remains to be defined. It is notable, however, that stratifying human cancer patients according to serum Mg<sup>2+</sup> abundance was discriminating study participants with regard to relevant endpoints in both a CAR T&nbsp;cell- and an immune checkpoint trial. Yet, the retrospective nature of these analyses limits the significance of the associations detected. Therefore, as instructed by our findings, prospective controlled trials will need to clarify the clinical relevance of Mg<sup>2+</sup> as an immunomodulatory agent in cancer medicine.</div></section></section><section id="sec-4"><h2>STAR★Methods</h2><section id="sec-4-1"><h3>Key resources table</h3><div id="p0115" role="paragraph"><div class="figure-wrap"><figure id="undtbl1" class="table" data-figureviewer-ignore="true"><div class="table-wrap"><table data-figureviewer-ignore="true" tabindex="0"><thead><tr class="rowsep"><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr class="rowsep"><td colspan="3"><b>Antibodies</b></td></tr><tr><td>Mouse Anti-Human CD3</td><td>BioLegend</td><td>Cat# 300333, RRID:<a id="interref70" href="https://antibodyregistry.org/AB_2616669" target="_blank">AB_2616669</a></td></tr><tr><td>Mouse Anti-Human CD28</td><td>BioLegend</td><td>Cat# 302943; RRID:<a id="interref75" href="https://antibodyregistry.org/AB_2616667" target="_blank">AB_2616667</a></td></tr><tr><td>Armenian Hamster Anti-Mouse CD3</td><td>BioLegend</td><td>Cat# 100359; RRID:<a id="interref80" href="https://antibodyregistry.org/AB_2616673" target="_blank">AB_2616673</a></td></tr><tr><td>Syrian Hamster Anti-Mouse CD28</td><td>BioLegend</td><td>Cat# 102121; RRID:<a id="interref85" href="https://antibodyregistry.org/AB_2810330" target="_blank">AB_2810330</a></td></tr><tr><td>Mouse Anti-Human CD11a/CD18 (LFA-1) (clone m24), unlabeled, AF488, PE</td><td>BioLegend</td><td>Cat# 363402; RRID:<a id="interref90" href="https://antibodyregistry.org/AB_2564213" target="_blank">AB_2564213</a><br>Cat# 363406; RRID:<a id="interref95" href="https://antibodyregistry.org/AB_2721627" target="_blank">AB_2721627</a><br>Cat# 363404; RRID:<a id="interref100" href="https://antibodyregistry.org/AB_2565289" target="_blank">AB_2565289</a></td></tr><tr><td>Mouse Anti-Human CD11a (clone TS2/4), unlabeled, FITC</td><td>BioLegend</td><td>Cat# 350602; RRID:<a id="interref105" href="https://antibodyregistry.org/AB_10662540" target="_blank">AB_10662540</a><br>Cat# 350604; RRID:<a id="interref110" href="https://antibodyregistry.org/AB_10662904" target="_blank">AB_10662904</a></td></tr><tr><td>Mouse Anti-Human CD18 (clone KIM127), unlabeled</td><td>M. Sperandio, LM University Munich and InVivo Biotech Services GmbH</td><td>custom; RRID:CVCL_0F09</td></tr><tr><td>Mouse Anti-Human CD18 (clone CBR LFA-1/2, Ultra-LEAF)</td><td>BioLegend</td><td>custom</td></tr><tr><td>Mouse Anti-Human CD18 (clone TS1/18)</td><td>BioLegend</td><td>Cat# 302116; RRID:<a id="interref115" href="https://antibodyregistry.org/AB_2561483" target="_blank">AB_2561483</a></td></tr><tr><td>Mouse Anti-Human CD54 (ICAM-1)</td><td>Thermo Fisher</td><td>Cat# 16-0549-82; RRID:<a id="interref120" href="https://antibodyregistry.org/AB_468981" target="_blank">AB_468981</a></td></tr><tr><td>Mouse Anti-Human CD102 (ICAM-2)</td><td>Thermo Fisher</td><td>Cat# BMS109; RRID:<a id="interref125" href="https://antibodyregistry.org/AB_10598677" target="_blank">AB_10598677</a></td></tr><tr><td>Mouse Anti-Human CD50 (ICAM-3)</td><td>Thermo Fisher</td><td>Cat# BMS111; RRID:<a id="interref130" href="https://antibodyregistry.org/AB_10597746" target="_blank">AB_10597746</a></td></tr><tr><td>Mouse IgG1 κ Isotype control</td><td>BioLegend</td><td>Cat# 400166; RRID:<a id="interref135" href="https://antibodyregistry.org/AB_11146992" target="_blank">AB_11146992</a></td></tr><tr><td>Mouse IgG1 κ Isotype control</td><td>Thermo Fisher</td><td>Cat#16-4714-82; RRID:<a id="interref140" href="https://antibodyregistry.org/AB_470161" target="_blank">AB_470161</a></td></tr><tr><td>Mouse IgG2a κ Isotype control</td><td>Thermo Fisher</td><td>Cat#16-4724-82; RRID:<a id="interref145" href="https://antibodyregistry.org/AB_470164" target="_blank">AB_470164</a></td></tr><tr><td>InVivoMab Anti-Mouse CD3ε F(ab′)2 fragment</td><td>BioXCell</td><td>Cat# BE0001-1FAB; RRID:<a id="interref150" href="https://antibodyregistry.org/AB_2687679" target="_blank">AB_2687679</a></td></tr><tr><td>InVivoMab Anti-Mouse PD-1 (CD279)</td><td>BioXCell</td><td>Cat# BE0146; RRID:<a id="interref155" href="https://antibodyregistry.org/AB_10949053" target="_blank">AB_10949053</a></td></tr><tr><td>InVivoMAb Anti-Mouse CD16/CD32</td><td>BioXCell</td><td>Cat# BE0307; RRID:<a id="interref160" href="https://antibodyregistry.org/AB_2736987" target="_blank">AB_2736987</a></td></tr><tr><td>InVivoMab rat IgG2a isotype control</td><td>BioXCell</td><td>Cat# BE0089; RRID:<a id="interref165" href="https://antibodyregistry.org/AB_1107769" target="_blank">AB_1107769</a></td></tr><tr><td>Rabbit Anti-Human/Mouse phospho-FAK (Tyr397)</td><td>Thermo Fisher</td><td>Cat# 700255; RRID:<a id="interref170" href="https://antibodyregistry.org/AB_2532307" target="_blank">AB_2532307</a></td></tr><tr><td>Phospho-Tyrosine (P-Tyr-1000) MultiMab Rabbit mAb mix</td><td>Cell Signaling Technology</td><td>Cat# 8954; RRID:<a id="interref175" href="https://antibodyregistry.org/AB_2687925" target="_blank">AB_2687925</a></td></tr><tr><td>Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204), Rabbit mAb</td><td>Cell Signaling Technology</td><td>Cat# 4370; RRID:<a id="interref180" href="https://antibodyregistry.org/AB_2315112" target="_blank">AB_2315112</a></td></tr><tr><td>Phospho-c-Jun (Ser73), Rabbit mAb</td><td>Cell Signaling Technology</td><td>Cat# 3270; RRID:<a id="interref185" href="https://antibodyregistry.org/AB_2129575" target="_blank">AB_2129575</a></td></tr><tr><td>p44/42 MAPK (Erk1/2), Rabbit mAb</td><td>Cell Signaling Technology</td><td>Cat# 137F5; RRID:<a id="interref190" href="https://antibodyregistry.org/AB_10693607" target="_blank">AB_10693607</a></td></tr><tr><td>c-Jun, Rabbit mAb</td><td>Cell Signaling Technology</td><td>Cat# 60A8; RRID:<a id="interref195" href="https://antibodyregistry.org/AB_2130165" target="_blank">AB_2130165</a></td></tr><tr><td>β-Actin, Mouse mAb</td><td>Cell Signaling Technology</td><td>Cat# 8H10D10; RRID:<a id="interref200" href="https://antibodyregistry.org/AB_2242334" target="_blank">AB_2242334</a></td></tr><tr><td>Recombinant Anti-gamma Tubulin</td><td>Abcam</td><td>Cat# ab179503; RRID:<a id="interref205" href="https://antibodyregistry.org/AB_2904198" target="_blank">AB_2904198</a></td></tr><tr><td>Purified Mouse Anti-Human Perforin</td><td>BD Biosciences</td><td>Cat# 556434; RRID:<a id="interref210" href="https://antibodyregistry.org/AB_396418" target="_blank">AB_396418</a></td></tr><tr><td>Goat anti-Mouse IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 568</td><td>Thermo Fisher</td><td>Cat# A-11031; RRID:<a id="interref215" href="https://antibodyregistry.org/AB_144696" target="_blank">AB_144696</a></td></tr><tr><td>Goat anti-Rabbit IgG (H+L) Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor 647</td><td>Thermo Fisher</td><td>Cat# A-21245; RRID:<a id="interref220" href="https://antibodyregistry.org/AB_2535813" target="_blank">AB_2535813</a></td></tr><tr><td>Goat anti-Mouse IgG1 Cross-Adsorbed Secondary Antibody, Alexa Fluor 488</td><td>Thermo Fisher</td><td>Cat# A-21121; RRID:<a id="interref225" href="https://antibodyregistry.org/AB_2535764" target="_blank">AB_2535764</a></td></tr><tr><td>Mouse anti-ERK1/2 Phospho (Thr202/Tyr204), AF647</td><td>BioLegend</td><td>Cat# 369504; RRID:<a id="interref230" href="https://antibodyregistry.org/AB_2571896" target="_blank">AB_2571896</a></td></tr><tr><td>Hamster Anti-Mouse CD3, BUV805</td><td>BD Biosciences</td><td>Cat# 749276; RRID:<a id="interref235" href="https://antibodyregistry.org/AB_2873651" target="_blank">AB_2873651</a></td></tr><tr><td>Rat anti-mouse CD4, BUV496</td><td>BD Biosciences</td><td>Cat# 612952; RRID:<a id="interref240" href="https://antibodyregistry.org/AB_2813886" target="_blank">AB_2813886</a></td></tr><tr><td>Hamster Anti-mouse CD8a, eFluor 450</td><td>eBioscience</td><td>Cat# 48-0081-82; RRID:<a id="interref245" href="https://antibodyregistry.org/AB_1272198" target="_blank">AB_1272198</a></td></tr><tr><td>Rat Anti-mouse CD11b, APC/Cyanine7</td><td>BioLegend</td><td>Cat# 101226; RRID:<a id="interref250" href="https://antibodyregistry.org/AB_830642" target="_blank">AB_830642</a></td></tr><tr><td>Armenian Hamster Anti-Mouse CD11c, FITC</td><td>BioLegend</td><td>Cat# 117306; RRID:<a id="interref255" href="https://antibodyregistry.org/AB_313775" target="_blank">AB_313775</a></td></tr><tr><td>Rat Anti-Mouse CD19 Antibody, BB515</td><td>BD Biosciences</td><td>Cat# 564509; RRID:<a id="interref260" href="https://antibodyregistry.org/AB_2738830" target="_blank">AB_2738830</a></td></tr><tr><td>Rat Anti-Mouse CD25 Antibody, PE-Cyanine5.5</td><td>eBioscience</td><td>Cat# 35-0251-82; RRID:<a id="interref265" href="https://antibodyregistry.org/AB_11218898" target="_blank">AB_11218898</a></td></tr><tr><td>Rat Anti-Mouse CD45, BUV395</td><td>BD Biosciences</td><td>Cat# 565967; RRID:<a id="interref270" href="https://antibodyregistry.org/AB_2739420" target="_blank">AB_2739420</a></td></tr><tr><td>Armenian Hamster Anti-Mouse CD80 Antibody, FITC</td><td>BioLegend</td><td>Cat# 104706; RRID:<a id="interref275" href="https://antibodyregistry.org/AB_313127" target="_blank">AB_313127</a></td></tr><tr><td>Hamster Anti-Mouse CD103, BV650</td><td>BD Biosciences</td><td>Cat# 748256; 748256</td></tr><tr><td>Armenian Hamster Anti-Mouse CD80, Brilliant Violet 605</td><td>BioLegend</td><td>Cat# 104729; RRID:<a id="interref280" href="https://antibodyregistry.org/AB_11126141" target="_blank">AB_11126141</a></td></tr><tr><td>Rat Anti-Mouse CD206, Brilliant Violet 711</td><td>BioLegend</td><td>Cat# 141727; RRID:<a id="interref285" href="https://antibodyregistry.org/AB_2565822" target="_blank">AB_2565822</a></td></tr><tr><td>Hamster Anti-Mouse CD183 (CXCR3), BUV737</td><td>BD Biosciences</td><td>Cat# 741895; RRID:<a id="interref290" href="https://antibodyregistry.org/AB_2871214" target="_blank">AB_2871214</a></td></tr><tr><td>Rat Anti-Mouse F4/80, Alexa Fluor 647</td><td>BioLegend</td><td>Cat# 123122; RRID:<a id="interref295" href="https://antibodyregistry.org/AB_893480" target="_blank">AB_893480</a></td></tr><tr><td>FOXP3, rat mAb, APC</td><td>eBioscience</td><td>Cat# 17-5773-82;RRID:<a id="interref300" href="https://antibodyregistry.org/AB_469457" target="_blank">AB_469457</a></td></tr><tr><td>Granzyme B, mouse mAb, PE-eFluor 610</td><td>Inivtrogen</td><td>Cat# 61-8898-82; RRID:<a id="interref305" href="https://antibodyregistry.org/AB_2574670" target="_blank">AB_2574670</a></td></tr><tr><td>Ki-67, rat mAb, Alexa Fluor 532</td><td>eBioscience</td><td>Cat# 58-5698-82; RRID:<a id="interref310" href="https://antibodyregistry.org/AB_2802365" target="_blank">AB_2802365</a></td></tr><tr><td>Rat Anti-mouse CD11a (LFA-1alpha), Super Bright 436</td><td>Thermo Fisher</td><td>Cat# 62-0111-82; RRID:<a id="interref315" href="https://antibodyregistry.org/AB_2762648" target="_blank">AB_2762648</a></td></tr><tr><td>Rat Anti-Mouse Ly-6G, BUV563</td><td>BD Biosciences</td><td>Cat# 612921; RRID:<a id="interref320" href="https://antibodyregistry.org/AB_2870206" target="_blank">AB_2870206</a></td></tr><tr><td>Rat Anti-Mouse Ly-6c, PerCP</td><td>BioLegend</td><td>Cat# 128028; RRID:<a id="interref325" href="https://antibodyregistry.org/AB_10897805" target="_blank">AB_10897805</a></td></tr><tr><td>Rat Anti-Mouse I-A/I-E (MHCII), BV510</td><td>BioLegend</td><td>Cat# 107636; RRID:<a id="interref330" href="https://antibodyregistry.org/AB_2734168" target="_blank">AB_2734168</a></td></tr><tr><td>Rat Anti-Mouse CD335 (NKp46), BV563</td><td>BD Biosciences</td><td>Cat# 741435; RRID:<a id="interref335" href="https://antibodyregistry.org/AB_2870912" target="_blank">AB_2870912</a></td></tr><tr><td>Rat Anti-Mouse CD279 (PD-1), Brilliant Violet 785</td><td>BioLegend</td><td>Cat# 135225; RRID:<a id="interref340" href="https://antibodyregistry.org/AB_2563680" target="_blank">AB_2563680</a></td></tr><tr><td>Rat Anti-Mouse CD274 (PD-L1), Brilliant Violet 421</td><td>BioLegend</td><td>Cat# 124315; RRID:<a id="interref345" href="https://antibodyregistry.org/AB_10897097" target="_blank">AB_10897097</a></td></tr><tr><td>Rat Anti-Mouse TCF7/TCF1, Alexa fluor 700</td><td>R&amp;D Systems</td><td>Cat# FAB8224N; RRID:<a id="interref350" href="https://antibodyregistry.org/AB_2904199" target="_blank">AB_2904199</a></td></tr><tr><td>Mouse Anti-Mouse CD366 (TIM-3), BB700</td><td>BD Biosciences</td><td>Cat# 747619; RRID:<a id="interref355" href="https://antibodyregistry.org/AB_2744185" target="_blank">AB_2744185</a></td></tr><tr><td>Rat Anti-Mouse CD8a, FITC</td><td>BioLegend</td><td>Cat# 100706; RRID:<a id="interref360" href="https://antibodyregistry.org/AB_312745" target="_blank">AB_312745</a></td></tr><tr><td>Rat Anti-Mouse CD11b, PE/Cyanine5</td><td>BioLegend</td><td>Cat# 101210; RRID:<a id="interref365" href="https://antibodyregistry.org/AB_312793" target="_blank">AB_312793</a></td></tr><tr><td>Armenian Hamster Anti-Mouse CD11c, PE/Cyanine5</td><td>BioLegend</td><td>Cat# 117316; RRID:<a id="interref370" href="https://antibodyregistry.org/AB_493566" target="_blank">AB_493566</a></td></tr><tr><td>Rat Anti-Mouse/Human CD45R/B220, PE/Cyanine5</td><td>BioLegend</td><td>Cat# 103210; RRID:<a id="interref375" href="https://antibodyregistry.org/AB_312995" target="_blank">AB_312995</a></td></tr><tr><td>Rat Anti-Mouse F4/80, PE/Cyanine5</td><td>BioLegend</td><td>Cat# 123112; RRID:<a id="interref380" href="https://antibodyregistry.org/AB_893482" target="_blank">AB_893482</a></td></tr><tr><td>Rat Anti-Mouse CD69, APC</td><td>BioLegend</td><td>Cat# 104514; RRID:<a id="interref385" href="https://antibodyregistry.org/AB_492843" target="_blank">AB_492843</a></td></tr><tr><td>Rat Anti-Mouse CD107a (LAMP-1), PE/Cyanine7</td><td>BioLegend</td><td>Cat# 121620; RRID:<a id="interref390" href="https://antibodyregistry.org/AB_2562147" target="_blank">AB_2562147</a></td></tr><tr><td>Tetramer/PE - H-2 Kb OVA (SIINFEKL)</td><td>Tetramers core facility, University of Lausanne</td><td>N/A</td></tr><tr><td>Rat Anti-Mouse CD11a, FITC</td><td>BioLegend</td><td>Cat# 101106; RRID:<a id="interref395" href="https://antibodyregistry.org/AB_312779" target="_blank">AB_312779</a></td></tr><tr><td>Rat Anti-Mouse CD11a/CD18, Pacific Blue</td><td>BioLegend</td><td>Cat# 141014; <a id="interref400" href="https://antibodyregistry.org/AB_2800653" target="_blank">AB_2800653</a></td></tr><tr><td>Rat Anti-Mouse CD4, R718</td><td>BD Biosciences</td><td>Cat# 566939; RRID:<a id="interref405" href="https://antibodyregistry.org/AB_2869957" target="_blank">AB_2869957</a></td></tr><tr><td>Rat Anti-Mouse CD8, BUV805</td><td>BD Biosciences</td><td>Cat# 612898; RRID:<a id="interref410" href="https://antibodyregistry.org/AB_2870186" target="_blank">AB_2870186</a></td></tr><tr><td>Rat Anti-Mouse CD45, APC-Cy7</td><td>BioLegend</td><td>Cat# 103115; RRID:<a id="interref415" href="https://antibodyregistry.org/AB_312980" target="_blank">AB_312980</a></td></tr><tr><td>Armenian Hamster Anti-Mouse CD69, Brilliant Violet 650</td><td>BioLegend</td><td>Cat# 104541; RRID:<a id="interref420" href="https://antibodyregistry.org/AB_2616934" target="_blank">AB_2616934</a></td></tr><tr><td>Armenian Hamster Anti-Mouse TCRβ, Brilliant Violet 711</td><td>BioLegend</td><td>Cat# 109243; RRID:<a id="interref425" href="https://antibodyregistry.org/AB_2629564" target="_blank">AB_2629564</a></td></tr><tr><td>Armenian Hamster Anti-Mouse CD11c, Brilliant Violet 650</td><td>BioLegend</td><td>Cat# 117339; RRID:<a id="interref430" href="https://antibodyregistry.org/AB_2562414" target="_blank">AB_2562414</a></td></tr><tr><td>Armenian Hamster Anti-Mouse CD69, PE/Cyanine5</td><td>BioLegend</td><td>Cat# 104510; RRID:<a id="interref435" href="https://antibodyregistry.org/AB_313113" target="_blank">AB_313113</a></td></tr><tr><td>Armenian Hamster Anti-Mouse CD80, FITC</td><td>BioLegend</td><td>Cat# 104706; RRID:<a id="interref440" href="https://antibodyregistry.org/AB_313127" target="_blank">AB_313127</a></td></tr><tr><td>Armenian Hamster Anti-Mouse TCR γ/δ Antibody, PE</td><td>BioLegend</td><td>Cat# 118108; RRID:<a id="interref445" href="https://antibodyregistry.org/AB_313832" target="_blank">AB_313832</a></td></tr><tr><td>Mouse Anti-Mouse NK-1.1, APC</td><td>BioLegend</td><td>Cat# 108710; RRID:<a id="interref450" href="https://antibodyregistry.org/AB_313397" target="_blank">AB_313397</a></td></tr><tr><td>Rat Anti-Mouse Anti-Mouse Ly-6G/Ly-6C (Gr-1), Brilliant Violet 510</td><td>BioLegend</td><td>Cat# 108457; RRID:<a id="interref455" href="https://antibodyregistry.org/AB_2650931" target="_blank">AB_2650931</a></td></tr><tr><td>Rat Anti-Mouse CD11a, PE/Cyanine7</td><td>BioLegend</td><td>Cat# 153108; RRID:<a id="interref460" href="https://antibodyregistry.org/AB_2716057" target="_blank">AB_2716057</a></td></tr><tr><td>Rat Anti-Mouse CD19, PE/Cyanine5</td><td>BioLegend</td><td>Cat# 115510; RRID:<a id="interref465" href="https://antibodyregistry.org/AB_313645" target="_blank">AB_313645</a></td></tr><tr><td>Rat Anti-Mouse CD62L, Pacific Blue</td><td>BioLegend</td><td>Cat# 104424; RRID:<a id="interref470" href="https://antibodyregistry.org/AB_493380" target="_blank">AB_493380</a></td></tr><tr><td>Rat Anti-Mouse CD8, PE</td><td>BioLegend</td><td>Cat# 100708; RRID:<a id="interref475" href="https://antibodyregistry.org/AB_312747" target="_blank">AB_312747</a></td></tr><tr><td>Rat Anti-Mouse CD4, Brilliant Violet 650</td><td>BioLegend</td><td>Cat# 100555; RRID:<a id="interref480" href="https://antibodyregistry.org/AB_2562529" target="_blank">AB_2562529</a></td></tr><tr><td>Rat Anti-Mouse F4/80, PE/Cyanine7</td><td>BioLegend</td><td>Cat# 123114; RRID:<a id="interref485" href="https://antibodyregistry.org/AB_893478" target="_blank">AB_893478</a></td></tr><tr><td>Rat Anti-Mouse Ly-6C, FITC</td><td>BioLegend</td><td>Cat# 128005; RRID:<a id="interref490" href="https://antibodyregistry.org/AB_1186134" target="_blank">AB_1186134</a></td></tr><tr><td>Rat Anti-Mouse/Human CD11b, PE</td><td>BioLegend</td><td>Cat# 101208; RRID:<a id="interref495" href="https://antibodyregistry.org/AB_312791" target="_blank">AB_312791</a></td></tr><tr><td>Rat Anti-Mouse/Human CD44, FITC</td><td>BioLegend</td><td>Cat# 103006; RRID:<a id="interref500" href="https://antibodyregistry.org/AB_312957" target="_blank">AB_312957</a></td></tr><tr><td>Mouse Anti-Human CD54 (ICAM-1), PE</td><td>BioLegend</td><td>Cat# 353106; RRID:<a id="interref505" href="https://antibodyregistry.org/AB_10897647" target="_blank">AB_10897647</a></td></tr><tr><td>Mouse Anti-Human CD102 (ICAM-2), PE</td><td>BioLegend</td><td>Cat# 328506; RRID:<a id="interref510" href="https://antibodyregistry.org/AB_2122200" target="_blank">AB_2122200</a></td></tr><tr><td>Mouse Anti-Human CD50 (ICAM-3), PE</td><td>BioLegend</td><td>Cat# 330005; RRID:<a id="interref515" href="https://antibodyregistry.org/AB_1186057" target="_blank">AB_1186057</a></td></tr><tr><td>Mouse Anti-Human CD25, APC</td><td>BD Biosciences</td><td>Cat# 340939; RRID:<a id="interref520" href="https://antibodyregistry.org/AB_400551" target="_blank">AB_400551</a></td></tr><tr><td>Mouse Anti-Human CD45RA, Pacific Blue</td><td>Beckmann</td><td>Cat# 82946; RRID:<a id="interref525" href="https://antibodyregistry.org/AB_2904200" target="_blank">AB_2904200</a></td></tr><tr><td>Mouse Anti-Human CD62L, APC</td><td>ImmunoTools</td><td>Cat# 21279626</td></tr><tr><td>Mouse Anti-Human CD69, PerCP, FITC</td><td>BioLegend</td><td>Cat# 310928; RRID:<a id="interref530" href="https://antibodyregistry.org/AB_10679124" target="_blank">AB_10679124</a><br>Cat# 310904; RRID:<a id="interref535" href="https://antibodyregistry.org/AB_314839" target="_blank">AB_314839</a></td></tr><tr><td>Mouse Anti-Human CD71, PE</td><td>BioLegend</td><td>Cat# 334106; RRID:<a id="interref540" href="https://antibodyregistry.org/AB_2201481" target="_blank">AB_2201481</a></td></tr><tr><td>Mouse Anti-Human CD107a (LAMP-1), Alexa Fluor 647</td><td>BioLegend</td><td>Cat# 328612; RRID:<a id="interref545" href="https://antibodyregistry.org/AB_1227506" target="_blank">AB_1227506</a></td></tr><tr><td>Mouse Anti-Human CD98, FITC</td><td>BioLegend</td><td>Cat# 315603; RRID:<a id="interref550" href="https://antibodyregistry.org/AB_2190795" target="_blank">AB_2190795</a></td></tr><tr><td>Mouse Anti-Human TCR V β13.1, FITC, PE/Cyanine7</td><td>BioLegend</td><td>Cat# 362404; RRID:<a id="interref555" href="https://antibodyregistry.org/AB_2564032" target="_blank">AB_2564032</a><br>Cat# 362406; RRID:<a id="interref560" href="https://antibodyregistry.org/AB_2721346" target="_blank">AB_2721346</a></td></tr><tr><td>Mouse Anti-Human TNF, APC, PE</td><td>BioLegend</td><td>Cat# 502912; RRID:<a id="interref565" href="https://antibodyregistry.org/AB_315264" target="_blank">AB_315264</a><br>Cat# 502909; RRID:<a id="interref570" href="https://antibodyregistry.org/AB_315261" target="_blank">AB_315261</a></td></tr><tr class="rowsep"><td>Blincyto (Blinatumomab)</td><td>Amgen</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Bacterial and virus strains</b></td></tr><tr><td><i>Listeria monocytogenes</i> expressing chicken Ovalbumin (AA134-387)</td><td>E. Palmer, University of Basel</td><td>N/A</td></tr><tr><td>NY-ESO-1 TCR lentiviral vector, codon optimized, pairing optimized: pRRL 131 (WT) T2A 1xATG Cys</td><td>Provided to M. Trefny from M. Hebeisen and N. Rufer, University of Lausanne</td><td>N/A</td></tr><tr class="rowsep"><td>Anti-CD19-CD28z-T2A-copGFP</td><td>Provided to M. Trefny from W. Schamel, University of Freiburg</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Biological samples</b></td></tr><tr><td>Human Peripheral Blood Buffy Coat</td><td>Blood Donation Center Basel and Lausanne, Switzerland</td><td>N/A</td></tr><tr class="rowsep"><td>Human AB+ male serum</td><td>Blood Donation Center Basel, Switzerland</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Chemicals, peptides, and recombinant proteins</b></td></tr><tr><td>BIRT377</td><td>Tocris</td><td>Tocris; Cat# 4776</td></tr><tr><td>XVA143</td><td>Roche</td><td>N/A</td></tr><tr><td>NY-ESO-1 peptide 9C: SLLMWITQC &gt;95% purity</td><td>EZ Biolabs</td><td>custom</td></tr><tr><td>Ovalbumin EndoFit</td><td>InvivoGen</td><td>Cat# vac-pova-100</td></tr><tr><td>OVA (257-264), SIINFEKL, Peptide Fragment</td><td>Eurogentec</td><td>Cat# AS- 60193</td></tr><tr><td>OVA-G4 Peptide, SIIGFEKL, OVA (257-264) Variant</td><td>Eurogentec</td><td>Cat# AS-64384</td></tr><tr><td>OVA (257-264) Variant, SIIQFERL, Q4R7</td><td>Eurogentec</td><td>custom</td></tr><tr><td>OVA-Q4H7 Peptide, pQ4H7, SIIQFEHL, OVA (257-264) Variant</td><td>Eurogentec</td><td>Cat# AS-64402</td></tr><tr><td>DAPI</td><td>Sigma Aldrich</td><td>Cat# D9542</td></tr><tr><td>Phalloidin-iFluor 555 Reagent</td><td>Abcam</td><td>Cat# ab176756</td></tr><tr><td>CellTrace Far Red Cell Proliferation Kit</td><td>ThermoFisher</td><td>Cat# C34564</td></tr><tr><td>CellTrace Violet Cell Proliferation Kit</td><td>ThermoFisher</td><td>Cat# C34557</td></tr><tr><td>CellTrace CFSE Cell Proliferation Kit</td><td>ThermoFisher</td><td>Cat# C34554</td></tr><tr><td>Mag-Fluo-4, AM, cell permeant</td><td>ThermoFisher</td><td>Cat# M14206</td></tr><tr><td>Fluo-4, AM, cell permeant</td><td>ThermoFisher</td><td>Cat# F14201</td></tr><tr><td>Fura Red, AM, cell permeant</td><td>ThermoFisher</td><td>Cat# F3021</td></tr><tr><td>Calbryte 520 AM</td><td>AAT Bioquest</td><td>Cat# 20653</td></tr><tr><td>BioTracker NucView 488 Green Caspase-3 Dye</td><td>Merck Millipore</td><td>Cat# SCT100</td></tr><tr><td>BioTracker NucView 405 Blue Caspase-3 Dye</td><td>Merck Millipore</td><td>Cat# SCT102</td></tr><tr><td>NucView 488 Caspase-3 Enzyme Substrate</td><td>Biotium</td><td>Cat# 10402</td></tr><tr><td>CellEvent Caspase-3/7 Green Detection Reagent</td><td>ThermoFisher</td><td>Cat# C10423</td></tr><tr><td>Incucyte Caspase-3/7 Dye for Apoptosis</td><td>Sartorius</td><td>Cat# 4440</td></tr><tr><td>2-NBDG</td><td>Abcam</td><td>Cat# ab235976</td></tr><tr><td>Proleukin (Aldesleukin, recombinant IL-2)</td><td>Novartis</td><td>N/A</td></tr><tr><td>Human IL-7</td><td>Mylteni Biotec</td><td>Cat# 130-095-363</td></tr><tr><td>Human IL-15</td><td>Mylteni Biotec</td><td>Cat# 310-095-765</td></tr><tr><td>Zombie UV Fixable Viability Kit</td><td>BioLegend</td><td>Cat# 423108</td></tr><tr><td>Zombie Aqua Fixable Viability Kit</td><td>BioLegend</td><td>Cat# 423102</td></tr><tr><td>Zombie Green Fixable Viability Kit</td><td>BioLegend</td><td>Cat# 423112</td></tr><tr><td>Zombie Red Fixable Viability Kit</td><td>BioLegend</td><td>Cat# 423110</td></tr><tr><td>LIVE/DEAD Fixable Blue Dead Cell Stain Kit</td><td>ThermoFisher</td><td>Cat# L34962</td></tr><tr><td>LIVE/DEAD Fixable Near-IR Stain Kit</td><td>ThermoFisher</td><td>Cat# 15519340</td></tr><tr><td>CD8 MicroBeads human</td><td>Mylteni Biotec</td><td>Cat# 130-045-201</td></tr><tr><td>CD8a (Ly-2) MicroBeads mouse</td><td>Mylteni Biotec</td><td>Cat# 130-117-044</td></tr><tr><td>LS Cloumns</td><td>Mylteni Biotec</td><td>Cat# 130-042-401</td></tr><tr><td>T cell stimulation and expansion kit</td><td>Mylteni Biotec</td><td>Cat# 130-091-441</td></tr><tr><td>Cas9</td><td>QB3 MacroLab, UC Berkeley</td><td>N/A</td></tr><tr><td>EasySep Mouse Naïve CD8+ T Cell Isolation Kit</td><td>Stem Cell Technologies</td><td>Cat# 19858</td></tr><tr><td>EasySep Mouse CD8+ T Cell Isolation Kit</td><td>Stem Cell Technologies</td><td>Cat# 19853</td></tr><tr class="rowsep"><td>EasySep Mouse CD4+ T Cell Isolation Kit</td><td>Stem Cell Technologies</td><td>Cat# 19852</td></tr><tr class="rowsep"><td colspan="3"><b>Critical commercial assays</b></td></tr><tr><td>P4 Primary Cell 4D-Nucleofector X Kit L</td><td>Lonza</td><td>Cat# V4XP-4024</td></tr><tr><td>Cell Line Nucleofector Kit V</td><td>Lonza</td><td>Cat# VCA-1003</td></tr><tr><td>ELISA MAX Deluxe Set Human IFN-γ</td><td>BioLegend</td><td>Cat# 430104</td></tr><tr><td>LEGENDplex Human Th1 Panel (5-plex)</td><td>BioLegend</td><td>Cat# 741036</td></tr><tr><td>LEGENDplex Mouse Th1 Panel (5-plex)</td><td>BioLegend</td><td>Cat# 740025</td></tr><tr><td>ProQuantumMouse Granzyme B Immunoassay Kit</td><td>Inivtrogen</td><td>Cat# A44238</td></tr><tr class="rowsep"><td>Mouse ANA (Anti-nuclear Antibody) ELISA Kit</td><td>Hoelzl Biotech</td><td>Cat# MBS7606315-96</td></tr><tr class="rowsep"><td colspan="3"><b>Experimental models: Cell lines</b></td></tr><tr><td>Jurkat, Clone E6-1</td><td>ATCC</td><td>RRID:CVCL_0367</td></tr><tr><td>HEK-293T</td><td>ATCC</td><td>RRID:CVCL_0063</td></tr><tr><td>T2</td><td>A. Zippelius, University of Basel</td><td>RRID:CVCL_2211</td></tr><tr><td>Ramos</td><td>A. Zippelius, University of Basel</td><td>RRID:CVCL:0597</td></tr><tr><td>LCL</td><td>G. Bantug, University of Basel</td><td>N/A</td></tr><tr><td>EL4</td><td>A. Zippelius, University of Basel</td><td>RRID:CVCL_0255</td></tr><tr><td>PC3-PIP</td><td>Provided to M. Irving by A. Rosato, University of Padua</td><td>N/A</td></tr><tr class="rowsep"><td>MC38-OVA</td><td>Provided to A. Marti by P. Romero, University of Lausanne</td><td>RRID_CVCL_XY96</td></tr><tr class="rowsep"><td colspan="3"><b>Experimental models: Organisms/strains</b></td></tr><tr><td>C57BL/6NRj</td><td>Animal Facility University of</td><td>N/A</td></tr><tr><td>C57BL/6NCrl</td><td>Animal Facility University of Basel, Charles River, Janvier</td><td>N/A</td></tr><tr><td>OT-I (B6.129S6-Rag2tm1Fwa Tg(TcraTcrb)1100Mjb)</td><td>Taconic, Animal Facility University of Basel</td><td>Cat# 2334; RRID:IMSR_TAC:2334</td></tr><tr><td>LFA-1 KO (B6.129S7-Itgaltm1Bll/J)</td><td>Jackson Laboratory, Animal Facility University of Basel</td><td>Cat# 005257; RRID:IMSR_JAX:005257</td></tr><tr class="rowsep"><td>NSG (NOD.Cg-Prkdc&lt;scid&gt;Il2rg&lt;tm1Wjl&gt;SzJ)</td><td>Animal Facility University of Basel and University of Lausanne</td><td>RRID:IMSR_ARC:NSG</td></tr><tr class="rowsep"><td colspan="3"><b>Oligonucleotides</b></td></tr><tr><td>Hs.Cas9.ITGAL.1.AA (TGCCCGACTGGCACTGATAG)</td><td>Integrated DNA Technologies IDT</td><td>N/A</td></tr><tr><td>Mm.Cas9.ITGAL.1.AB (CACATAGTTGATGGCACGAA)</td><td>Integrated DNA Technologies IDT</td><td>N/A</td></tr><tr><td>CRISPR-Cas9 Negative Control crRNA #1</td><td>Integrated DNA Technologies IDT</td><td>Cat# 224163224</td></tr><tr class="rowsep"><td>Alt-R CRISPR-Cas9 tracrRNA</td><td>Integrated DNA Technologies IDT</td><td>Cat# 222427350</td></tr><tr class="rowsep"><td colspan="3"><b>Software and algorithms</b></td></tr><tr><td>FlowJo</td><td>BD Biosciences</td><td><a id="intref0010" href="https://www.flowjo.com/" target="_blank">https://www.flowjo.com/</a></td></tr><tr><td>GraphPad Prism</td><td>GraphPad Software</td><td><a id="intref0015" href="https://www.graphpad.com/scientific-%20software/prism/" target="_blank">https://www.graphpad.com/scientific- software/prism/</a></td></tr><tr><td>ImageLab</td><td>Biorad</td><td><a id="intref0020" href="https://www.bio-rad.com/" target="_blank">https://www.bio-rad.com/</a></td></tr><tr><td>FiJi</td><td>National Institute of Health</td><td><a id="intref0025" href="https://imagej.net/software/fiji/" target="_blank">https://imagej.net/software/fiji/</a></td></tr><tr><td>Huygens - Huygens Remote Manager - Deconvolution</td><td>N/A</td><td><a id="intref0030" href="https://www.huygens-rm.org/wp/" target="_blank">https://www.huygens-rm.org/wp/</a></td></tr><tr><td>OMERO - The Open Microscopy Environment</td><td>OME</td><td><a id="intref0035" href="https://www.openmicroscopy.org/" target="_blank">https://www.openmicroscopy.org/</a></td></tr><tr><td>Imaris</td><td>Bitplane</td><td><a id="intref0040" href="https://imaris.oxinst.com/" target="_blank">https://imaris.oxinst.com/</a></td></tr><tr class="rowsep"><td>BioRender</td><td>N/A</td><td><a id="intref0045" href="https://biorender.com/" target="_blank">https://biorender.com/</a></td></tr><tr class="rowsep"><td colspan="3"><b>Other</b></td></tr><tr><td>AIN-76A Rodent Diet</td><td>Research Diets, Inc.</td><td>Cat# D1001</td></tr><tr><td>AIN-76A Rodent Diet Without Added Magnesium</td><td>Research Diets, Inc.</td><td>Cat# D16601</td></tr></tbody></table></div><figcaption><div class="core-table-tools"><ul><li><a class="core-table-show-action" href="/action/showFullTableHTML?isHtml=true&amp;tableId=undtbl1&amp;pii=S0092-8674%2821%2901561-0" target="_blank">Open table in a new tab</a></li></ul></div></figcaption></figure></div></div></section><section id="sec-4-2"><h3>Resource availability</h3><section id="sec-4-2-1"><h4>Lead contact</h4><div id="p0120" role="paragraph">Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Christoph Hess (<a id="intref0050" href="mailto:ch818@cam.ac.uk">ch818@cam.ac.uk</a>, or <a id="intref0055" href="mailto:chess@uhbs.ch">chess@uhbs.ch</a>).</div></section><section id="sec-4-2-2"><h4>Material availability</h4><div id="p0125" role="paragraph">This study did not generate new unique reagents.</div></section></section><section id="sec-4-3"><h3>Experimental models and subject details</h3><section id="sec-4-3-1"><h4>Cell lines</h4><div id="p0130" role="paragraph">Primary T&nbsp;cells were obtained from Buffy coats of healthy donors (Blood donor center, University Hospital Basel or Blood donor center Lausanne). Jurkat T&nbsp;cells (Clone E61, TIB-152) and HEK-293T were originally purchased from ATCC. T2, Ramos and EL4 cells were kindly provided by A. Zippelius (University of Basel). MC38-OVA cells were provided to A.M.L. by P. Romero (University of Lausanne). PC3-PIP cell lines were provided to M.I. by A. Rosato (University of Padua, Padova). Lymphoblastoid cell lines (LCLs) were provided by G. Bantug (University of Basel).</div><div id="p0135" role="paragraph">For the culture of primary human CD8<sup>+</sup> T&nbsp;cells, PHA-induced T&nbsp;cell blasts, Jurkat T&nbsp;cells, PC3-PIP, Ramos, LCL and T2 cells, RPMI-1640 medium (Invitrogen) was supplemented with heat-inactivated 10% fetal calf serum (HI FCS, Gibco), 50&nbsp;U mL<sup>-1</sup> penicillin (Invitrogen) and 50&nbsp;μg mL<sup>-1</sup> streptomycin (Invitrogen). Human REP T&nbsp;cells were expanded in AIM V medium (ThermoFisher) mixed 1:1 with RPMI-1640 (Invitrogen) supplemented with 10% human HI AB serum, 50&nbsp;U mL<sup>-1</sup> penicillin (Invitrogen) and 50&nbsp;μg mL<sup>-1</sup> streptomycin, 1&nbsp;mM pyruvate (Gibco), 1% MEM Non-Essential Amino Acids (Gibco), 1% GlutaMAX (Gibco) and 3,000&nbsp;U mL<sup>-1</sup> human recombinant IL-2 (Proleukin, Novartis). Murine T&nbsp;cells und EL4 cells were kept in RPMI-1640 medium containing 10% HI FCS, 100&nbsp;U mL<sup>-1</sup> penicillin, 100&nbsp;μg streptomycin, 0.29&nbsp;mg mL<sup>-1</sup> L-glutamine, 50&nbsp;μM 2-Mercaptoethanol (Invitrogen). 293T human embryonic kidney (HEK-293T) were cultured in RPMI-1640 supplemented with 10% HI FCS, 2&nbsp;mmol l-glutamine, 100&nbsp;μg mL<sup>-1</sup> penicillin and 100&nbsp;U mL<sup>-1</sup> streptomycin (all purchased from Invitrogen). MC38-OVA cells were maintained in RPMI-1640-Glutamax medium supplemented with 10% FCS, 50&nbsp;U mL<sup>-1</sup> penicillin and 50&nbsp;μg mL<sup>-1</sup> streptomycin, 1&nbsp;mM sodium pyruvate, 50&nbsp;μM 2-Mercaptoethanol and under geneticin selection (0.4&nbsp;mg mL<sup>-1</sup> G418). All reagents were purchased from Gibco. Magnesium-free medium was made in-house, using double distilled water supplemented according to manufacturer’s instruction with RPMI-1640 amino acid solution (Sigma Aldrich), RPMI-1640 vitamin solution (Sigma Aldrich), 1% GlutaMAX (Gibco), 25&nbsp;mM HEPES (Gibco), 2&nbsp;g L<sup>-1</sup> sodium bicarbonate (Sigma Aldrich), 2g L<sup>-1</sup> glucose (Sigma Aldrich), 100&nbsp;mg L<sup>-1</sup> calcium nitrate (Sigma Aldrich), 400&nbsp;mg L<sup>-1</sup> potassium chloride (Sigma Aldrich), 6&nbsp;g L<sup>-1</sup> sodium chloride (Sigma Aldrich), 800&nbsp;mg L<sup>-1</sup> sodium phosphate dibasic (Sigma Aldrich), 1&nbsp;mg L<sup>-1</sup> Glutathion (Sigma Aldrich), 50&nbsp;U m<sup>-1</sup> penicillin and 50&nbsp;μg mL<sup>-1</sup> streptomycin and 10% HI dialyzed FCS (dFCS, Gibco). For functional readouts, the medium was either supplemented, as indicated, with 1.2&nbsp;mM MgCl<sub>2</sub> or 0.05&nbsp;mM MnCl<sub>2</sub> or left untreated (=0&nbsp;mM Mg<sup>2+</sup>). Cells of every condition were washed initially twice in magnesium-free medium prior to any functional read out. Low background Mg<sup>2+</sup> values in <i>self-made</i> medium was verified by ICP-MS (data not shown).</div></section><section id="sec-4-3-2"><h4>Mice</h4><div id="p0140" role="paragraph">Information on sex and age of the mice used in each experimental setting can be found in the corresponding section. C57BL/6NRj, C57BL/6NCrl and NOD.Cg-Prkdc&lt;scid&gt;Il2rg&lt;tm1Wjl&gt;SzJ (NSG) mice were bred and housed at specific pathogen free (SPF) conditions at the Universities of Basel or Lausanne. MHC class I-restricted OVA-specific T&nbsp;cell receptor (B6.129S6-Rag2tm1Fwa Tg(TcraTcrb)1100Mjb) (OT-I) transgenic, B6.129S7-Itgaltm1Bll/J (LFA-1 KO) were originally purchased from Taconic (OT-I) or Jackson Laboratories (LFA-1 KO), and thereafter bred and housed at SPF conditions at the University of Basel. For some experiments, C57BL/6NCrl were purchased from Charles River as well as Janvier, and maintained at SPF conditions and acclimatized for 1&nbsp;week prior to experiments at the animal facilities of the Universities of Geneva or Basel, respectively. Anti-CD19 CAR T&nbsp;cell experiments were conducted with NSG mice at the University of Basel. Anti-PSMA CAR T&nbsp;cell experiments were conducted with NSG mice which were bred and housed in a specific and opportunistic pathogen-free animal facility in the Oncology Department of the University of Lausanne. All experiments were conducted in accordance to the Swiss Federal Veterinary Office guidelines and were approved by the Cantonal Veterinary Office (Canton of Basel-Stadt, Vaud and Geneva). All cages provided free access to food and water. During experimentation, all animals were monitored at least every other day for signs of distress and, if required, body weight was measured three times a week. Mice were sacrificed at the endpoint by carbon dioxide overdose.</div></section><section id="sec-4-3-3"><h4>Human data</h4><div id="p0145" role="paragraph">The retrospective analysis of B cell lymphoma cohort treated with Axicabtagene ciloleucel (Axi-cel) was approved by the Institutional Review Board of MD Anderson Cancer Center and conducted in accordance with institutional guidelines and the principles of the Declaration of Helsinki. All included patients provided written informed consent. The SAKK16/14 trial (NCT02572843) was conducted in accordance with the principles of the Declaration of Helsinki. The protocol was approved by the ethics committee of each participating site. Written informed consent was obtained from all patients.</div></section></section><section id="sec-4-4"><h3>Method details</h3><section id="sec-4-4-1"><h4>Chemicals</h4><div id="p0150" role="paragraph">LFA-1 inhibitor studies were performed using BIRT377 (Tocris) and XVA143 (Roche). Both inhibitors were used at 10&nbsp;μM. TCR independent activation of T&nbsp;cells were conducted with PMA (50&nbsp;ng mL<sup>-1</sup>; Sigma Aldrich) and ionomycin (1&nbsp;μg mL<sup>-1</sup>; Sigma Aldrich). All chemicals were aliquoted in DMSO and stored at -20°C until further use.</div></section><section id="sec-4-4-2"><h4>Flow cytometry</h4><div id="p0155" role="paragraph">Either a BD Fortessa LSR II (BD Bioscience), Cytek Aurora (Cytek Biosciences) or Cytoflex S (Beckmann) flow cytometer were used for flow cytometry. For analysis of surface markers, T&nbsp;cells were harvested at indicated time points after activation <i>in&nbsp;vitro</i>, washed once in cold PBS and, if required, stained with Fixable Viability Dyes for 15&nbsp;min at 4°C. Surface markers were stained with appropriate antibodies for 20&nbsp;min at 4°C. For stainings of cell suspension from murine organs, cells were additionally pre-incubated with anti-mouse Fc block 10&nbsp;μg mL<sup>-1</sup> (anti-CD16/CD32, BioXCell). For intracellular TNF staining, cells were activated for 4 h. During the final 2&nbsp;h of activation, cells were treated either with brefeldin A solution (BioLegend) to block cytokine secretion. Cells were then washed and fixed for 20&nbsp;min at RT (fixation/permeabilization solution, BD Biosciences) and washed with permeabilization buffer (BD Biosciences) prior to staining for 45&nbsp;min and further washing before acquisition. For analysis of protein phosphorylation, T&nbsp;cells were stimulated as indicated and stained as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref28" href="#" role="doc-biblioref" data-xml-rid="bib28" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref28" aria-controls="sref28">Krutzik and Nolan, 2003</a><div class="dropBlock__holder" data-db-target-of="sref28"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">28.</div><div>Krutzik, P.O. ∙ Nolan, G.P.</div><div><strong>Intracellular phospho-protein staining techniques for flow cytometry: Monitoring single cell signaling events</strong></div><div><em>Cytometry A.</em> 2003; <strong>55</strong>:61-70</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/cyto.a.10072" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0346244001" target="_blank" aria-label="Open Scopus in new tab">Scopus (473)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/14505311/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fcyto.a.10072&amp;pmid=14505311" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, for assessment of phosphorylation of ERK1/2, c-Jun and FAK, T&nbsp;cells were activated for 45&nbsp;min either by CD3/28 Ab, antigen-pulsed target cells or PMA/Ionomycin. Cells were fixed by adding 8% Paraformaldehyde (PFA) (Thermo Fisher) directly into the culture medium to obtain a final concentration of 4% PFA. Cells were incubated for 15&nbsp;min at RT, washed with FACS buffer, followed by permeabilization with ice cold methanol at 4°C for 5&nbsp;min. After washing with FACS buffer, cells were stained at room temperature for 30&nbsp;min, washed and acquired. For evaluation of activation-induced LFA-1 conformation, T&nbsp;cells were cultured in respective medium for 45&nbsp;min ± activation (CD3/28 Ab or antigen-pulsed target cells). For probing of open headpiece anti-human CD11a/CD18 (clone m24) was directly added to the medium and incubated for 15&nbsp;min at 37°C followed by incubation on ice for 20&nbsp;min. Cells were then washed twice in FACS Buffer and fixed in 2% PFA, incubated at room temperature for 20&nbsp;min and washed with FACS Buffer before acquisition. For assessment of LFA-1 extension, the anti-human CD18 (clone KIM127) was used. The cells were activated for 45&nbsp;min, fixed directly in medium with PFA at a final concentration of 2%, washed and then incubated with KIM127. For 2-NBDG uptake assays, previously activated T&nbsp;cells were co-incubated for last 45&nbsp;min of experiment directly with a final concentration of 20&nbsp;μM 2-NBDG (Abcam). Cells were washed twice in FACS buffer before acquisition. The following antibodies were used:</div><section id="sec-4-4-2-1"><h5>Human <i>in&nbsp;vitro</i> activation</h5><div id="p0160" role="paragraph">CD11a (FITC, BioLegend), CD18 (PE, BioLegend), CD25 (APC, BD Biosciences), CD45RA (Pacific Blue, Beckmann), CD62L (APC, Immuno Tools), CD69 (PerCP, FITC, BioLegend), CD71 (PE, BioLegend), CD107a (AF647 and PE-Cy7, both BioLegend), CD98 (FITC, BD Bioscience and BioLegend), ICAM-1 (PE, BioLegend), ICAM-2 (PE, BioLegend), ICAM-3 (PE, BioLegend), m24 epitope LFA-1 (PE, BioLegend), phospho-c-Jun (Ser<sub>73</sub>, unlabeled, Cell Signaling Technology), phospho-ERK1/2 (Thr<sub>202</sub>/Thr<sub>204</sub>, AF647, BioLegend), phospho-FAK (Tyr<sub>397</sub>, unlabeled, Thermo Fisher), goat anti-rabbit IgG (AF488, Thermo Fisher), goat anti-mouse IgG1 (AF488, ThermoFisher), TCR V β13.1 (FITC and PE-Cy7, BioLegend), TNF (PE, APC, BioLegend), Viability Dye (Aqua Zombie, BioLegend; Zombie Green, BioLegend).</div></section><section id="sec-4-4-2-2"><h5>Murine <i>in&nbsp;vitro</i> activation</h5><div id="p0165" role="paragraph">CD11a (FITC, BioLegend), LFA-1 (BV421, BioLegend), CD8a (FITC, BioLegend), CD69 (APC, BioLegend), CD107a (PE-Cy7, BioLegend), phospho-ERK1/2 (Thr<sub>202</sub>/Thr<sub>204</sub>, AF647, BioLegend), phospho-FAK (Tyr<sub>397</sub>, unlabeled, Thermo Fisher), goat anti-rabbit IgG (AF488, Thermo Fisher), Viability Dye (Aqua Zombie, BioLegend).</div></section><section id="sec-4-4-2-3"><h5>Murine immune cell subset characterization in&nbsp;vivo (comprising 3 individual stainings)</h5><div id="p0170" role="paragraph">CD4 (BV650, BioLegend), CD8 (PE, BioLegend), CD11a (PE/Cy7, BioLegend), CD11b (PE, BioLegend), CD11c (BV650, BioLegend), CD19 (PE/Cy5, BioLegend), CD44 (FITC, BioLegend), CD62L (PB, BioLegend), CD69 (PE/Cy5, BioLegend), CD80 (FITC, BioLegend), F4/80 (PE/Cy7, BioLegend), Gr-1 (BV510, BioLegend), Ly6-C (FITC, BioLegend), NK1.1 (APC, BioLegend), TCR γ/δ (PE, BioLegend), LIVE/DEAD Fixable Near-IR (ThermoFisher)</div></section><section id="sec-4-4-2-4"><h5>Polyclonal CD8 T&nbsp;cell activation <i>in&nbsp;vivo</i> with anti-CD3ε <i>F</i>(ab′)2 fragment</h5><div id="p0175" role="paragraph">CD4 (R718, BD Bioscience), CD8 (BUV805, BD Bioscience), CD45 (APC-Cy7, BioLegend), CD69 (BV650, BioLegend), TCRβ (BV711, BioLegend), LIVE/DEAD Fixable Blue Dead Cell Stain Kit (Thermo Fisher).</div></section><section id="sec-4-4-2-5"><h5>Murine peritonitis model</h5><div id="p0180" role="paragraph">CD8 (FITC, BioLegend), CD11b (PE-Cy5, BioLegend), CD11c (PE-Cy5, BioLegend), CD69 (APC, BioLegend), CD107a (PE/Cy7, BioLegend), B220 (PE-Cy5, BioLegend), F4/80 (PE-Cy5, BioLegend), Tetramer H-2 Kb OVA (PE, Tetramer core facility, University of Lausanne), Viability Dye (Zombie Red, BioLegend,).</div></section><section id="sec-4-4-2-6"><h5>MC38-OVA tumor model</h5><div id="p0185" role="paragraph">CD3 (BUV805, BD Biosciences), CD4 (BUV496, BD Biosciences), CD8 (eFluor450, eBioscience), CD11b (APC-Cy7, BioLegend), CD11c (FITC, BioLegend), CD19 (BB515, BD Biosciences), CD25 (PE-Cy5.5, eBioscience), CD45 (BUV385, BD Biosciences), CD80 (BV605, BioLegend), CD103 (BV650, BD Biosciences), CD206 (BV711, BioLegend), CXCR3 (BUV737, BD Biosciences), F4/80 (AF647, BioLegend), FoxP3 (APC, eBioscience), GzmB (PE-eFluor610, Inivtrogen), Ki67 (AF532, eBioscience), LFA-1 (SB436, Thermo Fisher), Ly-6G (BUV563, BD Biosciences), Ly-6c (PerCP, BioLegend), MHCII (BV510, BioLegend), NKp46 (BUV563, BD Biosciences), PD-1 (BV785, BioLegend), PD-L1 (BV421, BioLegend), TCF-7 (AF700, R&amp;D Systems), Tim-3 (BB700, BD Biosciences), Zombie UV Fixable Viability Kit (BioLegend).</div></section></section><section id="sec-4-4-3"><h4>Human naïve and memory T&nbsp;cell isolation</h4><div id="p0190" role="paragraph">Blood samples were obtained from healthy male and female donors (18–65 years old) as buffy coats after written informed consent (Blood donor center, University Hospital Basel). Peripheral blood mononuclear cells (PBMCs) were isolated by standard density-gradient centrifugation protocols (Lymphoprep; Fresenius Kabi). MACS beads and LS columns (both Milteny Biotec) were used to sort CD8<sup>+</sup> positive T&nbsp;cells. The positively selected CD8<sup>+</sup> T&nbsp;cells were incubated with APC anti-CD62L mAb (ImmunoTools) and Pacific Blue anti-CD45RA (Beckman Coulter). Naïve and EM CD8<sup>+</sup> T&nbsp;cells were identified as CD62L<sup>+</sup> CD45RA<sup>+</sup> and CD62L<sup>–</sup> CD45RA<sup>–</sup> populations, respectively. Cell sorting was performed using a BD FACSAria III or BD influx cell sorter (BD Bioscience). Cells were rested for 24&nbsp;h at 37°C prior to further experiments.</div></section><section id="sec-4-4-4"><h4>Metabolic assays</h4><div id="p0195" role="paragraph">A Seahorse XF-96e extracellular flux analyzer (Seahorse Bioscience, Agilent) was used to determine the metabolic profile of cells. T&nbsp;cells were plated (2×10<sup>5</sup> cells/well) onto Celltak (Corning, USA) coated cell plates. Experiments were carried out in unbuffered, serum- and Mg<sup>2+</sup>-free <i>self-made</i> medium. Medium was reconstituted with 1.2&nbsp;mM MgCl<sub>2</sub> or 0.05 mM MnCl<sub>2</sub> as indicated in individual experiments. Reconstitution of cations was either present from beginning of experiment or applied onto plated cells via the instrument’s multi-injection port. All following concentration represent final well concentrations of indicated substance. Human T&nbsp;cells were activated by injection anti-CD3 Ab (1&nbsp;μg mL<sup>-1</sup>) and anti-CD28 Ab (10&nbsp;μg mL<sup>-1</sup>). Murine T&nbsp;cells were activated by injection anti-CD3 Ab (5&nbsp;μg mL<sup>-1</sup>) and anti-CD28 Ab (2.5&nbsp;μg mL<sup>-1</sup>). Glycolytic activity was quantified by subtracting maximal ECAR from baseline ECAR-measurements. Mitochondrial perturbation experiments were carried out by sequential addition of oligomycin (1&nbsp;μM, Sigma Aldrich), FCCP (2&nbsp;μM, Carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone, Sigma Aldrich), and rotenone (1&nbsp;μM, Sigma Aldrich). Glycolysis stress test was performed in medium as described above but devoid of glucose. Sequential injections of glucose (10&nbsp;mM, Sigma Aldrich), oligomycin (1&nbsp;μM) and 2-deoxy-glucose (50&nbsp;mM, Sigma Aldrich). Oxygen consumption rates (OCR, pmol/min) and extracellular acidification rates (ECAR, mpH/min) were monitored in real time after injection of each compound.</div></section><section id="sec-4-4-5"><h4>Flow cytometry-based Mg<sup>2+</sup> and Ca<sup>2+</sup> flux assay</h4><div id="p0200" role="paragraph">Naïve and EM CD8<sup>+</sup> T&nbsp;cells were washed and incubated in Mg<sup>2+</sup> or Ca<sup>2+</sup> free medium for 1 h, followed by loading with MagFluo4 (Thermo Fisher) or Fluo4 (Thermo Fisher) and FuraRed (Thermo Fisher) at a final concentration of 2&nbsp;μM, in Mg<sup>2+</sup>- or Ca<sup>2+</sup>-free Dulbecco's phosphate-buffered saline (DPBS, Thermo Fisher) for 30&nbsp;min at 37°C. The cells were washed twice in DPBS, and 0.5–1×10<sup>6</sup> cells were acquired using an AccuriC6 flow cytometer (Becton Dickinson). The buffer was reconstituted with 3&nbsp;mM MgCl<sub>2</sub> or 3&nbsp;mM CaCl<sub>2</sub> at the indicated time points.</div></section><section id="sec-4-4-6"><h4>Generation of human T&nbsp;cell blasts (PHA blasts)</h4><div id="p0205" role="paragraph">PBMCs were obtained as described above and activated with 10&nbsp;μg mL<sup>-1</sup> Phytohaemagglutinin (PHA, Thermo Fisher) and 300&nbsp;U mL<sup>-1</sup> human recombinant IL-2 (Proleukin, Novartis). PHA blasts were expanded by adding fresh IL-2 every 3-4&nbsp;days.</div></section><section id="sec-4-4-7"><h4><i>In&nbsp;vitro</i> activation primary human T&nbsp;cells and PHA blasts</h4><div id="p0210" role="paragraph">Unless stated otherwise, human EM CD8<sup>+</sup> T&nbsp;cells and PHA blasts were activated in presence of plate-bound anti-CD3 Ab (HIT3a, BioLegend) at 1&nbsp;μg mL<sup>-1</sup> and soluble anti-CD28 Ab (CD28.2, BioLegend) at 5&nbsp;μg mL<sup>-1</sup>. Naïve CD8<sup>+</sup> T&nbsp;cells were activated with in-house generated anti-CD3/anti-CD28 coated microbeads. Polybead microspheres (4.5&nbsp;mm, Polyscience Eppenheim) were incubated with 1&nbsp;μg anti-CD3 Ab and 10&nbsp;μg anti-CD28 Ab. T&nbsp;cells were plated at 2×10<sup>5</sup> cells per well in flat bottom 96 well plates (Greiner Bio One) in self-made medium supplemented with 10% dFCS and indicated supplementation of cations or LFA-1 inhibitor. For analysis of surface markers, primary human T&nbsp;cells were activated for 24 h, PHA blasts for 4 h. For phospho-flow and LFA-1 conformational states, T&nbsp;cells were activated for 45&nbsp;min. When using inhibitory or activating antibodies or chemical LFA-1 inhibitors, T&nbsp;cells were pre-incubated with respective treatment for 20&nbsp;min before activation.</div></section><section id="sec-4-4-8"><h4>Venn diagram</h4><div id="p0215" role="paragraph">Venn diagram visualizes the following gene lists: metal ion binding (GO:0046872), leukocyte cell-cell adhesion (GO:0007159), immunological synapse (GO:0001772) and differentially expressed protein between naïve and memory CD8<sup>+</sup> T&nbsp;cells (memory&gt;naïve) (<span class="dropBlock reference-citations"><a id="body-ref-sref67-2" href="#" role="doc-biblioref" data-xml-rid="bib67" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref67-2" aria-controls="sref67-2">van Aalderen et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref67-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>van Aalderen, M.C. ∙ van den Biggelaar, M. ∙ Remmerswaal, E.B.M. ...</div><div><strong>Label-free analysis of CD8+ T&nbsp;cell subset proteomes supports a progressive differentiation model of human-virus-specific T&nbsp;cells</strong></div><div><em>Cell Rep.</em> 2017; <strong>19</strong>:1068-1079</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.celrep.2017.04.014&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.celrep.2017.04.014&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85018956495" target="_blank" aria-label="Open Scopus in new tab">Scopus (22)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28467900/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2017.04.014&amp;pmid=28467900" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Venn diagram was made with InteractiVenn online tool (<span class="dropBlock reference-citations"><a id="body-ref-sref22" href="#" role="doc-biblioref" data-xml-rid="bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22" aria-controls="sref22">Heberle et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref22"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Heberle, H. ∙ Meirelles, G.V. ∙ da Silva, F.R. ...</div><div><strong>InteractiVenn: A web-based tool for the analysis of sets through Venn diagrams</strong></div><div><em>BMC Bioinformatics.</em> 2015; <strong>16</strong>:169</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s12859-015-0611-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84929463087" target="_blank" aria-label="Open Scopus in new tab">Scopus (1457)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25994840/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs12859-015-0611-3&amp;pmid=25994840" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-4-9"><h4>ICAM blockade</h4><div id="p0220" role="paragraph">PHA blasts were pre-incubated with respective anti-ICAM or isotype control antibody (anti-ICAM-1, clone <i>HA58</i><i>;</i> anti-ICAM-2, clone <i>CBR-IC2/2</i><i>;</i> anti-ICAM-3 clone <i>CBR-IC3/1</i> and matching isotype control, all from Thermo Fisher) at a concentration of 10&nbsp;μg mL<sup>-1</sup> for 20&nbsp;min at room temperature prior to activation.</div></section><section id="sec-4-4-10"><h4>NY-ESO peptides</h4><div id="p0225" role="paragraph">NY-ESO-9c peptide (SLLMWITQC) was purchased in &gt;95% purity from EZ Biolabs. Lyophilized peptides were resuspended at 10&nbsp;mM in sterile dimethyl sulfoxide (DMSO) and stored at -20°C until further use.</div></section><section id="sec-4-4-11"><h4>T cell receptor construct for REP T&nbsp;cells</h4><div id="p0230" role="paragraph">The lentiviral construct encoding for the codon-optimized WT LAU155 NY-ESO-1 T&nbsp;cell receptor α and β chains under an hPGK promotor separated by an IRES domain was kindly provided to M.P.T. by M. Hebeisen and N. Rufer at the University of Lausanne (<span class="dropBlock reference-citations"><a id="body-ref-sref21" href="#" role="doc-biblioref" data-xml-rid="bib21" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref21" aria-controls="sref21">Hebeisen et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref21"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">21.</div><div>Hebeisen, M. ∙ Oberle, S.G. ∙ Presotto, D. ...</div><div><strong>Molecular insights for optimizing T&nbsp;cell receptor specificity against cancer</strong></div><div><em>Front. Immunol.</em> 2013; <strong>4</strong>:154</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3389/fimmu.2013.00154" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84883790660" target="_blank" aria-label="Open Scopus in new tab">Scopus (32)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23801991/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3389%2Ffimmu.2013.00154&amp;pmid=23801991" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>; <span class="dropBlock reference-citations"><a id="body-ref-sref55" href="#" role="doc-biblioref" data-xml-rid="bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55" aria-controls="sref55">Schmid et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref55"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Schmid, D.A. ∙ Irving, M.B. ∙ Posevitz, V. ...</div><div><strong>Evidence for a TCR affinity threshold delimiting maximal CD8 T&nbsp;cell function</strong></div><div><em>J.&nbsp;Immunol.</em> 2010; <strong>184</strong>:4936-4946</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.1000173" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-77954472387" target="_blank" aria-label="Open Scopus in new tab">Scopus (172)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20351194/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.1000173&amp;pmid=20351194" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This TCR has a K<sub>D</sub>=21.4&nbsp;μM for its endogenous NY-ESO-1 SLLMWITQC peptide.</div></section><section id="sec-4-4-12"><h4>Generation of lentivirus for REP T&nbsp;cells</h4><div id="p0235" role="paragraph">To generate lentivirus, 2.5×10<sup>6</sup> low passage HEK293T cells were cultured in DMEM medium (Thermo Fisher) and seeded into a 15&nbsp;cm tissue-culture treated dish. After 3&nbsp;days, 2<sup>nd</sup> generation LTR-containing donor plasmid, packaging plasmid pCMV-delta8.9 and the envelope plasmid VSV-G were mixed at a 4:2:1 ratio in non-supplemented Opti-MEM (Thermo Fisher) and sterile filtered. This solution was then mixed with polyethyleneimine 25&nbsp;kDa (Polysciences Inc.), also diluted in Opti-MEM at a DNA:PEI ratio of 1:3. 28&nbsp;μg of DNA was transfected per 15&nbsp;cm dish. After 2&nbsp;days, supernatants were collected from cells (exchange medium) and filtered through a 0.45&nbsp;μm PES filter. Supernatants were stored for 1&nbsp;day at 4°C until the second batch of supernatant was collected 24&nbsp;h later. The supernatant containing lentiviral particles was concentrated by ultra-centrifugation at 40,000 x g for 2&nbsp;h at 4°C, resuspended in 0.1% BSA in PBS, and frozen to -80°C until further use.</div></section><section id="sec-4-4-13"><h4>Transduction of human T&nbsp;cells for REP T&nbsp;cell production</h4><div id="p0240" role="paragraph">To generate NY-ESO-1 TCR specific T&nbsp;cells, human healthy donor PBMC were thawed and washed in PBS. CD8<sup>+</sup> T&nbsp;cells were then isolated using the CD8<sup>+</sup> microbeads (Miltenyi) according to the manufacturer’s instructions on an AutoMACS (Myltenyi). Isolated cells were washed and resuspended in medium supplemented with 150&nbsp;U mL<sup>-1</sup> IL-2 and plated at 1.5 mio mL<sup>-1</sup>. CD8<sup>+</sup> T&nbsp;cells were then activated at a 1:1 ratio with activation beads from T&nbsp;cell activation and expansion kit (Miltenyi) according to manufacturer’s instructions. 24&nbsp;h later, NY-ESO-1 TCR lentiviral particles, produced as described above, were added at a multiplicity of infection (MOI) of 2. Cells were then expanded every 2&nbsp;days with fresh medium and replenishing 50&nbsp;UmL<sup>-1</sup> IL-2 for 5&nbsp;days. NY-ESO-1 TCR positive T&nbsp;cells were sorted using a FACSAria III or FACS SorpAria (BD) and re-stimulated with NY-ESO-9c peptide. A cell density of 0.5–2×10<sup>6</sup> cells mL<sup>-1</sup> was maintained for expansion and 3,000&nbsp;U mL<sup>-1</sup> IL-2 replaced ever third day. After 1&nbsp;week of expansion, cells were either stored in liquid nitrogen or further expanded and subsequently used for functional read outs as described below.</div></section><section id="sec-4-4-14"><h4>REP T&nbsp;cells: Activation <i>in&nbsp;vitro</i> and cytotoxicity assays</h4><div id="p0245" role="paragraph">REP T&nbsp;cells were incubated with T2 target cells in flat bottom 96 well-plate at a 1:1 ratio (4-6×10<sup>4</sup> each). In order to distinguish the different cell populations, REP T&nbsp;cells were labeled with CTV and T2 target cells with carboxyfluorescein diacetate succinimydyl ester (CFSE, Invitrogen) or CFTR (Invitrogen). Prior to co-incubation, T2 target cells were pulsed with NY-ESO-9c peptide at 10<sup>-8</sup> M for 30&nbsp;min in magnesium-free medium before being washed and re-suspended with REP T&nbsp;cells in magnesium-free medium supplemented with 10% dFCS at indicated cation or LFA-1 inhibitor concentration. For all co-incubation experiments, cells were allowed to sediment without centrifugation. For analysis of protein phosphorylation, co-incubation was terminated after 25&nbsp;min as described above. In these experiments, Mn<sup>2+</sup> concentration was 0.5&nbsp;mM instead of 0.05&nbsp;mM as in all other experiments. For degranulation assays, an anti-CD107a-AF647 Ab was added directly into culture medium throughout the entire co-incubation. After 4 h, cells were harvested, washed in cold FACS Buffer and gently fixed with PFA 2% for 15&nbsp;min at room temperature. Cytotoxicity was examined with NucView 488 fluorogenic caspase-3 substrate (Biotium). Fluorogenic caspase substrate was added to wells at the beginning of co-incubation at final concentration of 1&nbsp;μM. After 45&nbsp;min, cells were washed in FACS Buffer and gently fixed with PFA 2% for 15&nbsp;min at room temperature.</div></section><section id="sec-4-4-15"><h4>Imaging of immune synapse with confocal microscopy</h4><div id="p0250" role="paragraph">Pictures from immunofluorescence imaging were recorded on a Nikon Ti with a Yokogawa CSU-W2 spinning disk module on a Photometrics 95B (22&nbsp;mm back-illuminated sCMOS) camera. A Nikon CFI Apo Lambda 60x objective or Nikon CFI Apo TIRF NA 1.49 100x objective was used with 1.515 oil mounted samples. Diode-pumped solid-state lasers at 405, 488, 561, and 647nm were used together with filters for DAPI (ET460/50nm), AF488 (ET525/50nm), AF555 (ET630/75nm) and AF647 (ET700/75nm) with a Quad BS Dichroic mirror. If required, raw nd2 format image stacks were deconvoluted using Huygens using a theoretical point spread function classical maximum likelihood estimation using 100 iterations and a quality stop criterion of 0.05.</div></section><section id="sec-4-4-16"><h4>Immunofluorescent staining of immune synapse components of REP T&nbsp;cell/T2 cell conjugates</h4><div id="p0255" role="paragraph">REP T&nbsp;cells and T2 target cells were individually labeled with CTV or CFSE. T2 cells were loaded with 10<sup>-7</sup> M NY-ESO-9c peptide for 30&nbsp;min. T2 and REP T&nbsp;cells were washed three times in serum- and Mg<sup>2+</sup>-free medium, mixed 1:1 and resuspended to a final concentration of 2.5×10<sup>6</sup> cells mL<sup>-1</sup>. Cell suspension was incubated 5&nbsp;min at RT, before aliquoting in 50&nbsp;μl onto glass multi-well slides (Thermo Fisher) and incubating for indicated time. Cell conjugates were fixed for 20&nbsp;min at RT in 4% methanol-free PFA (Sigma Aldrich), permeabilized with 0.1% Triton-X100 (Sigma Aldrich) in PBS for 5&nbsp;min and quenched with 50&nbsp;mM Glycine (Sigma Aldrich) in PBS for 20&nbsp;min. Fixation was followed by blocking in 1% bovine serum albumin (Sigma Aldrich) in PBS (blocking buffer) for 45&nbsp;min at 4°C. Primary antibodies were then incubated in the same blocking buffer for 1&nbsp;h at RT or overnight at 4°C. Samples were then washed four times with blocking buffer, followed by incubation with secondary antibodies in blocking buffer at room temperature for 1 h. Slides were then mounted with Prolong Diamond Antifade Mountant (Thermo Fisher) and analyzed after 24&nbsp;h of curing. Of note, for visualization of LFA-1 with open head-piece, m24 antibody was added directly in multi-well slides for the last 10 min of co-incubation. Cells were fixed after 10–25&nbsp;min for m24 and pan-phospho staining and and 35–45 min for perforin and centrosome staining. The following reagents and antibodies were used for staining: CD11a/CD18 (clone m24, BioLegend), gamma Tubulin (clone EPR16793, Abcam), perforin (clone δG9, BD Bioscience), phospho-tyrosine P-Tyr-1000 (#8954S, Cell Signaling Technology), secondary goat anti-mouse (AF568, Thermo Fisher), secondary goat anti-rabbit (AF647, Thermo Fisher).</div></section><section id="sec-4-4-17"><h4>Image analysis and quantitation of REP T&nbsp;cell-T2 target cell conjugates</h4><div id="p0260" role="paragraph">For analysis of open head-piece LFA-1 and pan phospho-tyrosine intensity in REP T&nbsp;cells, confocal <i>Z</i>-stacks were acquired and analyzed using Imaris software (Bitplane). REP T&nbsp;cell volumes were identified using the <i>surface</i>-tool: source channel 4 (DAPI=CTV), 5&nbsp;μm diameter cut-off with 0.369&nbsp;μm surface detail and &gt; 1689 voxels. Fluorescent signal of source channel 3 (AF555=LFA-1 m24 staining) outside of REP T&nbsp;cell-surface was masked and extended LFA-1 was quantified with <i>surface</i>-tool: source channel 5 (masked AF555), 1.39&nbsp;μm diameter cut-off with 0.369&nbsp;μm surface detail and &gt; 154 voxels. Number of LFA-1 m24-objects were normalized to REP T&nbsp;cell number per field of view. Pan phospho-tyrosine intensity was determined by plotting <i>median intensity</i> of source channel 2 (AF647) per REP T&nbsp;cell volume identified as described above. For analysis of perforin and centrosome polarization, position of REP T and T2 target cells in confocal <i>Z</i>-stacks were characterized with <i>spot</i>-tool: Source channel 1 (AF488=CFSE) with the following parameters 10&nbsp;μm estimated diameter and spot classification with quality threshold &gt; 27.4 was used to identify T2 target cells and source channel 4 (DAPI=CTV) with 8&nbsp;μm estimated diameter and spot classification with quality threshold &gt; 37.8, for REP T&nbsp;cells respectively. For detection of centrosome and perforin granules in REP T&nbsp;cells <i>surface</i>-tool was applied on source channel 4 (DAPI=CTV), 5&nbsp;μm diameter cut-off of with 0.369&nbsp;μm surface detail and &gt; 2014 voxel cut-off. Fluorescent signal of source channel 1 (AF488=perforin) and source channel 2 (AF647=centrosome) outside of defined REP T&nbsp;cell surface was masked and positions of respective objects were identified with <i>spot</i>-tool: 0.8&nbsp;μm estimated diameter and spot classification with quality threshold &gt; 1365 for perforin and 1.84&nbsp;μm estimated diameter and spot classification with quality threshold &gt; 637 for centrosome. X, Y, Z values of each individual spot (cells, perforin granule and centrosome) were subjected to further analysis using script in R. For each spot we identified its parent T&nbsp;cell and for each T&nbsp;cell its nearest tumor cell using the RANN package. T&nbsp;cell-cancer cell interactions were considered if their centers were between 3 and 25&nbsp;μm apart, which reduces distant non-interacting cells and artefacts. Then the spot-to-cancer-cell distance was divided by the cell-to-cell distance to calculate the polarization ratio for each interaction pair. Median polarization ratios between conditions and field of views were compared in Graphpad Prism.</div></section><section id="sec-4-4-18"><h4>Immunoblot analysis</h4><div id="p0265" role="paragraph">Activated memory T&nbsp;cells and PHA blasts were lysed in RIPA buffer (Thermo Fisher) containing protease- and phosphatase-inhibitors (Roche, #05 892 970 001 and #04 906 837 001), and protein concentrations determined with a BCA protein assay kit (Thermo Fisher). Whole-cell lysates were denatured with 4× Laemmli buffer and separated by 4%–20% SDS-PAGE and transferred to nitrocellulose or PVDF membranes (Biorad). Membranes were probed with the following primary antibodies: P-p44/42 MAPK (Erk1/2, Thr202/Tyr204, #D13.14.4E, Cell Signaling Technology), P-c-Jun (S73, #D47G9, Cell Signaling Technology), p44/42 MAPK (Erk1/2, #137F5, Cell Signaling Technology), c-Jun (#60A8, Cell Signaling Technology) and Actin (#8H10D10, Cell Signaling Technology). Blots were then stained with HRP-conjugated anti-rabbit or anti-mouse (both from Jackson Immuno Research Laboratories) secondary antibodies. SuperSignal West Pico PLUS Chemiluminescent Substrate (Thermo Fisher) according to the manufacturer’s instructions and ChemiDoc Imaging System (Biorad) were used for detection and FiJi software for quantification.</div></section><section id="sec-4-4-19"><h4>CRISPR-Cas9 editing of murine OT-I cells</h4><div id="p0270" role="paragraph">Single cell suspensions were made from lymph nodes and spleens harvested from OT-I mice (male and female, 6-10&nbsp;weeks, equal distribution of sex and age). 2×10<sup>6</sup> mL<sup>-1</sup> OT-I lymphocytes were resuspended in medium containing 100&nbsp;ng mL<sup>-1</sup> OVA<sub>257–264</sub> peptide (Eurogentec) and 100&nbsp;U mL<sup>-1</sup> of IL-2 (Proleukin) and incubated for 48 h. OT-I cells were nucleofected with the P4 Primary Cell 4D-Nucleofector (Lonza) according to manufacturer’s instructions using 4D-Nucleofector (Lonza). Briefly, 1×10<sup>7</sup> activated OT-I T&nbsp;cells were resuspended in 100&nbsp;μl of Nucleofector Solution and combined with RNP solution. crRNAs were selected from predesigned CRISPR-Cas9 guide RNAs Tool from IDT. Product ID and sequences are listed in <a id="crosref1250" href="#mmc1">Table S1</a>. Per reaction, 900 pmol crRNA (IDT) or 900 pmol negative control crRNA #1 (IDT) were mixed with 900 pmol trRNA (IDT) in nuclease-free duplex buffer (IDT), annealed at 95°C for 5&nbsp;min and added to 300 pmol μM Cas9 (QB3 MacroLab, UC Berkeley) followed by incubation at room temperature for at least 10&nbsp;min. An appropriate nucleofector program was applied. OT-I lymphocytes were rested in Mouse T Cell Nucleofector Medium (Lonza) for 12&nbsp;h and then washed and seeded in fresh medium at 10<sup>6</sup> mL<sup>-1</sup> in round bottom 96 well-plates with 500&nbsp;U mL<sup>-1</sup> IL-2. Fresh IL-2 was added on a daily basis. Knock-out efficiency was validated by flow cytometry and purified by cell sorting.</div></section><section id="sec-4-4-20"><h4>CRISPR-Cas9 editing of human Jurkat T&nbsp;cells</h4><div id="p0275" role="paragraph">Jurkat T&nbsp;cells were nucleofected using the AMAXA cell line V nucleofection kit (Lonza) according to manufacturer’s instructions using 2b Nucleofector (Lonza). Briefly, 1×10<sup>6</sup> Jurkat T&nbsp;cells were resuspended in 100&nbsp;μl of Nucleofector Solution and combined with RNP solution. crRNAs were selected from predesigned CRISPR-Cas9 guide RNAs Tool from IDT. Product ID and sequences are listed in <a id="crosref1255" href="#mmc1">Table S1</a>. crRNA (IDT) or negative control crRNA #1 (IDT) and trRNA (IDT) were mixed at a 1:1 ratio to a final concentration of 50&nbsp;μM in nuclease-free duplex buffer (IDT), annealed at 95°C for 5&nbsp;min and added to 40&nbsp;μM Cas9 (QB3 MacroLab, UC Berkeley) followed by incubation at room temperature for at least 10&nbsp;min. An appropriate nucleofector program was applied. Knock-out efficiency was validated by flow cytometry and purified by cell sorting. Jurkat T&nbsp;cells were initially expanded for 1&nbsp;week and then stored in liquid nitrogen until further use.</div></section><section id="sec-4-4-21"><h4>Plate reader-based Ca<sup>2+</sup> flux assay</h4><div id="p0280" role="paragraph">Murine OT-I CTLs were loaded with Calbryte 520 AM (AAT Bioquest) and Jurkat T&nbsp;cells were loaded with Fluo4 (Thermo Fisher). Both calcium indicator dyes were used at a final concentration of 2&nbsp;μM in Mg<sup>2+</sup>-free self-made medium for 30&nbsp;min at 37°C. Cells were washed twice and plated at 5×10<sup>5</sup> per well (OT-I CTLs) and 2×10<sup>5</sup> per well (Jurkat T&nbsp;cells) in a black flat bottom 96 well-plate (Greiner BIO-one) which had been precoated with Poly-D-Lysine (Gibco) in case of OT-I CTLs or collagen (Thermo Fisher) for Jurkat T&nbsp;cell respectively. An additional incubation for 15&nbsp;min at 37°C allowed cells to adhere and Fluo4 probe to de-esterified completely. OT-I CTLs were stimulated with 10&nbsp;μM OVA<sub>257–264</sub> peptide (SIINFEKL, Eurogentec) and Jurkat T&nbsp;cells with 10&nbsp;μg mL<sup>-1</sup> anti-CD3. Fluorescence intensity over time was measure with a Tecan Spark M10 plate reader. The mean of fluorescent signal intensity was normalized to unstimulated baseline values.</div></section><section id="sec-4-4-22"><h4>Murine CTLs: Differentiation and cultivation</h4><div id="p0285" role="paragraph">Single cell suspensions were made from lymph nodes and spleens harvested from C57BL/6 and LFA-1 KO mice (male and female, 6–10&nbsp;weeks, equal distribution of sex and age). Naïve CD8<sup>+</sup> T&nbsp;cells were isolated using a magnetic bead-based negative selection kit following the manufacturer’s recommendations (easySEP, Stem Cell Technologies). Naïve T&nbsp;cells (2×10<sup>5</sup> per well) were plated in presence of 5&nbsp;μg anti-CD3 Ab (plate-bound) and 1μg anti-CD28 Ab (soluble; both from BioLegend) for 2&nbsp;days in presence 100&nbsp;U mL<sup>-1</sup> of IL-2 (Proleukin). Cells were washed and seeded in fresh medium at 10<sup>6</sup> mL<sup>-1</sup> in round bottom 96 well-plates with 500&nbsp;U mL<sup>-1</sup> IL-2. A cell density of 0.5–2&nbsp;× 10<sup>6</sup> cells mL<sup>-1</sup> was maintained for expansion and IL-2 was replaced on a daily basis. Functional read outs were carried out 7-19&nbsp;days after initial activation and in the absence of IL-2.</div></section><section id="sec-4-4-23"><h4>Murine CTLs: <i>In&nbsp;vitro</i> activation and cytotoxicity assay</h4><div id="p0290" role="paragraph">CTLs of WT (C57BL/6) or LFA-1 KO were activated for with plate-bound anti-CD3 Ab (145-2C11, BioLegend) at 0.05&nbsp;μg mL<sup>-1</sup> and soluble anti-CD28 Ab (37.51, BioLegend) at 1&nbsp;μg mL<sup>-1</sup> at 2×10<sup>5</sup> cells per well in a flat bottom 96 well plate. For stainings of surface activation markers, CTLs were activated for 8&nbsp;h and for evaluation of 2-NBDG uptake, cells were activated for 6 h. For analysis of ERK1/2 phosphorylation, CTLs were stimulated with 5&nbsp;μg mL<sup>-1</sup> anti-CD3 Ab and 1&nbsp;μg mL<sup>-1</sup> anti-CD28 for 20&nbsp;min prior to fixation and permeabilization. For cytotoxicity assays with WT or LFA-1 KO derived CTLs, cytotoxicity was evaluated with NucView 488 fluorogenic caspase-3 substrate (Biotium). Prior to co-incubation, CTLs were labeled with CellTrace Violet (CTV, Invitrogen) and EL4 target cells with CellTrace Far Red (CFTR, Invitrogen). Both cell population were then co-incubated at a CTL-target cell ratio of 3:1 (1.5×10<sup>5</sup> CTLs and 5×10<sup>4</sup> EL4 target cells) in presence of 10&nbsp;μg mL<sup>-1</sup> PHA for 4&nbsp;h in a flat bottom 96 well plate. Caspase-3 substrate was added for final 45&nbsp;min of incubation at final concentration of 1&nbsp;μM. Cells were harvested, washed in FACS Buffer and fixed with PFA 2% for 15&nbsp;min at RT prior to analysis by FACS. For cytotoxicity assays with OT-I derived CTLs were labeled with CTV, EL4 target cells were labeled with CFTR and pulsed with OVA<sub>257–264</sub> peptide (SIINFEKL, Eurogentec) or the altered peptide ligands R7 (SIIQFERL, Eurogentec), H7 (SIIQFEHL, Eurogentec) or G4 (SIIGFEKL, Eurogentec) at 1&nbsp;μM for 30&nbsp;min. EL4 target cells were washed 3 times prior to co-incubation at a CTL-target cell ratio of 3:1 (1.5×10<sup>5</sup> CTLs and 5×10<sup>4</sup> EL4 target cells) in a flat bottom 96 well plate for 4h. Cytotoxicity was quantified with CellEvent Caspase-3/7 Green Detection Reagent (Invitrogen, ThermoFisher) as described above.</div></section><section id="sec-4-4-24"><h4>Immunofluorescent staining of immune synapse components in Jurkat T&nbsp;cells and PHA blasts</h4><div id="p0295" role="paragraph">Cells were activated on species-appropriate anti-CD3-coated (1&nbsp;μg mL<sup>-1</sup>) glass-coverslips (Thermo Fisher) for 2&nbsp;min for phosphor-tyrosine analysist. Cell conjugates were fixed for 20&nbsp;min at RT in 4% methanol-free PFA (Sigma Aldrich), permeabilized with 0.1% Triton-X100 (Sigma Aldrich) in PBS for 5&nbsp;min and quenched with 50&nbsp;mM Glycine (Sigma Aldrich) in PBS for 20&nbsp;min. Fixation was followed by blocking in 1% bovine serum albumin (Sigma Aldrich) in PBS (blocking buffer) for 45&nbsp;min at 4°C. Primary antibodies were then incubated in the same blocking buffer for 1&nbsp;h at RT or overnight at 4°C. Samples were then washed four times with blocking buffer, followed by incubation with secondary antibodies in blocking buffer at room temperature for 1 h. Slides were then mounted with Prolong Diamond Antifade Mountant (Thermo Fisher) and analyzed after 24&nbsp;h of curing time at RT. The following reagents and antibodies were used for staining: phospho-tyrosine <i>P-Tyr-1000</i> (multiple monoclonal antibodies, unlabeled, Cell Signaling Technology), secondary goat anti-rabbit (AF647, Thermo Fisher), Phalloidin-iFluor (AF555, Abcam) and DAPI (Sigma Aldrich).</div></section><section id="sec-4-4-25"><h4>Image analysis and quantitation of phospho-tyrosine signal intensity</h4><div id="p0300" role="paragraph">For measurement of pan-phospho tyrosine signal intensity, FiJi software was used. Series of confocal Z-stacks were displayed as maximum intensity z-projections using <i>Z project</i>- tool. Individual cells were selected manually with <i>freehand selection</i>-tool according to cell boundaries indicated by phalloidin staining and fluorescent intensity was measured accordingly with <i>measure</i>-tool.</div></section><section id="sec-4-4-26"><h4>Magnesium-restricted diet</h4><div id="p0305" role="paragraph">Magnesium-restricted diet and matching control diet, based on the purified ingredient rodent diet <i>AIN-76A</i>, were purchased at Research Diets Inc. (USA).</div></section><section id="sec-4-4-27"><h4>Sample collection of tissue interstitial fluid</h4><div id="p0310" role="paragraph">Healthy C57BL/6NRj mice (male and female, 6-10&nbsp;weeks, groups were sex and age adjusted) were kept on magnesium-restricted diet or corresponding control diet for 2&nbsp;weeks. At day 14, liver, spleen and peripheral lymph nodes, muscle (musculus quadriceps femoris) and subcutaneous fat (flank) were aseptically removed. Organs were weighed, 50-300 ul PBS added (adjusted according to weight), and gently centrifuged at 300 x g for 8&nbsp;min at 4°C. Organ supernatants were recovered and stored at -80°C. Peritoneal fluid was harvested upon injection if 10&nbsp;mL sterile PBS into peritoneal cavity; peritoneum was gently massaged and then aseptically opened by incision and lavage was collected. Tumor interstitial fluid of MC38-OVA tumors were collected 1&nbsp;h after intratumoral injection of either 50&nbsp;μl 3&nbsp;mM MgCl<sub>2</sub> or 50&nbsp;μl 3&nbsp;mM NaCl. Tumors were aseptically excised, weighed and supernatant was recovered as described above. Tissue interstitial fluid of tumors from <i>in&nbsp;vivo</i> CAR T&nbsp;cell experiments were collected from UTD and saline control mice reaching ethically acceptable end point. Tumors were aseptically excised, weighed and supernatant was recovered as described above.</div></section><section id="sec-4-4-28"><h4>Magnesium measurements with ICP-MS</h4><div id="p0315" role="paragraph">Samples of varying volumes (serum 5&nbsp;μl; Muscle 10&nbsp;μl; liver, lymph node, peritoneal fluid, subcutaneous fat and tumor 25&nbsp;μl; spleen 50&nbsp;μl) were added to 200&nbsp;μl 67-69% HNO<sub>3</sub> (VWR Chemicals; NORMATOM® grade; LOT 1119100) and incubated at 95°C for 2 h. Digestates were filled up to 5&nbsp;mL volume using ultra-pure H<sub>2</sub>O (&lt;18mΩ; Merckmillipore, 115333) and stored at 4°C. Samples were analyzed using triple quadrupole inductively coupled plasma mass spectrometry (qqq-ICP-MS) on an 8800 system (Agilent, Basel, Switzerland), using general-purpose operational settings. The system was operated in single quad mode using helium as collision gas and quantification done on <sup>24</sup>Mg<sup>+</sup>. To account for matrix effects, <sup>103</sup>Rh was used as the internal standard. Organ Mg<sup>2+</sup> levels were normalized to tissue weight.</div></section><section id="sec-4-4-29"><h4>Blood count mice</h4><div id="p0320" role="paragraph">Blood samples (70uL) were harvested in EDTA-coated tubes and diluted with 210uL NaCl 0.9%. Samples were run on the ADVIA 2120i hematology analyzer (Siemens) and analyzed by the multi-species program.</div></section><section id="sec-4-4-30"><h4>Polyclonal CD8 T&nbsp;cell activation <i>in&nbsp;vivo</i> with anti-CD3ε F(ab′)2 fragment</h4><div id="p0325" role="paragraph">Healthy C57BL/6NRj and LFA-1 KO mice (male and female, 6–10&nbsp;weeks, groups were sex and age adjusted) were put on AIN76A magnesium-restricted or control diet for two weeks. On day 14, each mouse received 0.5&nbsp;μg anti-CD3ε F(ab′)2 fragment (BioXCell) per i.v. tail-vein injection. After 6 h, spleens were harvested splenocyte suspensions were analyzed by flow-cytometry.</div></section><section id="sec-4-4-31"><h4><i>In&nbsp;vivo</i> killing assay</h4><div id="p0330" role="paragraph">C57BL/6NRj mice (male and female, 6-10&nbsp;weeks, groups were sex and age adjusted) were immunized against OVA at day -19. In a first experiment, mice were immunized s.c. with 100&nbsp;μg OVA protein (Invivogen) and 50&nbsp;μg of CpG-B (Invivogen). In a second experiment, mice were immunized i.v. with 5×10<sup>3</sup> CFU LmOVA. On day 0, mice were put on magnesium-restricted or control diet for two weeks. On day 14, target splenocytes were harvested from naïve, syngeneic mice and either loaded with OVA<sub>257–264</sub> peptide (Eurogentec) or left untreated. Unloaded control splenocytes were labeled brightly with 2.50&nbsp;μM CTV (CTV<sup>bright</sup>) and OVA<sub>257-264</sub>-loaded splenocytes dimly with 0.25&nbsp;μM CTV (CTV<sup>dim</sup>). Cells were then counted, mixed at 1:1 ratio in PBS, and 2-4×10<sup>6</sup> total target splenocytes were injected i.v. into pre-immunized and naive control mice. Additionally, 200&nbsp;μl of 3&nbsp;mM MgCl<sub>2</sub> and 200&nbsp;μl of 3&nbsp;mM NaCl were administered i.p., respectively. After 12 h, spleens were harvested and splenocyte suspensions were analyzed by flow-cytometry. Percentages of specific <i>in&nbsp;vivo</i> killing were calculated as [1-(% CTV<sup>dim</sup> naive / % CTV<sup>bright</sup> naive) / (% CTV<sup>dim</sup> immunized / % CTV<sup>bright</sup> immunized)]×100.</div></section><section id="sec-4-4-32"><h4>Listeria peritonitis model</h4><div id="p0335" role="paragraph">C57BL/6NRj mice (male and female, 6-10&nbsp;weeks, groups were sex and age adjusted) were immunized i.p. with 5×10<sup>4</sup> CFU Listeria monocytogenes expressing the OVA-peptide (<i>Listeria monocytogenes</i> expressing chicken Ovalbumin (AA134–387) originally gifted from Prof. Ed Palmer, University of Basel). After 19&nbsp;days, mice were put on Mg<sup>2+</sup>-restricted or matching control diet for 2&nbsp;weeks. Mice were then re-infected i.p. with 5×10<sup>5</sup> CFU LmOVA. Bacterial inoculum was either spiked with 3&nbsp;mM MgCl<sub>2</sub> or 3&nbsp;mM NaCl diluted in 200&nbsp;μl ddH<sub>2</sub>O. Mice were sacrificed 12&nbsp;h post infection and peritoneal fluid was harvested. Peritoneal fluid was harvested upon injection if 10&nbsp;mL sterile PBS into peritoneal cavity; peritoneum was gently massaged and then aseptically opened by incision and lavage was collected. Peritoneal fluid was then plated on BHI agar-plates and colonies counted upon 24&nbsp;h of incubation. Remaining peritoneal fluid were centrifuged at 300 x g for 10&nbsp;min and supernatant recovered. Peritoneal fluid and sera were frozen at -80°C prior to further analysis. For flow cytometric analysis of memory CD8<sup>+</sup> T&nbsp;cell compartment, mice were scarified 20&nbsp;h post infection, and peritoneal fluid was harvested. MACS beads and LS columns (both Milteny Biotec) were used to enrich cell suspension for CD8<sup>+</sup> T&nbsp;cells. Cells were stained as described above and analyzed by FACS.</div></section><section id="sec-4-4-33"><h4>Cytometric bead array</h4><div id="p0340a" role="paragraph">Cytokine concentrations in cell culture supernatants, peritoneal fluids and serum were determined using the LegendPlex cytrometric bead array (CBA) Th1-Pannel (human and mouse, both from Biolegend) according to manufacturer’s instructions.</div></section><section id="sec-4-4-34"><h4>Perforin quantification</h4><div id="p0340" role="paragraph">Perforin concentrations in peritoneal fluids were determined using ProQuantumMouse Granzyme B Immunoassay Kit (Inivtrogen) according to manufacturer’s instructions.</div></section><section id="sec-4-4-35"><h4>Murine MC38-OVA tumor model – set up</h4><div id="p0345" role="paragraph">Unless stated otherwise, C57BL/6NCrl (female, 6 to 12&nbsp;weeks old) were used for experiments. In assays with pre-immunized mice, mice were immunized 19&nbsp;days before tumor implantation by subcutaneous injection of 100&nbsp;μg of OVA protein (Invivogen) and 50&nbsp;μg of CpG-B ODN 1826 (Eurogentec), resuspended in 100&nbsp;μL of PBS. For tumor implantation, mice were inoculated subcutaneously onto the flanks with 0.5×10<sup>6</sup> MC38-OVA cells, resuspended in 100&nbsp;μL of PBS. In bilateral tumor experiments, mice received 50&nbsp;μL intra-tumoral injections of either 3&nbsp;mM NaCl or 3&nbsp;mM MgCl<sub>2</sub> (both diluted in ddH<sub>2</sub>O). Injections of NaCl solution was applied in left flank tumor, whereas MgCl<sub>2</sub> solution was injected in contralateral tumor. I.t. injections were initiated once tumors were palpable, usually between day 5 and 10 after tumor injection. Injections were repeated every third day. Tumor size was quantified using a caliper and tumor volume was calculated using a rational ellipse formula (α<sup>2</sup> × β × π/6, α being the shorter axis and β the longer axis). In all survival experiments, mice were withdrawn from the study after any tumor dimension had reached a length greater than 15&nbsp;mm.</div></section><section id="sec-4-4-36"><h4>Murine MC38-OVA tumor model – with NSG mice</h4><div id="p0350" role="paragraph">On day 0, 0.25×10<sup>6</sup> MC38-OVA cells were implanted subcutaneously onto the flank of NSG mice (female mice, 6–8&nbsp;weeks old). On day 9, 2.5×10<sup>6</sup> LFA-1<sup>-/-</sup> or WT OT-I CTLs were transferred by tail-vein injection. CRISPR-Cas9 gene editing was carried out as described above. From day 9 onwards, intratumoral 3&nbsp;mM NaCl or 3&nbsp;mM MgCl<sub>2</sub> injections were initiated and repeated every second to third day.</div></section><section id="sec-4-4-37"><h4>Murine MC38-OVA tumor model – <i>in&nbsp;vivo</i> CD8<sup>+</sup> T&nbsp;cell depletion</h4><div id="p0355" role="paragraph">For CD8 depletion experiment, mice were immunized with OVA, as described above, and inoculated with 0.5×10<sup>6</sup> MC38-OVA cells unilaterally on the flank. Intratumoral injections of either 3&nbsp;mM NaCl or 3&nbsp;mM MgCl<sub>2</sub> were initiated, and repeated every third day as tumors became palpable. CD8 T&nbsp;cells were depleted by administering anti-CD8a Ab (53–6.72, BioXCell) at 10 mg kg<sup>-1</sup> i.p. once per week.</div></section><section id="sec-4-4-38"><h4>Murine MC38-OVA tumor model – <i>in&nbsp;vivo</i> PD-1 blockade</h4><div id="p0360" role="paragraph">For PD-1 blockade experiments, mice were immunized with OVA, as described above, and inoculated with 0.5×10<sup>6</sup> MC38-OVA cells unilaterally on the flank. As tumors became palpable - at day 5 - intratumoral injections of either 3&nbsp;mM NaCl or 3&nbsp;mM MgCl<sub>2</sub> were initiated, and repeated every third day for 8 cycles. Mice were additionally injected i.p. with isotype control (IgG2a) or anti-PD-1 Ab on day 9, 12, and 15 post-tumor implantations, at a dose of 200&nbsp;μg per mouse diluted in 100&nbsp;μL of pH-matched PBS (according to manufacturer’s recommendations). The antibodies used were: anti-PD-1 IgG2a Ab (clone RMP1-14) or IgG2a isotype control Ab (clone 2A3, both purchased from BioXCell).</div></section><section id="sec-4-4-39"><h4>Murine MC38-OVA tumor model – flow cytometry analysis of tumor-infiltrating immune cells</h4><div id="p0365" role="paragraph">Tumor tissue was isolated from mice, weighed and minced using razor blades. Tissue was then digested using accutase (PAA), collagenase IV (Worthington), hyaluronidase (Sigma), and DNAse type IV (Sigma) for 60&nbsp;min at 37 °C with constant shaking. The cell suspensions were filtered using a cell strainer (70&nbsp;μm). Precision Counting beads (Biolegend) were added before staining to quantify the number of cells per gram of tumor. Single cell suspensions were blocked with rat anti-mouse FcγIII/II receptor (CD16/CD32) blocking antibodies ('Fc-block') and stained with live/dead cell-exclusion dye. Cells were then incubated with fluorophore-conjugated antibodies directed against cell surface antigens, washed and resuspended in FACS buffer (PBS+2% FBS). For intracellular/intranuclear antigens, cells stained with cell surface antibodies were fixed and permeabilized using Foxp3/transcription factor staining buffer (eBioscience) prior to incubation with antibodies directed against intracellular antigens.</div></section><section id="sec-4-4-40"><h4>Murine MC38-OVA tumor model – liposome and immunoliposome application</h4><div id="p0370" role="paragraph">Liposomes were prepared using the thin film-hydration method (<span class="dropBlock reference-citations"><a id="body-ref-sref24" href="#" role="doc-biblioref" data-xml-rid="bib24" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref24" aria-controls="sref24">Huwyler et&nbsp;al., 1997</a><div class="dropBlock__holder" data-db-target-of="sref24"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Huwyler, J. ∙ Yang, J. ∙ Pardridge, W.M.</div><div><strong>Receptor mediated delivery of daunomycin using immunoliposomes: Pharmacokinetics and tissue distribution in the rat</strong></div><div><em>J.&nbsp;Pharmacol. Exp. Ther.</em> 1997; <strong>282</strong>:1541-1546</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS0022-3565%2824%2936946-0&amp;cf=fulltext&amp;site=jpet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS0022-3565%2824%2936946-0&amp;cf=pdf&amp;site=jpet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9316870/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0022-3565%2824%2936946-0&amp;pmid=9316870" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The lipid composition consisted of DSPC (1,2-distearoyl-sn-glycero-3-phosphocholine, Avanti Polar Lipids, Alabaster, AL), Cholesterol (3β-Hydroxy-5-cholestene, 5-Cholesten-3β-ol, Sigma Aldrich, Schaffhausen, Switzerland), DSPE-PEG2000 (1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000], Avanti Polar Lipids, Alabaster, AL), DSPE-PEG2000-Mal (1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[maleimide(polyethyleneglycol)-2000], Avanti Polar Lipids, Alabaster, AL), and DiI (DiIC18(3), Sigma Aldrich, Schaffhausen, Switzerland) at a molar ratio of 69:27:2.5:0.5:1. Lipids were mixed in ethanol and a homogenous thin film was prepared using a Rotavapor A-134 (Büchi, Switzerland). Dried lipid films were stored under vacuum overnight and rehydrated with either 150&nbsp;mM NaCl or 100&nbsp;mM MgCl<sub>2</sub> at 70°C with constant stirring. Liposomes were extruded 13x through polycarbonate filters with an average pore diameter of 100&nbsp;nm (Nucleopore, Whatman, North Bend, OH). Amicon Ultra-4 centrifugal filter units (MWCO 10&nbsp;kDa) were used to concentrate the liposomes and to exchange the buffer to PBS pH 7.2. The liposomes were used within 4&nbsp;h for anti-PD-1 conjugation via SATA-maleimide conjugation chemistry. Briefly, anti-PD-1 antibodies (clone RMP1-14, BioXCell) were functionalized with 10x molar excess of SATA (N-succinimidyl-S-acetylthioacetate, Fisher Scientific, Reinach, Switzerland) to introduce sulfhydryl groups according to the supplier’s recommendations. The reactive sulfhydryl group on the antibody was then conjugated to the maleimide moieties on the liposome for 2&nbsp;h at RT (ratio SH: maleimide&nbsp;= 1:4). Free maleimide groups were blocked by incubating with a 10x molar excess L-Cysteine for 30&nbsp;min at RT. The anti-PD-1-conjugated liposomes were purified by gel filtration chromatography (Sepharose CL4B, elution buffer PBS pH 7.2). Fractions containing liposomes were pooled and concentrated using Amicon Ultra-4 centrifugal filter units (MWCO 10&nbsp;kDa, Merck Millipore Ltd., Tullagreen, Carrigtwhohill, Co Cork IRL). Average size, size distribution and particle concentration were determined by dynamic light scattering using a Zetasizer Ultra (Malvern Panalytical, Volketswil, Switzerland). For intratumoral liposome injection, 4×10<sup>12</sup> of MgCl<sub>2</sub>-loaded liposomes and 2.6×10<sup>12</sup> of NaCl-loaded liposomes were used. For immunoliposome experiments, 100&nbsp;μg of anti-PD-1 Ab coupled to MgCl<sub>2</sub>- or NaCl-loaded liposomes were injected i.p. at indicated time points.</div></section><section id="sec-4-4-41"><h4>Anti-nuclear antibody (ANA) quantification</h4><div id="p0375" role="paragraph">ANA concentrations were determined in murine serum 25&nbsp;days after the start of i.t. NaCl or MgCl<sub>2</sub> injection as well in age- and sex-matched untreated control mice, using the mouse anti-nuclear antibody ELISA kit (Hoelzl Biotech) according to manufacturer’s instructions.</div></section><section id="sec-4-4-42"><h4>Co-culture assay with <i>Blinatumomab</i></h4><div id="p0380" role="paragraph">Blinatumomab (Amgen) was derived from the leftover of infusions. Human PHA blasts were incubated with Ramos or LCL target cells in flat bottom 96 well-plate at a 0.5:1 ratio (6.5×10<sup>4</sup> PHA blasts and 1.3×10<sup>5</sup> target cells) at indicated Blinatumomab concentrations. In order to distinguish the different cell populations, PHA blasts were labeled with CTV and target cells with CFTR Invitrogen. Anti-CD18 antibodies, CBR-LFA-1/2 (unlabeled, Ultra-LEAF, BioLegend), TS1/18 (unlabeled, Ultra-LEAF, BioLegend) as well Mouse IgG1 κ Isotype control (unlabeled, Ultra-LEAF, BioLegend) were used at a final concentration of 10&nbsp;μg mL<sup>-1</sup>. For all co-incubation experiments, cells were allowed to sediment without centrifugation. For analysis of protein phosphorylation, co-incubation was terminated after 60&nbsp;min with fixation of of 4% PFA and methanol as described in more detail above. For assessing LFA-1 headpiece opening, m24 antibody was directly added to the cell culture medium and stained for 30&nbsp;min on ice before washing and subsequent fixation with 2% PFA. Cytotoxicity was quantified after 3.5&nbsp;h with CellEvent Caspase-3/7 Green Detection Reagent (Invitrogen, Thermo Fisher) as described above. Caspase substrate was added for final 45&nbsp;min of incubation at final concentration of 2&nbsp;μM. Cells were harvested, washed in FACS Buffer and fixed with PFA 2% for 15&nbsp;min at RT prior to analysis by FACS.</div></section><section id="sec-4-4-43"><h4>Production of anti-CD19 CAR T&nbsp;cells for <i>in&nbsp;vitro</i> experiments</h4><div id="p0385" role="paragraph">24&nbsp;h before transfection, HEK-293T cells were seeded (3.8×10<sup>6</sup> cells 10&nbsp;mL<sup>-1</sup> media). All plasmid DNA was purified using the Endotoxin-free Plasmid Maxiprep Kit (Sigma). HEK-293T cells were transfected with 1.3 pmol psPAX2 (lentiviral packaging plasmid) and&nbsp;0.72 pmol pMD2G (VSV-G envelope expressing plasmid) and 1.64 pmol of pCAR-CD19CAR-p2a-EGFP (Creative Biogene) using Lipofectamine 2000 (Invitrogen) and Optimem medium (Invitrogen, Life Technologies). The viral supernatant was collected 48&nbsp;h after transduction. Viral particles were concentrated using PEG precipitation and stored at -80°C. Blood samples (Blood donor center, University Hospital Basel) were obtained from healthy donors after written informed consent. PBMCs were isolated by standard density-gradient centrifugation protocols (Lymphoprep; Fresenius Kabi). CD4<sup>+</sup> and CD8<sup>+</sup> T&nbsp;cells were positively selected using magnetic CD4<sup>+</sup> and CD8<sup>+</sup> beads (Miltenyi Biotec). Purified CD4<sup>+</sup> and CD8<sup>+</sup> T&nbsp;cells were cultured in R10AB. CD4<sup>+</sup> and CD8<sup>+</sup> T&nbsp;cells were plated into a 24-well cell culture plate and stimulated with anti-CD3 and anti-CD28 mAb-coated beads (Miltenyj, T&nbsp;cell activation &amp; expansion kit) in a ratio of 1:1 in medium containing IL-2 (150&nbsp;U mL<sup>-1</sup>). T&nbsp;cells were transduced with lentiviral particles at 18-22&nbsp;h after activation in media containing Polybrene (6&nbsp;μg mL<sup>-1</sup>, Millipore). Every second day medium was replaced with fresh IL-2 (150&nbsp;U mL<sup>-1</sup>). Five days after transduction GFP<sup>+</sup> cells were sorted enrich CD19-CAR<sup>+</sup> cells and magnetic beads were removed from non-transduced cells. Cells were further expanded for 3&nbsp;days in medium containing IL-2 (150&nbsp;U mL<sup>-1</sup>) before the target cell killing assay.</div></section><section id="sec-4-4-44"><h4>Cytotoxicity assay with anti-CD19 CAR T&nbsp;cells</h4><div id="p0390" role="paragraph">CD8<sup>+</sup> anti-CD19 CAR T-cells were incubated with Ramos target cells at a 0.1-0.33:1 ratio (0.5-1.5×10<sup>4</sup> CAR T&nbsp;cells and 5×10<sup>4</sup> Ramos Target cells). Ramos cells had been labeled with CFTR prior to co-incubation. Cells were allowed to sediment without centrifugation in flat bottom 96 well-plate and incubated for 3 h. Cytotoxicity was quantified by flow cytometry using BioTracker NucView 405 Blue Caspase-3 Dye (Sigma-Aldrich).</div></section><section id="sec-4-4-45"><h4>Primary human T&nbsp;cell transduction for anti-CD19 CAR T&nbsp;cell generation used in in <i>vivo</i> experiments</h4><div id="p0395" role="paragraph">To generate human CD8<sup>+</sup> CAR-T cells, we isolated CD8<sup>+</sup> T&nbsp;cells from heathy donor PBMCs using the CD8 human microbead MACS kit according to manufacturer’s instruction. Cells were then cultured in RPMI-1640 (Sigma) with 10% heat inactivated human male AB<sup>+</sup> serum with 1mM Sodium Pyruvate (Sigma), 2mM Glutamine (contained in RPMI formulation), 10&nbsp;mM HEPES (Gibco), 5mM beta-mercapto-Ethanol (Gibco), 1% PenicilinStreptomycin (Sigma). Cells were stimulated on the same day with 1:1 ratio of CD3/CD28 beads (Human T&nbsp;cell Activation and Expansion kit, Miltenyi) and 150&nbsp;U mL<sup>-1</sup> rh-IL-2 (Proleukin). The next day, cells were collected into a falcon tube and 4&nbsp;μg mL<sup>-1</sup> Polybrene (Sigma) was added together with VSV-g pseudotyped lentivirus encoding an anti-human-CD19-FMC63vH chimeric antigen receptor with a CD28 transmembrane domain and a CD28 and CD3ζ signaling domain with a c-terminal T2A self-cleaving copGFP protein (anti-CD19-CD28z-T2A-copGFP). The cell and lentiviral mixture was centrifuged for 90&nbsp;min at 1000&nbsp;g (spinfection) and the resuspended and plated for 24&nbsp;h at 37°C. Then cells were expanded 1:2 every 2&nbsp;days for 2 iterations with fresh medium and 50&nbsp;U/mL rh-IL-2. GFP<sup>+</sup> CD8<sup>+</sup> (CD8-APC SK1 clone, Biolegend) live (DAPI, Sigma) cells were then sorted using a BD FACS Melody, washed in medium and the plated at 1.5 Mio mL<sup>-1</sup> in fresh medium and 50&nbsp;U mL<sup>-1</sup> rh-IL-2 for another 24h. Cells were then counted, washed by centrifugation at 500g 3&nbsp;min in PBS and transferred in PBS intravenously to female NSG mice (6-8&nbsp;weeks old) subcutaneously injected 5&nbsp;days before with 0.5 Mio Raji (ATCC) in 50% Matrigel (Corning, standard formulation). Intratumoral injections of either 3&nbsp;mM NaCl or 3&nbsp;mM MgCl<sub>2</sub> were initiated 7&nbsp;days after tumor implantation, and repeated every second to third day.</div></section><section id="sec-4-4-46"><h4>Recombinant lentivirus production for anti-PSMA CAR T&nbsp;cells</h4><div id="p0400" role="paragraph">High-titer replication-defective lentivirus was produced and concentrated by ultracentrifugation for primary T&nbsp;cell transduction. Briefly, 24&nbsp;h before transfection, HEK-293 cells were seeded at 10&nbsp;× 10<sup>6</sup> in 30&nbsp;mL of medium in a T-150 tissue culture flask. All plasmid DNA was purified using the Endo-free Maxiprep kit (Invitrogen, Life Technologies). HEK-293T cells were transfected with 7&nbsp;μg pVSV-G (VSV glycoprotein expression plasmid), 18&nbsp;μg of R874 (Rev and Gag/Pol expression plasmid) and 15&nbsp;μg of pELNS transgene plasmid, using a mix of Turbofect (Thermo Fisher) and Optimem medium (Invitrogen, Life Technologies, 180&nbsp;μl of Turbofect for 3&nbsp;mL of Optimem). The viral supernatant was collected 48&nbsp;h after transfection. Viral particles were concentrated by ultracentrifugation for 2&nbsp;h at 24,000 x g and resuspended in 400&nbsp;μl medium, followed by immediate snap freezing on dry ice.</div></section><section id="sec-4-4-47"><h4>Primary human T&nbsp;cell transduction for anti-PSMA CAR T&nbsp;cell generation</h4><div id="p0405" role="paragraph">Primary human T&nbsp;cells were isolated from the peripheral blood mononuclear cells of healthy donors (HDs; prepared as buffycoats or apheresis filters). All blood samples were collected with informed consent of the healthy donors, and genetically engineered with ethics approval from the Canton of Vaud, Switzerland. PBMC were obtained via Lymphoprep (Axonlab) separation solution, using a standard protocol of centrifugation. CD4 and CD8<sup>+</sup> T&nbsp;cells were isolated using a magnetic bead-based negative selection kit following the manufacturer’s recommendations (easySEP, Stem Cell technology). Purified CD4 and CD8<sup>+</sup> T&nbsp;cells were cultured at a 1:1 ratio and stimulated with anti-CD3 and anti-CD28 Ab coated beads (Invitrogen, Life Technologies) at a ratio of 1:2 T&nbsp;cells to beads. T&nbsp;cells were transduced with lentivirus particles at 18-22&nbsp;h after activation. Human recombinant IL-2 (h-IL-2; Glaxo) was replenished every other day for a concentration of 50 IU mL<sup>-1</sup> until 5&nbsp;days after stimulation (day&nbsp;+ 5). At day&nbsp;+ 5, magnetic beads were removed, and h-IL-7 and h-IL-15 (Miltenyi Biotec) were added to the cultures at 10&nbsp;ng mL<sup>-1</sup> replacing h-IL-2. A cell density of 0.5–1&nbsp;× 10<sup>6</sup> cells mL<sup>-1</sup> was maintained for expansion. Rested engineered T&nbsp;cells were adjusted for equivalent transgene expression before all functional assays.</div></section><section id="sec-4-4-48"><h4>Cytotoxicity assay with anti-PSMA CAR T&nbsp;cells</h4><div id="p0410" role="paragraph">Cytotoxicity assays were performed using the IncuCyte Instrument (Essen Bioscience). Briefly, 1.25×10<sup>4</sup> PC3-PIP target cells were seeded in flat bottom 96-well plates (Costar, Vitaris). Four hours later, rested T&nbsp;cells (no cytokine addition for 48 h) were washed and seeded at 2.5&nbsp;× 10<sup>4</sup> per well, at a 2:1 effector to target ratio in self-made medium supplemented with 10% dFCS and ±0.6&nbsp;mM MgCl<sub>2</sub>. No exogenous cytokines were added during the co-culture period. IncuCyte Caspase-3/7 (Essen Bioscience) was added at a final concentration of 5&nbsp;μM in a total volume of 200&nbsp;μl. Internal experimental negative controls were included in all assays, including co-incubation of untransduced (UTD)-T cells and tumor cells in the presence of IncuCyte Caspase-3/7 reagent to monitor spontaneous cell death over time. As a positive control, tumor cells alone were treated with 1% triton solution to evaluate maximal killing in the assay. Images of total green area per well were collected every 2&nbsp;h of the co-culture. The total green area per well was obtained by using the same analysis protocol on the IncuCyte ZOOM software provided by Essen Bioscience. Cytotoxicity is reported as total area under the curve of the fluorescence driven by incorporation of cytotoxic green reagent in dead target cells (green area per μm<sup>2</sup>). All data were normalized by subtracting the background fluorescence observed at time zero (before any cell killing by CAR T&nbsp;cells) from all further time points.</div></section><section id="sec-4-4-49"><h4>Cytokine release assay of anti-PSMA CAR T&nbsp;cells</h4><div id="p0415" role="paragraph">Cytokine release assays were performed by co-culture of 5×10<sup>4</sup> T&nbsp;cells with 5×10<sup>4</sup> target cells per well in 96-well round-bottom plates, in duplicate, in a final volume of 200&nbsp;μl of self-made medium supplemented with 10% dFCS and 0.6&nbsp;mM MgCl<sub>2</sub> or without Mg<sup>2+</sup> supplementation. After 24 h, the co-culture supernatants were collected and tested for the presence of IFN-γ by commercial enzyme-linked immunosorbent assay kits according to the manufacturer’s protocol (BioLegend).</div></section><section id="sec-4-4-50"><h4>Anti-PSMA CAR T&nbsp;cell <i>in&nbsp;vivo</i> experiment</h4><div id="p0420" role="paragraph">Male NSG mice of 10–12&nbsp;weeks were put on Mg<sup>2+</sup>-restricted or matching control diet 5&nbsp;days prior to tumor injection and kept on respective diet throughout the experiment. 5×10<sup>6</sup> PC3-PIP tumor cells were injected subcutaneously. After 5&nbsp;days intravenous injection of saline solution or 2×10<sup>6</sup> T&nbsp;cells (UTD or CAR T&nbsp;cells) were adoptively transferred intravenously. Tumor volume was monitored twice per week. The animals were monitored daily and the tumors were calipered every other day. Tumor volumes were calculated using the formula V=1/2(length × width<sup>2</sup>), where length is the greatest longitudinal diameter and width is the greatest transverse diameter determined via caliper measurement.</div></section></section><section id="sec-4-5"><h3>Quantification and statistical analysis</h3><div id="p0425" role="paragraph">Statistical significance was tested for using Prism 9.0 (GraphPad Software, USA). P values of less than 0.05 were considered statistically significant.</div><section id="sec-4-5-1"><h4>Graphical illustrations</h4><div id="p0430" role="paragraph">All graphical illustrations were created with <a id="intref0060" href="http://BioRender.com" target="_blank">BioRender.com</a>.</div></section></section></section><section id="acknowledgments" role="doc-acknowledgments"><h2>Acknowledgments</h2><div id="p0435" role="paragraph">J. Loet. was supported by SNSF grant 323530_171148 as well grants from the Freiwillige Akademische Gesellschaft Basel and Nikolaus und Bertha Burckhardt-Bürgin-Stiftung; P.D. by SNSF grant 183980; M.L.B. by SNSF grant PMPDP3_171261/1, PCEFP3_194618 / 1, and a Novartis Foundation grant 17C141; A.Z. by SNSF grant 320030_188576; M.I. by SNSF grant 310030_204326; and C.H. by SNSF grants 31003A_172848, FZEB-0-180487, and 310030_192677. We thank Ricardo Mancuso for helpful discussion and scientific input; Klaus Ley and Markus Sperandio for providing reagents; Veronica Richina for help with the hematology analyzer; and Priska Grünig, Tobias Öttl, and Michael Mayr for organizational help during the revision.</div><section id="sec-5"><h3>Author contributions</h3><div id="p0440" role="paragraph">J. Lötscher designed, performed, and analyzed most experiments and wrote the manuscript; A.M.L., N.K., G.G., E.C., M.T., M.L., M.K., P.D., J. Löliger, L.L., C.L., S.H.S., N.P., D.S., V.K., D.L., J.G., and A.-V.B. performed and analyzed experiments; S.I.R., P.S., and M.P. provided clinical data; D.K., M.L.B., D.M., J.H., M.I., W.R., C.G.K., and A.Z. supervised and coordinated experiments; C.H. designed, supervised, and coordinated the study and wrote the manuscript. All authors reviewed the manuscript and approved its final version.</div></section><section id="sec-6"><h3>Declaration of interests</h3><div id="p0445" role="paragraph">J. Lötscher and C.H. are inventors on a patent relating to this study filed by the University of Basel (EP20/191392.8), which is being developed by a start-up company (Hornet Therapeutics Ltd—Scientific Founder: C.H.). J.G. is an employee of Hornet Therapeutics. The authors declare no other competing financial interests.</div></section></section><section id="supplementary-material" data-type="supplementary-materials"><h2>Supplemental Information (1)</h2><div id="p0455" role="paragraph"><div id="mmc1" class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="/cms/10.1016/j.cell.2021.12.039/attachment/bbb4804d-1a40-4382-90f2-f2e5da94effc/mmc1.pdf" download="mmc1.pdf" aria-labelledby="mmc1-heading mmc1-link"><span id="mmc1-link">PDF (45.94 KB)</span></a></div><div class="core-description"><div id="mmc1-heading" class="heading">Table S1. crRNA sequences used in CRISPR-Cas9 gene editing experiments, related to Figures&nbsp;3, 4, and S3</div></div></div></div></section></div></section><div class="core-linked-content">
    

        

</div><section id="backmatter" data-extent="backmatter"><div class="core-container"><section id="data-availability" class="core-data-availability"><h2>Data and code availability</h2><div id="p0030" role="paragraph">This study did not generate or analyze unique datasets or code.</div></section><section id="references"><h2>References</h2><div id="bibliography" role="doc-bibliography"><div role="list"><div role="listitem" data-has="label"><div id="bib1" class="citations"><div id="sref1" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref1" title="View in article">1.</a></div><div>Abramson, J.S. ∙ Palomba, M.L. ∙ Gordon, L.I. ...</div><div><strong>Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (transcend NHL 001): a multicentre seamless design study</strong></div><div><em>Lancet.</em> 2020; <strong>396</strong>:839-852</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS0140-6736%2820%2931366-0&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS0140-6736%2820%2931366-0&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85090978508" target="_blank" aria-label="Open Scopus in new tab">Scopus (1357)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32888407/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0140-6736%2820%2931366-0&amp;pmid=32888407" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib2" class="citations"><div id="sref2" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref2" title="View in article">2.</a></div><div>Akizawa, Y. ∙ Koizumi, S. ∙ Itokawa, Y. ...</div><div><strong>Daily magnesium intake and serum magnesium concentration among Japanese people</strong></div><div><em>J.&nbsp;Epidemiol.</em> 2008; <strong>18</strong>:151-159</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.2188/jea.JE2007381" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-54449099515" target="_blank" aria-label="Open Scopus in new tab">Scopus (24)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18635902/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.2188%2Fjea.JE2007381&amp;pmid=18635902" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib3" class="citations"><div id="sref3" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref3" title="View in article">3.</a></div><div>Angenendt, L. ∙ Hilgefort, I. ∙ Mikesch, J.H. ...</div><div><strong>Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia</strong></div><div><em>Ann. Hematol.</em> 2021; <strong>100</strong>:1871-1878</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s00277-020-04382-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85097748603" target="_blank" aria-label="Open Scopus in new tab">Scopus (4)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33341918/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs00277-020-04382-y&amp;pmid=33341918" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib4" class="citations"><div id="sref4" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref4" title="View in article">4.</a></div><div>Bantug, G.R. ∙ Galluzzi, L. ∙ Kroemer, G. ...</div><div><strong>The spectrum of T&nbsp;cell metabolism in health and disease</strong></div><div><em>Nat. Rev. Immunol.</em> 2018; <strong>18</strong>:19-34</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri.2017.99" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85039067207" target="_blank" aria-label="Open Scopus in new tab">Scopus (302)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28944771/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri.2017.99&amp;pmid=28944771" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib5" class="citations"><div id="sref5" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref5-1" title="View in article">5.</a></div><div>Chen, J. ∙ Salas, A. ∙ Springer, T.A.</div><div><strong>Bistable regulation of integrin adhesiveness by a bipolar metal ion cluster</strong></div><div><em>Nat. Struct. Biol.</em> 2003; <strong>10</strong>:995-1001</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nsb1011" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0344628802" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/14608374/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnsb1011&amp;pmid=14608374" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib6" class="citations"><div id="sref6" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref6" title="View in article">6.</a></div><div>Costello, R.B. ∙ Elin, R.J. ∙ Rosanoff, A. ...</div><div><strong>Perspective: the case for an evidence-based reference interval for serum magnesium: the time has come</strong></div><div><em>Adv. Nutr.</em> 2016; <strong>7</strong>:977-993</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3945/an.116.012765" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84997207644" target="_blank" aria-label="Open Scopus in new tab">Scopus (144)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28140318/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3945%2Fan.116.012765&amp;pmid=28140318" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib7" class="citations"><div id="sref7" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref7" title="View in article">7.</a></div><div>Costello, R.B. ∙ Nielsen, F.</div><div><strong>Interpreting magnesium status to enhance clinical care: Key indicators</strong></div><div><em>Curr. Opin. Clin. Nutr. Metab. Care.</em> 2017; <strong>20</strong>:504-511</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1097/MCO.0000000000000410" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85030773304" target="_blank" aria-label="Open Scopus in new tab">Scopus (38)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28806179/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1097%2FMCO.0000000000000410&amp;pmid=28806179" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib8" class="citations"><div id="sref8" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref8" title="View in article">8.</a></div><div>Coyle, L. ∙ Morley, N.J. ∙ Rambaldi, A. ...</div><div><strong>Open-label, phase 2 study of Blinatumomab as second salvage therapy in adults with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma</strong></div><div><em>Leuk.</em> 2020; <strong>61</strong>:2103-2112</div><div>Lymphoma</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=L.CoyleN.J.MorleyA.RambaldiK.D.MasonG.VerhoefC.L.FurnessA.ZhangA.S.JungD.CohanJ.L.FranklinOpen-label%2C+phase+2+study+of+Blinatumomab+as+second+salvage+therapy+in+adults+with+relapsed%2Frefractory+aggressive+B-cell+non-Hodgkin+lymphomaLeuk61202021032112Lymphoma" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib9" class="citations"><div id="sref9" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref9" title="View in article">9.</a></div><div>Dransfield, I. ∙ Cabañas, C. ∙ Barrett, J. ...</div><div><strong>Interaction of leukocyte integrins with ligand is necessary but not sufficient for function</strong></div><div><em>J.&nbsp;Cell Biol.</em> 1992; <strong>116</strong>:1527-1535</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.116.6.1527" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0026581198" target="_blank" aria-label="Open Scopus in new tab">Scopus (129)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/1541641/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.116.6.1527&amp;pmid=1541641" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib10" class="citations"><div id="sref10" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref10-1" title="View in article">10.</a></div><div>Dransfield, I. ∙ Cabañas, C. ∙ Craig, A. ...</div><div><strong>Divalent cation regulation of the function of the leukocyte integrin LFA-1</strong></div><div><em>J.&nbsp;Cell Biol.</em> 1992; <strong>116</strong>:219-226</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1083/jcb.116.1.219" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0026601096" target="_blank" aria-label="Open Scopus in new tab">Scopus (431)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/1346139/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1083%2Fjcb.116.1.219&amp;pmid=1346139" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib11" class="citations"><div id="sref11" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref11" title="View in article">11.</a></div><div>Dudley, M.E. ∙ Wunderlich, J.R. ∙ Robbins, P.F. ...</div><div><strong>Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes</strong></div><div><em>Science.</em> 2002; <strong>298</strong>:850-854</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/science.1076514" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0037174674" target="_blank" aria-label="Open Scopus in new tab">Scopus (2492)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12242449/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscience.1076514&amp;pmid=12242449" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib12" class="citations"><div id="sref12" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref12" title="View in article">12.</a></div><div>Enamorado, M. ∙ Iborra, S. ∙ Priego, E. ...</div><div><strong>Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T&nbsp;cells</strong></div><div><em>Nat. Commun.</em> 2017; <strong>8</strong>:16073</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms16073" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85024480656" target="_blank" aria-label="Open Scopus in new tab">Scopus (209)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28714465/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms16073&amp;pmid=28714465" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib13" class="citations"><div id="sref13" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref13" title="View in article">13.</a></div><div>Fan, S.T. ∙ Brian, A.A. ∙ Lollo, B.A. ...</div><div><strong>CD11a/CD18 (LFA-1) integrin engagement enhances biosynthesis of early cytokines by activated T&nbsp;cells. Cell</strong></div><div><em>Immunol.</em> 1993; <strong>148</strong>:48-59</div></div><div class="external-links"><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar?q=S.T.FanA.A.BrianB.A.LolloN.MackmanN.L.ShenT.S.EdgingtonCD11a%2FCD18+%28LFA-1%29+integrin+engagement+enhances+biosynthesis+of+early+cytokines+by+activated+T%C2%A0cells.+CellImmunol14819934859" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib14" class="citations"><div id="sref14" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref14" title="View in article">14.</a></div><div>Fan, Z. ∙ McArdle, S. ∙ Marki, A. ...</div><div><strong>Neutrophil recruitment limited by high-affinity bent β2 integrin binding ligand in cis</strong></div><div><em>Nat. Commun.</em> 2016; <strong>7</strong>:12658</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ncomms12658" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84985018876" target="_blank" aria-label="Open Scopus in new tab">Scopus (86)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27578049/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fncomms12658&amp;pmid=27578049" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib15" class="citations"><div id="sref15" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref15" title="View in article">15.</a></div><div>Franco, M.S. ∙ Gomes, E.R. ∙ Roque, M.C. ...</div><div><strong>Triggered drug release from liposomes: Exploiting the outer and inner tumor environment</strong></div><div><em>Front. Oncol.</em> 2021; <strong>11</strong>:623760</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3389/fonc.2021.623760" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85103384300" target="_blank" aria-label="Open Scopus in new tab">Scopus (44)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33796461/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3389%2Ffonc.2021.623760&amp;pmid=33796461" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib16" class="citations"><div id="sref16" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref16" title="View in article">16.</a></div><div>Franquiz, M.J. ∙ Short, N.J.</div><div><strong>Blinatumomab for the treatment of adult B-cell acute lymphoblastic leukemia: toward a new era of targeted immunotherapy</strong></div><div><em>Biologics.</em> 2020; <strong>14</strong>:23-34</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32103893/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=32103893" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib17" class="citations"><div id="sref17" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref17" title="View in article">17.</a></div><div>Gérard, A. ∙ Cope, A.P. ∙ Kemper, C. ...</div><div><strong>LFA-1 in T&nbsp;cell priming, differentiation, and effector functions</strong></div><div><em>Trends Immunol.</em> 2021; <strong>42</strong>:706-722</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.it.2021.06.004&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.it.2021.06.004&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85111020033" target="_blank" aria-label="Open Scopus in new tab">Scopus (43)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34266767/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.it.2021.06.004&amp;pmid=34266767" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib18" class="citations"><div id="sref18" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref18" title="View in article">18.</a></div><div>Giannoni, E. ∙ Chiarugi, P. ∙ Cozzi, G. ...</div><div><strong>Lymphocyte function-associated antigen-1-mediated T&nbsp;cell adhesion is impaired by low molecular weight phosphotyrosine phosphatase-dependent inhibition of FAK activity</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2003; <strong>278</strong>:36763-36776</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M302686200&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M302686200&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0141703588" target="_blank" aria-label="Open Scopus in new tab">Scopus (29)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/12815062/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M302686200&amp;pmid=12815062" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib19" class="citations"><div id="sref19" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref19" title="View in article">19.</a></div><div>Goodman, S.L. ∙ Picard, M.</div><div><strong>Integrins as therapeutic targets</strong></div><div><em>Trends Pharmacol. Sci.</em> 2012; <strong>33</strong>:405-412</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.tips.2012.04.002&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.tips.2012.04.002&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84862686491" target="_blank" aria-label="Open Scopus in new tab">Scopus (317)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22633092/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.tips.2012.04.002&amp;pmid=22633092" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib20" class="citations"><div id="sref20" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref20" title="View in article">20.</a></div><div>Han, J. ∙ Khatwani, N. ∙ Searles, T.G. ...</div><div><strong>Memory CD8+ T&nbsp;cell responses to cancer</strong></div><div><em>Semin. Immunol.</em> 2020; <strong>49</strong>:101435</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.smim.2020.101435" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85096951476" target="_blank" aria-label="Open Scopus in new tab">Scopus (92)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/33272898/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.smim.2020.101435&amp;pmid=33272898" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib21" class="citations"><div id="sref21" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref21" title="View in article">21.</a></div><div>Hebeisen, M. ∙ Oberle, S.G. ∙ Presotto, D. ...</div><div><strong>Molecular insights for optimizing T&nbsp;cell receptor specificity against cancer</strong></div><div><em>Front. Immunol.</em> 2013; <strong>4</strong>:154</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3389/fimmu.2013.00154" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84883790660" target="_blank" aria-label="Open Scopus in new tab">Scopus (32)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23801991/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3389%2Ffimmu.2013.00154&amp;pmid=23801991" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib22" class="citations"><div id="sref22" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref22" title="View in article">22.</a></div><div>Heberle, H. ∙ Meirelles, G.V. ∙ da Silva, F.R. ...</div><div><strong>InteractiVenn: A web-based tool for the analysis of sets through Venn diagrams</strong></div><div><em>BMC Bioinformatics.</em> 2015; <strong>16</strong>:169</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1186/s12859-015-0611-3" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84929463087" target="_blank" aria-label="Open Scopus in new tab">Scopus (1457)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25994840/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1186%2Fs12859-015-0611-3&amp;pmid=25994840" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib23" class="citations"><div id="sref23" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref23" title="View in article">23.</a></div><div>Hogg, N. ∙ Patzak, I. ∙ Willenbrock, F.</div><div><strong>The insider's guide to leukocyte integrin signalling and function</strong></div><div><em>Nat. Rev. Immunol.</em> 2011; <strong>11</strong>:416-426</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri2986" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-79957621253" target="_blank" aria-label="Open Scopus in new tab">Scopus (322)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21597477/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri2986&amp;pmid=21597477" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib24" class="citations"><div id="sref24" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref24" title="View in article">24.</a></div><div>Huwyler, J. ∙ Yang, J. ∙ Pardridge, W.M.</div><div><strong>Receptor mediated delivery of daunomycin using immunoliposomes: Pharmacokinetics and tissue distribution in the rat</strong></div><div><em>J.&nbsp;Pharmacol. Exp. Ther.</em> 1997; <strong>282</strong>:1541-1546</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS0022-3565%2824%2936946-0&amp;cf=fulltext&amp;site=jpet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS0022-3565%2824%2936946-0&amp;cf=pdf&amp;site=jpet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9316870/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0022-3565%2824%2936946-0&amp;pmid=9316870" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib25" class="citations"><div id="sref25" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref25" title="View in article">25.</a></div><div>Kanarek, N. ∙ Petrova, B. ∙ Sabatini, D.M.</div><div><strong>Dietary modifications for enhanced cancer therapy</strong></div><div><em>Nature.</em> 2020; <strong>579</strong>:507-517</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41586-020-2124-0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85082404548" target="_blank" aria-label="Open Scopus in new tab">Scopus (229)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/32214253/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41586-020-2124-0&amp;pmid=32214253" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib26" class="citations"><div id="sref26" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref26" title="View in article">26.</a></div><div>Kanellopoulou, C. ∙ George, A.B. ∙ Masutani, E. ...</div><div><strong>Mg2+ regulation of kinase signaling and immune function</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2019; <strong>216</strong>:1828-1842</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20181970" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85070636174" target="_blank" aria-label="Open Scopus in new tab">Scopus (44)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31196981/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20181970&amp;pmid=31196981" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib27" class="citations"><div id="sref27" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref27-1" title="View in article">27.</a></div><div>Kiyoi, H. ∙ Morris, J.D. ∙ Oh, I. ...</div><div><strong>Phase 1b/2 study of Blinatumomab in Japanese adults with relapsed/refractory acute lymphoblastic leukemia</strong></div><div><em>Cancer Sci.</em> 2020; <strong>111</strong>:1314-1323</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/cas.14322" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85079468567" target="_blank" aria-label="Open Scopus in new tab">Scopus (18)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31971321/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fcas.14322&amp;pmid=31971321" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib28" class="citations"><div id="sref28" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref28" title="View in article">28.</a></div><div>Krutzik, P.O. ∙ Nolan, G.P.</div><div><strong>Intracellular phospho-protein staining techniques for flow cytometry: Monitoring single cell signaling events</strong></div><div><em>Cytometry A.</em> 2003; <strong>55</strong>:61-70</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1002/cyto.a.10072" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0346244001" target="_blank" aria-label="Open Scopus in new tab">Scopus (473)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/14505311/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1002%2Fcyto.a.10072&amp;pmid=14505311" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib29" class="citations"><div id="sref29" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref29" title="View in article">29.</a></div><div>Labadia, M.E. ∙ Jeanfavre, D.D. ∙ Caviness, G.O. ...</div><div><strong>Molecular regulation of the interaction between leukocyte function-associated antigen-1 and soluble ICAM-1 by divalent metal cations</strong></div><div><em>J.&nbsp;Immunol.</em> 1998; <strong>161</strong>:836-842</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.161.2.836" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9670961/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.161.2.836&amp;pmid=9670961" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib30" class="citations"><div id="sref30" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref30" title="View in article">30.</a></div><div>Lajer, H. ∙ Daugaard, G.</div><div><strong>Cisplatin and hypomagnesemia</strong></div><div><em>Cancer Treat. Rev.</em> 1999; <strong>25</strong>:47-58</div></div><div class="external-links"><div class="core-xlink-abstract"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1053%2Fctrv.1999.0097&amp;cf=abstract&amp;site=yctrv-site" target="_blank" aria-label="Open Abstract in new tab">Abstract</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1053%2Fctrv.1999.0097&amp;cf=pdf&amp;site=yctrv-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0033081313" target="_blank" aria-label="Open Scopus in new tab">Scopus (204)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10212589/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1053%2Fctrv.1999.0097&amp;pmid=10212589" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib31" class="citations"><div id="sref31" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref31" title="View in article">31.</a></div><div>Larsson, S.C. ∙ Orsini, N. ∙ Wolk, A.</div><div><strong>Dietary magnesium intake and risk of stroke: A meta-analysis of prospective studies</strong></div><div><em>Am. J. Clin. Nutr.</em> 2012; <strong>95</strong>:362-366</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3945/ajcn.111.022376" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84856380753" target="_blank" aria-label="Open Scopus in new tab">Scopus (143)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22205313/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3945%2Fajcn.111.022376&amp;pmid=22205313" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib32" class="citations"><div id="sref32" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref32" title="View in article">32.</a></div><div>Lee, C. ∙ Raffaghello, L. ∙ Brandhorst, S. ...</div><div><strong>Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy</strong></div><div><em>Sci. Transl. Med.</em> 2012; <strong>4</strong>:124ra27</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1126/scitranslmed.3003293" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84863229916" target="_blank" aria-label="Open Scopus in new tab">Scopus (509)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22323820/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1126%2Fscitranslmed.3003293&amp;pmid=22323820" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib33" class="citations"><div id="sref33" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref33" title="View in article">33.</a></div><div>Li, D. ∙ Molldrem, J.J. ∙ Ma, Q.</div><div><strong>LFA-1 regulates CD8+T cell activation via T&nbsp;cell receptor-mediated and LFA-1-mediated ERK1/2 signal pathways</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2009; <strong>284</strong>:21001-21010</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M109.002865&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M109.002865&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-68949085309" target="_blank" aria-label="Open Scopus in new tab">Scopus (56)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19483086/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M109.002865&amp;pmid=19483086" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib34" class="citations"><div id="sref34" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref34" title="View in article">34.</a></div><div>Liu, W. ∙ Qdaisat, A. ∙ Soliman, P.T. ...</div><div><strong>Hypomagnesemia and survival in patients with ovarian cancer who received chemotherapy with carboplatin</strong></div><div><em>Oncologist.</em> 2019; <strong>24</strong>:e312-e317</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1634/theoncologist.2018-0465" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85063948902" target="_blank" aria-label="Open Scopus in new tab">Scopus (13)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30940743/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1634%2Ftheoncologist.2018-0465&amp;pmid=30940743" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib35" class="citations"><div id="sref35" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref35" title="View in article">35.</a></div><div>Locke, F.L. ∙ Ghobadi, A. ∙ Jacobson, C.A. ...</div><div><strong>Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial</strong></div><div><em>Lancet Oncol.</em> 2019; <strong>20</strong>:31-42</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS1470-2045%2818%2930864-7&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS1470-2045%2818%2930864-7&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85059501669" target="_blank" aria-label="Open Scopus in new tab">Scopus (1541)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30518502/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1470-2045%2818%2930864-7&amp;pmid=30518502" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib36" class="citations"><div id="sref36" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref36" title="View in article">36.</a></div><div>Lötscher, J. ∙ Balmer, M.L.</div><div><strong>Sensing between reactions - how the metabolic microenvironment shapes immunity</strong></div><div><em>Clin. Exp. Immunol.</em> 2019; <strong>197</strong>:161-169</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/cei.13291" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85063410302" target="_blank" aria-label="Open Scopus in new tab">Scopus (9)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30868561/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fcei.13291&amp;pmid=30868561" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib37" class="citations"><div id="sref37" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref37" title="View in article">37.</a></div><div>Lowenstein, F.W. ∙ Stanton, M.F.</div><div><strong>Serum magnesium levels in the United States, 1971–1974</strong></div><div><em>J.&nbsp;Am. Coll. Nutr.</em> 1986; <strong>5</strong>:399-414</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/07315724.1986.10720143" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0022510113" target="_blank" aria-label="Open Scopus in new tab">Scopus (129)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/3771947/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F07315724.1986.10720143&amp;pmid=3771947" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib38" class="citations"><div id="sref38" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref38" title="View in article">38.</a></div><div>Moore, T.I. ∙ Aaron, J. ∙ Chew, T.L. ...</div><div><strong>Measuring integrin conformational change on the cell surface with super-resolution microscopy</strong></div><div><em>Cell Rep.</em> 2018; <strong>22</strong>:1903-1912</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.celrep.2018.01.062&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.celrep.2018.01.062&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85042002828" target="_blank" aria-label="Open Scopus in new tab">Scopus (44)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29444440/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2018.01.062&amp;pmid=29444440" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib39" class="citations"><div id="sref39" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref39" title="View in article">39.</a></div><div>Mould, A.P. ∙ Barton, S.J. ∙ Askari, J.A. ...</div><div><strong>Role of ADMIDAS cation-binding site in ligand recognition by integrin alpha 5 beta 1</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2003; <strong>278</strong>:51622-51629</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M306655200&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M306655200&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0347695986" target="_blank" aria-label="Open Scopus in new tab">Scopus (80)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/14532288/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M306655200&amp;pmid=14532288" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib40" class="citations"><div id="sref40" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref40" title="View in article">40.</a></div><div>Nakamura, Y. ∙ Mochida, A. ∙ Choyke, P.L. ...</div><div><strong>Nanodrug delivery: Is the enhanced permeability and retention effect sufficient for curing cancer?</strong></div><div><em>Bioconjug. Chem.</em> 2016; <strong>27</strong>:2225-2238</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/acs.bioconjchem.6b00437" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84992363294" target="_blank" aria-label="Open Scopus in new tab">Scopus (757)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27547843/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Facs.bioconjchem.6b00437&amp;pmid=27547843" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib41" class="citations"><div id="sref41" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref41" title="View in article">41.</a></div><div>Nasulewicz, A. ∙ Wietrzyk, J. ∙ Wolf, F.I. ...</div><div><strong>Magnesium deficiency inhibits primary tumor growth but favors metastasis in mice</strong></div><div><em>Biochim. Biophys. Acta.</em> 2004; <strong>1739</strong>:26-32</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.bbadis.2004.08.003" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-10644240115" target="_blank" aria-label="Open Scopus in new tab">Scopus (78)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15607114/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.bbadis.2004.08.003&amp;pmid=15607114" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib42" class="citations"><div id="sref42" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref42" title="View in article">42.</a></div><div>Neelapu, S.S. ∙ Locke, F.L. ∙ Bartlett, N.L. ...</div><div><strong>Axicabtagene Ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2017; <strong>377</strong>:2531-2544</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1707447" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85040170618" target="_blank" aria-label="Open Scopus in new tab">Scopus (3898)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29226797/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1707447&amp;pmid=29226797" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib43" class="citations"><div id="sref43" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref43" title="View in article">43.</a></div><div>Onley, D.J. ∙ Knight, C.G. ∙ Tuckwell, D.S. ...</div><div><strong>Micromolar Ca2+ concentrations are essential for Mg2+-dependent binding of collagen by the integrin alpha 2beta 1 in human platelets</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2000; <strong>275</strong>:24560-24564</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M004111200&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M004111200&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0034636864" target="_blank" aria-label="Open Scopus in new tab">Scopus (70)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10827198/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M004111200&amp;pmid=10827198" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib44" class="citations"><div id="sref44" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref44" title="View in article">44.</a></div><div>Oronsky, B. ∙ Caroen, S. ∙ Oronsky, A. ...</div><div><strong>Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management</strong></div><div><em>Cancer Chemother. Pharmacol.</em> 2017; <strong>80</strong>:895-907</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s00280-017-3392-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85025127650" target="_blank" aria-label="Open Scopus in new tab">Scopus (70)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28730291/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs00280-017-3392-8&amp;pmid=28730291" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib45" class="citations"><div id="sref45" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref45" title="View in article">45.</a></div><div>Qu, X. ∙ Jin, F. ∙ Hao, Y. ...</div><div><strong>Magnesium and the risk of cardiovascular events: A meta-analysis of prospective cohort studies</strong></div><div><em>PLoS One.</em> 2013; <strong>8</strong>, e57720</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pone.0057720" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84874780456" target="_blank" aria-label="Open Scopus in new tab">Scopus (155)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23520480/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pone.0057720&amp;pmid=23520480" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib46" class="citations"><div id="sref46" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref46" title="View in article">46.</a></div><div>Ravell, J. ∙ Otim, I. ∙ Nabalende, H. ...</div><div><strong>Plasma magnesium is inversely associated with Epstein-Barr virus load in peripheral blood and Burkitt lymphoma in Uganda</strong></div><div><em>Cancer Epidemiol.</em> 2018; <strong>52</strong>:70-74</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.canep.2017.12.004" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85038022583" target="_blank" aria-label="Open Scopus in new tab">Scopus (17)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29248801/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.canep.2017.12.004&amp;pmid=29248801" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib47" class="citations"><div id="sref47" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref47" title="View in article">47.</a></div><div>Rothschild, S.I. ∙ Zippelius, A. ∙ Eboulet, E.I. ...</div><div><strong>SAKK 16/14: durvalumab in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small-cell lung cancer-a multicenter single-arm phase II trial</strong></div><div><em>J.&nbsp;Clin. Oncol.</em> 2021; <strong>39</strong>:2872-2880</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1200/JCO.21.00276" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85116171412" target="_blank" aria-label="Open Scopus in new tab">Scopus (178)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/34251873/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1200%2FJCO.21.00276&amp;pmid=34251873" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib48" class="citations"><div id="sref48" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref48" title="View in article">48.</a></div><div>Sabatos, C.A. ∙ Doh, J. ∙ Chakravarti, S. ...</div><div><strong>A synaptic basis for paracrine interleukin-2 signaling during homotypic T&nbsp;cell interaction</strong></div><div><em>Immunity.</em> 2008; <strong>29</strong>:238-248</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.immuni.2008.05.017&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.immuni.2008.05.017&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-48749084864" target="_blank" aria-label="Open Scopus in new tab">Scopus (119)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18674934/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2008.05.017&amp;pmid=18674934" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib49" class="citations"><div id="sref49" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref49" title="View in article">49.</a></div><div>Sakaguchi, Y. ∙ Fujii, N. ∙ Shoji, T. ...</div><div><strong>Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis</strong></div><div><em>Kidney Int.</em> 2014; <strong>85</strong>:174-181</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1038%2Fki.2013.327&amp;cf=fulltext&amp;site=kint-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1038%2Fki.2013.327&amp;cf=pdf&amp;site=kint-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84891560448" target="_blank" aria-label="Open Scopus in new tab">Scopus (246)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23986148/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fki.2013.327&amp;pmid=23986148" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib50" class="citations"><div id="sref50" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref50" title="View in article">50.</a></div><div>Salas, A. ∙ Shimaoka, M. ∙ Kogan, A.N. ...</div><div><strong>Rolling adhesion through an extended conformation of integrin alphaLbeta2 and relation to alpha I and beta I-like domain interaction</strong></div><div><em>Immunity.</em> 2004; <strong>20</strong>:393-406</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS1074-7613%2804%2900082-2&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS1074-7613%2804%2900082-2&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-1842684991" target="_blank" aria-label="Open Scopus in new tab">Scopus (172)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15084269/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1074-7613%2804%2900082-2&amp;pmid=15084269" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib51" class="citations"><div id="sref51" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref51" title="View in article">51.</a></div><div>San Sebastian, E.S. ∙ Mercero, J.M. ∙ Stote, R.H. ...</div><div><strong>On the affinity regulation of the metal-ion-dependent adhesion sites in integrins</strong></div><div><em>J.&nbsp;Am. Chem. Soc.</em> 2006; <strong>128</strong>:3554-3563</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1021/ja054142a" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-33645408058" target="_blank" aria-label="Open Scopus in new tab">Scopus (35)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16536528/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1021%2Fja054142a&amp;pmid=16536528" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib52" class="citations"><div id="sref52" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref52" title="View in article">52.</a></div><div>Santoro, S.P. ∙ Kim, S. ∙ Motz, G.T. ...</div><div><strong>T cells bearing a chimeric antigen receptor against prostate-specific membrane antigen mediate vascular disruption and result in tumor regression</strong></div><div><em>Cancer Immunol. Res.</em> 2015; <strong>3</strong>:68-84</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2326-6066.CIR-14-0192" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84962247223" target="_blank" aria-label="Open Scopus in new tab">Scopus (85)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25358763/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2326-6066.CIR-14-0192&amp;pmid=25358763" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib53" class="citations"><div id="sref53" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref53" title="View in article">53.</a></div><div>Saris, N.E. ∙ Mervaala, E. ∙ Karppanen, H. ...</div><div><strong>Magnesium. An update on physiological, clinical and analytical aspects</strong></div><div><em>Clin. Chim. Acta.</em> 2000; <strong>294</strong>:1-26</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/S0009-8981(99)00258-2" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0034015289" target="_blank" aria-label="Open Scopus in new tab">Scopus (1245)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10727669/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS0009-8981%2899%2900258-2&amp;pmid=10727669" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib54" class="citations"><div id="sref54" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref54" title="View in article">54.</a></div><div>Schaller, M.D. ∙ Hildebrand, J.D. ∙ Shannon, J.D. ...</div><div><strong>Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src</strong></div><div><em>Mol. Cell. Biol.</em> 1994; <strong>14</strong>:1680-1688</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1128/MCB.14.3.1680" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0028350859" target="_blank" aria-label="Open Scopus in new tab">Scopus (1133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7509446/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1128%2FMCB.14.3.1680&amp;pmid=7509446" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib55" class="citations"><div id="sref55" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref55" title="View in article">55.</a></div><div>Schmid, D.A. ∙ Irving, M.B. ∙ Posevitz, V. ...</div><div><strong>Evidence for a TCR affinity threshold delimiting maximal CD8 T&nbsp;cell function</strong></div><div><em>J.&nbsp;Immunol.</em> 2010; <strong>184</strong>:4936-4946</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.1000173" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-77954472387" target="_blank" aria-label="Open Scopus in new tab">Scopus (172)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20351194/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.1000173&amp;pmid=20351194" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib56" class="citations"><div id="sref56" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref56" title="View in article">56.</a></div><div>Schulze, M.B. ∙ Schulz, M. ∙ Heidemann, C. ...</div><div><strong>Fiber and magnesium intake and incidence of type 2 diabetes: a prospective study and meta-analysis</strong></div><div><em>Arch. Intern. Med.</em> 2007; <strong>167</strong>:956-965</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1001/archinte.167.9.956" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-34248554410" target="_blank" aria-label="Open Scopus in new tab">Scopus (477)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17502538/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1001%2Farchinte.167.9.956&amp;pmid=17502538" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib57" class="citations"><div id="sref57" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref57-1" title="View in article">57.</a></div><div>Schürpf, T. ∙ Springer, T.A.</div><div><strong>Regulation of integrin affinity on cell surfaces</strong></div><div><em>EMBO J.</em> 2011; <strong>30</strong>:4712-4727</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/emboj.2011.333" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-82455189778" target="_blank" aria-label="Open Scopus in new tab">Scopus (144)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21946563/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Femboj.2011.333&amp;pmid=21946563" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib58" class="citations"><div id="sref58" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref58" title="View in article">58.</a></div><div>Semmrich, M. ∙ Smith, A. ∙ Feterowski, C. ...</div><div><strong>Importance of integrin LFA-1 deactivation for the generation of immune responses</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2005; <strong>201</strong>:1987-1998</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20041850" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-22344438374" target="_blank" aria-label="Open Scopus in new tab">Scopus (103)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15955836/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20041850&amp;pmid=15955836" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib59" class="citations"><div id="sref59" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref59" title="View in article">59.</a></div><div>Sen, M. ∙ Koksal, A.C. ∙ Yuki, K. ...</div><div><strong>Ligand- and cation-induced structural alterations of the leukocyte integrin LFA-1</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2018; <strong>293</strong>:6565-6577</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.RA117.000710&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.RA117.000710&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85046032698" target="_blank" aria-label="Open Scopus in new tab">Scopus (19)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29507098/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.RA117.000710&amp;pmid=29507098" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib60" class="citations"><div id="sref60" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref60" title="View in article">60.</a></div><div>Shimaoka, M. ∙ Salas, A. ∙ Yang, W. ...</div><div><strong>Small molecule integrin antagonists that bind to the β2 subunit I-like domain and activate signals in one direction and block them in the other</strong></div><div><em>Immunity.</em> 2003; <strong>19</strong>:391-402</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS1074-7613%2803%2900238-3&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS1074-7613%2803%2900238-3&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0141746138" target="_blank" aria-label="Open Scopus in new tab">Scopus (128)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/14499114/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1074-7613%2803%2900238-3&amp;pmid=14499114" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib61" class="citations"><div id="sref61" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref61" title="View in article">61.</a></div><div>Siddiqi, T. ∙ Soumerai, J.D. ∙ Dorritie, K.A. ...</div><div><strong>Rapid undetectable MRD (uMRD) responses in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) treated with lisocabtagene maraleucel (liso-cel), a CD19-directed CAR T&nbsp;cell product: updated results from transcend CLL 004, a phase 1/2 study including patients with high-risk disease previously treated with ibrutinib</strong></div><div><em>Blood.</em> 2019; <strong>134</strong>:503</div></div><div class="external-links"><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31186276/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?pmid=31186276" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib62" class="citations"><div id="sref62" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref62" title="View in article">62.</a></div><div>Sojka, J.E. ∙ Weaver, C.M.</div><div><strong>Magnesium supplementation and osteoporosis</strong></div><div><em>Nutr. Rev.</em> 1995; <strong>53</strong>:71-74</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/j.1753-4887.1995.tb01505.x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-0029014977" target="_blank" aria-label="Open Scopus in new tab">Scopus (146)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7770187/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fj.1753-4887.1995.tb01505.x&amp;pmid=7770187" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib63" class="citations"><div id="sref63" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref63" title="View in article">63.</a></div><div>Thomas, R. ∙ Al-Khadairi, G. ∙ Roelands, J. ...</div><div><strong>NY-ESO-1 based immunotherapy of cancer: current perspectives</strong></div><div><em>Front. Immunol.</em> 2018; <strong>9</strong>:947</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.3389/fimmu.2018.00947" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85046286771" target="_blank" aria-label="Open Scopus in new tab">Scopus (269)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29770138/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.3389%2Ffimmu.2018.00947&amp;pmid=29770138" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib64" class="citations"><div id="sref64" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref64-1" title="View in article">64.</a></div><div>Topp, M.S. ∙ Gökbuget, N. ∙ Stein, A.S. ...</div><div><strong>Safety and activity of Blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: A multicentre, single-arm, phase 2 study</strong></div><div><em>Lancet Oncol.</em> 2015; <strong>16</strong>:57-66</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS1470-2045%2814%2971170-2&amp;cf=fulltext&amp;site=lancet-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2FS1470-2045%2814%2971170-2&amp;cf=pdf&amp;site=lancet-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84926099033" target="_blank" aria-label="Open Scopus in new tab">Scopus (1013)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25524800/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2FS1470-2045%2814%2971170-2&amp;pmid=25524800" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib65" class="citations"><div id="sref65" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref65" title="View in article">65.</a></div><div>Trebak, M. ∙ Kinet, J.P.</div><div><strong>Calcium signalling in T&nbsp;cells</strong></div><div><em>Nat. Rev. Immunol.</em> 2019; <strong>19</strong>:154-169</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41577-018-0110-7" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85059679768" target="_blank" aria-label="Open Scopus in new tab">Scopus (290)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30622345/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41577-018-0110-7&amp;pmid=30622345" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib66" class="citations"><div id="sref66" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref66" title="View in article">66.</a></div><div>Valdramidou, D. ∙ Humphries, M.J. ∙ Mould, A.P.</div><div><strong>Distinct roles of beta1 metal ion-dependent adhesion site (MIDAS), adjacent to MIDAS (ADMIDAS), and ligand-associated metal-binding site (LIMBS) cation-binding sites in ligand recognition by integrin alpha2beta1</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2008; <strong>283</strong>:32704-32714</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M802066200&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M802066200&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-57749106677" target="_blank" aria-label="Open Scopus in new tab">Scopus (47)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18820259/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M802066200&amp;pmid=18820259" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib67" class="citations"><div id="sref67" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref67-1" title="View in article">67.</a></div><div>van Aalderen, M.C. ∙ van den Biggelaar, M. ∙ Remmerswaal, E.B.M. ...</div><div><strong>Label-free analysis of CD8+ T&nbsp;cell subset proteomes supports a progressive differentiation model of human-virus-specific T&nbsp;cells</strong></div><div><em>Cell Rep.</em> 2017; <strong>19</strong>:1068-1079</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.celrep.2017.04.014&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1016%2Fj.celrep.2017.04.014&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-85018956495" target="_blank" aria-label="Open Scopus in new tab">Scopus (22)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28467900/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.celrep.2017.04.014&amp;pmid=28467900" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib68" class="citations"><div id="sref68" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref68" title="View in article">68.</a></div><div>Vorup-Jensen, T. ∙ Waldron, T.T. ∙ Astrof, N. ...</div><div><strong>The connection between metal ion affinity and ligand affinity in integrin I domains</strong></div><div><em>Biochim. Biophys. Acta.</em> 2007; <strong>1774</strong>:1148-1155</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.bbapap.2007.06.014" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-34548288408" target="_blank" aria-label="Open Scopus in new tab">Scopus (34)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17702677/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.bbapap.2007.06.014&amp;pmid=17702677" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib69" class="citations"><div id="sref69" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref69" title="View in article">69.</a></div><div>Wang, Y. ∙ Li, D. ∙ Nurieva, R. ...</div><div><strong>LFA-1 affinity regulation is necessary for the activation and proliferation of naive T&nbsp;cells</strong></div><div><em>J.&nbsp;Biol. Chem.</em> 2009; <strong>284</strong>:12645-12653</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M807207200&amp;cf=fulltext&amp;site=jbc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=10.1074%2Fjbc.M807207200&amp;cf=pdf&amp;site=jbc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_69_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-67649814709" target="_blank" aria-label="Open Scopus in new tab">Scopus (45)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19297325/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1074%2Fjbc.M807207200&amp;pmid=19297325" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib70" class="citations"><div id="sref70" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref70" title="View in article">70.</a></div><div>Zhan, Y. ∙ Chen, R. ∙ Zheng, W. ...</div><div><strong>Association between serum magnesium and anemia: China health and nutrition survey</strong></div><div><em>Biol. Trace Elem. Res.</em> 2014; <strong>159</strong>:39-45</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s12011-014-9967-x" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_70_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84902537269" target="_blank" aria-label="Open Scopus in new tab">Scopus (38)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24789475/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs12011-014-9967-x&amp;pmid=24789475" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib71" class="citations"><div id="sref71" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref71" title="View in article">71.</a></div><div>Zhang, K. ∙ Chen, J.</div><div><strong>The regulation of integrin function by divalent cations</strong></div><div><em>Cell Adh. Migr.</em> 2012; <strong>6</strong>:20-29</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4161/cam.18702" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_71_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2021.12.039&amp;key=2-s2.0-84860360231" target="_blank" aria-label="Open Scopus in new tab">Scopus (166)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22647937/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4161%2Fcam.18702&amp;pmid=22647937" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div></div></div></section></div></section><div class="core-linked-content">
    

        


    

            

            

            <div data-widget-id="8633d695-b258-4908-b86f-e2c268ec3c6b" data-widget-name="UX3HTMLWidget"><script type="text/javascript">
if($('.content-navigation__body__title').length){
$('.content-navigation__body__title').each(function(){
var html=this.innerHTML;
var div = document.createElement("div");
div.innerHTML = html;
var text = div.textContent || div.innerText || "";
this.innerHTML=text;
});
}
</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="393effff-5b44-4681-a9b4-4f029b3540b7" data-widget-name="UX3HTMLWidget"><style>
.linkback-ad .pb-ad {
    display: block;
   height: auto;
    margin-left: 0px;
    margin-right: auto;
}
</style></div>

            

        

    

        

</div></div></div><div class="core-collateral-aside"><section id="core-collateral-figures"><h2>Figures (14)<button class="js--openFigureViewer"><span>Figure Viewer</span></button></h2><div class="core-collateral-aside-wrapper"><div class="grid"><a class="figure__open__ctrl" href="#fig1" aria-label="Go to Figure&amp;nbsp;1"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.12.039/asset/2749bce4-823c-42cd-a4c4-33083ae04a91/main.assets/gr1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs1" aria-label="Go to Figure&amp;nbsp;S1"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.12.039/asset/b4a993ed-77f1-4537-ba1f-25748f12e244/main.assets/figs1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig2" aria-label="Go to Figure&amp;nbsp;2"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.12.039/asset/cbbf1e30-8eef-4902-a166-358cd5fd68d8/main.assets/gr2.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs2" aria-label="Go to Figure&amp;nbsp;S2"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.12.039/asset/b9c8af47-b43c-464a-a4d8-c5c28d7c57f3/main.assets/figs2.jpg" aria-hidden="true"></a></div><div id="collapsible-figures" data-expandable="item"><div class="content grid" style="display:none;" role="region" id="collapsible-figures_content"><a class="figure__open__ctrl" href="#fig3" aria-label="Go to Figure&amp;nbsp;3"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.12.039/asset/32dba184-c9ff-4069-9f3e-4a769e72e5e5/main.assets/gr3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs3" aria-label="Go to Figure&amp;nbsp;S3"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.12.039/asset/c867bde5-f8d7-41dd-8566-be48dfb1a77d/main.assets/figs3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig4" aria-label="Go to Figure&amp;nbsp;4"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.12.039/asset/7cdd0378-7bac-4c79-80f6-319d6d15c1d6/main.assets/gr4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs4" aria-label="Go to Figure&amp;nbsp;S4"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.12.039/asset/ef2a5e2d-f1ab-436e-8d56-f7c3a588c804/main.assets/figs4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig5" aria-label="Go to Figure&amp;nbsp;5"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.12.039/asset/8414b066-4d8e-45c7-931d-72575e9c6896/main.assets/gr5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs5" aria-label="Go to Figure&amp;nbsp;S5"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.12.039/asset/d4ceacaa-186e-4ca9-9206-5a844057fe29/main.assets/figs5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig6" aria-label="Go to Figure&amp;nbsp;6"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.12.039/asset/1fb99c06-0951-4bd4-9075-16972e4c9fd2/main.assets/gr6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs6" aria-label="Go to Figure&amp;nbsp;S6"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.12.039/asset/a91c3b6d-82c1-458e-911b-4d99f5e73367/main.assets/figs6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig7" aria-label="Go to Figure&amp;nbsp;7"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.12.039/asset/1a385ec4-a122-480d-a345-856a3bcdd6d2/main.assets/gr7.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs7" aria-label="Go to Figure&amp;nbsp;S7"><img src="https://www.cell.com/cms/10.1016/j.cell.2021.12.039/asset/d52e3150-9a37-4963-8b49-3c437b7e7e54/main.assets/figs7.jpg" aria-hidden="true"></a></div><button class="trigger" aria-controls="collapsible-figures_content" aria-expanded="false" tabindex="0" role="button"><span class="expand">Show all figures</span><span class="collapse">Hide figures</span><i class="icon-section_arrow_d" aria-hidden="true"></i></button></div></div></section>
    

        


    

            

            

            <section id="core-collateral-metrics" class="publication-list__axel-section"><h2>Article metrics</h2><div><ul class="publication-list rlist publication-list--list plum-x--lazy-load publication-list--axel" data-plum-x-url="/pb/widgets/ux3/publicationList/plumx?widgetId=66dd7e11-7768-4006-93d8-a72b60e2a264&amp;pbContext=%3Bproduct%3Aproduct%3Aelsevier%5C%3Aproduct%5C%3Acell%3Bwebsite%3Awebsite%3Acell-site%3Bissue%3Aissue%3Apii%5C%3AS0092867421X00050%3Bctype%3Astring%3AJournal+Content%3Bjournal%3Ajournal%3Acell%3BpageGroup%3Astring%3AArticle+View%3Bpage%3Astring%3AShow+Full+Text%3BrequestedJournal%3Ajournal%3Acell%3Bwgroup%3Astring%3ADefault+Website+Group%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3Apii%5C%3AS0092867421015610" data-pb-mode-enabled="false"><li aria-label="loading articles" role="alert" class="js--loading plum-x--spinner hidden"></li></ul></div></section>

            

        
<section id="core-collateral-supplementary"><h2>Supplemental information (1)</h2><div class="core-collateral-aside-wrapper"><div class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2021.12.039/attachment/bbb4804d-1a40-4382-90f2-f2e5da94effc/mmc1.pdf" download="mmc1.pdf"><span id="mmc1-link">PDF (45.94 KB)</span></a><div class="core-description">Table S1. crRNA sequences used in CRISPR-Cas9 gene editing experiments, related to Figures&nbsp;3, 4, and S3</div></div></div></div></section>
    

        


    

            

            

            <section id="core-collateral-relatedArticles" class="axel-related-articles"><h2 id="relatedArticles" class="top axel-related-articles__title" data-title="Related articles">Related Articles</h2><div data-pb-widget-type="ux3-relatedArticles" data-widget-id="8d3844d1-450e-497c-ab75-a63fc41750ac" data-widget-name="AtyponTempUX3RelatedArticlesWidget" data-article-pii="S0092867421015610" class="ux3DeferredOnScrollWidget axel-related-articles__body ux3DeferredLoaded" data-show-more="true">We haven't found any related articles.</div></section>

            

        
</div></div><aside data-core-aside="right-rail"><div class="inner-wrapper">

    

        


    

            

            

            <div data-widget-id="dca7470d-9085-4d21-a6f4-a66397718146" data-widget-name="UX3HTMLWidget"><input type="hidden" id="gptPage" value="cell-videos"></div>

            

        











        <div data-widget-def="literatumAd" data-widget-id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc" class="adplaceholders" style="right: 0px; position: static;">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd alignCenter  widget-verticalAd" id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc">
                
                
                    
                

                <div class="wrapped " id="Marketplace-Recs">
                    
                    <div class="widget-body body body-verticalAd "><div class="verticalAdContainer">
    <div class="verticalAdLabelContainer">
        <div class="verticalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adVert.gif" alt="Advertisement">
        </div>
    </div>
    <div class="verticalAd">
        





        <div class="pb-ad">
            <script src="//cdn.pbgrd.com/core-cell.js" async=""></script>
<div id="pbgrd-skyr-c"><div id="pbgrd-skyr" style="width: inherit; position: relative; background: transparent;"></div></div>
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

        </div>
    

</div></aside><div class="core-authors-details" style="display:none"><section class="core-authors"></section></div></article><div data-extent="article-wrapper"><div class="core-container"></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1016/j.cell.2021.12.039","data-is-retraction":false,"data-is-retired":false}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><template id="figure_nav_template"><a href="#" class="open-in-viewer btn btn-dark figure-pop-btn"><i aria-hidden="true" class="icon-export_citation"></i><span>Open in viewer</span></a></template><div id="figure-viewer" role="dialog" aria-modal="true" aria-label="Figure Viewer" class="showCaption showThumbstrip figure-viewer"><nav class="nav-bar figure-viewer__top"><a href="#" title="Close Figure Viewer" role="button" class="figure-viewer__close"><i aria-hidden="true" class="icon-tools_close"></i></a><div class="figure-viewer__title">Magnesium sensing via LFA-1 regulates CD8+ T&nbsp;cell effector function</div></nav><div class="frames"><ul class="frames__list"><li><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2021.12.039/asset/2749bce4-823c-42cd-a4c4-33083ae04a91/main.assets/gr1.jpg" height="919" width="659" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/5fea6f02-b490-4125-9828-8a2030db1879/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2021.12.039/asset/b4a993ed-77f1-4537-ba1f-25748f12e244/main.assets/figs1.jpg" height="907" width="657" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/08789da6-9833-4035-b3c9-5efe4e8d5ed3/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2021.12.039/asset/cbbf1e30-8eef-4902-a166-358cd5fd68d8/main.assets/gr2.jpg" height="939" width="711" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/47ff5cb7-1e9a-4207-954a-6d2d5392e36d/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2021.12.039/asset/b9c8af47-b43c-464a-a4d8-c5c28d7c57f3/main.assets/figs2.jpg" height="870" width="753" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/782e85c5-f588-4ef2-94e7-4ea75010210a/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2021.12.039/asset/32dba184-c9ff-4069-9f3e-4a769e72e5e5/main.assets/gr3.jpg" height="934" width="659" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/9c3faf58-3315-4d37-9917-8438e911f509/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2021.12.039/asset/c867bde5-f8d7-41dd-8566-be48dfb1a77d/main.assets/figs3.jpg" height="931" width="684" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/71dc8aaa-7aef-4879-9a99-c3fa2f42a8cd/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2021.12.039/asset/7cdd0378-7bac-4c79-80f6-319d6d15c1d6/main.assets/gr4.jpg" height="632" width="656" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/8a16e910-128f-4f80-b587-754d38e0cfb0/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2021.12.039/asset/ef2a5e2d-f1ab-436e-8d56-f7c3a588c804/main.assets/figs4.jpg" height="942" width="734" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/1cb79309-b5ed-4140-a268-9a079d3602cf/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2021.12.039/asset/8414b066-4d8e-45c7-931d-72575e9c6896/main.assets/gr5.jpg" height="629" width="753" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/aae324c8-9a4d-46dc-b7c6-6f9a5d309b91/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2021.12.039/asset/d4ceacaa-186e-4ca9-9206-5a844057fe29/main.assets/figs5.jpg" height="187" width="753" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/e97a97f8-161a-4c72-84dc-1799858582e2/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2021.12.039/asset/1fb99c06-0951-4bd4-9075-16972e4c9fd2/main.assets/gr6.jpg" height="915" width="659" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/b7de6730-9962-4eb0-a854-0a28ed1b7132/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2021.12.039/asset/a91c3b6d-82c1-458e-911b-4d99f5e73367/main.assets/figs6.jpg" height="932" width="696" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/3b4503a6-5f3e-4844-a67d-51b267e491f3/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2021.12.039/asset/1a385ec4-a122-480d-a345-856a3bcdd6d2/main.assets/gr7.jpg" height="941" width="687" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/c776df61-a6ce-4a8e-aabb-38106f419e76/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2021.12.039/asset/d52e3150-9a37-4963-8b49-3c437b7e7e54/main.assets/figs7.jpg" height="941" width="677" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/ce6da560-3a5d-48d3-bcd6-7259147632fe/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle fw-loaded" style="position: relative;"></div></li></ul><a href="#" title="Previous Frame" class="frameButton previousFrameButton frames__prev"><!--span Previous Frame--><i class="icon-arrow_l"></i></a><a href="#" title="Next Frame" class="frameButton nextFrameButton frames__next"><!--span Next Frame--><i class="icon-arrow_r"></i></a></div><div class="caption"><div class="figure-viewer__caption-body"></div></div><div class="toolbar figure-viewer__toolbar"><span class="figure-viewer__counter"></span><a href="#" class="button toggle-caption-button figure-viewer__caption__ctrl"><i aria-hidden="true" class="icon icon-info"></i><span class="label">Hide Caption</span></a><a href="#" class="button download-options-button"><i aria-hidden="true" class="icon icon-gizmo-folder-in download-size-icon"></i><span class="label">Download</span></a><a href="#figures" class="button see-figures figure-viewer__see-figure__ctrl"><i aria-hidden="true" class="icon icon-gizmo-image_figure viewer-size-icon"></i><span class="label">See figure in Article</span></a></div><div class="thumbstrip"><a href="#" class="toggleButton thumbstrip__ctrl"><span>Toggle Thumbstrip</span></a><a href="#" title="Previous Thumbnails" class="thumbstripButton previousThumbstripButton thumbstrip__prev"><i aria-hidden="true" class="icon-arrow_l"></i></a><a href="#" title="Next Thumbnails" class="thumbstripButton nextThumbstripButton thumbstrip__next"><i aria-hidden="true" class="icon-arrow_r"></i></a><div class="thumbstrip__wrapper"><ul class="rlist figure-viewer__thumbslist"><li><div class="thumbnail__label">Figure&nbsp;1</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2021.12.039/asset/2749bce4-823c-42cd-a4c4-33083ae04a91/main.assets/gr1.jpg" height="919" width="659" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/5fea6f02-b490-4125-9828-8a2030db1879/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S1</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2021.12.039/asset/b4a993ed-77f1-4537-ba1f-25748f12e244/main.assets/figs1.jpg" height="907" width="657" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/08789da6-9833-4035-b3c9-5efe4e8d5ed3/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;2</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2021.12.039/asset/cbbf1e30-8eef-4902-a166-358cd5fd68d8/main.assets/gr2.jpg" height="939" width="711" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/47ff5cb7-1e9a-4207-954a-6d2d5392e36d/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S2</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2021.12.039/asset/b9c8af47-b43c-464a-a4d8-c5c28d7c57f3/main.assets/figs2.jpg" height="870" width="753" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/782e85c5-f588-4ef2-94e7-4ea75010210a/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;3</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2021.12.039/asset/32dba184-c9ff-4069-9f3e-4a769e72e5e5/main.assets/gr3.jpg" height="934" width="659" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/9c3faf58-3315-4d37-9917-8438e911f509/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S3</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2021.12.039/asset/c867bde5-f8d7-41dd-8566-be48dfb1a77d/main.assets/figs3.jpg" height="931" width="684" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/71dc8aaa-7aef-4879-9a99-c3fa2f42a8cd/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;4</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2021.12.039/asset/7cdd0378-7bac-4c79-80f6-319d6d15c1d6/main.assets/gr4.jpg" height="632" width="656" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/8a16e910-128f-4f80-b587-754d38e0cfb0/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S4</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2021.12.039/asset/ef2a5e2d-f1ab-436e-8d56-f7c3a588c804/main.assets/figs4.jpg" height="942" width="734" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/1cb79309-b5ed-4140-a268-9a079d3602cf/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;5</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2021.12.039/asset/8414b066-4d8e-45c7-931d-72575e9c6896/main.assets/gr5.jpg" height="629" width="753" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/aae324c8-9a4d-46dc-b7c6-6f9a5d309b91/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S5</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2021.12.039/asset/d4ceacaa-186e-4ca9-9206-5a844057fe29/main.assets/figs5.jpg" height="187" width="753" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/e97a97f8-161a-4c72-84dc-1799858582e2/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;6</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2021.12.039/asset/1fb99c06-0951-4bd4-9075-16972e4c9fd2/main.assets/gr6.jpg" height="915" width="659" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/b7de6730-9962-4eb0-a854-0a28ed1b7132/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S6</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2021.12.039/asset/a91c3b6d-82c1-458e-911b-4d99f5e73367/main.assets/figs6.jpg" height="932" width="696" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/3b4503a6-5f3e-4844-a67d-51b267e491f3/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;7</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2021.12.039/asset/1a385ec4-a122-480d-a345-856a3bcdd6d2/main.assets/gr7.jpg" height="941" width="687" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/c776df61-a6ce-4a8e-aabb-38106f419e76/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S7</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2021.12.039/asset/d52e3150-9a37-4963-8b49-3c437b7e7e54/main.assets/figs7.jpg" height="941" width="677" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2021.12.039/asset/ce6da560-3a5d-48d3-bcd6-7259147632fe/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li></ul></div></div><div class="download figure-viewer__download"><div class="pointer"></div><ul class="rlist downlad__wrapper"><li class="hidden-xs hidden-sm"><a href="/action/downloadFigures?pii=e00489&amp;id=" class="downloadAllButton"><i class="icon icon-gizmo-ppt figure-viewer__download__viewer-size-icon figure-viewer__download__viewer-size-icon--ppt"></i><span class="figure-viewer__download__text"> Download .PPT</span></a></li></ul></div></div><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--inverse"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-do="Digital Object" data-figures="Figures" data-metrics="Article Metrics" data-related="Related articles" data-supplementary="Supplemental information"></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-  widget-compact-all" id="756cf18d-e910-4468-936c-0225ae7c669f">
                
                
                    
                

                <div class="wrapped " id="ad for nucleus-single-molecule-technologies">
                    
                    <div class="widget-body body body-  body-compact-all"><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(21)01561-0';

if(URL_var.indexOf("S0165-6147(17)30205-5") > -1
|| URL_var.indexOf("S0167-7799(18)30204-X") > -1 
|| URL_var.indexOf("S0092-8674(18)31649-0") > -1 
|| URL_var.indexOf("S0092-8674(19)30404-0") > -1 
|| URL_var.indexOf("S1097-2765(18)30756-1") > -1 
|| URL_var.indexOf("S0092-8674(18)31452-1") > -1 
|| URL_var.indexOf("S1097-2765(19)30175-3") > -1 
|| URL_var.indexOf("S0092-8674(18)30852-3") > -1 
|| URL_var.indexOf("S0006-3495(18)30295-9") > -1 
|| URL_var.indexOf("S1097-2765(19)30063-2") > -1 
|| URL_var.indexOf("S0006-3495(17)33208-3") > -1 
|| URL_var.indexOf("S2211-1247(18)31639-5") > -1 
|| URL_var.indexOf("S1097-2765(18)30978-X") > -1 
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-single-molecule-technologies" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-" id="754b1780-1117-4371-9285-9cd7020963d5">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body- "><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(21)01561-0';

if(URL_var.indexOf("S1535-6108(19)30104-7") > -1
|| URL_var.indexOf("S0092-8674(18)31394-1") > -1
|| URL_var.indexOf("S1074-7613(19)30033-0") > -1
|| URL_var.indexOf("S1535-6108(18)30473-2") > -1
|| URL_var.indexOf("S0092-8674(19)30154-0") > -1
|| URL_var.indexOf("S1550-4131(18)30178-5") > -1
|| URL_var.indexOf("S1535-6108(19)30242-9") > -1
|| URL_var.indexOf("S1074-7613(18)30431-X") > -1
|| URL_var.indexOf("S0092-8674(19)30618-X") > -1
|| URL_var.indexOf("S1535-6108(18)30472-0") > -1
|| URL_var.indexOf("S1535-6108(18)30120-X") > -1
|| URL_var.indexOf("S0092-8674(18)31247-9") > -1
|| URL_var.indexOf("S1074-7613(18)30085-2") > -1
|| URL_var.indexOf("S1074-7613(18)30080-3") > -1
|| URL_var.indexOf("S1471-4906(18)30210-2") > -1
|| URL_var.indexOf("S1550-4131(19)30304-3") > -1
|| URL_var.indexOf("S1934-5909(18)30599-X") > -1
|| URL_var.indexOf("S2405-8033(19)30024-X") > -1
|| URL_var.indexOf("S1535-6108(18)30109-0") > -1
|| URL_var.indexOf("S0962-8924(18)30127-2") > -1
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-tumor-immune-microenvironment" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="9c9ff7a1-a035-49f6-a336-600c9419c518" data-widget-name="UX3HTMLWidget"><!-- Start of HubSpot Embed Code --> 

<script type="text/plain" class="optanon-category-4" id="hs-script-loader" async="" defer="" src="//js.hs-scripts.com/519224.js"></script> 

<!-- End of HubSpot Embed Code --></div>

            

        

    

        


    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget sessionValidationWidget none  widget-none  widget-compact-all" id="0257aef7-6074-4898-a989-1c3f693225a2">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><script>
    $.ajax({
        url: "https://www.cell.com/ssoSessionCheck",
        type: "GET",
        dataType: "jsonp",
        success: function (data) {
            if(data.RefreshSession) {
                location.reload();
            }
        },
        error : function (){
            console.warn("can't validate CSAS session.");
        }
    });
</script></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasSsoUrls none  widget-none  widget-compact-all" id="948bc5c4-8b0d-47be-b5ad-6570559802d1">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><!-- clear SSO URLs after all iFrames are rendered or after passing a time out-->
<script>
    setTimeout(clearSsoUrlsFun,10000);
    var iFramesList = document.getElementById("sso-urls-div").getElementsByTagName("iframe");
    var renderedIFramesCount = 0;
    var numberOfIFrames = iFramesList.length;
    var skipRefresh = false;
    for (var i = 0; i < iFramesList.length; i++) {
        var iFrame = iFramesList[i];
        iFrame.addEventListener("load", function() {
            renderedIFramesCount = renderedIFramesCount + 1;
            if (renderedIFramesCount >= numberOfIFrames)
            {
                clearSsoUrlsFun();
            }
        });
    }

    function clearSsoUrlsFun() {
        if (skipRefresh == false && numberOfIFrames > 0)
        {
            skipRefresh = true;
            $.ajax({
                url: "https://www.cell.com/action/clearSsoUrls",
                type: "GET",
                dataType: "jsonp",
                error : errorCallingAjx
            });
        }
    }

    function errorCallingAjx(){
        console.log("can't delete sso urls .")
    }
</script></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" class="ux3 ">
        
    

        


    

            

            

            <div data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" data-widget-name="ux3-layout-widget" class="fonts-loaded"><div class="footer clearfix">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header widget-horizontalAd" id="a07ee92b-3942-49f8-9186-a2a08fc3fc56">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 4 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="4"></div>
<!-- End AdSlot 4 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="23703bbc-af46-4f3f-a5bb-dd52891ff0ff" data-widget-name="UX3HTMLWidget"><div class="footer__top">
    <div class="footer__logo centered"><a href="/home" title="Cell Press"><!-- Generator: Adobe Illustrator 25.2.1, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 300 72" style="enable-background:new 0 0 300 72;" xml:space="preserve">
<style type="text/css">
	.st0{fill:#007DBC;}
</style>
<g>
	<path class="st0" d="M39.4,7.5c-2.3-0.3-4.4,1.1-4.9,3.3l-1.8,7.4c-0.4,1.8-1.9,3.1-3.8,3.3l-10.5,1.2C7.1,24-1,34.3,0.7,45.6
		c1.3,9,8.6,15.7,17.2,17c2.3,0.3,4.4-1.1,4.9-3.3l1.8-7.4c0.4-1.8,1.9-3.1,3.8-3.3l10.5-1.2c11.3-1.2,19.4-11.6,17.8-22.9
		C55.3,15.4,48.1,8.8,39.4,7.5z M37.1,34l-6.6,0.8c-1.1,0.1-2,0.9-2.3,2l-1.9,8.1c-0.6,2.4-2.5,4.2-5,4.5c-3.8,0.4-7.1-2.4-7.4-6.2
		c-0.3-3.7,2.6-6.8,6.3-7.2l6.6-0.8c1.1-0.1,2-0.9,2.3-2l1.9-8.1c0.6-2.4,2.5-4.2,5-4.5c3.8-0.4,7.1,2.4,7.4,6.2
		C43.7,30.5,40.8,33.6,37.1,34z"></path>
	<rect x="153.1" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M90.2,20.4c7.3,0,8.6,4.8,9.4,7.3h8.8c-0.5-6.2-5.6-14.9-18.2-14.9c-10.9,0-19.4,7.5-19.4,22.3
		c0,14.6,8.1,22.2,19.3,22.2c10.6,0,16.6-6.4,18.4-15.6h-8.8c-1.1,5.2-4.5,7.9-9.4,7.9c-7.5,0-10.5-6.8-10.5-14.4
		C79.7,23.3,85.9,20.4,90.2,20.4z"></path>
	<path class="st0" d="M125.2,24c-13.7,0-15,12.1-15,15.8c0,12.9,6.8,17.1,15.6,17.1c5.4,0,11.6-2.5,13.8-10H131
		c-0.7,2.2-3,3.4-5.3,3.4c-6.6,0-7.1-5.3-7.3-7.7h21.5v-1.5C139.9,27,131.3,24,125.2,24z M118.6,37.4c0.5-4.1,2.5-6.6,6.4-6.6
		c2.6,0,5.9,1.5,6.4,6.6H118.6z"></path>
	<rect x="142" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M174,13.8h-9.8V21h7.2c4.3,0,8.2,0.9,8.2,6.4c0,5.4-3.9,6.4-8.2,6.4h-7.2V41h9.8c10.6,0,14.7-6.7,14.7-13.6
		C188.7,20.5,184.6,13.8,174,13.8z"></path>
	<path class="st0" d="M210.5,24.9c-0.5-0.2-1.2-0.3-1.8-0.3c-4.1,0-8.3,2.7-9.8,6.5h-0.1v-5.7h-8v30.7h8.4V42.3
		c0-5.4,2.1-9.9,8.3-9.9c1,0,2.3,0.1,3,0.3V24.9z"></path>
	<path class="st0" d="M225.6,24.6c-9.3,0-15.7,7-15.7,16.2c0,9.5,6,16.1,15.7,16.1c6.9,0,12-3.1,14.4-10.3h-7.4
		c-0.5,1.9-3.3,4-6.6,4c-4.7,0-7.3-2.4-7.5-7.8h22.1C241.1,33.4,236,24.6,225.6,24.6z M218.4,37.5c0.1-2.4,1.7-6.5,7-6.5
		c4.1,0,5.9,2.3,6.7,6.5H218.4z"></path>
	<path class="st0" d="M260.3,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		C242,54.3,248.9,57,256,57c7,0,14-2.6,14-10.7C270.1,40.6,265.2,38.8,260.3,37.7z"></path>
	<path class="st0" d="M289.8,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		c0.4,8.1,7.3,10.8,14.4,10.8c7,0,14-2.6,14-10.7C299.6,40.6,294.7,38.8,289.8,37.7z"></path>
	<path class="st0" d="M34.1,57.6c0.3-0.2,0.4-0.6,0.4-1c0-0.5-0.2-0.9-0.5-1.1c-0.3-0.2-0.8-0.3-1.4-0.3h-1.9v5.1h0.8V58h0.8
		l1.3,2.2h0.9l-1.4-2.2C33.6,57.9,33.9,57.8,34.1,57.6z M32.5,57.3h-0.9v-1.5h1c0.1,0,0.3,0,0.4,0c0.1,0,0.3,0,0.4,0.1
		c0.1,0,0.2,0.1,0.3,0.2c0.1,0.1,0.1,0.2,0.1,0.4c0,0.2,0,0.3-0.1,0.4c-0.1,0.1-0.2,0.2-0.3,0.2c-0.1,0.1-0.2,0.1-0.4,0.1
		C32.8,57.3,32.6,57.3,32.5,57.3z"></path>
	<path class="st0" d="M35.6,54.2c-0.4-0.4-0.9-0.7-1.4-0.9c-0.5-0.2-1.1-0.3-1.7-0.3c-0.6,0-1.2,0.1-1.7,0.3c-0.6,0.2-1,0.5-1.4,0.9
		c-0.4,0.4-0.7,0.9-1,1.5c-0.2,0.6-0.4,1.2-0.4,1.9c0,0.7,0.1,1.3,0.3,1.8c0.2,0.6,0.5,1,0.9,1.5c0.4,0.4,0.9,0.7,1.4,1
		c0.6,0.2,1.2,0.4,1.8,0.4c0.6,0,1.2-0.1,1.7-0.3c0.5-0.2,1-0.5,1.4-0.9c0.4-0.4,0.7-0.9,1-1.5c0.2-0.6,0.4-1.2,0.4-1.9
		c0-0.7-0.1-1.3-0.4-1.9C36.4,55.1,36,54.6,35.6,54.2z M35.7,59.1c-0.2,0.5-0.4,0.9-0.8,1.2c-0.3,0.3-0.7,0.6-1.1,0.8
		c-0.4,0.2-0.9,0.3-1.4,0.3c-0.6,0-1-0.1-1.5-0.3c-0.4-0.2-0.8-0.5-1.1-0.8c-0.3-0.3-0.5-0.7-0.7-1.2c-0.2-0.5-0.2-1-0.2-1.5
		c0-0.6,0.1-1.1,0.3-1.5c0.2-0.5,0.4-0.9,0.8-1.2c0.3-0.3,0.7-0.6,1.1-0.8c0.4-0.2,0.9-0.3,1.4-0.3c0.5,0,1,0.1,1.4,0.3
		c0.4,0.2,0.8,0.4,1.1,0.8c0.3,0.3,0.6,0.7,0.8,1.2c0.2,0.5,0.3,1,0.3,1.5C36,58.1,35.9,58.6,35.7,59.1z"></path>
</g>
</svg></a></div>
    <div class="footer__social-links">
        <ul class="rlist rlist--inline centered">
            <li><a href="http://on.fb.me/1tgHakh" title="Facebook" target="_blank"><i aria-hidden="true" class="icon-Icon_Facebook"></i></a></li>

            <li><a href="https://www.instagram.com/cellpress/" title="Instagram" target="_blank"><svg width="18px" height="18px" viewBox="0 0 18 18" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-147.000000, -16.000000)" fill-rule="nonzero" fill="#969696"> <g id="Instagram-Logo" transform="translate(147.000000, 16.000000)"> <path d="M9,1.62580645 C11.4096774,1.62580645 11.7,1.62580645 12.6290323,1.68387097 C13.5,1.71290323 13.9935484,1.85806452 14.3129032,2.00322581 C14.7193548,2.17741935 15.0387097,2.3516129 15.3580645,2.67096774 C15.6774194,2.99032258 15.8806452,3.28064516 16.0258065,3.71612903 C16.1419355,4.03548387 16.2870968,4.5 16.3451613,5.4 C16.3741935,6.35806452 16.4032258,6.61935484 16.4032258,9.02903226 C16.4032258,11.4387097 16.4032258,11.7290323 16.3451613,12.6580645 C16.316129,13.5290323 16.1709677,14.0225806 16.0258065,14.3419355 C15.8516129,14.7483871 15.6774194,15.0677419 15.3580645,15.3870968 C15.0387097,15.7064516 14.7483871,15.9096774 14.3129032,16.0548387 C13.9935484,16.1709677 13.5290323,16.316129 12.6290323,16.3741935 C11.6709677,16.4032258 11.4096774,16.4322581 9,16.4322581 C6.59032258,16.4322581 6.3,16.4322581 5.37096774,16.3741935 C4.5,16.3451613 4.00645161,16.2 3.68709677,16.0548387 C3.28064516,15.8806452 2.96129032,15.7064516 2.64193548,15.3870968 C2.32258065,15.0677419 2.11935484,14.7774194 1.97419355,14.3419355 C1.85806452,14.0225806 1.71290323,13.5580645 1.65483871,12.6580645 C1.62580645,11.7 1.62580645,11.4096774 1.62580645,9 C1.62580645,6.59032258 1.62580645,6.3 1.68387097,5.37096774 C1.71290323,4.5 1.85806452,4.00645161 2.00322581,3.68709677 C2.17741935,3.28064516 2.3516129,2.96129032 2.67096774,2.64193548 C2.99032258,2.32258065 3.28064516,2.11935484 3.71612903,1.97419355 C4.03548387,1.85806452 4.5,1.71290323 5.4,1.65483871 C6.3,1.62580645 6.59032258,1.62580645 9,1.62580645 L9,1.62580645 Z M9,0 C6.56129032,0 6.24193548,0 5.28387097,0.0580645161 C4.32580645,0.116129032 3.65806452,0.261290323 3.10645161,0.464516129 C2.52580645,0.696774194 2.00322581,1.01612903 1.50967742,1.50967742 C1.01612903,2.00322581 0.696774194,2.52580645 0.464516129,3.10645161 C0.232258065,3.68709677 0.0870967742,4.32580645 0.0580645161,5.28387097 C0,6.24193548 0,6.56129032 0,9 C0,11.4387097 0,11.7580645 0.0580645161,12.716129 C0.116129032,13.6741935 0.261290323,14.3419355 0.464516129,14.8935484 C0.696774194,15.4741935 1.01612903,15.9967742 1.50967742,16.4903226 C2.00322581,16.983871 2.52580645,17.3032258 3.10645161,17.5354839 C3.68709677,17.7677419 4.32580645,17.9129032 5.28387097,17.9419355 C6.24193548,18 6.56129032,18 9,18 C11.4387097,18 11.7580645,18 12.716129,17.9419355 C13.6741935,17.883871 14.3419355,17.7387097 14.8935484,17.5354839 C15.4741935,17.3032258 15.9967742,16.983871 16.4903226,16.4903226 C16.983871,15.9967742 17.3032258,15.4741935 17.5354839,14.8935484 C17.7677419,14.3129032 17.9129032,13.6741935 17.9419355,12.716129 C18,11.7580645 18,11.4387097 18,9 C18,6.56129032 18,6.24193548 17.9419355,5.28387097 C17.883871,4.32580645 17.7387097,3.65806452 17.5354839,3.10645161 C17.3032258,2.52580645 16.983871,2.00322581 16.4903226,1.50967742 C15.9967742,1.01612903 15.4741935,0.696774194 14.8935484,0.464516129 C14.3129032,0.232258065 13.6741935,0.0870967742 12.716129,0.0580645161 C11.7580645,0 11.4387097,0 9,0 L9,0 Z"></path> <path d="M9,4.38387097 C6.44516129,4.38387097 4.38387097,6.44516129 4.38387097,9 C4.38387097,11.5548387 6.44516129,13.616129 9,13.616129 C11.5548387,13.616129 13.616129,11.5548387 13.616129,9 C13.616129,6.44516129 11.5548387,4.38387097 9,4.38387097 Z M9,11.9903226 C7.34516129,11.9903226 6.00967742,10.6548387 6.00967742,9 C6.00967742,7.34516129 7.34516129,6.00967742 9,6.00967742 C10.6548387,6.00967742 11.9903226,7.34516129 11.9903226,9 C11.9903226,10.6548387 10.6548387,11.9903226 9,11.9903226 Z"></path> <circle id="Oval" cx="13.7903226" cy="4.20967742" r="1.07419355"></circle> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.linkedin.com/company/cell-press/" title="LinkedIn" target="_blank"><i aria-hidden="true" class="icon-linkedin"></i></a></li>
            
                        <li><a href="http://bit.ly/1zq7Q5T" title="Twitter" target="_blank">
                <!--<i aria-hidden="true" class="icon-Icon_Twitter"></i></a>-->
                
                <svg id="xicon" viewBox="0 0 1200 1227" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" role="none"><path fill="#969696" d="M714.163 519.284L1160.89 0H1055.03L667.137 450.887L357.328 0H0L468.492 681.821L0 1226.37H105.866L515.491 750.218L842.672 1226.37H1200L714.137 519.284H714.163ZM569.165 687.828L521.697 619.934L144.011 79.6944H306.615L611.412 515.685L658.88 583.579L1055.08 1150.3H892.476L569.165 687.854V687.828Z"></path></svg> 

                    <style>
                    .footer svg#xicon {
                      height: 16px;
                    }
                    </style>
            </a></li>

            
            <li><a href="/pb-assets/marketing/WeChat/WeChat-1557753222727.jpg" title="WeChat" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-122.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="wechat" transform="translate(122.000000, 17.000000)"> <path d="M12.375,4.5 L12.375,4.5 L12.4875,4.5 L12.4875,4.5 C12.6898579,4.48604473 12.8520408,4.32704187 12.87,4.125 C12.8705905,4.04725572 12.8470025,3.9712499 12.8025,3.9075 C11.94,1.5675 9.4425,0 6.5625,0 C2.9475,0 0,2.52 0,5.625 C0.0313772094,7.34410122 0.895513317,8.94093526 2.3175,9.9075 L1.5675,11.46 C1.49009368,11.6087816 1.52088865,11.7908702 1.64291494,11.9059236 C1.76494122,12.0209769 1.94852501,12.0410168 2.0925,11.955 L4.08,10.8225 C4.61861992,11.0129999 5.17724298,11.1413322 5.745,11.205 C5.86564124,11.2178337 5.98503738,11.1715098 6.06545426,11.0806685 C6.14587113,10.9898272 6.17737153,10.865694 6.15,10.7475 C6.06148727,10.4219419 6.01114891,10.0871918 6,9.75 C6,6.855 8.8575,4.5 12.375,4.5 Z M8.25,3 C8.66421356,3 9,3.33578644 9,3.75 C9,4.16421356 8.66421356,4.5 8.25,4.5 C7.83578644,4.5 7.5,4.16421356 7.5,3.75 C7.5,3.33578644 7.83578644,3 8.25,3 Z M4.5,4.5 C4.08578644,4.5 3.75,4.16421356 3.75,3.75 C3.75,3.33578644 4.08578644,3 4.5,3 C4.91421356,3 5.25,3.33578644 5.25,3.75 C5.25,4.16421356 4.91421356,4.5 4.5,4.5 Z"></path> <path d="M18,9.75 C18,7.2675 15.48,5.25 12.375,5.25 C9.27,5.25 6.75,7.2675 6.75,9.75 C6.75,12.2325 9.27,14.25 12.375,14.25 C12.9568557,14.2502837 13.5364258,14.1772075 14.1,14.0325 L15.96,14.9625 C16.0114248,14.9874074 16.0678613,15.0002339 16.125,15 C16.2497193,14.9993787 16.3659682,14.9367912 16.4351508,14.8330172 C16.5043335,14.7292432 16.5173955,14.5978644 16.47,14.4825 L15.96,13.2075 C17.1784092,12.4716325 17.9450305,11.1723221 18,9.75 L18,9.75 Z M10.5,9 C10.0857864,9 9.75,8.66421356 9.75,8.25 C9.75,7.83578644 10.0857864,7.5 10.5,7.5 C10.9142136,7.5 11.25,7.83578644 11.25,8.25 C11.25,8.66421356 10.9142136,9 10.5,9 Z M14.25,9 C13.8357864,9 13.5,8.66421356 13.5,8.25 C13.5,7.83578644 13.8357864,7.5 14.25,7.5 C14.6642136,7.5 15,7.83578644 15,8.25 C15,8.66421356 14.6642136,9 14.25,9 Z" opacity="0.959999979"></path> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.weibo.com/CellPress" title="Weibo" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-99.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="weibo" transform="translate(99.000000, 14.000000)"> <g transform="translate(0.000000, 3.000000)"> <path d="M13.2402211,7.47054172 C12.9918392,7.39866484 12.821608,7.34902326 12.9514975,7.03290287 C13.232804,6.34602189 13.2622915,5.75359781 12.9571055,5.33095486 C12.3847236,4.5380684 10.8191759,4.58064295 9.02514573,5.30975376 C9.02514573,5.30889193 8.46144724,5.54882627 8.60544724,5.11515185 C8.88150754,4.25435294 8.83953769,3.53386047 8.41043216,3.11759508 C7.43716583,2.17285363 4.84824121,3.15344733 2.62745729,5.3059617 C0.964944724,6.9186238 0,8.62798358 0,10.105855 C0,12.9324952 3.73748744,14.8235294 7.39429146,14.8235294 C12.1877186,14.8235294 15.3768844,11.9501778 15.3768844,9.80576471 C15.3768844,8.50974008 14.2514774,7.77442408 13.2402211,7.47054172 Z M7.40424121,13.5561176 C4.48625126,13.8315595 1.9678794,12.5686293 1.77811055,10.7327524 C1.58870352,8.89773735 3.80098492,7.18579207 6.71861307,6.90948837 C9.63678392,6.63266758 12.1556985,7.89663201 12.3447437,9.73164706 C12.533608,11.5675239 10.3227739,13.2796416 7.40424121,13.5561176 Z M18,5.16875787 C17.9985528,2.31402189 15.5695477,0 12.5728643,0 C12.222995,0 11.9396985,0.270098495 11.9396985,0.603283174 C11.9396985,0.936640219 12.222995,1.20656635 12.5728643,1.20656635 C14.8708945,1.20656635 16.7336683,2.98159781 16.7336683,5.17099863 C16.7336683,5.50435568 17.0173266,5.77428181 17.3668342,5.77428181 C17.7167035,5.77428181 18,5.50435568 18,5.17099863 C18,5.17099863 18,5.1696197 18,5.16875787 Z M15.4841608,5.08016142 C15.1948945,3.73415048 14.0812462,2.67323393 12.6683819,2.39744733 C12.3262915,2.33039672 11.9914372,2.54051163 11.9212462,2.86680164 C11.8506935,3.19309166 12.0712161,3.51179754 12.4133065,3.57919289 C13.3319397,3.75845417 14.0559196,4.44774829 14.2438794,5.32302599 C14.3146131,5.64931601 14.6491055,5.85925855 14.9915578,5.7923803 C15.3338291,5.72498495 15.5541709,5.40627907 15.4841608,5.08016142 Z M5.90761809,8.7069275 C4.7321005,8.9320383 3.93901508,9.87126402 4.1358392,10.8044569 C4.33248241,11.7378222 5.44504523,12.311803 6.62056281,12.0865198 C7.79571859,11.861409 8.58916583,10.922528 8.3921608,9.98899042 C8.19569849,9.0559699 7.08277387,8.48181669 5.90761809,8.7069275 Z"></path> </g> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.youtube.com/user/cellvideoabstracts" title="YouTube" target="_blank"><svg width="18px" height="13px" viewBox="0 0 18 13" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-76.000000, -19.000000)" fill-rule="nonzero" fill="#969696"> <g id="youtube" transform="translate(76.000000, 14.000000)"> <path d="M17.2984219,6.41974219 C16.6486641,5.64735937 15.4490625,5.33232422 13.1580703,5.33232422 L4.84175391,5.33232422 C2.49834375,5.33232422 1.27838672,5.66771484 0.631089844,6.49001953 C0,7.29172266 0,8.47304297 0,10.1080547 L0,13.2243047 C0,16.3917773 0.748792969,18 4.84175391,18 L13.1581055,18 C15.1448555,18 16.2457383,17.7219844 16.9579688,17.040375 C17.688375,16.3413984 18,15.2001211 18,13.2243047 L18,10.1080547 C18,8.38381641 17.951168,7.19553516 17.2984219,6.41974219 Z M11.5560703,12.0963867 L7.77965625,14.0700586 C7.69524609,14.1141797 7.60289062,14.136082 7.51071094,14.136082 C7.40629687,14.136082 7.30212891,14.1079922 7.20987891,14.0521289 C7.03613672,13.9468711 6.93007031,13.7585391 6.93007031,13.5554414 L6.93007031,9.62075391 C6.93007031,9.41800781 7.03585547,9.22985156 7.20924609,9.12452344 C7.38267187,9.01919531 7.59839062,9.01198828 7.77832031,9.10546875 L11.5547344,11.0664141 C11.7468633,11.1661523 11.8675195,11.3645039 11.8678008,11.5809258 C11.8680469,11.7975586 11.747918,11.9961914 11.5560703,12.0963867 Z"></path> </g> </g> </g></svg></a></li>
            
        </ul>
    </div>
</div>

<style>

.ux3 .footer__logo svg {
    max-width: 160px !important;
}

.ux3 .footer__social-links a svg {
    max-width: 26px;
    height: 1.15rem;
    width: auto;
}

.ux3 .footer__social-links a:hover svg path {
    fill: #353535;
}

</style></div>

            

        

    

        


    

            

            
                <div class="footer__bottom text-onDark">
            

            <div data-widget-id="06227714-c621-4651-9879-b0ce5176cccc" data-widget-name="ux3-layout-widget"><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="07e1d276-b4dd-4870-b858-ed74e70d64ef" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Life &amp; medical sciences journals</h2>
		<ul class="rlist clearfix sided">
		<li>
			<a alt="Cell" href="/cell/home">Cell</a>
		</li>
		<li>
			<a alt="Cancer Cell" href="/cancer-cell/home">Cancer Cell</a>
		</li>
		<li>
			<a alt="Cell Chemical Biology" href="/cell-chemical-biology">Cell Chemical Biology</a>
		</li>
		<li>
			<a alt="Cell Genomics" href="/cell-genomics/home">Cell Genomics</a>
		</li>
		<li>
			<a alt="Cell Host and Microbe" href="/cell-host-microbe/home">Cell Host &amp; Microbe</a>
		</li>
		<li>
			<a alt="Cell Metabolism" href="/cell-metabolism/home">Cell Metabolism</a>
		</li>
		<li>
			<a alt="Cell Reports" href="/cell-reports/home">Cell Reports</a>
		</li>
		<li>
			<a alt="Cell Reports Medicine" href="/cell-reports-medicine/home">Cell Reports Medicine</a>
		</li>
		<li>
			<a alt="Cell Stem Cell" href="/cell-stem-cell/home">Cell Stem Cell</a>
		</li>
		<li>
			<a alt="Cell Systems" href="/cell-systems/home">Cell Systems</a>
		</li>
		<li>
			<a alt="Current Biology" href="/current-biology/home">Current Biology</a>
		</li>
		<li>
			<a alt="Developmental Cell" href="/developmental-cell/home">Developmental Cell</a>
		</li>
		<li>
			<a alt="Immunity" href="/immunity/home">Immunity</a>
		</li>
		<li>
			<a alt="Med" href="/med/home">Med</a>
		</li>
		<li>
			<a alt="Molecular Cell" href="/molecular-cell/home">Molecular Cell</a>
		</li>
		<li>
			<a alt="Neuron" href="/neuron/home">Neuron</a>
		</li>
		<li>
			<a alt="Structure" href="/structure/home">Structure</a>
		</li>
		<li>
			<a alt="American Journal of Human Genetics" href="/ajhg/home">American Journal of Human Genetics (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Journal" href="/biophysj/home">Biophysical Journal (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Reports" href="/biophysreports/home">Biophysical Reports (<i>partner</i>)</a>
		</li>	
		<li>
			<a alt="HGG Advances" href="/hgg-advances/home">Human Genetics and Genomics Advances (<i>partner</i>)</a></li>
		<li>
			<a alt="Molecular Plant" href="/molecular-plant/home">Molecular Plant (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy" href="/molecular-therapy-family/molecular-therapy/home">Molecular Therapy (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Methods and Clinical Development" href="/molecular-therapy-family/methods/home">Molecular Therapy Methods &amp; Clinical Development (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Nucleic Acids" href="/molecular-therapy-family/nucleic-acids/home">Molecular Therapy Nucleic Acids (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Oncology" href="/molecular-therapy-family/oncology/home">Molecular Therapy Oncology (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Plant Communications" href="/plant-communications/home">Plant Communications (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Stem Cell Reports" href="/stem-cell-reports/home">Stem Cell Reports (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biochemical Sciences" href="/trends/biochemical-sciences/home">Trends in Biochemical Sciences</a>
		</li>
		<li>
		</li><li>
			<a alt="Trends in Cancer" href="/trends/cancer/home">Trends in Cancer</a>
		</li>
		<li>
			<a alt="Trends in Cell Biology" href="/trends/cell-biology/home">Trends in Cell Biology</a>
		</li>
		<li>
			<a alt="Trends in Ecology and Evolution" href="/trends/ecology-evolution/home">Trends in Ecology &amp; Evolution</a>
		</li>
		<li>
			<a alt="Trends in Endocrinology and Metabolism" href="/trends/endocrinology-metabolism/home">Trends in Endocrinology &amp; Metabolism</a>
		</li>
		<li>
			<a alt="Trends in Genetics" href="/trends/genetics/home">Trends in Genetics</a>
		</li>
		<li>
			<a alt="Trends in Immunology" href="/trends/immunology/home">Trends in Immunology</a>
		</li>
		<li>
			<a alt="Trends in Microbiology" href="/trends/microbiology/home">Trends in Microbiology</a>
		</li>
		<li>
			<a alt="Trends in Molecular Medicine" href="/trends/molecular-medicine/home">Trends in Molecular Medicine</a>
		</li>
		<li>
			<a alt="Trends in Neurosciences" href="/trends/neurosciences/home">Trends in Neurosciences</a>
		</li>
		<li>
			<a alt="Trends in Parasitology" href="/trends/parasitology/home">Trends in Parasitology</a>
		</li>
		<li>
			<a alt="Trends in Pharmacological Sciences" href="/trends/pharmacological-sciences/home">Trends in Pharmacological Sciences</a>
		</li>
		<li>
			<a alt="Trends in Plant Science" href="/trends/plant-science/home">Trends in Plant Science</a>
		</li>
		</ul>
	</div>

	<div class="group">
		<h2 class="group__title">Physical sciences &amp; engineering journals</h2>
		<ul class="rlist clearfix sided">
		  <li><a alt="Cell Biomaterials" href="/cell-biomaterials/home">Cell Biomaterials</a></li>
		  <li>
			<a alt="Cell Reports Physical Science" href="/cell-reports-physical-science/home">Cell Reports Physical Science</a>
		</li>
		<li>
			<a alt="Chem" href="/chem/home">Chem</a>
		</li>
		<li>
			<a alt="Chem Catalysis" href="/chem-catalysis/home">Chem Catalysis</a>
		</li>
		<li>
			<a alt="Device" href="/device/home">Device</a>
		</li>
		<li>
			<a alt="Joule" href="/joule/home">Joule</a>
		</li>
		<li>
			<a alt="Matter" href="/matter/home">Matter</a>
		</li>	
		<li><a alt="Matter" href="/newton/home">Newton</a></li>
		<li>
			<a alt="Trends in Chemistry" href="/trends/chemistry/home">Trends in Chemistry</a>
		</li>			
		</ul>
	</div>

<div class="group">
	<h2 class="group__title">Multidisciplinary journals</h2>
	<ul class="rlist clearfix sided">
	  		<li>
			<a alt="Cell Reports Methods" href="/cell-reports-methods/home">Cell Reports Methods</a>
		</li>
		<li>
			<a alt="Cell Reports Sustainability" href="/cell-reports-sustainability/home">Cell Reports Sustainability</a>
		</li>
		<li>
			<a alt="Heliyon" href="/heliyon/home">Heliyon</a>
		</li>	
		<li>
			<a alt="iScience" href="/iscience/home">iScience</a>
		</li>
		<li>
			<a alt="One Earth" href="/one-earth/home">One Earth</a>
		</li>
		<li>
			<a alt="Patterns" href="/patterns/home">Patterns</a>
		</li>
		<li>
			<a alt="STAR Protocols" href="/star-protocols/home">STAR Protocols</a>
		</li>
		<li>
			<a alt="Nexus" href="/nexus/home">Nexus (<i>partner</i>)</a>
		</li>			
        <li>
			<a alt="The Innovation" href="/the-innovation/home">The Innovation (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biotechnology" href="/trends/biotechnology/home">Trends in Biotechnology</a>
		</li>
		<li>
			<a alt="Trends in Cognitive Sciences" href="/trends/cognitive-sciences/home">Trends in Cognitive Sciences</a>
		</li>
	</ul>
</div>

</div>
</div>

            

        
</div><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="850476de-00cb-4c0d-943c-bf1881da24f9" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="clearfix">
		<div class="group sided">
			<h2 class="group__title">Authors</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Submit article" href="/submit-to-cell-press">Submit article</a>
				</li>
				<li>
					<a alt="Multi-Journal Submission" href="/multi-journal-submission">Multi-Journal Submission</a>
				</li>
				<li>
					<a alt="STAR Methods" href="/star-authors-guide">STAR Methods</a>
				</li>
				<li>
					<a alt="Sneak Peek – Preprints" href="/sneakpeek">Sneak Peek – Preprints</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Reviewers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Reviewers" href="/reviewers">Information for reviewers</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">News &amp; events</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Newsroom" href="/newsroom">Newsroom</a>
				</li>
				<li>
					<a alt="Events" href="/events">Events</a>
				</li>
				<li>
					<a alt="Cell Symposia" href="/symposia">Cell Symposia</a>
				</li>
				<li>
					<a alt="Consortia Hub" href="/consortia">Consortia Hub</a>
				</li>
				<li>
					<a alt="Webinars" href="/webinars">Webinars</a>
				</li>
								<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Multimedia</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Podcast" href="/podcast">Cell Press Podcast</a>
				</li>
				<li>
					<a alt="Cell Press Videos" href="/video">Cell Press Videos</a>
				</li>
				<li>
					<a alt="Color and Comics" href="/comics">Coloring and Comics</a>
				</li>
				<li>
					<a alt="Figure360" href="/video-guidelines">Figure360</a>
				</li>
				<li>
					<a alt="Cell Picture Show" href="/pictureshow">Cell Picture Show</a>
				</li>
				<li>
					<a alt="Research Arc" href="/research-arc">Research Arc</a>
				</li>
			</ul>
		</div>

		<div class="group sided">
			<h2 class="group__title">About</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="About Cell Press" href="/about">About Cell Press</a>
				</li>

				<li>
					<a alt="Open access" href="/open-access">Open access</a>
				</li>
				<li>
					<a alt="COVID Hub" href="/covid-19">COVID Hub</a>
				</li>
				<li>
					<a alt="Sustainability" href="/sustainability">Sustainability hub</a>
				</li>
				<li>
					<a alt="Inclusion and diversity" href="/diversity">Inclusion and diversity</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Contact</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Contact us" href="/contact">Contact us</a>
				</li>
				<li>
					<a alt="Help and Support" href="https://service.elsevier.com/app/overview/cell-press/" target="_blank">Help &amp; Support</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Careers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Careers" href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" target="_blank">Cell Press Careers</a>
				</li>
			</ul>
		</div>
	</div>
</div></div>

            

        
</div><div class="col-sm-4 col-md-2 clearfix">
    

        


    

            

            

            <div data-widget-id="beafac41-1cfc-440b-9b55-74aba4a5612c" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Access</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Subscribe" href="/subscribe">Subscribe</a>
			</li>
			<li>
				<a alt="Claim" href="/activate">Claim</a>
			</li>
			<li>
				<a alt="Read It Now" href="/read-it-now">Read-It-Now</a>
			</li>
			<li>
				<a alt="Recommend to Librarian" href="http://info.cell.com/request-access-to-cell-press-content" target="_blank">Recommend to Librarian</a>
			</li>
			<li>
				<a alt="Publication Alerts" href="/action/showPreferences?menuTab=Alerts">Publication Alerts</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Collections</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Best of Cell Press" href="/bestof">Best of Cell Press</a>
			</li>
			<li>
				<a alt="Cell Press Reviews" href="/reviews">Cell Press Reviews</a>
			</li>
			<li>
				<a alt="Cell Selections" href="/selections">Cell Press Selections</a>
			</li>
			<li>
				<a alt="Nucleus Collections" href="/nucleus">Nucleus Collections</a>
			</li>
			<li>
				<a alt="SnapShots" href="/snapshots">SnapShot Archive</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Information</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="For Advertisters" href="/media-kit">For Advertisers</a>
			</li>
			<li>
				<a alt="For Recruiters" target="_blank" href="/pb-assets/Cell/common/CP-RecruitmentKit-US-2018-LowRes-1712070648.pdf">For Recruiters</a>
			</li>
			<li>
				<a alt="For Librarians" target="_blank" href="https://www.elsevier.com/products/sciencedirect/journals/direct-subscription-journals">For Librarians</a>
			</li>
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms and Conditions</a>
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>
			</li>
		</ul>
	</div>
</div></div>

            

        
</div></div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="779ad11f-7bcd-4a2a-a2cd-8c67b649cbb2" data-widget-name="UX3HTMLWidget"><style>
 
button#cookieBtn {
   text-decoration: none;
   background-color: transparent;
   color: #005789;
   font-weight: bold;
   padding: 0;
   margin: 0;
   font-size: 14px;
}
 
button#cookieBtn:hover {
   text-decoration: underline;
}

</style>
<script>
// HIDE ONETRUST BACKGROUND AFTER USER PRESSES ESCAPE KEY
setTimeout(function(){ 
   $("#onetrust-pc-sdk").on("keydown", function(e) { 
      if (e.keyCode == 27) {  // ESC key
         setTimeout(function(){ 
            $(".onetrust-pc-dark-filter").css("display","none");
         }, 100); 
      }
   });
}, 5000);
</script>

<span class="align-center copy-right">
<hr>
<p align="center"><b>The content on this site is intended for healthcare professionals and researchers across all fields of science.</b></p>
<hr>
<div>
<p>We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the 
      <b><button id="cookieBtn" class="ot-sdk-show-settings" type="button" aria-label="Manage cookie consent preferences">Cookie Settings</button></b> for this site.<br>

All content on this site: Copyright © 2025 Elsevier Inc., its licensors, and contributors. <br>All rights are reserved, including those for text and data mining, AI training, and similar technologies. <br>For all open access content, the relevant licensing terms apply.
</p>
<ul class="rlist--inline">
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms &amp; Conditions</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Help and Support" target="_blank" href="https://service.elsevier.com/app/overview/cell-press/">Help &amp; Support</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Contact" href="/contact">Contact</a>
			</li>
			</ul>
<p>
<a href="https://www.relx.com"><img src="/pb/assets/raw/Health%20Advance/images/relx-1554393210983.png" alt="RELX" rel="nofollow" target="_new"></a></p>
</div>

</span></div>

            

        

    

        


    

            

            

            <div data-widget-id="c5e179c1-156e-41e3-af7f-5e307efa8acf" data-widget-name="UX3HTMLWidget"><style>#brandingRow{
    background-color:#fff;
    padding:7px 26px 7px 30px;
    color:#007DBC;
    font-size:14px;
    clear:both;
    width:100%
}
#brandingRow a{
    text-decoration:none;
    color:#007DBC
}
#brandingRow a:hover{
    text-decoration:underline
}
#brandingRowRight{
    display:inline;
    float:right;
    width:auto;
    padding:0;
    margin:0
}
svg#cp_logo {
  float: none;
  height: 36px;
  width: 36px;
  margin-left: 0px;
  margin-top: 0px;
}

footer hr {
  display: block;
}

@media screen and (max-width: 600px){
    #brandingRow{
        font-size:12px
    }
}
@media screen and (max-width: 750px){
    #brandingRow{
        padding:7px 18px 7px 16px
    }
    svg#cp_logo{
        margin-right:10px
    }
}
@media screen and (max-width: 800px) {
   a#cpIconLnk {
      display: none;
   }
}

.header__wrapper.clearfix .col-xs-6:first-of-type{
    width:55%
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2){
    width:45%
}
@media screen and (min-width: 800px) and (max-width: 1000px){
    .header__wrapper.clearfix .col-xs-6:first-of-type{
        width:75%
    }
    .header__wrapper.clearfix .col-xs-6:nth-of-type(2){
        width:25%
    }
}

</style>

<script>
var partnerx = false;
var overrideEndorsement = "";
var tmpj = $("input[name='journalCode']").attr("value");
	
if (window.location.pathname == "/molecular-therapy-family/home") {
	tmpj = "ymthe";
}
	
var ribbonx = "";
if (tmpj == "ajhg" || tmpj == "bpj" || tmpj == "molp" || tmpj == "xplc" || tmpj == "stemcr" || tmpj == "ymthe" || tmpj == "xhgg" || tmpj == "omtn" || tmpj == "omto" || tmpj == "omtm" || tmpj == "biophysreports" ||  tmpj == "bpr" || tmpj == "xinn" || tmpj == "omton") {
	partnerx = true;
	ribbonx = "<a href='https://www.cell.com' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press partner journal</a>";
} else if (tmpj != "" && tmpj != "undefined" && tmpj != undefined) {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press journal</a>";
} else {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press resource</a>";
}
	
if (window.location.pathname == "/") {
	ribbonx = "";
}
if (overrideEndorsement != "") {
	ribbonx = overrideEndorsement;
}

$(".header__wrapper.clearfix").prepend("<div id='brandingRow'><a href='/' data-aa-name='science that inspires' data-aa-region='cp global header' title='Visit Cell.com'>Science that inspires</a><p id='brandingRowRight'>" + ribbonx + "</p></div>");
	
// handle scrolling effect on article pages
if ($("article").length > 0) {
	var scrollx;
	$(window).scroll(function() {
		scrollx = $(window).scrollTop();
		if (scrollx > 0) { 
			$("#brandingRow").css("display","none"); 
		} else {
			$("#brandingRow").css("display","block");
		}
	});
}

if (window.location.pathname == "/" || partnerx == false) {
               $("<a href='/home' id='cpIconLnk' data-aa-name='cell press logo' data-aa-region='cp global header' title='Cell Press' target='_blank'><svg id='cp_logo' version='1.1' xmlns='http://www.w3.org/2000/svg' xmlns:xlink='http://www.w3.org/1999/xlink' x='0px' y='0px' viewBox='0 0 100 98.1' style='enable-background:new 0 0 100 98.1;' xml:space='preserve' height='100' width='98.1'><path style='fill:#FFFFFF;' d='M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z'/></svg></a>").insertBefore(".header__wrapper.clearfix .journal-logos:eq(0)");
}


</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="1af759b7-9bb6-4413-ada9-51a8333e8fb8" data-widget-name="UX3HTMLWidget"><style>
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-444969 - c#4]*/
    [data-tab-id="changelogTab"] {
        display: none !important;
    }
    
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-518839]*/
    @media (min-width: 769px) {
        .ux3 .quick-search .dropBlock [data-db-target-of],
        .quick-search .dropBlock [data-db-target-of] {
            width: 100vw !important;
        }
    }
</style></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="d7e0813b-a300-497a-ab37-9c3ddaf03e71" data-widget-name="UX3HTMLWidget"><!--
<div class="session-reminder hidden">
    <div class="session-reminder__overlay">
        <div class="session-reminder__dialog">
            <div class="session-reminder__dialog-inner">
                <div class="dialog-header" role="dialog" aria-labelledby="dialog-title" aria-describedby="dialog-desc">
                    <h2 class="dialog-header-title" id="dialog-title">
                        <span>Session Timeout</span>
                        <div class="dialog-timer">(2:00)</div>
                    </h2>
                    <button class="dialog-close" type="button" aria-label="close dialog">
                        <i class="icon-tools_close" aria-hidden="true"></i>
                    </button>
                </div>
                <div class="dialog-body">
                    <p class="dialog-desc" id="dialog-desc">Your session will expire shortly. If you are still working, click the ‘Keep Me Logged In’ button below. If you do not respond within the next minute, you will be automatically logged out.</p>
                    <p class="dialog-expired sr-only" aria-live="polite"></p>
                </div>
                <div class="dialog-footer">
                    <button class="session-reset" type="button">Keep Me Logged In</button>
                </div>
            </div>
        </div>
    </div>
</div>
<a class="sr-only" href="javascript:void(0)" aria-hidden="true"></a>
--></div>

            

        
        </div>
    </div>


































    



















        
        
            
                <script src="/products/marlin/cell/releasedAssets/js/main.bundle-90475670808d5d3eee41.js"></script>
            
        
        
        

    




<script type="text/javascript">
    var pageData =  {"journal":{"specialty":"Cell Press","issn":"0092-8674","name":"Cell"},"page":{"loadTimestamp":"1749592587576","server":"cell","environment":"prod","businessUnit":"ELS:RAP:JBS","noTracking":"","name":"fulltext:html","section":"Cell","language":"en","type":"CP-CA","productName":"JB"},"visitor":{"departmentName":"|ae:ScienceDirect Guests","accessType":"ae:ANON_GUEST|ae:ANON_GUEST","accountId":"ae:838949|ae:228598","accountName":"ae:Cell Guest Account|ae:ScienceDirect Guests","departmentId":"ae:977212|ae:291352","ipAddress":"189.120.74.179","loginStatus":"anonymous","userId":"ae:246228266|ae:12975512"},"content":[{"accessType":"article:free:openarchive","volumeNumber":"185","issueNumber":"4","viewState":"fulltext","format":"MIME-HTML","id":"pii:S0092867421015610","coverDate":"202202","type":"XOCS-JOURNAL:SCOPE-FULL","title":"Magnesium sensing via LFA1 regulates CD8supsup Txa0cell effector function","status":"S300"}]};
</script>

<script type="text/javascript">
    if(typeof pageDataTracker !== "undefined") {
        pageDataTracker.trackPageLoad();
    }
</script>
<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94dc1e60dcad428c',t:'MTc0OTU5MjU4Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94dc1e60dcad428c&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;57a02315956f4b2e82817b3dfa99b1a2&quot;}" crossorigin="anonymous"></script>


<div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div><div id="onetrust-consent-sdk" data-nosnippet="true"><div class="onetrust-pc-dark-filter ot-fade-in" style="z-index:2147483645;"></div><div id="onetrust-banner-sdk" class="otFlat bottom ot-wo-title ot-buttons-fw" tabindex="0" role="region" aria-label="Cookie banner"><div role="dialog" aria-modal="true" aria-label="Privacy"><div class="ot-sdk-container"><div class="ot-sdk-row"><div id="onetrust-group-container" class="ot-sdk-eight ot-sdk-columns"><div class="banner_logo"></div><div id="onetrust-policy"><div id="onetrust-policy-text">We use cookies that are necessary to make our site work. We may also use additional cookies to analyze, improve, and personalize our content and your digital experience. For more information, see our<a class="ot-cookie-policy-link" href="https://www.elsevier.com/legal/cookienotice" target="_blank" aria-label=", opens in a new tab" rel="noopener">Cookie Policy</a></div></div></div><div id="onetrust-button-group-parent" class="ot-sdk-three ot-sdk-columns"><div id="onetrust-button-group"><button id="onetrust-pc-btn-handler" class="cookie-setting-link">Cookie Settings</button>  <button id="onetrust-accept-btn-handler">Accept all cookies</button></div></div></div></div><!-- Close Button --><div id="onetrust-close-btn-container"></div><!-- Close Button END--></div></div><div id="onetrust-pc-sdk" class="otPcCenter ot-hide ot-fade-in" lang="en" aria-label="Preference center" role="region"><div role="dialog" aria-modal="true" style="height: 100%;" aria-label="Cookie Preference Center"><!-- Close Button --><div class="ot-pc-header"><!-- Logo Tag --><div class="ot-pc-logo" role="img" aria-label="Company Logo"><img alt="Company Logo" src="https://cdn.cookielaw.org/logos/static/ot_company_logo.png"></div></div><!-- Close Button --><div id="ot-pc-content" class="ot-pc-scrollbar"><div class="ot-optout-signal ot-hide"><div class="ot-optout-icon"><svg xmlns="http://www.w3.org/2000/svg"><path class="ot-floating-button__svg-fill" d="M14.588 0l.445.328c1.807 1.303 3.961 2.533 6.461 3.688 2.015.93 4.576 1.746 7.682 2.446 0 14.178-4.73 24.133-14.19 29.864l-.398.236C4.863 30.87 0 20.837 0 6.462c3.107-.7 5.668-1.516 7.682-2.446 2.709-1.251 5.01-2.59 6.906-4.016zm5.87 13.88a.75.75 0 00-.974.159l-5.475 6.625-3.005-2.997-.077-.067a.75.75 0 00-.983 1.13l4.172 4.16 6.525-7.895.06-.083a.75.75 0 00-.16-.973z" fill="#FFF" fill-rule="evenodd"></path></svg></div><span></span></div><h2 id="ot-pc-title">Cookie Preference Center</h2><div id="ot-pc-desc">We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our <a href="https://www.elsevier.com/legal/cookienotice/_nocache" target="_blank">Cookie Policy</a> and the list of <a href="https://support.google.com/admanager/answer/9012903" target="_blank">Google Ad-Tech Vendors</a>.
<br>
<br>
You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer. See the different category headings below to find out more or change your settings.
<br>
</div><button id="accept-recommended-btn-handler">Allow all</button><section class="ot-sdk-row ot-cat-grp"><h3 id="ot-category-title"> Manage Consent Preferences</h3><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="1"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-1" aria-labelledby="ot-header-id-1 ot-status-id-1"></button><!-- Accordion header --><div class="ot-acc-hdr ot-always-active-group"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-1">Strictly Necessary Cookies</h4><div id="ot-status-id-1" class="ot-always-active">Always active</div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-1">These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
<br><br></p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="1">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="3"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-3" aria-labelledby="ot-header-id-3"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-3">Functional Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-3" id="ot-group-id-3" role="switch" class="category-switch-handler" data-optanongroupid="3" aria-labelledby="ot-header-id-3"> <label class="ot-switch" for="ot-group-id-3"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Functional Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-3">These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="3">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="2"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-2" aria-labelledby="ot-header-id-2"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-2">Performance Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-2" id="ot-group-id-2" role="switch" class="category-switch-handler" data-optanongroupid="2" aria-labelledby="ot-header-id-2"> <label class="ot-switch" for="ot-group-id-2"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Performance Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-2">These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="2">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="4"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-4" aria-labelledby="ot-header-id-4"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-4">Targeting Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-4" id="ot-group-id-4" role="switch" class="category-switch-handler" data-optanongroupid="4" aria-labelledby="ot-header-id-4"> <label class="ot-switch" for="ot-group-id-4"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Targeting Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-4">These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. If you do not allow these cookies, you will experience less targeted advertising.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="4">Cookie Details List‎</button></div></div></div><!-- Groups sections starts --><!-- Group section ends --><!-- Accordion Group section starts --><!-- Accordion Group section ends --></section></div><section id="ot-pc-lst" class="ot-hide ot-hosts-ui ot-pc-scrollbar"><div id="ot-pc-hdr"><div id="ot-lst-title"><button class="ot-link-btn back-btn-handler" aria-label="Back"><svg id="ot-back-arw" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 444.531 444.531" xml:space="preserve"><title>Back Button</title><g><path fill="#656565" d="M213.13,222.409L351.88,83.653c7.05-7.043,10.567-15.657,10.567-25.841c0-10.183-3.518-18.793-10.567-25.835
                    l-21.409-21.416C323.432,3.521,314.817,0,304.637,0s-18.791,3.521-25.841,10.561L92.649,196.425
                    c-7.044,7.043-10.566,15.656-10.566,25.841s3.521,18.791,10.566,25.837l186.146,185.864c7.05,7.043,15.66,10.564,25.841,10.564
                    s18.795-3.521,25.834-10.564l21.409-21.412c7.05-7.039,10.567-15.604,10.567-25.697c0-10.085-3.518-18.746-10.567-25.978
                    L213.13,222.409z"></path></g></svg></button><h3>Cookie List</h3></div><div class="ot-lst-subhdr"><div class="ot-search-cntr"><p role="status" class="ot-scrn-rdr"></p><input id="vendor-search-handler" type="text" name="vendor-search-handler" placeholder="Search…" aria-label="Cookie list search"> <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 -30 110 110" aria-hidden="true"><title>Search Icon</title><path fill="#2e3644" d="M55.146,51.887L41.588,37.786c3.486-4.144,5.396-9.358,5.396-14.786c0-12.682-10.318-23-23-23s-23,10.318-23,23
            s10.318,23,23,23c4.761,0,9.298-1.436,13.177-4.162l13.661,14.208c0.571,0.593,1.339,0.92,2.162,0.92
            c0.779,0,1.518-0.297,2.079-0.837C56.255,54.982,56.293,53.08,55.146,51.887z M23.984,6c9.374,0,17,7.626,17,17s-7.626,17-17,17
            s-17-7.626-17-17S14.61,6,23.984,6z"></path></svg></div><div class="ot-fltr-cntr"><button id="filter-btn-handler" aria-label="Filter" aria-haspopup="true"><svg role="presentation" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 402.577 402.577" xml:space="preserve"><title>Filter Icon</title><g><path fill="#fff" d="M400.858,11.427c-3.241-7.421-8.85-11.132-16.854-11.136H18.564c-7.993,0-13.61,3.715-16.846,11.136
      c-3.234,7.801-1.903,14.467,3.999,19.985l140.757,140.753v138.755c0,4.955,1.809,9.232,5.424,12.854l73.085,73.083
      c3.429,3.614,7.71,5.428,12.851,5.428c2.282,0,4.66-0.479,7.135-1.43c7.426-3.238,11.14-8.851,11.14-16.845V172.166L396.861,31.413
      C402.765,25.895,404.093,19.231,400.858,11.427z"></path></g></svg></button></div><div id="ot-anchor"></div><section id="ot-fltr-modal"><div id="ot-fltr-cnt"><button id="clear-filters-handler">Clear</button><div class="ot-fltr-scrlcnt ot-pc-scrollbar"><div class="ot-fltr-opts" role="list"><div class="ot-fltr-opt" role="listitem"><div class="ot-chkbox"><input id="chkbox-id" type="checkbox" class="category-filter-handler"> <label for="chkbox-id"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div><div class="ot-fltr-btns"><button id="filter-apply-handler">Apply</button> <button id="filter-cancel-handler">Cancel</button></div></div></div></section></div></div><section id="ot-lst-cnt" class="ot-host-cnt ot-pc-scrollbar"><div id="ot-sel-blk"><div class="ot-sel-all"><div class="ot-sel-all-hdr"><span class="ot-consent-hdr">Consent</span> <span class="ot-li-hdr">Leg.Interest</span></div><div class="ot-sel-all-chkbox"><div class="ot-chkbox" id="ot-selall-hostcntr"><input id="select-all-hosts-groups-handler" type="checkbox"> <label for="select-all-hosts-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-vencntr"><input id="select-all-vendor-groups-handler" type="checkbox"> <label for="select-all-vendor-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-licntr"><input id="select-all-vendor-leg-handler" type="checkbox"> <label for="select-all-vendor-leg-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div></div><div class="ot-sdk-row"><div class="ot-sdk-column"><ul id="ot-host-lst"></ul></div></div></section></section><div class="ot-pc-footer ot-pc-scrollbar"><div class="ot-btn-container"> <button class="save-preference-btn-handler onetrust-close-btn-handler">Confirm my choices</button></div><!-- Footer logo --><div class="ot-pc-footer-logo"><a href="https://www.onetrust.com/products/cookie-consent/" target="_blank" rel="noopener noreferrer" aria-label="Powered by OneTrust Opens in a new Tab"><img alt="Powered by Onetrust" src="https://cdn.cookielaw.org/logos/static/powered_by_logo.svg" title="Powered by OneTrust Opens in a new Tab"></a></div></div><!-- Cookie subgroup container --><!-- Vendor list link --><!-- Cookie lost link --><!-- Toggle HTML element --><!-- Checkbox HTML --><!-- plus minus--><!-- Arrow SVG element --><!-- Accordion basic element --><span class="ot-scrn-rdr" aria-atomic="true" aria-live="polite"></span><!-- Vendor Service container and item template --></div><iframe class="ot-text-resize" sandbox="allow-same-origin" title="onetrust-text-resize" style="position: absolute; top: -50000px; width: 100em;" aria-hidden="true"></iframe></div></div><div id="crossmark-widget" style="display: none;"><div class="crossmark-reset crossmark-overlay"></div><div class="crossmark-reset crossmark-popup"><div class="crossmark-reset crossmark-popup__offset"><div class="crossmark-reset crossmark-popup__inner"><div class="crossmark-reset crossmark-popup__header"><button class="crossmark-reset crossmark-popup__btn-close"><span class="sr-only">__("articleCrossmark.closePopup")</span></button></div><div class="crossmark-reset crossmark-popup__content-wrapper"><iframe class="crossmark-reset crossmark-popup__content" title="Crossmark service - Intentionally blank" aria-hidden="false" tabindex="0" src="https://crossmark.crossref.org/dialog?doi=10.1016%2Fj.cell.2021.12.039&amp;domain=www.cell.com&amp;uri_scheme=https%3A&amp;cm_version=v2.0"></iframe></div></div></div></div></div></body></html>